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Dynamic modelling has significantly improved our understanding of the com-
plex molecular mechanisms underpinning neurobiological processes. The de-
tailed mechanistic insights these models offer depend on the availability of
a diverse range of experimental observations. Despite the huge increase in
biomolecular data generation from novel high-throughput technologies and
extensive research in bioinformatics and dynamical modelling, efficient cre-
ation of accurate dynamical models remains highly challenging. To study this
problem, three perspectives are considered: comparison of modelling methods,
prioritisation of results and analysis of primary data sets. Firstly, I compare two
models of the DARPP-32 signalling network: a classically defined model with
ordinary differential equations (ODE) and its equivalent, defined using a novel
rule-based (RB) paradigm. The RB model recapitulates the results of the ODE
model, but offers a more expressive and flexible syntax that can efficiently han-
dle the “combinatorial complexity” commonly found in signalling networks,
and allows ready access to fine-grain details of the emerging system. RB mod-
elling is particularly well suited to encoding protein-centred features such as
domain information and post-translational modification sites. Secondly, I pro-
pose a new pipeline for prioritisation of molecular species that arise during
model simulation using a recently developed algorithm based on multivariate
mutual information (CorEx) coupled with global sensitivity analysis (GSA) us-
ing the RKappa package. To efficiently evaluate the importance of parameters,
Hilber-Schmidt Independence Criterion (HSIC)-based indices are aggregated
into a weighted network that allows compact analysis of the model across con-
ditions. Finally, I describe an approach for the development of disease-specific
dynamical models using genes known to be associated with Attention Deficit
Hyperactivity Disorder (ADHD) as an exemplar. Candidate disease genes are
mapped to a selection of datasets that are potentially relevant to the modelling
process (e.g. interactions between proteins and domains, protein-domain and
kinase-substrates mappings) and these are jointly analysed using network clus-
tering and pathway enrichment analyses to evaluate their coverage and utility




The activity of a cell and its function is driven by interacting molecules,
in particular proteins. As proteins can have functionally different states and
bind more than one partner, a possible number of ways and outcomes of such
interactions can be difficult to trace. The unfolding of exact mechanics behind
these interactions becomes particularly important when protein functions are
disrupted leading to disease. Their intricate character greatly hampers un-
derstanding of exact reasons and mechanisms of such disruptions that to be
effectively counteracted require accurately designed medications. Details of
such interactions have been traditionally studied with computational mod-
els formulated as mathematical equations, in particular, ordinary differential
equations (ODEs). These models attempt to reproduce experimental obser-
vations by integrating existing knowledge into one controllable and explicit
representation. However, not all molecular processes are representable with
this traditional method. Moreover, gathering detailed information to construct
such models is a slow and laborious process what limits the number of studied
molecules and research goals. Possibility to circumvent these issues with a
relatively novel rule-based (RB) modelling approach is examined in this thesis.
This is attempted in three areas. Firstly, ODE and RB modelling approaches are
compared based on one model represented with the two methods to identify
differences and conditions under which the RB model is advantageous. Sec-
ondly, a pipeline for RB model analysis is proposed to automatically identify
which molecules and reactions become important dependent on conditions,
such as a disrupted versus an undisrupted state. Lastly, to learn if model
building can be accelerated and simplified, large scale data acquired with cost-
efficient high-through methods, typically unused in ODE-type of modelling,
are collected from public databases. Among these data sets are pairs of inter-
acting proteins and their functional segments (domains). Scope and detail of
these datasets are examined by asking a question what molecular mechanisms
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Cells of multicellular and unicellular organisms developed mechanisms
to perceive and respond to environment with a range of behaviours. In
multicellular organisms, their behaviours vary from differentiaton, apoptosis,
growth or survival, and depend on the cell history and its current state. Cell
signalling is an overarching term encompassing mechanisms of cell communi-
cation and its outcome determining cell response [1]. It can be characterised
with such concepts as input fidelity, output specificity, signal amplification,
sensitivity and diversity of response, and flexibility of reaction, features com-
monly associated with electrical engineering [2]. Such complex properties of
molecular signalling emerge from characteristics of proteins, major players of
any subcellular process, and biochemical events they are involved in.
1.1.1 Proteins as key players of molecular signalling
Proteins are characterised with amino acid sequences, protein domain
compositions, protein 3D structures and functions. Based on similarity in these
features, proteins are classified into families and define their properties. Fam-
ily definitions classify and annotate newly sequenced proteins with functions
[3]. Understanding protein functions is also studied through protein bind-
ing characteristics and interactions. Binding properties of proteins are often
determined by their functional subunits, such as domains, repeats and motifs.
Domains are autonomous and stably folded segments of amino acid
chains that can mediate protein binding and catalytic events [1]. It is estimated
that around 65% of eukaryotic proteins are composed of more than one domain
1
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[4]. Compositions of domains in proteins, termed domain architecture, can define
their unique identities. As domains differ with respect to mediated functional
roles, rearrangements of their compositions underlie evolution of novel classes
of functionally sophisticated proteins [5–7]. Elementary events shaping new
domain architectures are deletions and insertions, repetitions and exchanges.
They can occur through gene fusion/fission identified as an important factor of
multi-domain protein evolution in bacteria [8]. The evolutionary conservation
of domains is also connected with preservation of binding properties between
domains. Domain interactions are divided into homo- or hetero-domain that
occur between the same and different domains, respectively. Domain inter-
actions are also categorised as inter- and intra-chain interactions. Inter-chain
interactions take place between two different polypeptide chains whereas intra-
chain interactions, between domains composing the same chain [7].
Another type of functionally separate protein modules are short linear
motifs (SLiMs). SLiMs are encoded by peptides of 3 to 10 amino acids, typically
located in intrinsically disordered proteins that do not form a stable 3D struc-
ture [9]. SLiMs were found to perform multiple diverse functions, such as cell
regulation, cooperative formation of protein complexes [10] and internalization
and trafficking of membrane receptors [11]. SLiM-mediated interactions have
relatively low binding affinity what characterise them as transient, conditional
and tunable, ideal to mediate cell signalling [12].
Next to modularity of proteins, another biochemical mechanism that di-
versifies protein function and activity is their modulation by post-translational
modifications (PTMs) [13]. PTMs are covalent protein modifications that occur
after protein synthesis. Though there are multiple types of PTMs, phospho-
rylation is the most important and abundant form [14]. Phosphorylation is
an enzymatic reaction of phosphate group transfer from adenosine triphos-
phate (ATP) to particular amino acids of the substrate protein, such as Serine,
Threonine or Tyrosine. Phosphorylation is catalysed by protein kinases. By
inducing conformational changes that exposes or hides protein active sites,
phosphorylation activates or inhibits activity of proteins, such as enzymes and
receptors [15, 16]. Phosphorylation can also trigger translocation of a protein to
a different cell compartment [17]. A phosphorylated protein site is recognised
and bound by proteins with phospho-binding domains [5]. Reverse reaction
of detachment of the phosphate group from substrate proteins is catalysed by
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protein phosphatase enzymes [1].
Proteins involved in signalling often are regulated by multiple phos-
phorylation sites, such as the canonical example of epidermal growth factor
receptor (EGFR) that is composed of more than 9 Tyrosine phosphorylation
sites, alongside multiple protein domains [18]. EGFR is one of a large family
of transmembrane receptor Tyrosine kinases [19]. It is an important target of
multiple extracellular signals. When activated, it dimerises and a particular
subset of phosphorylation sites become autophosphorylated. These phospho-
rylated sites bind to a number of protein complexes that trigger distinctive cell
behaviours, such as cell cycle or transcription [18].
A variety of mechanisms are connected to the ability of proteins to bind
multiple partners. For instance, proteins can form heterogeneous complexes
by docking multiple partners. Important for signalling are special types of
protein complexes called scaffold proteins [20]. Composed of multiple protein
domains and motifs, protein scaffolds have diverse interaction interfaces. They
bind several signalling proteins at a time whereby they are involved in mul-
tiple parallel reactions. Protein scaffolds form functional modules with other
signalling proteins locating signalling units in close milieu. This mechanism
secures selectivity and efficiency of the cellular signal [20, 21]. Scaffold pro-
teins can distally control activation of their binding partners through allosteric
regulation or themselves be subjected to such regulation [20]. Allosteric regula-
tion describes mechanisms where a molecule can regulate enzyme activity by
binding to its regulatory site that affects conformation of the enzyme’s active
site. Alteration of the active site either enables or blocks binding and activation
of the enzyme target [22]. If a protein has multiple binding sites [23], allosteric
regulation can lead to cooperative binding. This mechanism occurs when bind-
ing of one molecule affects the strength of binding (affinity) of other molecules
[23].
Another mechanism grounded in various levels of promiscuity in inter-
actions between signalling proteins and small molecules is competition. Com-
petition is an important mechanism in cell signalling. It can be observed on
examples of multiple substrates activated by a single promiscuous kinase, or a
phosphatase [24, 25].
A series of consecutive reactions between molecules that produce a
certain outcome are known as molecular pathways. Phosphorylation cascades are
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characteristic pathways in cell signalling, where an activated substrate becomes
kinase of the subsequent reaction. A canonical example of phosphorylation
cascade is the mitogen-activated protein kinase cascade [26].
Triggered by multiple incoming signals, molecular pathways do not act
alone but interact with each other forming cross-talks between pathways. In sig-
nalling networks, such inter-pathway interactions are commonly founded by
promiscuous kinases that targets substrates of multiple pathways [25]. These
multiple interacting pathways form complex molecular networks [27].
Cross-talks between pathways contribute to diversity of dynamic re-
sponse and therefore, allow the cell to discriminate between specific combi-
nations of input signals [28]. These complex interactions are regulated and
controlled to maintain specificity and fidelity between the input signal and the
output response. Among highly sophisticated dynamic non-linear responses
are ultrasensitivity, multistability, and oscillations [29, 30]. For instance the
mitogen-activated protein kinase cascade was found to produce ultrasenstivie
dynamic response, characterised by a sudden switch from one state to another
[26]. However, there are other mechanisms that are known to trigger ultra-
sensitivity, such as substrate competition [24, 25]. It has been observed that
complex dynamic responses can be attributed to particular topologies of cir-
cuits embedded within biological networks that induce control over signalling
systems.
1.1.2 Circuits of signalling control
In analogy to control systems studied in engineering, it has been ob-
served that in biological networks, such as transcription and signalling net-
works, sequences of interactions between genes or proteins form regulatory
circuits that control signals. They are composed of activation and inhibition in-
teractions between input (source) and output (target) signals. These regulatory
circuits are called network motifs [31]. Presence of such motifs in biological net-
works is manifestation of signal-processing functions existing within complex
networks of interactions [31]. Elementary regulation types found among net-
work motifs are: simple regulation when activation between two different genes
or proteins occurs directly without intermediate steps, negative or positive au-
toregulation when a gene or protein inhibits or activates itself, respectively [31].
These simple regulation motifs form composite circuits divided into feedback
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loops and feedforward loops [27, 32]. A feedback loop is a control circuit where
the output signal returns as an input to regulate the signal source after one or
more steps. Feedback loops are divided into positive and negative depending
on whether the returning input has activating or inhibiting effect, respectively.
In general, a positive feedback loop amplifies the signal, whereas the negative feed-
back loop attenuates it. The other type of control circuit is a feedforward loop.
In this circuit, a single molecule inhibits or activates two others thereby the
signal is forked into two routes that meets again after a few steps on the same
target protein or gene. One of these two routes is usually a direct control of
the target by the signal source and the other route is composed of a chain of
connected interactors, either inhibiting or activating one another. Feedforward
loops are classified into two general types. To explain these classification, let
us assume that inhibiting actions per interactor are denoted with a minus sign
and positive ones with a plus sign. If result of multiplication of signs in indi-
rect route agrees with the sign on the direct route, then this feedforward loop
is called coherent, otherwise it is incoherent [33]. Identification of such motifs
in complex signalling networks characterises dynamics of involved molecules
and response of the system under study in such terms as robustness to pertur-
bations, adaptation and threshold response [31, 34].
1.1.3 Neuronal signalling
Groups of communicating neurons form neural circuits that pass elec-
trical signals through action potentials [35]. The signal between two commu-
nicating neurons is passed biochemically through synapses during the process
of synaptic transmission. Repeated interactions of neurons cause strengthen-
ing or weakening of neuronal synapses having impact on efficiency of signal
transmission. These action-dependent modifications of synapses define synap-
tic plasticity that underlies foundation of learning and memory [36]. Synaptic
transmission can be modified for short period of time, from miliseconds to
minutes, or for much longer, lasting from minutes to hours and days [37]. Pro-
longed increase in strength and efficiency of synaptic transmission is termed
long-term potentiation (LTP) and opposite process is called long-term depres-
sion (LTD) [38]. Among others (e.g. metaplasticity, spike timing dependent
plasticity), these are the most intensively studied forms of activity-dependent
synaptic plasticities [37]. LTP and LTD were first studied in hippocampal neu-
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rons where they are conditioned by the amount of calcium ions (Ca2+) influx
through N-methyl-D-aspartate receptor (NMDAR) activated by glutamatergic
neurotransmitters. High levels of Ca2+ indirectly activates Ca2+/calmodulin-
dependent protein kinase II (CaMKII) that results with LTP. Moderate levels
of Ca2+ activate protein phosphatase 3/calcineurin (PP2B) producing LTD [38].
These mechanisms triggering either LTD or LTP are characteristic for hip-
pocampal neurons. In other brain regions, activity-based synaptic plasticity
can be produced by different mechanisms. There are multiple factors that con-
tribute to variety of mechanisms underlying synaptic plasticity in other brain
regions, such as different types of neurotransmitters, receptors and spatio-
temporal patterns of stimulation [38]. For instance, in medium spiny projec-
tion neurons (MSPN) of brain striatum, LTP requires activation of NMDAR by
glutamate (Glu) and dopamine receptor D1 (DRD1) by dopamine (DA), termed
dopamine-dependent synaptic plasticity [39]. Integration of these two signals oc-
curs intracellularly through interacting pathways that modify gene expression,
or increase the input signal by insertion of α-amino-3-hydroxy-5-methyl-4-
isoxalone propionic acid receptors (AMPARs) into the cellular membrane [40].
1.1.4 Synaptic plasticity in neurobiological diseases
Wide range of neurobiological, cognitive and psychiatric disorders can
be linked to aberrations in synaptic transmission and synaptic plasticity [41–43].
Among these are Alzheimer’s disease, Parkinson’s disease, autism spectrum,
Attention Deficit Hyperactivity Disorder (ADHD), schizophrenia, addiction,
multiple sclerosis and chronic pain [42]. Many molecular mechanisms involved
in manifestation of neurobiological disorders are related to proteins expressed
in synapses and processes underlying various types of synaptic plasticity. For
instance, two closely associated proteins to Alzheimer disease, tau protein and
phosphorylating it glycogen synthase kinase 3 beta (GSK3B), are involved in
induction of LTD thereby point to causal relations between abnormalities in
LTD and Alzheimer’s disease [42, 44]. The same proteins can be linked to mul-
tiple disorders. For instance, the protein family voltage-dependent calcium
channel, CACNA1C and CACNB2, and two families of dopamine receptors,
DRD1 and dopamine receptor D2 (DRD2), are associated with ADHD, autis-
tic disorder, Alzheimer’s disease, Parkinson’s disease, and schizophrenia [45]
(Appendix D). Regulation of synaptic proteins by PTM and binding events me-
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diating complex composition are known to play central mechanistic roles in
healthy synaptic transmission [46]. For instance, aberrations in mammalian
target of rapamycin complex 1 (mTORC1) that controls protein synthesis, is
related to heritable disorders such as Fragile X or Rett syndrome [46]. Levels
of neurotransmitters directly influence the synaptic response and even though
not fully understood, their availability is a major target of today’s therapeutics
[42]. For instance, standard treatment of Parkinson’s disease aims to restore
levels of DA by administration of L-DOPA, precursor of this neurotransmitter
[47].
1.2 System-level approach to study molecular pro-
cesses
With increase of efficiency in computational techniques and develop-
ment of hight-throughput technologies that supply large quantities of ex-
perimental evidence, an integrative approach to study biological processes
appeared as a single but broad interdisciplinary domain of systems biology.
Contrary to reductionistic approach, system-level approach drives from obser-
vations that even simple relations or rules between multiple elements give rise
to non-additive properties and complex dynamic behaviour [48]. In molec-
ular signalling, among these complex and emerging properties we can find
bistable switch in abundances of molecular species triggered by distinctive out-
put thresholds, positive and negative feedback loops forming self-regulating
circuits, and robustness to perturbations [49]. These properties are not easy to
infer by studying molecular entities in isolation [48]. To uncover causative
mechanisms driving biological processes and disease conditions, two ma-
jor perspectives in studying systems biology emerged [50]. The first one,
data-driven or “bottom-up” approach, originates from rapid development of
high-throughput and cost-efficient large-scale experimental technologies, col-
lectively called omics-techniques [51]. These experimental technologies are
applied to investigate genetic variants associated with complex disease across
whole genomes (genomics) [52], examine types and counts of expressed genes
(transcriptomics), determine protein identities, their quantities and interactions
(proteomics), and identify phosphorylated protein sites (phosphoproteomics)
[51, 53]. Dependent on the experimental design, these data sets are collected
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from samples of different disease conditions, cell-lineages and under drug-
induced perturbations to gain insight into context-dependent alterations in
molecular components and biological functions they are involved in. Attempts
aiming to analyse integrated multiple omics data sets (“multi-omics”) promise
more precise identification of functional processes responsible for disease states
[51, 54]. These experiments commonly yield differentially expressed lists of
genes or gene products. To identify what biological process or molecular path-
ways are affected in the condition under study, these lists of molecular entities
are referred to pre-existing knowledge-bases that organise biological concepts
and annotate them with molecular entities based on evidence sourced from
research papers. Identified biological concepts divide these molecular entities
under study into associated or similar groups with respect to divers biolog-
ical categories. Among such knowledge-bases are repositories of molecular
pathways, ontologies associating genes with molecular functions, biological
processes and cell compartments, disease-associated genes, and molecular in-
teractions. Associations between molecular entities are investigated by using
formal approaches based on statistical techniques, network graphs, clustering
methods and enrichment analysis [55]. These formal procedures assists in
identification of core processes, molecular pathways and functions manifested
by differentially expressed genes in a disease state [55, 56]. For instance, anal-
ysis of high-throughput omics data with network-based associative approach
is one of important pillars of personalised medicine [57].
Other important perspective in systems biology is mechanisms-driven
or “top-down” approach of dynamic models [50]. Construction of dynamic
models can accommodate typically a fraction of molecular components anal-
ysed with data-driven approaches. Nevertheless, dynamic or kinetic mod-
elling allow to study biological phenomenons with mechanistic and quantita-
tive details [58]. Specification of dynamic models requires such details as a
list of biochemical reactions between molecules that regulate their concentra-
tions and kinetic parameters defining speed of these reactions. Formulated
with a mathematical formalism such as a system of ordinary differential equa-
tions (ODEs), kinetic models can replicate dynamic behaviour of interacting
molecules recorded as quantitative variations of molecular concentrations over
time, time courses or trajectories.
Precise knowledge of mechanisms is particularly important in devel-
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opment of new therapeutics. In spite of massive investments and extensive
exploitation of omics technologies, drug discovery is facing a high attrition
rate where a large number of clinical project fail to result with an approval
of new therapeutics. Longitudinal studies at AstraZeneca have shown that
lack of efficacy was a major reason of project closures in later phases of drug
development [59]. Though the advent of high-throughput screening increased
the number of new targets, the number of newly approved drugs remained
the same. Furthermore, data obtained with high-throughput drug-screenings
remain largely unexplored [57]. The lack of efficacy can be attributed to an in-
complete understanding of what are drugs effects on multiple levels that lead
to various unpredicted and often unwanted clinical outcomes such as drug
resistance and side effects [57]. For example, on and off-targets lead to cascad-
ing effect of response that propagates horizontally in gene regulatory, signal
transduction and metabolic networks, and across different levels of biological
organisation, through cell, tissue, organ interactions up to organismal level.
To predict consequences of therapeutic intervention induced on the molecular
level, combination of multi-omics and network-based techniques with large-
scale multilevel modelling have been recognised as a difficult but necessary
step in modern pharmacology [57].
Next sections present an outline of formal methods classified to the two
approaches in systems biology that are used in this thesis. Different knowledge-
bases and reference data sets, crucial in the data-driven approaches in systems
biology, are briefly outlined. Their more detailed description is provided in
chapter-specific introductory sections.
1.3 Approaches to analyse gene and protein lists
Two major techniques, classified to the qualitative “bottom-up” ap-
proaches and applied in this thesis, are network and enrichment analysis. This
section presents a general overview of both techniques as irreplaceable steps
in identification of biological context underlying mechanisms of diseases.
1.3.1 Network analysis
Network analysis is a part of mathematical domain of graph theory.
A network is a structure composed of abstract objects, called nodes or ver-
tices that can represent any category of interest. Associations existing between
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nodes are defined as edges or links drawn between network nodes. As such,
network analysis is a systemic approach that allows to shift attention from
properties of individual entities, like proteins or genes, to relations between
large numbers of them [56]. In the field of systems biology, network analysis is
a “bottom-up” approach [50] that exposes patterns in large scale omics data sets
by connecting molecular entities by experimentally determined associations,
such as gene expression or protein interactions [60, 61]. Depending on the
study subject, nodes typically represent biomolecular entities, i.e. ligands, sig-
nalling proteins, disease genes, enzymes and metabolites. Consequently, edges
can denote various relationships between these node types, such as “interact”,
“co-expressed” or “is associated to a disease”. A network can be composed
of more than one type of nodes, termed as bipartite or multipartite graphs for
two and mulitple node types, respectively [62]. There might be more than one
relation denoted with an edge between two nodes that can be characterised by
numerical or categorical attributes. These attributes provide additional level
of information that enriches representation and analysis of networks. For in-
stance, based on node or edge attributes, a network can be conditionally filtered
to obtain different perspectives of the network components. These attributes
can carry experimentally-derived information (e.g. level of gene expression),
or properties arising from network-structure (e.g. number of edges connected
to a node). Commonly used attributes characterising edges are weights. Net-
works containing weighted edges are termed weighted networks. Weights can be
represented with a numerical value to denote importance of relations between
nodes [63, p.34]. Network edges can be undirected or directed. In directed
networks, edges between node pairs have associated directionality, visualised
with arrows. In these kind of networks, nodes are divided into source and
target nodes.
Numerous properties and statistics can be derived from the network
structure. These statistics summarise either local or global network proper-
ties, determined by node or edge-related measures, or characterise general
tendencies of the entire network such as topology. Among popular concepts
characterising networks and their components are centrality, modularity, con-
nectivity, and distance measures [64]. Based on these concepts, more general
network characteristics are defined, such as different types of generative graph
models (scale-free, random), topology-based network types (linear, tree, star),
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and methods for partitioning network nodes into smaller subgroups, modules
or clusters. Definitions of all these terms are often based on most fundamental
graph concepts such as a path or node degree. A path between two nodes is a
distance measure defined as a sequence of joined nodes and edges, thereby a
shortest path is a minimal number of such links. A node degree is a number
of edges connected to a node (in- and out-degree in directed graphs). Among
many definitions of centralities, the node degree is the simplest concept of
network-based centrality measure. In general, centrality measures characterise
nodes, edges or subgraphs with respect to differently understood importance
measures. A node with large number of neighbouring edges, termed hubs, are
known to be in some respect more important than sparsely connected nodes.
For instance, in networks representing binary interactions between proteins
of Yeast Saccharomyces cerevisiae interactome, proteins identified as hubs were
found to be essential and evolutionarily conserved [65]. Deletion of hub pro-
teins in the same model organism was more likely to produce a lethal effect [66].
Other study found that perturbations of hub proteins caused larger diversity
in disease phenotypes [61].
Next to identification of single densely connected hubs, tightly con-
nected groups of nodes are important and biologically meaningful compo-
nents. By using degree statistics, a network can be divided into densely and
sparsely connected regions, cores and peripheries, respectively [67]. Localisation
of disease-associated genes in either of these network regions is correlated with
different disease classes [68]. For instance, it was shown that a large number
of non-lethal disease genes are found in network peripheries [64, 69].
Among definitions and approaches used to expose densely connected
network regions, or cohesive subgraphs, are cliques, n-cliques, n-clans, k-plexes
and k-cores [70]. Among them, cliques are most topologically rigorous groups
defined as subgraphs of completely connected nodes [71]. Such strong topo-
graphic relationships between nodes usually denote protein-complexes and
functional modules [72]. Due to insufficient knowledge of protein interactions,
clique identification might be affected by a high rate of false-negatives and
false-positives [71]. Therefore, different relaxation methods of the clique con-
cept were introduced, such as: γ-quasi-cliques, n-cliques, n-clans and k-plexes.
Compared to others, k-cores are most relaxed approach to identify densely con-
nected subnetworks [70]. Algorithmic implementation of k-cores identification
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is more efficient than in other approaches [73]. The k-core of a graph is ob-
tained by gradually removing vertices of degree < k. This procedure results
with a subgraph, or disconnected subgraphs, that have nodes of degree ≥ k.
The main-core is a subgraph with a maximal value of k-parameter [73]. By
removing least connected nodes, the central cores of densely connected graph
components are exposed. Stratification of networks by choosing a gradually
higher k-parameter was used to efficiently visualise large-scale networks [74].
The above concepts identify maximal cohesive subgraphs with respect
to specified property in the network graph. Though a cohesive subgraph is
a form of community, another class of methods to efficiently partition all net-
work nodes to communities were introduced in graph-based analyses [75].
Nodes associated to a community form subgraphs that have tighter connec-
tions within their community than to other communities [76]. Partitioning
of molecular networks into communities serve as proxies for identification of
functionally related proteins, diseases or physical modules [61, 64]. There is
no universal definition or a finite set of principles by which to define what
is a community or cluster and therefore, there are many clustering methods
[77]. In a recent comprehensive survey of community detection methods by
Javed et al. [78] clustering methods are classified into disjoint communities and
overlapping communities. In the first case, a node is exclusively associated to a
single cluster, whereas in the other one, a node can be a member of more than
one cluster. Among methods identifying disjoint communities, the reviewers
list three main categories of algorithms: traditional, modularity-based and dy-
namic. Traditional algorithms initiated the very first concepts and methods
of clustering that provided foundations for latter introduced categories of al-
gorithms. An important class of traditional community detection method is
hierarchical clustering. It can be divided into top-down (divisive) or bottom-up
(agglomerative) approaches, dependent on node-to-cluster assignment in the
initial step of iterative procedure. In the divisive class of algorithms, all nodes
are assigned to a single cluster that is gradually partitioned into smaller sub-
groups based on a similarity measure between nodes. In the agglomerative
algorithms, each network node is a singleton cluster that is merged with its
neighbouring cluster-nodes based on a predefined similarity, distance measure
or a strategy. An important example of the agglomerative approach combined
with a strategy is the Girvan–Newman algorithm that is based on removal of
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edges that are most “in-between” communities [76]. The computational cost
of the Girvan-Newman algorithm, impractical for large networks above 1000
nodes [79], led to proposition of an alternative method based on maximisation
of modularity score by Newman [80]. This became an important class of com-
munity detection algorithms [78]. Modularity is a global network property
that measures cluster quality [81]. It is defined as a number of edges within
groups minus a number of expected randomly distributed edges [75]. Optimi-
sation of a cluster modularity score is computationally hard [82] and therefore,
approximation methods that use local (greedy) optimisation techniques were
developed. These algorithms are based on the hierarchical agglomerative ap-
proach that at every iteration merge two separate clusters if these increase
the modularity score [81]. The algorithm proposed by Blondel et al. [82] is
considered as most efficient and scalable up to date [78].
Efficiency of an algorithm is an important aspect, being one of two emi-
nent criteria in algorithm comparison, the other one being accuracy. Systematic
comparison of clustering methods is a difficult task. It commonly relays on
benchmark generative networks combined with information recovery metrics,
e.g. Adjusted Rand Index (ARI) [78, 81]; or real-world networks of unknown
ground-truth clustering evaluated with cluster quality measures, e.g. modu-
larity [81]. The study by Emmons et al. [81] found that different information
recovery metrics and cluster quality measures disagree on performance eval-
uation of the same set of algorithms. Moreover, the authors admitted that
high performance obtained by the algorithm that they identified as the best
one, tested on a generative benchmark model, might be due to similarity of
a model underlying the algorithm and the benchmark network [81]. On the
other hand, testing accuracy of algorithms on real-world networks with cluster
quality measures does not offer any direct answer on correctness of cluster-
ing results. These type of networks might not even have uniquely defined
communities, and evaluation of communities requires support of metadata
information on cluster members to resolve quality of clusters [79]. It is com-
monly admitted that with the variety of network structures, sizes, and metrics
for clustering evaluation, categorical statement announcing superiority of any
particular clustering method over others is yet to be achieved [79, 81].
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1.3.2 Enrichment analysis
High-throughput experiments, such as performed with DNA microar-
rays, measure levels of messenger RNA (mRNA) transcripts as manifestation
of expressed genes in samples originating from different tissues, cell types and
disease conditions [83, 84]. These experiments yield differentially expressed
lists of genes in the sample of interest that are either over, under or neutrally
expressed compared to the reference sample [85]. To learn what biological
functions or processes these lists of genes are involved in, enrichment analysis is
performed against categories of a reference database. Associations to biological
concepts are also desired to be identified amongst genes associated to a disease
of interest, collected from various published studies in the subject, such as
genome-wide association studies, candidate-gene association studies, linkage
studies, mutational studies, genome-wide copy number variation analyses and
meta-analyses [86].
Based on evidence, each category in a reference database is associated
with a list of genes, where a gene can be a member of more than one category.
This thesis applies over-representation analysis (ORA), the simplest and most
commonly used approach for enrichment analysis [55]. ORA provides evalua-
tion of statistical significance that asses if proportion of differentially expressed
genes, associated to predefined biological categories, is larger than expected by
chance. To evaluate this significance, the hypergeometric distribution or the
one-tailed Fisher’s exact test is commonly applied, both known to be equivalent
measures [87].
ORA has well-known limitations. Unlike Functional Class Scoring (FCS)
[55], ORA takes into account only the number of genes that was significantly
expressed above a predefined threshold value. Differential gene expression
measured with microarrays assigns values to genes that denote change in their
expression. This information is not considered in identification of enriched
categories with ORA. For the purpose of this study, this is a more suitable
property as genes subjected to enrichment analysis are not associated with any
weighting values.
Enrichment analysis is primarily possible owing to predefined annota-
tions collected in reference databases. These databases link genes to various
categories that are often organised into ontologies. Ontology as a structured
and machine-readable representation of interlinked biological concepts that
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are based on controlled and uniform vocabularies specific to the subject area
[88]. Sharing ontologies improve interoperability and integration across re-
sources [88, 89]. One of the most prominent catalogue of controlled vocabu-
laries and categories annotating gene products used for enrichment analysis
is Gene Ontology (GO) [90, 91]. GO is abundantly cross-referenced and links
genes to three types of categories: molecular function, biological process and
cell compartment. Each category is composed of hierarchically organised bio-
logical terms linked with each other by multiple kinds of relations (e.g. “is a”,
“part of”, “regulates”). Each term is annotated with genes based on evidence
derived from biomedical publications [91].
Other commonly used reference dataset are databases annotating gene
products to molecular pathways [55]. Pathway maps or diagrams are impor-
tant sources of detailed information on reactions between molecular entities.
Molecular pathways are divided into three groups: metabolic, signalling and
gene regulatory [92]. Kyoto Encyclopedia of Genes and Genomes (KEGG) [93]
was one of the pioneering initiatives that issued a web-based and publicly
available expert-curated diagrams of different molecular pathways, observed
in multiple taxonomic species [92]. Since then, numerous commercial and aca-
demic resources of molecular pathways have appeared, often specialising in
one of the pathway types. A review by Chowdhury and Sarkar [92] analy-
ses a selection of 24 open-access pathway databases. The reviewers divided
pathway resources into self-curated primary databases, secondary databases
aggregating multiple resources, and hybrid databases that are combinations of
the first two. In the first category, arguably most commonly used databases
are REACTOME Pathway Database (REACTOME) [94] and KEGG. Examples
of the second and third categories are PathwayCommons [95] and Wikipath-
ways [96], respectively. For extended view, pathway databases enrich pathway
maps with other integrated resources, such as protein interactions, phospho-
proteomics or gene expression [92]. Unification of pathway resources is an
outstanding challenge [92] despite existence of standard community pathway
formats as Systems Biology Markup Language (SBML) [97] and Biological Path-
way Exchange (BioPAX) [98]. Multiple individual studies attempted pathway
data consolidations on different levels [99–102]. Nevertheless, these initiative
are often discontinued and result in partially integrated resources. Among
major obstacles of such consolidation are incompatibile data models, differ-
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ences in nomenclature, pathway names, molecular species and interaction sets
that define a certain pathway, non-uniformly accepted and applied standards
in pathway couration and used ontology [92, 100]. Even agreement on us-
ing a uniform pathway ontology across resources would be a step towards a
global pathway network [92, 103]. Integration of pathway datasets has to be
an effort of the whole community as this requires general agreement, trust and
recognition of introduced standards.
1.4 Dynamic modelling of signalling systems
Dynamic modelling is the second approach defining systems biology. It
aims to study mechanistically and quantitatively complex behaviours of inter-
acting molecules. This cannot be achieved by analysis of omics datasets with
network or enrichment analyses, as both methods identify links to biological
mechanisms and processes rather than explore them in detail. Dependent on
the availability of details regarding the biological system under study, dynamic
modelling give means to computationally explore how perturbations can affect
concentrations of molecules and alter behaviour of the system. This approach
could contribute to development of mechanism-based therapies with more
predictive power on outcomes of pharmaceutical interventions [57].
Dynamic computational modelling frameworks consist of a model spec-
ification and simulation methods. Model specification is a set of equations or
instructions written in a machine-interpretable language. These languages
are based on mathematical formalisms and define relationships between vari-
ables that change in quantities is measured over time. This is achieved with a
numerical simulation, defined as a computational procedure that realises the
principles encoded in the model over specified limit of time.
With suitable abstraction and expressible language for system descrip-
tion, experimentally-derived evidence can be encoded in formal machine-
readable representation and subjected to an executable procedure that outputs
realisations of system’s temporal dynamics, comparable to experimental obser-
vations. Suitable formalism should encode elementary facts in unambiguous,
and explicit notation thereby they remain disputable. The formalism of choice
should allow for a direct rather then interpreted description of biological phe-
nomenons. Because the model should flexibly accommodate more than one
hypothesis, its notation should be easy to modify. Moreover, the concept and
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Figure 1.1: The first step in building a kinetic model of molecular interactions is defini-
tion of chemical reactions between molecules. These reactions can describe chemical
transitions between states of one reactant catalysed by the other. An arrow denote di-
rection of the transformation and a double arrow, reversibility of a reaction. A set of
chemical reactions can be depicted with reaction diagram that are converted to their
mathematical representation of a coupled (simultaneously solved) system of ODEs.
Each rate equation expresses a change of one molecular species concentration over
time, formulated with reaction rates that directly influence the species change [104].
In this figure, a rate equation for X00 is defined with four rate laws of mass action for
each influencing reactions. The law of mass action states that the speed of reaction is
proportional to the product of the concentrations of the reactants [105, p.141]. Positive
and negative signs of reaction rates denote direction of arrows pointing respectively
towards and away of X00 [104]. Example adopted from Hlavacek et al. [106].
notation ought to be intuitive and transparent to ease its understanding. It is
especially important in the domain where knowledge spans across disciplines.
Dynamic models can integrate variable data sources that have yet to gain place
in the body of knowledge [48], thereby enabling consolidation of knowledge
and falsification of assumptions.
In this section a classic equation-based approach to dynamic modelling
of molecular systems is presented, followed by introduction to alternative
methods of modelling originating in computer science.
1.4.1 Ordinary differential equations
Dynamic modelling of molecular pathways has been traditionally achieved
by solving a set of coupled ODEs. The ODE-based modelling is acclaimed for-
malism with a long tradition [104]. Contrary to partial differential equations
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(PDEs), ODEs are equations formulated for a single independent variable. In
the models in systems biology this variable commonly denotes time. Equa-
tions for a kinetic model are defined according to a set of chemical reactions
that describe how reactants turn into products [107] (Figure 1.1). These chem-
ical reactions are often drawn as reaction diagrams to conceptually represent
transition rules in the system. Growing number of molecular reactions that
compose modelled pathways results with a larger number of elements that
have to be represented in such diagrams. This yields difficulties in reasoning
and understanding of behaviour of molecular reaction systems [108]. Such
diagrams are rather an auxiliary and intermediate step towards quantitative
evaluation of model behaviour achieved by converting these coupled chemical
reactions to a set of ODEs. The number of rate equations is equal to the number
of reacting species. Each rate equation expresses the change of concentration of
a single molecular species over time. A rate equation is formulated with rates
of reactions that directly take part in creation and elimination of this species
[104]. An example of a rate equation in Figure 1.1 is based on rate laws of
mass action. Each reaction rate is weighted by a rate constant, specific to each
reaction and dependent on temperature.
As real-size molecular systems are not analytically solvable with a pen
and paper, simulation of ODE-based models requires computer-aided calcu-
lations [48]. Hence, similarly to Knüpfer et al. [109], ODE-based models are
understood here as a type of computational models. ODE-based models are
routinely solved with numerical procedures, e.g. Runge-Kutta method [107].
A strong point of modelling with ODEs is a large number of mathematical
methods for model analysis, among which we can find stability analysis, fixed
points, phase planes, nullclines, rate balance plot, and bifurcation analysis
[110]. Moreover, extensive standard and software development support and
facilitate formulation and analysis of ODE-based models [104, 111, 112].
Time courses obtained by solving ODEs models are deterministic and
continuous, characterised by smooth and gradual change of species concentra-
tions over time [113]. Calculation outcomes are unchanged for the ODE model
with the same initial molecular states and input parameters. This setup does
not reflect the actual characteristics of subcellular events driven by random
collisions between discrete molecules [114]. Despite being an approximation
of the real molecular process, the ODEs-based modelling method has been
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successfully applied and founded the baseline approach to dynamic modelling
in systems biology. However, the deterministic and continuous approach is
correct as long as abundances of reactants are large enough to render random
fluctuations as negligible [115]. There are molecular properties and mech-
anisms that cannot be modelled with this approach, such as transcriptional
bursting [116] or DNA damage [113]. Molecular processes in synapses are
characterised by high numbers of divergent types of molecular species but
low numbers of instances per each type. In these conditions, magnitudes of
fluctuations in copy numbers of molecules becomes important [115]. Existence
of noise and its role in shaping characteristic properties of signalling systems
are acclaimed and closely studied [117]. Among others, inherent presence of
noise in signalling systems is attributed to transient, low-affinity and promis-
cuous protein interactions [118]. These variations in species counts can only
be captured with the stochastic simulation [115]. However, rate equations can
be expressed stochastically with stochastic differential equations (SDEs) [113].
Moreover, current development in standard formats encoding biological mod-
els, in particular Systems Biology Markup Language (SBML), allows to obtain
trajectories of the same model with different simulation methods, both deter-
ministic solvers and stochastic simulators, e.g. Gillepie’s Stochastic Simulation
Algorithm (SSA) [112, 119]. More important weaknesses of ODE-based models
lays in requirement of explicit enumeration of molecular species for which rate
equations are defined [120]. This precludes modelling of molecules charac-
terised by combinatorial explosion of possible states and numerous binding
partners, observed in such examples as EGFR (Section1.1). EGFR is an im-
portant family of protein receptors, targeted in cancer therapies [121]. When
activated, the receptor is autophosphorylated at multiple Tyrosine sites and
dimerises to yield a large number of possible states and functionally different
conformations [18]. EGFR binds and activates different protein targets prop-
agating extracellular signal through intracellular pathways. EGFR is one of
the most studied examples that remains intractable due to variability of con-
sequences of its multiplicity of states [122, 123]. Equations can be written for
only a fraction of all molecular species of EGFR [124].
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1.4.2 Methods inspired by computer science
Development of formal methods in computer science has prompted
attempts to use them in modelling molecular processes. These approaches
extended the number of observed properties of biological systems that can be
dynamically and quantitatively modelled [125]. These approaches are broadly
reviewed by Bartocci and Lió [125], Machado et al. [126], Tenazinha and Vinga
[127] and Ji et al. [128]. Computational methods are commonly divided into
temporal, where well-stirred medium of molecular events is assumed, and
spatio-temporal, that model impact of spacial distributions of molecules [125].
Some of these methods were more commonly used to model particular types of
pathways, such as signalling, gene regulatory or metabolic [126]. These meth-
ods can reflect different aspect of the same molecular processes by addressing
a subset of characteristics found in multiple biological system. There are also
methods that support versatile modelling features and tools. Methods are also
divided with respect to the level of provided detail, ranging from modelling
qualitative state transitions (e.g. Boolean networks) to detailed mechanisms
(e.g. process algebras) [129]. For the purpose of this study, non-spacial mech-
anistic modelling methods are considered that allow to define processes on
subcellular-level, as oppose to multiscale models. The multiscale modelling is
a very challenging task. The major concern in this type of modelling is creation
of an environment that integrates numerous baseline low-level formalisms.
A general difficulty lies in designing synchronisation strategies to integrate
output responses and time-scales of multiple connected modules defined with
low-level formalisms. These can either model different levels of detail [130]
or combine different levels of response, ranging from molecular, cell to tissue.
In systems neurobiology, there are examples of combined use of NEURON
and ECell [131], and NEURON with Kappa [132]. Next to these experimental
studies, there are also more established frameworks such as MOOSE (Multi-
scale Object-Oriented Simulation Environment), a general-purpose biological
simulator that at the ground level is based on ODEs.
This study is concerned with modelling methods that provide a low-
level definition of molecular interactions. Such formalisms commonly evolve
to encompass more complex problems that concern space [133], molecular
geometries [134] and multiscale processes [132].
Among most popular methods that fit these characteristics and offer
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most versatile collection of features are Petri nets, process algebras and rule-based
formalisms [126].
Petri nets are one of the first methods developed to study parallel and
distributed processes in computer science [135]. Among advantages of Petri
nets are intuitive graphical representation and methods for model analysis that
are based on matrix algebra. A Petri net model is represented as a bipartite
graph with two types of nodes, transitions and places. In a bipartite graph, only
nodes of different types are connected. Place nodes denote reactants whereas
transition nodes, reactions. Reaction execution triggers token passing that
can be translated to concentrations or copy numbers of interacting molecules.
There are multiple variants of Petri nets, both for qualitative and quantitative
(continuous, stochastic) modelling. However, Petri nets are unable to model
multi-state molecules characterised by combinatorial explosion of molecular
species as all network nodes (reagents) have to be enumerated beforehand.
Moreover, the advantage of graphical representation loses its strength when
the modelled system becomes large.
Following the invention of Petri nets, different process algebras were de-
veloped as formal languages to model and analyse distributed, interacting
processes in computer science [135]. On this canvas, large family of languages
for modelling biological systems emerged [136]. Differences between these
languages lie in the choice of what constitutes a basic element of biological pro-
cess [136]. For instance, π-calculus [137], Beta-binders [138], and BlenX [139]
(derived from Beta-binders) present a molecule-centred view, whereas BioPEPA
[136], a molecular species or reagent-centred view. Reagent-centred languages
such as BioPEPA, amongst other goals, aimed to match representation of bio-
chemical networks defined by the SBML standard format for biological models
(Level 2) [140]. Being compatible with the SBML format, it was not designed to
tackle combinatorially complex assemblies of molecular species. Only recently
a plugin to the SBML format, multi, was introduced that contains data struc-
tures to represent molecular entities with multiple states and components [141].
Only languages with molecule-centred view were able to model such processes
as self-assembly of actin polymerisation [142, 143]. Actin polymers are grown
by complexation of monomeric subunit of actin proteins. In reagent-centred
process algebras, gradually assembled polymers would have to be represented
as distinct molecular species.
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What is in common for the whole family of process algebras is that it
offers expressible formalism to represent, model and analyse biological pro-
cesses in modular and compositional way by describing modelled systems
with their components [144, 145]. Among a range of general biological aspects
that can be symbolically represented and modelled with process algebras are
cell compartments [146], protein domains [137] and polymerisation [142, 143].
However expressible process algebras can be, since they were originally devel-
oped in the other than biological context, concepts embedded in some variants
of these languages might be non-intuitive and obscure to comprehend for biol-
ogists [145] or might simply be redundant [147]. This is true even for adjusted
process algebras for the purpose of molecular modelling [136, 139]. To such
examples belong a concept of channels in π-calculus, that are shared between
processes (molecules) in a pair-wise communication [137].
Another approach to model biological systems is rule-based (RB) mod-
elling. It belongs to a more general class of agent-based modelling [148] that
was first brought about to study problems outside of the systems biology con-
text [149]. In the rule-based setting, actions of individual agents are defined
by a set of local and partially complete rules. In this way, a large set of system
behaviours can be represented by a much smaller number of general rules that
is the most prominent feature of RB modelling [149]. Among others [150],
arguably most popular representatives of RB modelling methods in systems
biology are based on graph rewriting: Kappa [147] and BioNetGen [151]. Both
form well-equipped frameworks that popularly exemplify RB modelling in
reviews presenting modelling formalisms in systems biology [126, 152–154].
Moreover, they offer an intuitive interpretation [155], where graph transforma-
tions formalise behaviour of agents represented as graphs. Graph rewriting
was developed to support operations on theoretical structures that are more
general than strings [156]. In the realm of computer science, a graph rewriting
can be understood as operations on graph data structures that evolve accord-
ing to a set of local instructions [156]. In the context of molecular modelling,
methods based on graph-rewriting represent a molecule-centred view, where
molecules are structured graph objects, i.e. nodes with sites. Reactions oc-
curring between molecules are represented as graph-transformations, where
bonds can be formed between sites of nodes. Graph transformations are en-
coded as rules that are instructions for local transformations. In this way a
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rule can represent a set of reactions or an exact reaction instance, dependent
on the rule specificity. This constitutes a significant advantage of rule notation
that can express an infinite number of reactions with a small and finite number
of rules. In the most of modelling methods mentioned above, every chemical
species has to be specified in advance what is highly problematic for species
with dozens of phosphorylation sites and many possible states. This limiting
factor makes these methods inappropriate for modelling complex interactions
of signalling proteins.
The ability to capture a protein as a graph with binding sites (e.g. do-
mains) that have internal states (e.g. phosphorylated) gives a sufficiently ex-
pressive system to capture principal mechanisms of signalling processes (e.g.
dissociation, synthesis, degradation, binding and complex formation [152]) as
well as insight into site-specific details of molecular interactions: affinities,
dynamics of post-translational modifications, domain availability, competitive
binding, causality, and the intrinsic structure of interactions.
A review of other rule-based modelling methods used in systems biol-
ogy that rely on other than graph-rewriting formalisms can be found in Stefan
et al. [150].
1.5 Rule-based modelling
In this project, RB modelling was found as a most flexible and suitable
formalism, tailored for stochastic modelling of site-specific protein interaction
networks. As an example of the RB modelling approach, the Kappa framework
is applied in this thesis. As a well-designed modelling framework, the speci-
fication language is separated from the simulator. The framework consists of
the Kappa language and the KaSim simulator. Each of the two components is
separately described in this section.
1.5.1 Kappa language
The Kappa language formulates principles of the model that combines
process algebras and graph transformations to create a tailored formalism for
protein interaction networks [147]. The next paragraphs will informally present
definitions of syntax and concepts necessary to understand result chapters of
this thesis. The syntax of rules described here is relevant to the 3.5 version of
the KaSim simulator [157].
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1.5.1.1 Agents
An agent is a fundamental object in rule-based models that represent
molecular entity, e.g. a protein (Figure 1.2A). Agents are atomic model compo-
nents that preserve identity [120] and cannot be decomposed any further [158].
An agent is defined by a name and interface, together forming an agent signature
(Code 1.1). The interface is a finite set of named sites. Each site is assigned with
a unique label that can simultaneously carry 2 types of information: internal
state and binding state. Each site can have multiple internal states and binding
partners during the simulation but only one of each at a time. Internal states
per site, by convention, are denoted with character letters following the site
label and the “˜” sign. Code 1.1 shows an example of the agent signature. “A”
is an agent name. Its interface is enclosed in brackets. The interface consists of
one site labelled as“pSite” that can have two internal states: “˜u” and “˜p”.
By convention, the binding state is denoted by an integer following the site
label and the “!” sign. There are 4 possible binding states that the site can be
in: free, semi-linked (bound to an unknown site), unspecified (free or bound)
or with a labelled bond (bound to a named site) (Code 1.2). A bond label can
exist exactly twice, shared between two sites. This implies that only binary
bonds are allowed [158]. The order of writing sites and agents is of no conse-
quence. Edge labels do not have to be identical within the model as long as
their uniqueness within the rule expression is satisfied [158].
Code 1.1: Example of agent signature specification
1 %agent: A(pSite˜p˜u)
Code 1.2: Agent’s possible binding states in a state p
1 A(pSite˜p) # free
2 A(pSite˜p?) # unspecified
3 A(pSite˜p!_) # semi-linked
4 A(pSite˜p!0) # bound with a labelled bond
1.5.1.2 Patterns
Two or more bound agents form a complex. The complex belongs to a
more general category of expression. The expression is composed of comma sep-
arated agents and complexes [159]. All agents and complexes at a given point





Figure 1.2: Diagram demonstrating main concepts and elements of the Kappa lan-
guage. (A) Agents represent molecular entities as named nodes (“A”, “B”) with sites
(“pSite”, “a”, “c”) and states (“u”). (B) Molecular species are agents and complexes
that contain full description of their states and site occupancy. As such, they can
only denote their one particular type. Patterns offer partial description of agents and
complexes thereby match larger groups of molecular species. (C) Rules define trans-
formations of agents understood here as reactions. Dependent on the generality of
agent description, a single rule can represent a set of reactions. (D) Observables are
desired simulation outputs that can be represented as patterns or molecular species.
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of simulation form mixture of existing molecular species in a system. A molec-
ular species is an agent or complex made of completely specified binding and
internal states of agents that exist in the mixture. Agents can have completely
or partially specified interfaces. Agents with partially specified interfaces are
termed expression patterns [159]. The pattern can be less or equally specific
to completely determined expressions of molecular species (Figure 1.2B). In
the former case, the pattern allows to omit information that is irrelevant or
unknown regarding agents states [159]. Compare Code 1.3 and Code 1.4.
Code 1.3: Agents with partially specified interfaces (patterns)
1 A() # unspecified internal and binding states
2 A(pSite?) # unspecified internal and binding states
3 # (equal to the above)
4 A(pSite!_) # unspecified internal state and binding partner
5 A(pSite˜p?) # internal state ‘p’ and unspecified binding state
Code 1.4: Agents with completely specified interfaces (molecular species)
1 A(pSite˜p) # in state ‘p’ and unbound
2 A(pSite˜u) # in state ‘u’ and unbound
3 A(pSite˜p!0) # in state ‘p’ and bound with a labelled bond
1.5.1.3 Rules
Two expressions separated with an arrow, e.g. “<-”, “->” or “<->”, form
a rule, composed of a left-hand site (LHS) and a a right-hand site (RHS) [158]
(Figure 1.2C). A rule is an instruction that expresses an action or state trans-
formation [156]. The type of an arrow determines direction and reversibility
of the transformation. Expressions forming a rule can be defined with pat-
terns. Less detailed rule pattern matches to more instances in the mixture of
molecular species thereby can represent more then one reaction. This pattern
matching can be formally understood both as string matching or graph embed-
ding. As the latter, it should satisfy injections on graphs with preservation of
elements of agent interfaces, i.e. names, sites, internal states and bonds [120].
Pattern matching in graphs is embedding of a less detailed graph in the rule
specification to a completely specified graph of a rule instance. Omission of
details regarding agent interfaces in the rule specification indicate that these
details does not restrain reactions to take place. The transformation instructed
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by a rule is performed by matching expression on LHS to instances existing
in a mixture of molecular species. An instance that matches a rule is trans-
formed according to the expression on RHS. Given that agents and complexes
are understood as graphs, rule application is a graph rewriting procedure. El-
ementary level transformations of molecular graphs expressed with rules are:
synthesis, degradation, binding, dissociation and state change.
A rule specified with complete information about agent interfaces is in
one-to-one correspondence to a chemical reaction. It is illustrated with the
following set of chemical reactions of two-step dephosphorylation of the agent
“A” by the agent “B”:
Ap + B −−−→Ap−B (1.1)
Ap−B −−−→Ap + B (1.2)
Ap−B −−−→A + B (1.3)
(1.4)
Equivalent rules to the above chemical reactions being in one-to-one correspon-
dence are as follows:
1 A(pSite˜p ),B(a ) -> A(pSite˜p!1),B(a!1)
2 A(pSite˜p!1),B(a!1) -> A(pSite˜p ),B(a )
3 A(pSite˜p!1),B(a!1) -> A(pSite˜u ),B(a )
1.5.1.4 Observables
In the RB modelling, outputs of interest resulting from the model sim-
ulation and represented as time courses are defined in the model as a list of
observables. Similarly to the rule definition, an observable can be represented
with different levels of detail (Figure 1.2D). The level of detail can range from
generic patterns that supply partial information on agent interfaces, to their
complete description that matches the definition of molecular species. An ob-
servable declared as incomplete pattern refers to multiple molecular species
that time courses are summed to represent a single trajectory denoted by this
observable of interest. For instance, Code 1.5 exemplifies an observable that
represents a sum of trajectories of the agent “A” that are phosphorylated and
in an unknown binding state.
Code 1.5: Example of observable definition
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1 %obs: ’Ap’ A(pSite˜p?)
1.5.1.5 Perturbations
The Kappa language provides means to induce perturbations during
the simulation. This extends control over the simulation and allows flexible
design of experiments. Perturbations can be applied once or repeatedly when
or while indicated preconditions are satisfied. A template of a command for a
one-time perturbation is shown in Code 1.6.
Code 1.6: Command template for one-time perturbation
1 %mod: <boolean expression> do <effect>
The%mod: operator initiates the perturbation command. <Boolean expression>
is a part of the command where preconditions are located. If the expression is
evaluated as true, the <effect> is executed. The boolean expression may refer
to a specific moment of the simulation, counted in seconds ([T]) or simulation
events ([E]). An event is defined as a rule application that transforms molecular
species in the mixture in progression of the simulation [157]. The time when
perturbation is induced can also be formulated as a moment when an agent’s
or a ratio of agents’ copy numbers reaches some predefined level. A command
template for repeated perturbation is shown in Code 1.7.
Code 1.7: Command template of repeated perturbation
1 %mod: repeat <boolean expression>
2 do <effect>
3 until <boolean expression>
In repeated perturbations, <effect> is executed until the second <boolean
expression> is evaluated to false. A complete list of effects can be found in the
Kappa manual [157]. Effect can be used either to apply changes to the model
or explore the simulation by collecting additional data during the model ex-
ecution. In this study, two effects were used to update rate constants and to
add molecules. The former with the $UPDATE command, the latter with the
$ADD command. Both result in alteration of molecular abundances during the
simulation. To collect additional data during the simulation, snapshots were
used to capture the state of molecular mixture at an indicated time point and












Figure 1.3: A snapshot generated with the Kappa framework that represents the
molecular mixture of the RB model example discussed in this section. Each rectan-
gle contains molecular species represented as connected graphs. Agents are repre-
sented with nodes of different colours and bonds between agents with edges. Copies
of the same agent composing molecular species are represented with the same colour.
Number of instances per molecular species are indicated at the bottom of the species
rectangle.
executed with the $SNAPSHOT command. Snapshots provide means of monitor-
ing and gathering information on molecular species and their quantities that
are created over the simulation (Figure 1.3).
1.5.1.6 Static and dynamic analysis
The Kappa framework offers graphical tools for static and dynamic
analysis of a model. The former are performed without model simulation and
as such are independent from kinetic parameters [157]. Static analyses provide
ways for model verification without a need of simulating the model. Among
the static methods are contact maps and influence maps. Contact maps produce
a diagram of all agents defined in the model, and their signatures composed
of binding sites and internal states. The diagram show all possible bonds
between agents as defined by the rule set. Influence maps inform on potential
positive and negative influences between observables and rules. For instance,
a rule can have a positive influence on the other if an agent state resulting from
application of the former rule can be embedded in the LHS of the latter rule
[157].
The dynamic analyses are performed during the simulation. Among
these are causal flows and flux maps. Causal flows show dependencies and
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conflicts between rule executions for indicated observables. Flux maps inform
on how much rules contribute to each others activities in terms of negative or
positive contributions, and are performed per indicated time interval [157].
1.5.2 KaSim simulation method
KaSim is a specially designed simulator for the Kappa language. It is
based on Gillespie’s Stochastic Simulation Algorithm (SSA) [114, 119]. The
Gillespie’s algorithm numerically simulates time courses of molecules mod-
elled with biochemical reaction networks [113, 119]. The algorithm uses a pro-
cedure of Continuous Time Markov Chains (CTMC) to transit between states
that depend only on the current state of the system (“memoryless” Markov
property) and can occur at any time point (continuous process) [107]. The
Gillespie’s algorithm simulates individual stochastic trajectories. These are
therefore samples from deterministic evolution of probability distributions of
molecular species, represented as the Chemical Master Equation (CME) [114].
CME is the most detailed representation of stochastic evaluation of reaction
networks. However, its practical use is limited to a very small, usually uni-
molecular reactions. The Gillespie method allows to obtain results for more
complex reaction networks.
An advantage of the Gillespie method over a typical procedure of solv-
ing ODEs, is that it does not approximate infinitesimal time increments by
small but finite steps [114, 119]. This approximation is known to give rise
to the numerical instability that causes deviation of results from the correct
solution by accumulation of approximation errors [160]. Other advantage is
that solution of ODEs is performed by stepping through dynamic process in
a synchronised manner [120] whereas, the Gillespie’s method is a concurrent
and asynchronious procedure.
Growing size of reaction networks rendered Gillespie-based numerical
simulations computationally intensive and efforts have been made to improve
efficiency of the algorithm [161]. The standard Gillespie’s algorithm requires
enumeration of all the possible species and therefore, its efficiency depends
on the network size that is defined by a number of reactions and molecular
species [162]. This requirement of knowing all molecular species in the model
precludes possibility of modelling signalling systems that dependent on activ-
ity of combinatorially complex proteins. To model these multi-state proteins,
1.5. Rule-based modelling 31
Danos [120] proposed a generalised variant of the Gillespie’s algorithm with
approximation of events that may happen and a particular correction scheme
[163], implemented as KaSim.
Figure 1.4A outlines simulation steps of the KaSim engine, presented
as an event loop [157]. An event is application of a rule to the current mixture
molecular species represented as graphs during the simulation. The procedure
is based on drawing two random numbers over each event loop. First, for
the time interval when the next reaction happen. Second one, for the next
reaction to occur. The probability of any rule application is proportional to the
rate constant of the rule, multiplied by the number of instances in the mixture
that the LHS of the rule can be embedded in. This defines the rule activity
(Equation 1.5). Summation of all rule activities gives the total reactivity of
the system (Equation 1.6). The systems reactivity is used as a parameter to
define the shape of exponential probability density function from which the
next reaction event is drawn (Figure 1.8). In consequence, the higher the total
activity of the system the shorter the time interval to the next reaction event
[157].
Comparison of similar algorithms designed for network-independent
simulation of RB models was performed by Suderman and Deeds [123]. The
authors compared performance of KaSim and NFsim [165] simulators. NFsim
is a simulator for models encoded with BioNetGen Language (BNGL). No
apparent difference in efficiency and time course dynamics was observed be-
tween simulators for the same models. Thus, both simulation methods appear
to be equally efficient.
1.5.3 Model examples
As a novel paradigm of dynamic modelling, the RB modelling al-
lowed to approach experimentally general understanding and implicit assump-
tions regarding the nature of cell signalling and protein interactions. One of
such questions concerns compositional characteristics of signalling complexes,
whether they form molecular machines with well defined quaternary structure,
e.g. ribosomes [122] and apoptosome [123], or whether they form pleiomor-
phic ensembles that are composed of dynamically changing heterogeneous
complexes. Formation of pleimorphic ensembles is a hypothesis inferred from
combinatorially explosion of molecular states and is yet to be experimentally
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P(δt > T) = exp(−a(x)T) (1.8)
Figure 1.4: (A) Event loop representing the KaSim engine. The next event time (“∗”)
is drawn according to the probability in Equation 1.8, the probability of a rule to be
executed (“∗∗”) is defined by Equation 1.7. (B) A list of equations defining the KaSim
engine, where r is a rule, x is a state of a mixture at a time, kr is a parameter of r, sr is
the LHS of r, [sr,x] is a number of matches of sr in x, a(r,x) is the activity of r, a(x) is a
total activity (or reactivity) of the system, δt is a time elapsed to the next event [164].
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verified [122]. It is unknown exactly what proportion of complex-based sig-
nalling occurs through formation of molecular machines and whether the cellu-
lar signal can be reliably processed with pleiomorphic ensembles [122]. Suder-
man and Deeds [123] computationally examined these perspectives encoded in
two RB models of Yeast pheromone pathway. In the first one, complexes were
hierarchically and completely assembled to form signalling machines. In the
second one, agents reacted freely forming pleiomorphic ensembles of wide va-
riety of complex types. Phenotypic difference between models was observed,
with advantage of the ensemble-based model. Unlike the machine-based one,
the ensemble-based model was able to reproduce experimental observations
where an overexpressed scaffold protein caused combinatorial inhibition of the
model response [123].
In other study by Deeds et al. [166] explored consequences of conflicts in
protein binding and combinatorial complexity in protein interaction networks.
The authors created a RB model of structurally resolved interactions between
Yeast proteins. Protein interaction network, that underlay the model, was
enriched with information on protein binding interfaces, in particular defining
which of these interactions are simultaneous and which mutually exclusive
[167].
Similarly relying on resolved information on binding interfaces but
through protein domain information, Sorokina et al. [168] constructed a model
of postsynaptic density. The information on protein-domain architectures and
domain interactions allowed to construct detailed interactions between scaffold
proteins in postsynaptic density, where specification of domain-based protein
interactions formed major content of the RB model [168]. Commonly analysed
aspects of these three models were sizes and heterogeneity of compositions of
protein complexes [123, 166, 168].
Next to these inquiries regarding general aspects of signalling protein
networks, there are numerous modelling examples aiming to model specific
molecular mechanisms with the RB framework. A list of models published
between 2007 and 2013 is provided by Chylek et al. [169]. The authors enlisted
21 models of various topics regarding cell signalling, and 13 models of immune
signalling. Summary of earlier published models than 2007 can be found in
Hlavacek et al. [106]. Table 1.1 shows examples of modelled mechanisms
published after 2014.
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Modelled subject Citation
Long-term potentiation and long-term depression Antunes et al. [170]
Insulin signalling Di Camillo et al. [171]
Lymphocyte-specific Tyrosine kinase autoregulation Rohrs et al. [172]
Cell-line specific early signalling of EGFR Stites et al. [173]
Base excision repair Köhler et al. [174]
Early T-cell receptor signalling Chylek et al. [175]
Table 1.1: Examples of topics modelled with the RB framework, unmentioned in the
previous reviews enlisting RB models [106, 169].
1.6 Organisation of thesis
In Chapter 2 of this thesis, I will present comparison of a RB model to an
ODE model representing the same molecular system. This comparison aims
to determine if dynamics encoded with the ODE model can be reproduced
within the RB framework, and to establish potential advantages of modelling
with rules. The RB model was obtained through translation of an existing ODE
model into the RB syntax. The models are compared with respect to speci-
fication components and by overlying time courses of corresponding model
outputs. The models are also analysed in different variants, a base-line and an
emulation of experimental perturbation.
In Chapter 3, a pipeline for extended and automated analysis of RB
simulation results is proposed. The pipeline is performed on the RB model
presented in Chapter 2. In the pipeline procedure, model outputs are parti-
tioned and scored based on sets of their time courses generated from the RB
model with randomly varied parameter sets. Selected observables are passed
to global sensitivity analysis (GSA) that measures sensitivity of the model out-
put to variation of rate constants. Selected model outputs and their scored
relations with parameters are represented as a weighted network graph to en-
hance analysis of relations between these model components. This network
representation is further used to identify differences between two model phe-
notypes.
In Chapter 4, I present explorations of molecule-centred resources that
are relevant in development of mechanistic and disease-related RB models. As-
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semblage of such repositories could accelerate the process of model construc-
tion and direct the subject of dynamic modelling towards disease-related mech-
anisms. Contents and coverage of these datasets were studied with respect to
Attention Deficit Hyperactivity Disorder (ADHD) as an example of complex
disorder with relatively high prevalence. A list of the ADHD-associated genes
was assembled from three resources representing different types of studies and
qualities. These resources are examined with respect to coverage, accuracy and
potential difficulties involved in their application. Among molecular-centred
repositories, the main focus was laid on protein-protein interactions (PPIs),
enriched with information on domain-domain interactions (DDIs) identified
in the ADHD-associated proteins. Kinase-substrate interactions (KSIs) were
included as most common form of PTMs that indicate reactants of phosphory-
lation reactions. As reactions and rate constants defining new models are often
derived from existing models, the BioModels database of mathematical models
is screened with the proteins associated to ADHD. Lastly, enrichment analysis
is performed to identify pathways where the ADHD genes are overrepresented.
In the final Chapter 5, I recap discussions of results presented in the
result chapters and reflect on future perspectives.
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1.7 List of Acronyms
AC adenylyl cyclase
ADHD Attention Deficit Hyperactivity Disorder
ARI Adjusted Rand Index
ATP adenosine triphosphate
A Avogadro’s constant





CaMKII Ca2+/calmodulin-dependent protein kinase II
cAMP cyclic adenosine monophosphate
CDK5 cyclin dependent kinase 5
CK1 casein kinase 1
CK2 casein kinase 2
CNS central nervous system
constSer137 constitutive Ser137
COPASI COmplex PAthway SImulator
CorEx Correlation Explanation
D137 DARPP-32 phosphorylated at Serine 137
D34 DARPP-32 phosphorylated at Threonine 34
D75 DARPP-32 phosphorylated at Threonine 75
DA dopamine




DOQCS Database of Quantitative Cellular Signaling
DRD1 dopamine receptor D1
DRD2 dopamine receptor D2
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eFAST extended Fourier Amplitude Senstivity Test
EGFR epidermal growth factor receptor




GSA global sensitivity analysis
GSDDI gold standard domain-domain interaction
HSIC Hilbert-Schmidt Independence Criterion
HUPO Human Proteomics Organisation
IDDI Integrated Domain-Domain Interactions
KSI kinase-substrate interaction




MIRIAM Minimal Information Requested In the Annotation of biochemical Models
MSPN medium spiny projection neurons
NCBI National Center for Biotechnology Information
NMDAR N-methyl-D-aspartate receptor
oBS one-binding-site DARPP-32
ODE ordinary differential equation
ORA over-representation analysis
PDB Protein Data Bank
PDE phosphodiesterase
PDI protein-domain interaction
PKA protein kinase A
PKAc protein kinase cAMP-activated catalytic subunit
PKAr protein kinase cAMP-dependent regulatory subunit
PP1 protein phosphatase 1 catalytic subunits
PP1 protein phosphatase 1
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PP2A protein phosphatase 2
PP2B protein phosphatase 3/calcineurin
PP2C protein phosphatase 2C
PPI protein-protein interaction
PPP1R1B protein phosphatase 1 regulatory inhibitor subunit 1B isoform 1
PRCC Partial Rank Correlation Coefficient
PSI Proteomics Standards Initiative
PTM post-translational modification
R2C2 Inactive PKA in the form of a heterotetramer. It consists of two regulatory and two
catalytic subunits.
RB rule-based
REACTOME REACTOME Pathway Database
RKHS Reproducing Kernel Hilbert Spaces
SA sensitivity analysis
SBML Systems Biology Markup Language
Ser102 Serine 102
Ser137 Serine 137
Ser137Ala Serine to Alanine mutation of DARPP-32 at Ser137
SNP Single Nucleotide Polymorphism
SSA Stochastic Simulation Algorithm
t-DARPP truncated DARPP
tBS three-binding-sites DARPP-32




UniProtKB the Universal Protein Resource Knowledgebase
UniProtKB AC UniProtKB accession
Chapter 2
Kappa model of DARPP-32
network
2.1 Motivations
As presented in Chapter 1, molecular signalling is characterised as a
complex system of coupled interacting components resulting with nonaddi-
tive effects. Its understanding has been facilitated with formal methods that
allow to study dynamics of such systems. A common way for studying such
systems in a powerful and detailed manner is by defining molecular reactions
as a set of ordinary differential equations (ODEs). However, as discussed in
Section 1.4, mechanisms underpinning the function of large scale signalling
networks demonstrates limitations of ODE-based representation. Develop-
ment of modelling methods derived from computer science has specifically
addressed growing complexity of represented systems. A particularly promis-
ing example of such methods is rule-based (RB) modelling, designed to model
a system of interacting proteins. The potential of the method has been exten-
sively discussed [108, 120, 124, 149] and shown on demonstrative examples
[120] or with models attempting to answer new biological questions (see Sec-
tion 1.5.3). These models were often based on existing ones, which in a great
majority are defined as ODEs. However, to the author’s knowledge, any di-
rect and systematic comparison of the same biological system defined in the
light of two formalisms has not been presented before. Moreover, application
of an existing method [176] for automated translation of a format encoding
ODE-based models to a RB model format appeared to be unsuccessful (Ap-
pendix A). Therefore, in this chapter, I examine differences between an existing
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ODE model compared to its RB counterpart resulted from the translation of
reactions underlying the ODE model to the RB syntax. With this setting, I
specifically ask if dynamics of an ODE-based model can be reproduced with
a RB-model? Secondly, if differences between both are observed, what are
their particular underpinnings? Lastly, if dynamics of ODE-defined system are
reproduced within RB one, what can be gained with a model defined in RB-
setting that would extend analytical framework of the system already defined
with a set of ODEs.
Such comparison of two formalisms could reveal consequences of di-
vergence in two types of model definitions and henceforth, give a better under-
standing of RB modelling. For instance, as presented in Section 1.4, the ODE-
based modelling represents a molecular system as concentrations of molecular
species and focuses on their reaction kinetics. Contrary to this, RB modelling
is an agent-focused method, where unfolding of molecular compositions can
be studied alongside their abundances [120]. Moreover, with respect to ODE
modelling, RB remains a relatively new paradigm. It still requires support
in research, tool development and applications by modelling community to
understand the differences in insights both formalism can offer and use it ap-
propriately.
2.2 Introduction
To perform comparison between the two formalisms, we first need to
translate an existing ODE model into a RB one. An ODE model of choice should
satisfy certain requirements. The first requirement is a quality of study that
is weighted by acknowledgement in the field of molecular neuroscience rep-
resented by frequency of reference to the model in successive studies. Second
requirement is reproducibility criteria. To directly compare dynamics of molec-
ular species, time-evolution of molecular concentrations has to be obtained for
both models. This requires the ODE model to be encoded in a machine-readable
format that could be numerically simulated with an appropriate software.
A model of the immediate interactors of dopamine- and cAMP-regulated
neuronal phosphoprotein with molecular weight 32 kDa (DARPP-32) network
by Fernandez et al. [177] was found to satisfy these criteria. The model is
considered by the community interested in modelling dopamine-dependent
synaptic plasticity to be a valuable study that can serve as a solid core for
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building larger and more complex models [178]. Moreover, it is a largely cited
study not only by modellers [131, 179, 180] but also experimentalists [181–
183]. As for the reproducibility criteria, the Fernandez et al. [177] model was
clearly created with this problem in mind. First of all, the model is encoded
in the standard Systems Biology Markup Language (SBML) format, as well
as the format used in its original environment (E-Cell, version 3). Further-
more, it is deposited in the BioModels database [184]. Each curated model in
the database is annotated with external common identifiers complying with
the Minimal Information Requested In the Annotation of biochemical Mod-
els (MIRIAM) standard [185]. For instance, proteins in a model are annotated
with the standard protein identifiers of the Universal Protein Resource Knowl-
edgebase (UniProtKB) [186] what allows for unique identification of protein
sequences.
It should be noted that the translation of the model of Fernandez et al.
[177] into the Kappa-based framework does not aim to demonstrate that a
stochastic model is more adequate to study this particular reaction network.
As copy numbers of molecules represented in the model are sufficiently high,
stochastic modelling would not lead to any substantial change of conclusions
obtained with the ODE-based formalism and therefore, the ODE-based model
is in this particular case a benchmark solution.
In this chapter, the conversion of the ODE model to a RB model is pre-
sented in detail. First, I introduce the biological setting of the chosen system
as well as the potential advantages of translating this system into a RB model.
Then I cover aspects of the model translation, such as how agents and observ-
ables where defined as well as the reaction(s)-to-rule(s) conversions. I present
the results of model comparison at the notation level and using model dynam-
ics under different conditions. Following that, I discuss the advantages and
disadvantages of the two model representations, and present suggestions for
future work.
2.2.1 Role and importance of the DARPP-32 protein
DARPP-32, officially named protein phosphatase 1 regulatory inhibitor
subunit 1B isoform 1 (PPP1R1B) [187], is an important multistate and intrin-
sically disordered protein [188] regulating synaptic plasticity. DARPP-32 was
first discovered by Walaas et al. [189]. Although expressed in multiple brain
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regions [190], it is a central protein studied in dopamine (DA)-dependent plas-
ticity in medium spiny projection neurons (MSPN) of striatum.
Striatum is a subcortical brain structure and the largest nuclei of basal
ganglia. Striatum integrates multiple inputs to the basal ganglia circuit, such
as glutamatergic excitatory afferents from the cortex and dopaminergic inputs
from the midbrain [191]. Around 95% of Human striatal cells are MSPNs,
in which signalling cascades activated simultaneously by glutamatergic and
dopaminergic stimuli is a necessary condition for the long-term potentiation
(LTP) that underlies context and reward-related learning [192].
The importance of studies on DARPP-32 in striatal signalling underpin-
ning DA-dependent synaptic plasticity stands in analogy with Ca2+/calmodulin-
dependent protein kinase II (CaMKII) in models of Ca2+-dependent synaptic
plasticity in hippocampal neurons [38]. Synapses in striatal MSPNs share some
pathways with hippocampal synapses that carry glutamate (Glu)-induced sig-
nal and include striatum-specific proteins involved in the DA signal. These
two signals are integrated by DARPP-32 that is involved in a complex net-
work of interactions regulating its phosphorylation sites. There are at least
eight phosphorylation sites in the DARPP-32 amino acid sequence that have
been confirmed by multiple studies1. However, only four are known to have
a regulatory impact on DARPP-32 [193]. These four phosphorylation sites are
Threonine 34 (Thr34), Threonine 75 (Thr75), Serine 137 (Ser137) and Serine
102 (Ser102) (positioned on the Rattus norvegicus protein sequence). The multi-
plicity of phosphorylation states leads to a large number of interacting partners
of DARPP-32 that affect these states. Based on the general process of phospho-
rylation, these interactors can be divided into two types, protein kinases and
phosphatases, which are important signalling modulators that mediate phos-
phorylation and dephosphorylation, respectively [1].
Among DARPP-32 interactors we can find protein phosphatase 2 (PP2A),
protein phosphatase 3/calcineurin (PP2B), protein phosphatase 1 (PP1), protein
phosphatase 2C (PP2C), cyclin dependent kinase 5 (CDK5), protein kinase
A (PKA), casein kinase 1 (CK1) and casein kinase 2 (CK2). The first three phos-
phatases are multimers composed of functionally different subunits. PP2C
denotes a protein family of monomeric enzymes. PKA is a multimeric protein
1Homo sapiens protein sequence: https://www.ncbi.nlm.nih.gov/protein/NP_115568.2.
Accessed 04-07-2017.
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family of kinases. The last two Caseins are distinct protein families.
The Threonine sites (Thr34, Thr75) have major regulatory roles in signal
processing. The former inhibits PP1 and the latter inhibits PKA, which in turn
phosphorylates Thr34. On the other hand, PKA activates the phosphatase of
Thr75, PP2A. The Serine sites (Ser137, Ser102) have a supporting role in Thr34
signal enhancement. Ser137 inhibits dephosphorylation of Thr34 by PP2B and
Ser102 increases phosphorylation of Thr34.
It has been shown that DARPP-32 malfunction and abundances re-
lates to multiple central nervous system (CNS) disorders. Among these are
Alzheimer disease [194], addiction [195], affective disorders [196] and schizophre-
nia [196, 197]. Its malfunction has been associated with missing phosphory-
lation sites that define its function. The lack of phosphorylation site can be
caused by splice variation, e.g. truncated DARPP (t-DARPP) [196] or protein
cleavage [194]. The former lacks Thr34 (the Rattus norvegicus protein sequence)
and the latter is cleaved at Threonine 153 (Thr153) (the Mus musculus pro-
tein sequence). Both of these mutations impair the PP1 inhibitory function of
DARPP-32. DARPP-32 is also indirectly linked to multiple diseases through its
mediation of symptoms caused by psychoactive drugs that affect DA transmis-
sion [193]. It has even been proposed as a potential drug target for dopamine-
related disorders [198].
The study of Stipanovich et al. [199] showed that nuclear accumula-
tion of DARPP-32 is promoted by drugs of abuse. They found that nuclear
DARPP-32 is essential for gene expression via phosphorylation of histone H3.
The nuclear transportation of DARPP-32 is regulated by Ser102 phoshophory-
lated by CK2.
2.2.2 Advances in DARPP-32 network modelling
An early dynamic model of DA-dependent synaptic plasticity that con-
tains DARPP-32 was built by Kötter [200]. The major aim of Kötter [200] was
to study molecular mechanisms underlying interactions between DA and Glu
afferent signalling in MSPNs. As the very first computational approach to this
problem, the model was represented as a set of equilibrium equations. The
major results report the quantitative sensitivities of phosphatases and kinases
to Glu and DA-signalling, dividing it into sensitive to the paired signals or to
Glu alone.
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Figure 2.1: Diagrammatic overview of the Lindskog et al. [201] model of glutamatergic
and dopaminergic signal integration in MSPNs.
The first ODE-based models of the DARPP-32 network were built in the
early 2000s by Lindskog et al. [201] and Fernandez et al. [177]. Similarly to the
model of Kötter [200], both models focused on Glu and DA signal integration
as an important factor of synaptic plasticity enhancing connections between
neurons of striatum.
Lindskog et al. [201] created a model of interacting cascades activated
by DA and Glu signalling that stimulated the dopamine receptor D1 (DRD1)
and influx of calcium ions (Ca2+) through the N-methyl-D-aspartate recep-
tor (NMDAR), respectively (Figure 2.1). The glutamatergic signalling cascade
included the CaMKII protein activation by calmodulin (CaM). The dopamin-
ergic signalling started with DA that bound postsynaptically to DRD1, that
as a G-protein–coupled receptor (GPCR), caused the G protein to dissassoci-
ate Gα and Gβγ subunits. Subsequently, Gα activated adenylyl cyclase (AC),
that catalysed production of cyclic adenosine monophosphate (cAMP) from
adenosine triphosphate (ATP). cAMP activated PKA, that phosphorylated
DARPP-32 at Thr34. DARPP-32 phosphorylated at Thr34 inhibited PP1, that
dephosphorylates CaMKII.
In the model Thr34 is both activated and inhibited by the Ca2+ feed-
forward signal, that is conveyed by the PKA–PP2A–Thr75 double negative
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feedback loop. PP2B dephosphorylates Thr75 but its action is enhanced by
Ca2+ and PKA. The model showed that the loop does not exclusively reinforce
PKA pathway stimulated by DA but instead acts as a competitive inhibitor for
PKA.
Lindskog et al.’s 2006 model become a foundation of a number of models
focused on different aspects of DA and Glu signalling integration, developed in
the Hellgren-Kotaleski Laboratory [179, 202, 203] and in other laboratories [204,
205]. These models only included Thr34 and Thr75 as major switching factors
between LTP and long-term depression (LTD). Since then, several models of the
system were built reusing all or some part of these three models and extending
them with downstream and/or upstream signalling events [180, 202–205].
All these dynamic models differ in the number of DARPP-32 phospho-
rylation sites included in models. Fernandez et al. [177] and Nakano et al. [180]
included three phosphorylation sites. Barbano et al. [206] and Qi et al. [204]
included four sites. These models incorporating all four phosphorylation sites,
were mainly focused on the overall system response either as a test case for a
novel method to analyse system robustness [206], or to test variable scenarios
of input signals [204]. All four phosphorylation sites have rarely been studied
in models due to the combinatorial complexity involved in modelling all com-
binations of DARPP-32 states, that was claimed as unnecessary with respect
to the studied subject [201]. For instance, a number of models of the DA and
Ca2+ signal integration have included only Thr34 and Thr75 as major switching
factors between LTP and LTD [201–203, 205]. As all models of DARPP-32 were
built with ODEs, extending such models with the additional molecular species
would cause growth in complexity of model specification. Addition of new
reactions might not only require specification of additional kinetic laws but also
rewriting the existing equations if concentrations of exiting molecular species
were affected by the added ones. This could be the least problematic task if the
enumeration of all possible molecular species was realistic to enumerate (see
an example of EGFR in Section 1.1). Therefore, if a large number of molecular
species is already included in an existing model, addition of new reactions and
molecular entities might become more difficult and laborious as the complexity
of the model increases. What often is practised in such occasions is omission of
molecular species and reactions which are assumed as non-contributing or not
affecting the subject of inquiry, or aggregation (lumping) of molecular species
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into one constituent. A simplified or reduced model might not align with the
future aims and discoveries made on the studied system. It might be argued
that reusing such reduced models as modules could be difficult. For instance,
so far only early signalling events of DARPP-32 signalling has been modelled,
localised mainly in cytosol. Therefore, Ser102 was omitted in the model be-
cause of no evidence that it can be affected by DA or Glu signalling [207, 208].
However, a recent study by Nishi et al. [17] suggests that Glu can decrease
the effect of DA signalling (phosphorylation of three other sites) by dephos-
phorylating DARPP-32 at Ser102 that causes accumulation of DARPP-32 in
nucleus.
Since DARPP-32 was first discovered by Walaas et al. [189], there has
been extensive research on its mechanisms of action driving multiple hypoth-
esis of its general role in the CNS [208]. However, most of these emerging
hypotheses have not been modelled or tested in integrated, formal represen-
tations. Moreover, ongoing research around DARPP-32 implies also need of
constant development of new models of DARPP-32-involved processes. The
traditional mode of constructing bespoke models does not help to tighten the
connection between in silico modelling and recent discoveries in molecular
biochemistry.
2.2.3 The Fernandez model of DARPP-32 signalling
Fernandez et al. [177] is a study of the integrative effect and sensitivities
of DA- and Glu-mediated signals on the DARPP-32 network in striatal DRD1-
expressing neurons. The model examined the effect of cAMP-pulse followed by
Ca2+ spike trains varying the distance between the stimuli. The study showed
that DARPP-32 is a robust integrator, indifferent both to its initial concentration
and delay between the stimuli.
At the time of the model creation, it was suggested that DARPP-32 was
a bistable-switch between DA and Glu signals, with cAMP and Ca2+ as second
messengers, respectively. The former inhibits PP1 when DARPP-32 is phos-
phorylated at Threonine 34 (Thr34). The latter inhibits PKA when DARPP-32
is phosphorylated at Threonine 75 (Thr75) counteracting DA-triggered events.
Further studies showed that the phosphorylation patterns activated by the Glu
input are far more ambiguous and complex. The study of Fernandez et al. [177]




Figure 2.2: Reaction diagrams representing different aspects of the DARPP-32 net-
work: (A) simplified with the emphasis on incoming signal and receptors, which are
not included in the model; (B) included in the ODE model by Fernandez et al. [177].
Nodes: stimuli (green), receptors (yellow), second messengers (magenta), kinas-
es/phosphatases (white). Edges: inhibiting reactions (blue), activating reactions (red).
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(A) (B) (C)
Figure 2.3: Reaction diagrams representing DARPP-32 subnetworks included in the
model: (A) double negative (positive) feedback loop (B) & (C): incoherent feedforward
loops. Nodes: phosphorylation sites of DARPP-32 (cyan), second messengers (ma-
genta), kinases/phosphatases (white). Edges: inhibiting reactions (blue), activating
reactions (red).
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To reproduce the system’s known behaviour, the authors included two
main pathways that mediate these signals, DA–cAMP–PKA–DARPP-32 phos-
phorylated at Threonine 34 (D34) and Glu–Ca2+–PP2B–DARPP-32 phosphory-
lated at Threonine 75 (D75) (Figure 2.2A).
Contrary to the model of Lindskog et al. [201] that also investigated
integration of Glu and DA signals, the reaction network consists of DARPP-32
with three phosphorylation sites: Thr34, Thr75 and Ser137. Each of these sites
has an associated kinase and phosphatase: PKA and PP2B (Thr34); CDK5 and
PP2A (Thr75); CK1 and PP2C (Ser137).
As mentioned earlier, the fourth phosphorylation site, Ser102, was not
included. The decision to exclude Ser102 from the model was based on its
weak effect on the phosphorylation of Thr34 site by PKA. Moreover, neither of
the stimuli was known to regulate Ser102’s phosphorylation.
In the model, the authors included two incoherent feedforward loops
triggered by the Ca2+ influx that both activates and inhibits Thr34. The first one
activates Thr34’s protein phosphatase, PP2B, that disinhibits CK1. This in turn
phosphorylates Ser137, known to inhibit dephosphorylation of Thr34 by PP2B
(Figure 2.3B). The second incoherent loop was induced by the enhancement
of PP2A dephosphorylation of tonically active D75 by its complexation with
Ca2+ (Figure 2.3C). Also, the phosphorylation of PP2A by PKA, activated on
cAMP signal, enhances the dephosphorylation of D75. The second incoherent
feedforward loop was designed to test the mechanism of signal integration
based on the experimentally observed decrease of both Thr34 and Thr75 on
Ca2+ stimulus [209]. The effect of this mechanism was tested by comparing
two models, “model A”, without the mechanism, and “model B”, with the
mechanism. “Model B” was represented with 32 supplementary reactions
added to “model A”. “Model B” showed a decreasing effect of Thr75 triggered
by Ca2+ influx. The results matched the experimental findings but did not
affect substantially PKA or Thr34 activity. Nevertheless, the simulation results
showed that DARPP-32 is not a bistable switch. “Model B” is used in this study
as this model variant reflected experimental results. For a detailed comparison
of mechanisms encoded in the two models see the original study of Fernandez
et al. [177].
Another important role of PP2A tested in the model was the PKA–
PP2A–D75 double negative feedback loop (Figure 2.3A). It was shown that the
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loop does not exclusively reinforce the PKA pathway activated by DA but acts
as a competitive inhibitor for PKA that balances D34 activation.
The focus of the model was on the role and sensitivities of the phos-
phatases and kinases of DARPP-32 to Ca2+ and cAMP-signals. Therefore,
although upstream events to direct DARPP-32 interactions were known at the
time, they were omitted or fused into simplified representations. For instance,
the Glu-activated cascade, including the CaMKII circuit, is represented by di-
rect Ca2+ binding to the phosphatases and kinases that act on DARPP-32. As
AC was not included in the model, the inhibitory effect of the Glu signal was
also absent from the model. Similarly to Glu-activated cascade, the pathway
directly activated by DA was also omitted by abridging the G-protein signalling
and the cAMP production step with a direct “injection” of cAMP molecules
during the simulation.
The authors also tested the role of Ser137 in model dynamics with two
in silico mutagenesis modifying its function. These mutations have two oppose
effects on Ser137. The first one inhibits the phosphorylation. In the experimen-
tal perspective, it can be compared to Serine to Alanine mutation of DARPP-32
at Ser137 (Ser137Ala), where Serine at 137 position is mutated to Alanine. It
was achieved by setting all catalytic constants to 0 in phosphorylation reactions
of DARPP-32 at Ser137 induced by kinase CK1. In consequence, CK1 can bind
to DARPP-32 but the site cannot be phosphorylated. This mutation enhances
the effect of Ca2+ stimuli on the Thr34 site phosphorylation manifested in its
greater drop in concentration after the Ca2+ stimulus than in the unmodified
model.
The second mutation leads to indefinite phosphorylation, where the
Ser137 site is always phosphorylated (constSer137). It was set by changing all
catalytic constants to 0 in dephosphorylation reactions of DARPP-32 at Ser137
induced by phosphatase PP2C. As Ser137 inhibits dephosphorylation of Thr34,
the mutation resulted in sustained effect of the cAMP stimulus and little impact
of the Ca2+ stimulus on Thr34 dephosphorylation.
2.3 Methodology
The aim of this chapter is describe the set of procedures to perform
a direct comparison of RB and ODE frameworks. Figure 2.4 shows a brief
outline of the approach. To obtain two representation of the same molecular
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Figure 2.4: Approach to methodology for comparison of ODE and RB modelling frame-
works. Source of graph plots: Wikipedia
system, in the first step, reactions underlying the ODE model of Fernandez
et al. [177] are translated to a RB language. In the next step, both models
are simulated with variable modifications to obtain time courses of selected
observables. Model translation can be divided into components that consists
of definitions of molecular agents, translation of rate constants and molecular
abundances from concentrations to copy numbers, encoding of stimuli during
the simulation and the simulation settings. In the next part of this section,
procedures required to compare time courses obtained with simulations are
described. Two variants of modifications applied to models’ baseline settings
are presented as well as details regarding applied simulators and a method of
selecting equivalent observables.
2.3.1 Model translation
In order to translate the model from ODE to RB, reactions underlying
the set of equations are decontextualised. This involves identification of agents
that have persistent molecular identities and generalisation of reactions into
reaction patterns that contain only relevant information denoting necessary
conditions for reaction to occur. We also need to translate molecular concentra-
tions, rate constants and initial molecular abundances to copy-numbers. Lastly,
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the cAMP pulse and the Ca2+ spiking, specified as events in the original model,
are translated into the RB syntax as a set of modification rules executed during
the simulation.
2.3.1.1 Definition of agents
Of 75 molecular species in the model, 11 were identified as agents,
based on their persisting chemical identity as described in Section 1.5.1.1.
Agent’s signatures were defined based on internal states and binding capabili-
ties contained in reaction definitions. Signatures of agents with more complex
structures are described here in more detail. These are DARPP-32, PP2A, PP2B
and R2C2, a heterotetramer harbouring inactive PKA.
The signature of DARPP-32 is defined with one binding site and three
internal states, each with phosphorylated and unphosphorylated states. The
binding site has multiple binding partners, which are the kinases and phos-
phatases of the three phosphorylated sites.
PP2A was defined as having two binding sites, one for Ca2+ and the
other for PKA and D75. The latter binding site has two states, phosphory-
lated and unphosphorylated. This particular design is implemented under
two assumptions. First, the phosphorylation state and binding to Ca2+ are
independent of binding to PKA or D75. Secondly, PP2A exclusively binds to
either PKA or D75.
PP2B is activated if bound to four Ca2+ ions. Hence, its signature was
defined with four Ca2+ binding sites and a separate site reserved for an internal
state description, either “active” or “inactive”. As in the ODE model, PP2B
binds to two Ca2+ ions at a time.
A kinases phosphorylating DARPP-32 at the Thr34 site, denoted as PKA,
is in fact protein kinase cAMP-activated catalytic subunit (PKAc), which in the
inactive form is a part of heterotetramer R2C2. It consists of two regulatory
and two catalytic subunits, protein kinase cAMP-activated catalytic subunits
(PKAcs) and protein kinase cAMP-dependent regulatory subunits (PKArs).
PKAc is activated by dissociation from regulatory subunits by binding of four
cAMP to R2C2. This mechanism was encoded by the introduction of an R2C2
agent with four binding sites for cAMP and two internal states, “on” and “off”,
denoting disassociation of two catalytic subunits, further called as PKA for
consistency with the original model. If all four binding sites are occupied,
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then one of the two states turns “on” and one PKA agent is created during the
simulation.
2.3.1.2 Translating reactions into rules
The rules of the RB model were encoded based on the list of reactions
published in Fernandez et al. [177] as “model B”. It is composed of 152 elemen-
tary irreversible chemical reactions that are combined with the same number
of rate constants to define rate laws. All reactions can be divided into three
classes: binding, phosphorylation and creation. Each of these reaction classes is
complemented with counteracting reactions: dissociation, dephosphorylation
and degradation. The phosphorylation and dephosphorylation occurs in two
steps. First, a kinase or phosphatase binds to its substrate, then it dissociates
with or without the site phosphorylated or dephosphorylated. It is assumed
that kinase or phosphatase can bind to its substrate on the condition that the
substrate is not already phosphorylated or dephosphorylated at the target site.
This assumption is called as absence of product rebinding [177].
As explained in Section 1.5.1.2 of the introductory chapter, a reaction
can be written as a rule and therefore, the translation could have been ac-
complished in a one-to-one manner. However, to fully take advantage of rule
patterns, multiple reactions can be condensed into fewer rules by removing ir-
relevant context, i.e. decontextualised. The context of a reaction in the RB model
is defined as the information about the agent’s binding sites, partners and in-
ternal states. Based on this definition of reaction context, the following criteria
guided decisions about condensing reactions into rules. Given a set of reactions
of the same type, either forward, backward, or catalytic, between two the same
reactants (agents), if the difference between reactions lays in agent states, either
internal or binding, that does not change after the transition from reactants to
products, and reaction constants in all these reactions have the same values,
then information about agent states is redundant to define reaction conditions;
hence, they can be removed from the reaction notation and form a single rule
pattern. For instance, the following reactions represent binding of DARPP-32
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by CDK5, that in the next step catalyses phosphorylation of Thr75:
D + CDK5 kon1−−−→D−CDK5 (2.1)
D34 + CDK5 kon4−−−→D34−CDK5 (2.2)
D137 + CDK5 kon11−−−−→D137−CDK5 (2.3)
D34:137 + CDK5 kon18−−−−→D34:137−CDK5 (2.4)
To represent binding of CDK5 to DARPP-32, reactions for four different states
of DARPP-32 are specified: unphosphorylated DARPP-32 (“D”), DARPP-32
phosphorylated only at Thr34 (“D34”), DARPP-32 phosphorylated only at
Ser137, and DARPP-32 phosphorylated at Thr34 and Ser137 (“D34:137”). Be-
cause of the absence of product rebinding, CDK5 binds to DARPP-32 only
when the Thr75 site is unphosphorylated. Therefore, combinations of states
with phosphorylation of Thr75 are not mentioned in the reaction set. To in-
dicate that an enzyme could bind to the product of its activation, these four
reaction have to be complimented with another four reactions between CDK5
and four combinations of DARPP-32 phosphorylated at Thr75. The rate con-
stants, written above each reaction arrow (“kon1”,“kon4”, “kon11”, “kon18”),
are the same for all four reactions. With earlier mentioned translation criteria,
this set of reactions can be translated to a rule as in Code 2.1.
Code 2.1: Rule representation of CDK5 binding to D75 (no product rebinding)
1 D(s, thr75˜u), CDK5(a) -> D(s!1, thr75˜u), CDK5(a!1) @’kon1’
The full signature of agent representing DARPP-32 is:
1 %agent: D(s, thr34˜u˜p, thr75˜u˜p, ser137˜u˜p)
The binding site is denoted as “s”. Three phosphorylation sites as “thr34”,
“thr75” and “ser137”, that can be in either of two states: “˜u” or “˜p”. In
the rule specified in Code 2.1, the “thr75” site is explicitly mentioned to be in
the unphosphorylated state when binding to “CDK5” because of the absence of
product rebinding. Because all rate constants are the same for four possible
states of DARPP-32 when CDK5 binds to it, the actual binding reaction is
independent of the states of two remaining sites, and therefore, the rule in
Code 2.1 represents all four reactions. There are exactly two elements of context
that condition reaction execution:
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• binding sites of interactors are free
• “thr75” site is in state “u”
Removing the second condition would mean that the product can rebind to
its enzyme. Encoding of such assumption, showed in Code 2.2, is the most
generic rule for binding of CDK5 to DARPP-32.
Code 2.2: Rule representation of CDK5 binding to D75 (product rebinding)
1 D(s), CDK5(a) -> D(s!1), CDK5(a!1) @’kon1’
The above example describes a case where phosphorylation sites are
independent of each other, that is their states do not inhibit nor change reaction
rates. In the set of reactions describing the model of Fernandez et al. [177] not
all phosphorylation sites are independent of each other. These dependences
can be first observed in the variation of values of constant rates assigned to
each reaction. In the rule notation, it results in more detailed context definition
for a reaction, i.e. more precision in the rule specification. For instance, since
all variations of DARPP-32 phosphorylated at Thr75 inhibit phosphorylation
of Thr34 by PKA, the state of Thr75 has to be explicitly mentioned in the rule
specification. Rules defined in Code 2.3 determine necessary conditions for
the Thr34 phosphorylation. The first rule alone is sufficient to describe this
behaviour; however, to allow for future exploration of the Thr75 inhibition
of PKA as encoded in the ODE model, the second rule is also included in
the RB model. In the baseline setting, the catalytic constant of the second rule
(“kcat8”) is set to zero and therefore, this rule will not be selected for execution
as its activity is also equal to zero (Section 1.5.2).
Code 2.3: D34 phophorylation rules
1 D(s!1, thr34˜u, thr75˜u), PKA(a!1)
2 -> D(s , thr34˜p, thr75˜u), PKA(a ) @’kcat3’
3
4 D(s!1, thr34˜u, thr75˜p), PKA(a!1)
5 -> D(s , thr34˜p, thr75˜p), PKA(a ) @’kcat8’
There are other examples of such influence that phosphorylation sites
have on each other. For instance, D75 is a poor substrate for PP2B, that is en-
coded as an increase in the off -rate dissociating PP2B from DARPP-32, when-
ever Thr75 is phosphorylated. The next example is DARPP-32 phosphorylated
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at Serine 137 (D137) that is also a poor substrate for PP2B. This fact is en-
coded as a decrease in all rates of Thr34 dephosphorylation by PP2B if Ser137
is phosphorylated.
All above mentioned rules represent the first binding step of the two
leading to substrate phosphorylation that, in this example, activates one of the
sites of DARPP-32. It is the simplest activation scheme in the reaction set. There
are also cases of more complex substrate activations, where multiple molecules
of the same type bind substrates on multiple sites, further called as combinatorial
binding. This require a particular approach, applied after Danos et al. [210], as
the Kappa syntax explicitly defines binding sites of interactors where each
binding site has to be unique and therefore, all binding combinations had to be
explicitly encoded.
The PKA and PP2B activation schemes are two such complex cases.
PKA activation is encoded as a combinatorial binding of four cAMP molecules
to four identical sites of R2C2 that dissociates into two catalytic subunits. More-
over, only one cAMP molecule can bind at a time. Similarly, PP2B activation
requires four Ca2+ ions to bind. However, because two Ca2+ ions bind to PP2B
at a time, as specified by the original model, its activation required less bind-
ing combinations to be represented as rules. As an example of combinatorial
binding, we can compare one of four PP2B activation represented as reactions
is defined as follows:
PP2Bi + 2Ca −−−→ PP2BiCa2 (2.5)
This reaction is encoded as six rules with Code 2.4. Each rule is written in two
rows with the left hand site of the rule in odd numbered rows and the right
hand site in even numbered rows starting with an arrow (->). All possible
bindings of two Ca2+ ions to two of four PP2B sites are explicitly defined.
The same method of notation is used for PKA activation reactions with the
difference that only one cAMP molecule can bind at a time.
Code 2.4: PP2B activation - first reaction
1 PP2B(ca1 ,ca2 ,ca3 ,ca4 ,state˜i),Ca2+(a ),Ca2+(a )
2 -> PP2B(ca1!1,ca2!2,ca3 ,ca4 ,state˜i),Ca2+(a!1),Ca2+(a!2)
3
4 PP2B(ca1 ,ca2 ,ca3 ,ca4 ,state˜i),Ca2+(a ),Ca2+(a )
5 -> PP2B(ca1!1,ca2 ,ca3!2,ca4 ,state˜i),Ca2+(a!1),Ca2+(a!2)
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6
7 PP2B(ca1 ,ca2 ,ca3 ,ca4 ,state˜i),Ca2+(a ),Ca2+(a )
8 -> PP2B(ca1!1,ca2 ,ca3 ,ca4!2,state˜i),Ca2+(a!1),Ca2+(a!2)
9
10 PP2B(ca1 ,ca2 ,ca3 ,ca4 ,state˜i),Ca2+(a ),Ca2+(a )
11 -> PP2B(ca1 ,ca2!1,ca3!2,ca4 ,state˜i),Ca2+(a!1),Ca2+(a!2)
12
13 PP2B(ca1 ,ca2 ,ca3 ,ca4 ,state˜i),Ca2+(a ),Ca2+(a )
14 -> PP2B(ca1 ,ca2!1,ca3 ,ca4!2,state˜i),Ca2+(a!1),Ca2+(a!2)
15
16 PP2B(ca1 ,ca2 ,ca3 ,ca4 ,state˜i),Ca2+(a ),Ca2+(a )
17 -> PP2B(ca1 ,ca2 ,ca3!1,ca4!2,state˜i),Ca2+(a!1),Ca2+(a!2)
2.3.1.3 Translation of concentrations to copy-numbers
In deterministic ODE-based models measured units are concentration-
based, denoting molecular abundance per unit volume. RB models are defined
in a stochastic framework and therefore, they are based on the numbers of
molecules [119]. For instance, the reaction rate in deterministic models is ex-
pressed in M/s, whereas the reaction rate in stochastic models is s−1. Therefore,
the units of the ODE model can be related to the RB model by a factor of vol-
ume (V) and Avogadro’s constant (A). In the Fernandez et al. [177] model,
V was equal to 1×10−15 l, denoting the volume of a dendritic spine compart-
ment. Avogadro’s constant is defined as the number of particles within a mol
of substance, equal toA = 6.02214129×1023 mol−1.
All conversions were performed as described in the Kappa manual [157]
and a primer for rule-based modelling [154]. The following paragraphs present
detail of the conversion of molecular abundances and rate constants.
Except for this standard approach to translation of deterministic to
stochastic units, other modifications of parameters aiming to match the RB
model to the ODE one were not attempted. This decision was dictated by
the aim to expose differences between rules and reactions defining the ODE
model with the same parameter values. By preserving the original parameters,
particular groups of rules that require adjustments regarding rate constants are
exposed and discussed.
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Conversion of rate constants In the reaction rate equations, the rate con-
stant is a constant of proportionality that relates reaction rates to reactant con-
centrations that are raised to the power of their respective reaction orders. The
order of reaction, defined per reactant or product, is an experimentally defined
exponent. This formulates a reaction law (Equation 2.8). A deterministic reac-
tion rate is defined as a change of initial species concentrations per time unit
(Equation 2.7), which in the stochastic framework is understood as a reaction
probability per time unit [119]. The reaction law for an elementary reaction
in the deterministic framework is based on the law of mass action, which also
applies directly to the stochastic reaction rates. The law generally states that
the reaction rate is proportional to the product of reactant concentrations [105,
p.141].
Given a following reaction
aA + bB −−−→ cC (2.6)
A, B and C are reactants and a product of the reaction, and a, b and c are

















that is equal to the following rate law:
r = k[A]x[B]y (2.8)
The k is the concentration based reaction constant. The exponents x and y will
both take values of 1, resulting in the total reaction order of 2.
In an elementary reaction, a partial order of reaction with respect to a
reactant is equal to a stoichiometric coefficient of the reactant. An elementary
reaction is a single step and single transition reaction that is defined with no
intermediates on a molecular level [211]. The overall order of an elementary
reaction is the same as its molecularity. Molecularity of a reaction is the num-
ber of reacting molecules and is deduced from a balance equation. The order
of reaction, stoichiometric constant and molecularity have no relation if a re-
action occurs in multiple steps [211]. In the Fernandez et al. [177] model, all
enzymatic processes where decomposed into three elementary reaction steps.
Based on this assumption, the units of reaction constants in the Fernandez et al.
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[177] model were defined. It is an important note as the units of determinis-
tic rate constants depend on the total reaction order, that also determines the
conversion to stochastic rates. The unimolecular reactions are first-order with
units of s−1. These are reactions of dissociation, phosphorylation and dephos-
phorylation. Bimolecular reactions, mostly formalising binding reactions, are
second-order with units M−1.s−1. Two reactions are trimolecular, where two
ions of Ca2+ bind to one molecule of PP2B, free or occupied with other Ca2+
ion. This is a third order reaction with units M−2.s−1. There is one zero-order
reaction for Ca2+ influx with units M.s−1.






where V is the volume, A is the Avogadro’s number, n ≥ 0 is a total reaction
order.
In the original model, around 65% of reaction constants were estimated
to match concentrations of different phosphorylation states of DARPP-32 ob-
served in vivo at the steady state and reviewed by Svenningsson et al. [208]
[177]. The remaining 35% are derived from the Database of Quantitative Cel-
lular Signaling (DOQCS) [212], BRENDA [213] and two published models of
hippocampal [214] and cerebellar brain regions [215].
Conversion of molecular species abundances The conversion of molecu-
lar abundances is necessary to specify initial molecule states. In deterministic
models they are defined in mole/l (M). To translate the concentration to the
number of molecules, the concentration is multiplied by V andA in l/mol units
[157]. However, because all the initial states were provided in the Fernandez
et al. [177] paper in both molecular numbers and concentrations, there was no
need to apply this rule.
2.3.1.4 Stimuli application
Modifications are designed to reproduce the stimulus of the original
model. It includes two stimuli during the course of the simulations. These are
sudden and large increases of cAMP and Ca2+ (Figure 2.5).
The cAMP pulse is followed by ten Ca2+ spike trains after 50 seconds.
Ca2+ is introduced to the system with a constant influx and outflux of Ca2+
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Figure 2.5: During the course of simulation of the DARPP-32 network model, two
different types of stimuli are introduced. These are a cAMP pulse and 10 Ca2+ spikes.
The first one occurs after 200 seconds and the second one after 250 seconds.
from the onset of the simulation. The induction of the spike train in the ODE
model is based on incease of the rate constants for Ca2+ creation (“k57”) from
2.5×10−8 M/s to 6.6×10−6 M/s every 4th second for a period of 2 seconds. This
scheme is reproduced in the RB model by translating the concentration-based
rate constants to stochastic rate constant with Equation 2.9. The variable n is
set to 0 as the reaction is zero-order. The basal stochastic rate constant Ca2+
creation is 15 /s and is increased to 3947 /s for spike train induction. Code 2.6
shows specification of Ca2+ spike train in the RB model.
Unlike Ca2+, cAMP is not present in the system at the beginning of the
simulation. It is introduced by addition of 4000 molecules after 200 seconds of
simulation. It is encoded in the RB model as in Code 2.5.
Code 2.5: Specification of a cAMP pulse
1 %mod: [T]=200 do $ADD 4000 cAMP(a, c˜on)
Code 2.6: Specification of ten Ca2+ spikes
1 %mod: [T]>250 do $UPDATE ’k57’ 3974
2 %mod: [T]>252 do $UPDATE ’k57’ 15
3 ...
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4 %mod: [T]>286 do $UPDATE ’k57’ 3974
5 %mod: [T]>288 do $UPDATE ’k57’ 15
2.3.1.5 Simulation settings
Model simulations were executed on Linux Operating System in bash
command-line with KaSim software version 3.5-250915 with the following com-
mand specifying input files and options:
1 #!/bin/bash
2 KaSim -i init.ka -i rates.ka -i rules.ka -i stimuli.ka -i
observables.ka -t 700 -p 1400 -o ./results.out
Five input files are provided followed by the -i indicator. These files contain
components of model specification: agent signature and their inital abundances
(init.ka), Variables representing rate constant names with assigned values
(rates.ka), rules (rules.ka), stimuli (stimuli.ka), and observables (observables
.ka). Three remainig option indicators, -t, -p, -o, set the time of simulation
in seconds (-t), the number of data points recorded per observable over the
indicated time of simulation (-p) and the output file (-o). The simulation is set
to last 700 seconds with two data points recorded every second resulting with
1400 points reported per observable.
2.3.2 Approach to comparison of models
The results of simulation of a dynamic model are represented in a form
of variations of observable quantities recorded per time point called as time-
series or time courses. To directly and systematically compare two dynamic
model results, their time courses of corresponding observables could be directly
superimposed for visual evaluation. However, before it could be performed
on the models in question, there are three major aspects to be determined in
order to make models become directly comparable in such manner. Firstly, we
have to identify analogous observables in two models to compare against each
other. Secondly, models are simulated in different schemes, that is determin-
istic and stochastic. The most preferable condition would be to compare both
timeseries simulated in the same scheme. Therefore, either the RB model has to
be deterministically solved or the ODE model simulated stochastically. Lastly,
models can be modified to illustrate various biological conditions of the same
molecular reaction system. By comparing models in variable conditions, we













Figure 2.6: Approach to comparisons of time-series. Both models are run in a stochas-
tic scheme in different conditions affecting the binding site availability of DARPP-32
and site-mutations of Ser137.
could compare models on broader levels and obtain better understanding of
exposed differences.
All these basic requirements are met as outlined on Figure 2.6. Both
models are simulated in the stochastic scheme but in different simulation
environments. The RB model is simulated with KaSim, which is its native
simulation environment. Whereas the original model with COPASI, which is
a common simulation environment for models defined in the SBML format
[112]. Both models are simulated in three different settings reflecting three
experimental phenotypes. The base-line setting is called a wild-type and two
others represent site-directed mutations applied in the original study of Fer-
nandez et al. [177] (see Section 2.2.3). The RB model is additionally tested with
two different binding schemes, further called as noncompetitive and compet-
itive binding. In the noncompetitive binding all interactors of DARPP-32 can
bind simultaneously to three different sites. The competitive binding assumes
that only one interactor can bind at the same time as there is only one binding
site. The latter scheme reflects the assumption of the ODE model and therefore,
is treated as a baseline scheme of the RB model.
Each of these aspects is described in greater detail in the following
2.3. Methodology 63
sections.
2.3.2.1 Variable conditions of model
Modifications of model’s basal conditions that mimic experimental per-
turbations is an important feature of a strong modelling framework. Therefore,
to extend the spectrum of aspects compared between RB and ODE modelling
frameworks, models were subjected to variable types of modifications. The
first type is based on modification of rate constants. It is seemingly the eas-
iest approach applied in ODE-based models. This type of modification was
used to induce site-directed mutations in the Fernandez model. It is important
to establish if this type of modification applied to the ODE model will give
similar results when performed on the RB one. Therefore, a similar modifica-
tion of appropriate rate constants is applied in the RB to emulate site-directed
mutations.
The other type of modification applies only to the RB model as it is spe-
cific to the RB model notation. It is based on increase of the number of agent’s
binding sites. This type of modification was not applied in the ODE model as
it would require to extend the model with additional molecular species rep-
resenting molecular complexes that are formed when the number of binding
sites is larger than one. As discussed in Section 1.1 of the introductory chapter
and will be discussed in more detail in the coming section (Section 2.3.2.1),
it is particularly problematic to enumerate and encode the resulting number
of molecular species in the ODE-based framework. In this case, the RB model
is not compared to the ODE one but rather compared to the RB model that
conforms to the ODE model assumption of a single binding site of DARPP-32.
Site-directed mutations As described in Section 2.2.3, the Fernandez model
was tested with two types of site-directed mutation of Ser137: Serine to Ala-
nine mutation of DARPP-32 at Ser137 (Ser137Ala) and constitutive Ser137
(constSer137). Mutations are designed to induce oppose effects on Ser137.
The first one inhibits the site phosphorylation, the second one, leads to its sus-
tained phosphorylation. In both cases, the modification of the model was based
on inactivation of particular set of reactions by turning to zero their constant
rates.
Reactions suppressed in Ser137Ala mutation are phosphorylation re-
actions of DARPP-32 at Ser137 by CK1. To introduce this mutation in the
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RB model, the catalytic constant of the rule that define phosphorylation of
DARPP-32 at Ser137 by CK1 was set to zero (“kcat2”). In the ODE model, it
was performed by setting “kcat2”, “kcat5”, “kcat7” and “kcat14” catalytic
constants to zero. These four constants parametrise four phosphorylation re-
actions of DARPP-32 at Ser137 by CK1. Each reaction has the same reactant,
which is a complex composed of DARPP-32 bound to CK1, with the exception
that DARPP-32 is in four variations of phosphorylation states at two other
phosphorylation sites. These four reactions are represented by one rule in
RB model, and therefore, a change of a single constant induced the Ser137Ala
mutation.
A similar procedure was performed to induce the constSer137 mutation.
In the ODE model suppressed reactions represent dephosphorylation reactions
of DARPP-32 at Ser137 by PP2C. The induction of mutation was based on
setting “kcat13”, “kcat20”, “kcat24” and “kcat28” catalytic constants to zero.
These four rate constants parameterise four reaction instances of PP2C that
dephosphorylate DARPP-32 at Ser137. Similarly to the first mutation, this set
of four reactions is defined with a single rule in the RB model. The constSer137
mutation in the RB models was performed by setting to zero a single catalytic
parameter, “kcat13”.
Variation of the number of agent’s binding sites Unlike in ODE model
specification, the syntax of rules with the agent signature denoting binding
sites and states, brings the protein interface to the attention of a modeller. The
Fernandez et al. [177] study does not discuss if DARPP-32 binding partners bind
to the same or different active sites. However, based on the ODE model spec-
ification, we can say that only one kinase or phosphatase can bind DARPP-32
at a time, as there is no molecular species representing complexes of more than
one binding partner (Figure 2.7A). As DARPP-32 is an intrinsically disordered
protein with nothing known about its 3D structure, the exact binding interface
of DARPP-32 to its partners has not been reported [9, 216–218].
One could ask how a different binding scenarios can change dynamics
of the DARPP-32 network. For instance, we could assume a less competitive
binding scenario, where kinases and phosphates concurrently bind to their
respective phosphorylation sites (Figure 2.7B). To define an ODE model for the
DARPP-32 interaction network where all three phosphorylation sites bound at
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(A) (B)
Figure 2.7: Two scenarios of binding schemes depicting implications of change in the
number of binding sites. In the non-competitive case (A), phosphorylation sites can
bind its respective kinases and phosphatases. In the other scenario (B), there is only
one site that is able to bind. This induces competition between interactors.
the same time to one of the two possible partners would require addition of new
equations and updating the existing ones. There are 42 equations representing
molecular species with DARPP-32. The new equations would have to represent
additional molecular species of all possible complexes composed of DARPP-32
and three of six other proteins including variations of three phosphorylation
sites. The fact that it is difficult to enumerate all these species and that it is
unknown if such complexes appear in this interaction network might have
decided on the competitive binding assumption in the ODE model.
Contrary to the ODE model specification, a definition of such binding
scenario in the RB notation requires exactly the same number of rules, provided
that concurrently bound interactors do not influence each other. The major
aspect that differentiates definitions of two binding scenarios in the RB syntax is
the DARPP-32 agent signature in rules where DARPP-32 is involved. Code 2.7
shows the complete signature of agent DARPP-32 definition that reflect the
original model assumption of a single binding site. Only “s” site can bind,
the rest of sites can only alter their internal states between “u” and “p”. The
equivalent complete signature that represents the alternative scenario of three-
binding partners is shown in Code 2.8. In these case each site with internal state
has also binding ability. The first scenario, where DARPP-32 has one binding
site, represents a competitive binding and the second, where DARPP-32 has
three biding sites, a less-competitive binding of enzymes to the substrate.
Code 2.7: One-binding site DARPP-32 agent definition.
1 %agent: D(s, thr34˜u˜p, ser137˜u˜p, thr75˜u˜p)
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Code 2.8: Three-binding site DARPP-32 agent definition.
1 %agent: D(thr34˜u˜p, ser137˜u˜p, thr75˜u˜p)
We can visualise these differences in the agent binding availability with
contact maps (defined in Section 1.5.1.6 of introductory chapter). Figure 2.8A
represents the contact map of DARPP-32 as defined in Code 2.7 and Figure 2.8B
as in Code 2.8.
As it is easy with RB modelling to define different versions of binding
availability of DARPP-32, the RB model is simulated in both scenarios and
corresponding time courses are compared. The following section will present
the methodology for direct comparison of model dynamics.
2.3.2.2 Simulating deterministic model with stochastic method
Given the time the model by Fernandez et al. [177] was build in, it is a
rare modelling study with a particular stress on reproducibility. As mentioned
before, there are in fact two models: “model A” and “model B”. The latter being
an extension of the former. Both models are provided with the publication and
encoded in two formats: SBML (version 2.0) and E-Cell (version 3) [219]. Both
are also published in BioModels database [184]2. They are also available in
multiple formats as they passed the manual curation procedure and became
automatically translated to other formats such as a molecular pathway standard
format BioPAX, and formats readable in other simulation environments like
Octave, SciLab, XPP and VCML. In spite of a great selection of available formats,
it was unclear whether the model could be run with the stochastic simulation
as it was intended and designed to be solved deterministically. Particularly if
we consider that 11 years passed since the original publication and a lifespan
of scientific software tends to be relatively short.
First attempts of running simulations were primary concentrated on
two model formats provided with the publication as directly indicated by the
authors. The model was executed in E-Cell version 3 simulation environment.
Unfortunately, rerunning the model in this format poses some difficulties.
Firstly, E-Cell version 3 requires to specify a simulation file that determines
details of the simulation, which is not provided with the publication. It involves
first to acquire some experience with the simulation language, which for the
3rd version is poorly documented. The other approach would be to run the
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model with the latest version of the simulator, supported with a more detailed
manual. However, the 3rd version is not forward compatible with the 4th
version as it does not accept a model encoded in the native format of the 3rd
version, with the “.eml” file extension, that the model is encoded in.
However, by including the model in the SBML format that is indepen-
dent of any specific simulation tool or method, the authors have opened a
number of alternative routes to simulate the model. Therefore, due to the
above mentioned difficulties with the native simulator, SBML was favoured as
a more flexible and versatile format. This format allowed testing of multiple
stochastic simulation tools designed to load models in the SBML format, among
which were COmplex PAthway SImulator (COPASI) [112], Python packages
like libRoadRunner [220] and StochPy [221]. With the exception of COPASI
in version 4.20, all tested stochastic simulators failed to simulate the model.
The most frequently occurring issue was related to the fact that the model in-
cludes events executed during simulation. These are encoded in SBML format
with the “Events” syntax component that triggers modification of an indicated
model variable at a certain time point of the simulation. In the Fernandez
et al. [177] model, it is used to introduce the stimuli, the cAMP pulse and Ca2+
spikes. The same issue was encountered with previous versions of COPASI,
which are incapable to run through the Ca2+ spiking events. This failure was
reported and the next version fully executed the model simulation.
To conclude, the final time-series of the original model were obtained
using the SBML model file with COPASI in the version 4.20. COPASI al-
lowed running of the same model with the deterministic solver (LSODA) and
stochastic simulator. The stochastic simulator is an implementation of direct
method introduced by Gillespie [119]. The units of abundances of molecular
species were set to be reported in copy numbers, in agreement with the units
of observables reported by the KaSim simulator.
2.3.2.3 Selecting and pairing observables
The complete list of molecular species abundances defined to be tracked
in the ODE model is 753. These molecular species are composed of variations
in binding partners and internal states of 11 molecules. To obtain more general
representation of the species of interest and present them in the original pub-
3List of molecular species (physical entities) of the Fernandez et al. [177] model on the
BioModels website: https://www.ebi.ac.uk/biomodels-main/BIOMD0000000153
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lication, the time courses of appropriate species were selected and summed
up to represent a single aggregated variable. For instance, “D34” is an ag-
gregated variable that contains counts of all molecular species of DARPP-32
phosphorylated at Thr34 regardless the states of other phosphorylation sites
and presence of binding partners. As the ODE model output results indicate,
there are 22 molecular species that match the definition of “D34”, which are
identified by presence of “34” in molecular species names. The concept of
aggregated variables corresponds to observables in RB modelling and therefore,
the term observable will be used here also for the ODE aggregated variables. As
described in Section 1.5.1.4 of the introductory chapter, variables traced over
the simulation of RB model are defined by a modeller as patterns with a de-
sired level of pattern completeness. For instance, to obtain a similarly defined
variable to “D34” from the RB model simulation, an observable is specified with
a partial pattern of DARPP-32 agent’s interface (Code 2.9) that will represent a
sum of trajectories of molecular species that are phosphorylated at the Thr34
site.
Code 2.9: D34 observable definition
1 %obs: ’D34’ D(thr34˜p)
In the original publication, there are seven observables that time courses
are plotted. Among them, there are three major observables denoting three
phosphorylated sites of DARPP-32. They are named as D34, D75 and D137, so
that all phosphorylation at the sites could be followed regardless of the states
of the other sites. It also means that these observables encompass overlapping
sets of molecular species. For example, the D34 observable counts molecular
species that are also phosphorylated on Thr75 and Ser137, bound or free. For
the same reason, overlapping sets of molecular species compose the other
plotted observables, unphosphorylated DARPP-32, PKA, Ca2+ and cAMP.
This list of the seven observables was extended to compare dynamics of
other molecules defined in the models. The choice of observables was guided
by an aim to capture impact of interactions on molecules. It can be generally
reduced to the following principles:
• if an agent has internal states, the activated state is set as its observable
form, e.g. “CK1(pSite˜u)”
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• if an agent is created and degraded over the simulation, its observable is
set to its least specific form, e.g. “PKA()”
• if an agent is not created and degraded during the simulation and thereby
its level remains constant throughout the simulation, and has no internal
states, its observable is set to its bound form, e.g. “CDK5! ”
To match observables of the RB model to the observables of the ODE
model, a list of partial strings was selected to group and sum species trajec-
tories of the ODE model output into a list of aggregated variables. To verify
this approach, obtained relevant observables of ODE model with this method
were visually compared with the seven observables plotted in the original
publication.
Table 2.1 presents a full list of names for RB and ODE observables that
trajectories are compared, accompanied by their descriptions.
2.4 Results
This section presents the comparison results of the ODE model to the
RB one. The models are compared with respect to two major aspects. The
first one is a model notation. It is analysed by dividing and comparing sizes
of model components. The expected result of this comparison is that the
reaction set underlying the ODE model will be represented with fewer rules.
This expectation is dictated by the main characteristics of RB modelling, that a
single rule can represent multiple reactions by expressing pattern that matches
multiple reactions.
The second aspect is based on analysis of model dynamics, where align-
ment of equivalent time courses obtained by simulating the models is analysed.
The comparison of time courses is performed between three variants of each
model. The first variant is a base-line condition (wild-type), and two other
variants are earlier mentioned site-directed mutations, that act in an opposite
manner on the phosphorylation of Ser137 by either blocking it (Ser137Ala)
or indefinitely activating (constSer137). Comparing models in these variable
conditions can elucidate whether the RB model can be modified in the same
manner as the ODE one, that render similar pattern of dynamics. This can
potentially augment understanding of differences between the models. Lastly,
to leverage the advantage of RB language regarding ease of modifying agents’
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RB ODE Definition
cAMP* cAMP cAMP binding unspecified
free Ca* free Ca Ca2+ unbound
all Ca* all Ca Ca2+ binding unspecified
PKA* PKA PKA binding unspecified
CDK5 * CDK5 CDK5 bound
CK1u* CK1u CK1 unphosphorylated, binding unspecified
PP2Ap* PP2Ap PP2A phosphorylated, all bindings unspecified
PP2ACa* PP2ACa PP2A bound to Ca2+, phosphorylation and
other bindings unspecified
PP2C * PP2C PP2C bound
PP2Bactive* PP2Bactive PP2B active, binding unspecified
PDEp* PDEp PDE phosphorylated, binding unspecified
D* D DARPP-32 unphosphorylated at all sites, bind-
ing unspecified
D34* D34 DARPP-32 phoshophorylated at Thr34 with
unspecified binding, other sites’ internal states
and binding unspecified
D75* D75 DARPP-32 phoshophorylated at Thr75 with
unspecified binding, other sites’ internal states
and binding unspecified
D137* D137 DARPP-32 phoshophorylated at Ser137 with
unspecified binding, other sites’ internal states
and binding unspecified
Table 2.1: RB observable names and corresponding ODE observable names with defi-
nitions. To obtain the ODE observables, the time-series of appropriate multiple molec-
ular species are summed, based on their names.
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ODE model RB model
Model Component Total counts Total counts Model Component
Reaction instances 152 132 Reaction rules
Concentration-based rate constants 152 62 Stochastic rate constants
Initial concentrations 75 8 Initial copy numbers
Molecular species 75 91/137 Molecular species
Stimuli events 21 21 Stimuli events
Table 2.2: Model specification can be divided into components. The total counts of
elements in each component is shown for the ODE and the RB model.
binding interfaces, and to reflect on alternative hypothesis of binding abilities
of DARPP-32, two variants of the RB model are compared. The first variant
corresponds to the assumption implemented in the ODE model. This vari-
ant represents DARPP-32 as an agent with a single binding site. The second
variant implements a hypothesis where DARPP-32 have three independent
binding sites. Results obtained in this section are summarised and further
discussed in a separate section.
2.4.1 Comparison of model specification
A model specification can be considered as a first layer of comparison
that demonstrates differences between the ODE and the RB models. The spec-
ification of models can be divided into components that are typically present
in most dynamic molecular models, such as molecular species that trajectories
are monitored over the simulation, initial concentrations of these molecular
species, and rate constants defining how fast reactions occur. Table 2.2 com-
pares the total counts of these components in each of the two models. The ODE
model is defined based on 152 elementary irreversible reactions that combined
with the same number of rate constants form rate laws. These rate laws are used
to define 75 equations, each determining trajectory of one molecular species.
All 75 molecular species require initial concentrations to be stated in the model
specification. Eight of these species have non-zero initial concentrations, what
means that only these eight exist at the beginning of the simulation. This fact is
reflected by the total count of agents that initial copy numbers is stated in the
RB model notation. The model encoded in the RB language encompasses 152
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reactions with 131 rules. As 37 rules are reversible, their definition comprises
a single line, that further reduces the model to 94 rules. Each of 132 rules is
parameterised by one of 62 unique rate constants. The number of unique rate
constants is defined by the outcome of the analysis and translation of reactions
instances into rules. The number of unique rate constants is lower than the total
number of rate constants used to parametrise the ODE model (152). Recalling
criteria of condensing reactions into rules described in Section 2.3.1.2, multi-
ple reaction instances can be replaced with one rule, if these reactions are of
the same type, occur between the same pair of reactants, and are parametrised
with the same values of rate constants. What follows, multiple rate constants
can be replaced with a single one. The final rule set is more than two fold larger
than the claimed here unique number of rate constants (compare 132 rules to
62 rate constants). This means that more than one rule is parametrised by the
same rate constant.
As opposed to the ODE model, the number of molecular species in the
RB model is not given in the model specification. This number can be obtained
only as an approximation obtained with analytical estimation or with use of
snapshots to sample the state of molecular mixture over the simulation (see
Section 1.5.1.5 for the snapshot definition). To obtain the maximal number
of molecular species presented in Table 2.2, multiple snapshots are repeatedly
taken from the start to the end of the simulation with a regular interval, every
10000th simulation event ( “[E]” ) (see Section 1.5.1.5 for the event definition).
The instruction defining a procedure of snapshot sampling was encoded in the
model definition as in Code 2.10.
Code 2.10: Definition of snapshot sampling
1 %mod: repeat [T]>0 && ([E] [mod] 10000)=0
2 do $SNAPSHOT
3 until [T]=700
This sampling resulted with 9322 snapshots that were parsed to obtain
unique expressions of molecular species. This procedure has shown that the
total number of molecular species is 91 for the competitive RB model, and 137
for the non-competitive one. In both cases, the sum of molecular species is
higher than in the ODE model (75).
The total count of stimuli events in the RB model was reproduced as in
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the original publication (detailed in Section 2.3.1.4). In both models, stimuli
events are composed of one cAMP pulse, ten rises and ten drops of the Ca2+
influx constant resulting in a total of 21 stimuli events.
In summary, there are two main observations that can be derived from
Table 2.2. Firstly, that the number of rules corresponding to reactions is lower.
Secondly, that the number of molecular species is much higher. These remarks
could have been easily anticipated based on the essential theoretical difference
contrasting the ODE and the RB modelling methods. The ODE-based mod-
elling framework requires an explicit encoding of a complete list of reaction
instances, molecular states and complexes that can appear in the modelled
system. Therefore, existence of each has to be known and defined in the model
specification. On the other hand, the RB model notation allows for representa-
tion of multiple reaction instances with one reaction pattern that contains only
necessary reaction context, thereby reducing the number of rules to encompass
the same number of reactions.
This capability of generating reaction instances with reaction patterns
is linked with the extended number of possible molecular species in the RB
model, compared to the ODE model. As a rule refers to partially defined
agents that in the molecular mixture might exist in variable forms, it can be
applied in many different contexts and generate molecular species, that are not
defined anywhere in the model specification but emerge over the simulation.
It can be observed from the model specification that the reaction pattern
notation exposes differences between reactions by hiding details that are default
but irrelevant in the reaction context. In consequence, the model specification
can be represented more clearly than with ODE. Moreover, a rule notation is
much closer to the notation of chemical reactions than equations. Therefore, it
is potentially much easier to encode a set of chemical reactions with rules than
with equations if a modeller is a biochemist.
However, implicitness of details in the rule and observable notation
requires from the modeller to be aware of what is hidden and, if not accounted
for, might produce unintended effects. For example, in the case of observable
specification, let assume an agent that has one site that can be in two states and
is also a binding site in the rule representation. If we would like to write an
observable that tracks the agent in one of the two internal states, regardless its
binding state, then not only the site with the desired state has to be mentioned
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Model component Reactions Rules Unique rate constants
1. DARPP-32 phosphorylation 84 27 27
2. CK1 phosphorylation 4 4 4
3. PDE phosphorylation 4 4 4
4. PP2A phosphorylation 4 4 4
5. PP2B activation 4 24 4
6. PKA activation 12 56 7
7. cAMP & Ca2+ degradation 8 8 8
8. PP2A activation by Ca2+ 32 4 4
Table 2.3: The list of reactions in the Fernandez et al. [177] publication was divided
into components based on more general molecular processes represented by subsets
of reactions, such as phosphorylation or activation. We can examine reaction to rule
relation more closely by comparing models by components. The table shows counts
of reaction rules to reaction instances and unique rate per model component. It can be
noted that reduction in the number of reaction instances due to translation of reactions
into the Kappa language occurred only in two model components (1. & 8.) but in two
others resulted in extension of the rule number (5. & 6.).
but also it has to be explicitly marked with “?” to denote its bond-indifference.
1 %agent: A(pSite˜p˜u) # pSite servers as binding site and has
2 # internal state
3
4 %obs: ’Ap’ A(pSite˜p) # pSite in state ’p’ and free
5 %obs: ’Ap’ A(pSite˜p?) # pSite in state ’p’ and unspecified
6 # binding state
This can be avoided by creating separately sites with internal states and sites
with binding states (Code 2.4.1).
1 %agent: B(b, pSite˜p˜u) # b servers as binding site
2 # pSite has internal state
3
4 %obs: ’Bp’ B(pSite˜p) # pSite in state ’p’ and unspecified
5 # binding state
Despite the advantage of rule notation for representation of reaction in-
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stances, the number of rules is only slightly lower than the number of reactions
(152 to 131). One would expect that with the reaction pattern notation, this
number could have been much lower. It appears that if we closely compare
models by parts representing more general molecular mechanisms, the trans-
lation of reactions into Kappa language rule patterns results in reduction of
the reaction number in some components but extension in others. Table 2.3
juxtaposes counts of reaction instances with rules and unique rate constants
per model component. This particular division of model representing molec-
ular mechanisms was defined by the original publication. We can see that the
reduced representation of reactions obtained with rules occurred in only two
components, “DARPP-32 phosphorylation” and “PP2A activation by Ca2+”.
Both parts mainly contain reactions where DARPP-32 is one of the reactants.
To represent a reaction between DARPP-32 and a reactant, all combinations of
states on DARPP-32 phosphorylation sites has to be named. This results in a
relatively high number of reaction instances but not reaction rules.
“PP2A activation by Ca2+” is a supplementary reaction set that was
added to the “model A” version of the original ODE model. Reactions of
the “PP2A activation by Ca2+” component and “model A” together compose
“model B”, the version of ODE model compared in this study. The “PP2A
activation by Ca2+” reaction set is composed of 32 reactions. In general, these
set of reactions introduces an mechanism where PP2A binds to Ca2+ that results
in a four fold decrease of the constant rate in reactions where PP2A dissociates
from D75 (“koff”). This makes PP2A more likely to dephosphorylate Thr75.
The activity of PP2A in both “model A” and “model B”, is enhanced by its
phosphorylation. In “model B”, it is further amplified by Ca2+ binding. All
this information is encoded both by manipulation of rates, and the structure
of reaction network. In the RB model, this reaction set was represented as
additional four rules and four rate constants. To include complexation of PP2A
with Ca2+, additional binding site reserved for the ion was introduced in the
PP2A agent signature.
In these two cases, where rule representation reduced the number of
reactions, the number of unique reaction rates is exactly the same as the number
of rules (column: “Unique rate constants” in Table 2.3). The number of unique
rate constants reflects the number of differences existing between reactions,
and therefore appears to set the threshold for the minimum number of rules
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that reactions can be rewritten to.
A different situation takes place in the other extreme cases where the
number of chemical reactions expanded in rule representation. Here the
amount of rate constants is much lower then rules. This happens in the “PKA
activation” and “PP2B activation” components. They both have four sites that
bind the same molecules, Ca2+ and cAMP respectively. This kind of agent
structure requires combinatorial binding in the rule notation, described in Sec-
tion 2.3.1.2. It is an example where RB language does not reduce and clarify
the model specification, what contradicts the expectation.
2.4.2 Comparison of trajectories
Figures 2.9 shows observable trajectories from simulations of the wild-
type ODE model obtained with a deterministic solver (Figure 2.9A) and a
stochastic simulator (Figure 2.9B). As described in Section 2.3.2.3, trajectories
of multiple molecular species of ODE model were summed to correspond to
the relevant trajectories presented in the original publication. All stochastic
trajectories are reported based on approximately 40 model simulations, where
a dark trance is a mean value and shade is a standard deviation from the
mean. These trajectories reveal general characteristics of model dynamics.
In the first 400 time-steps, the balance between unphosphorylated DARPP-32
(“D”) and two phosphorylated forms, “D137” and “D75”, settles to a steady
state. After 400 time-steps, the cAMP stimulus is applied, what is manifested
as a sharp peak. This leads to a similarly sharp phosphorylation of Thr34
(“D34”), and a mirrored drop in unphosphorylated DARPP-32 (“D”). After the
next 100 time-steps, Ca2+ spiking occurs causing a sudden drop in “D34”,
recovery of “D”, distinctive increase of D137, and slight decrease of “D75”. As
the stimulus ceases entering the relaxation phase, “D34” levels rebound to reach
its second peak at 800th second, reaching the level of “D”. Similar behaviour
can be clearly seen in both figures (compare Figures 2.9A and Figure 2.9B).
However, the standard deviation in the stochastically simulated ODE model
reveals a distinctive variation in abundance of the “D34” observable during the
relaxation phase.
Figure 2.10 presents the ODE model juxtaposed with the RB model
general dynamic traces. Albeit some visible differences, the RB model generally
recapitulates dynamics of the ODE model. Furthermore, there is a comparable























Figure 2.9: General dynamics of the ODE model obtained with (A) a deterministic
solver, and (B) a stochastic simulation. Trajectories of the stochastic simulation were


























Figure 2.10: General dynamics of (A) ODE model and (B) RB model, both in stochastic
setting.
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variability of “D34” and “D34*” that can be observed in the relaxation phase.
“D34” in the ODE model needs 100 more time steps to reach the second peak
than its RB counterpart (“D34*”). In the RB model, the peak is slightly higher
than in the ODE model. Lastly, the drop of the total number of cAMP molecules
in the ODE model (“cAMP”) is much sharper than in the RB model.
For a closer look at the model simulations, fifteen traces of observables
(defined in Table 2.1) obtained from ODE and RB simulations were paired and
superimposed (Figure 2.11). The results confirm the close agreement between
models. However, next to the clear matches (e.g. Figure 2.11: B, E, H, N), there
are discrepancies between paired curves. Five of these fifteen observables
(Figure 2.11: C, F, I, J, O) are examples of the largest discrepancies between
models, and are shown separately on Figure 2.12. “all Ca” and “all Ca*” ob-
servables in Figure 2.12A denote all Ca2+ ions present in the system during
the simulation. From the beginning of the simulation, a weak Ca2+ influx and
outflux causes a constant presence of ions in low quantities. At the 500th time
point, the Ca2+ spiking is induced by a large Ca2+ influx. This process is only
visible in the RB observable that trajectory elevates above zero and remains a
steady state until the Ca2+ stimulus occurs at the 500th time point. The “all Ca”
observable trajectory of ODE model remains flat and rises as the Ca2+ spiking
what resembles rather the observable representing abundances of free Ca2+
(Figure 2.11B). The other four observables (Figure 2.12: B, E, H, N) of two
models have similar pattern of behaviour though their levels are noticeably
lower in the RB model than in the ODE one. All four reflect general charac-
teristics of the “all Ca*” observable trajectory of the RB model what suggests
their dependence on the Ca2+ abundance. A fragment of the model reaction
diagram in Figure 2.13 demonstrates that these four observables are indeed
directly connected in a chain of activation reactions that begins with the Ca2+
ions that activate PP2B.
On the ODE observable list, an activated PP2B is named as “PP2Bactive”.
“PP2Bactive” dephosphorylates CK1, represented by the “CK1u” observable.
“CK1u” phosphorylates D137 (the “D137” observable), which is dephosphory-
lated by PP2C. As the quantity of PP2C is unchanged over the simulation, the
observable representing PP2C is encoded as its bound form, named “ PP2C”.
Due to this chained dependence between reactions, higher abundance of “all Ca”





















PP2Bactive and PP2Bactive* p
Figure 2.11: Superimposed ODE stochastic and RB stochastic time courses in the
base-line condition. Note that the scales on y-axis are different to closely visualise
traces of the observables. Trace colour: ODE (red), RB (black ).













* PP2Bactive and PP2Bactive**
Figure 2.12: The largest discrepancies between models can be seen in these observ-
ables. The difference between the RB observable “all Ca2+*” and the ODE observable
“all Ca”, denoting all Ca2+ ions present during the simulation is further investigated in
this section.
ables. However, the abundance of “all Ca” during steady states in two models
are opposite, lower for the ODE observable and higher for the RB one. The
next in the chain of responsibility is “PP2Bactive”. The higher level of active
PP2B is in agreement with the other three observables, what suggests that the
observable should be further examined as a potential factor generating these
discrepancies between models. Based on the trajectories of the ODE model, we
can reason that a stronger activation of PP2B results in a proportionally more
copies of the unphosphorylated CK1 and phosphorylated D137. This in turn
results in increase of substrate availability for PP2C and therefore, more copy-
numbers of its bound form. This effect is inverted in the trajectories derived
from the RB model.
It remains unclear why the “all Ca” observable trajectory produced by
the ODE model is much lower than in the RB model at the steady state. More-
over, “PP2Bactive” appears to dictate the higher effect on the other three ob-
servables (“D137”, “CK1u”, “ PP2C”). Therefore, of all five observables, “all Ca”
and “PP2Bactive” and their RB counterparts, seems to be most important in
explanation of differences between two model simulation results and therefore,
they are closer analysed in further steps.
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Figure 2.13: Reaction dia-
gram connecting observ-
ables that exhibits the
largest discrepancy be-
tween corresponding ob-
servables of ODE and RB
models. These observ-
ables are connected in a
chain of activation reac-
tions dependent on each
other and triggered by the
Ca2+ influx.
According to the reaction set underlying both
models, the activated PP2B is a complex composed
of four Ca2+ ions and PP2B. In the ODE model, a
name of variable representing an active form of PP2B
does not explicitly indicate that it is a complex har-
bouring Ca2+ ions. Therefore, actual copy numbers
of all Ca2+ ions in the simulated system should also
include copies of “PP2Bactive”. This would have to
be obtained with the analysis of relevant reaction con-
text of the ODE model, not only by summing copy-
numbers of molecular species that variable names
indicate the presence of Ca2+, as it was done so far.
In the RB model, the composition of each com-
plex species is explicitly represented in the simula-
tion, where obtaining an observable of interest is an
automated procedure that sums trajectories match-
ing the observable expression pattern. In the RB sim-
ulation, an active form of PP2B is represented as in
Code 2.11.
Code 2.11: Active form of PP2B
1 PP2B(ca1!0, ca2!1, ca3!2, ca4!3, state˜a),
2 Ca2+(a!0), Ca2+(a!1), Ca2+(a!2), Ca2+(a!3)
With this explicit representation, an observable that
is set to track copy numbers of all Ca2+ ions during the simulation of the RB
model will include ions bound to PP2B. Therefore, the comparison of “all Ca”
to “all Ca*” observable trajectories (Figure 2.12A) is inaccurate due to a differ-
ence in molecular species included in these observables. Similar inaccuracy,
related to naming observables, explains the divergence between time courses
of observables of the total number of cAMP (Figure 2.10). Contrary to the RB
model, multiple copies of cAMP bound to R2C2 are not included in this time
course of the ODE model (compare “cAMP” and “cAMP*”).
As a complete list of molecular species in the RB model is not included in
the specification, it is also unknown if there are other trajectories of molecular
species summed in “all Ca*”. To obtain such approximated list, all molecu-
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lar species containing Ca2+ in the RB model simulation were isolated from
snapshots as defined in Code 2.10. The number of these isolated species is
24, whereas in the ODE model, the number of molecular species composing
the “all Ca” observable is 13. Of these 24 species, 18 correspond to 13 species
composing the ODE observable. These 6 molecular species (24− 18), absent
in the “all Ca” observable, are composed of an active form of PP2B containing
four Ca2+ ions, either free or bound to phosphorylated CK1, or DARPP-32 in
four different combinations of phosphorylation states. These 18 species of RB
model that correspond to 13 species of the “all Ca” observable is higher by 5
because of the difference in number of species that represent a half-active form
of PP2B bound to two Ca2+ ions. In the ODE model, a half-active PP2B is
represented as a single species, with a variable named as “PP2BinactiveCa2”.
The same species in the RB model exists in six variants (Code 2.12).
Code 2.12: Molecular species of the half-active PP2B in the RB model
1 PP2B(ca1 ,ca2!0,ca3!1,ca4 ,state˜i),Ca2+(a!1),Ca2+(a!0)
2 PP2B(ca1!0,ca2 ,ca3!1,ca4 ,state˜i),Ca2+(a!0),Ca2+(a!1)
3 PP2B(ca1 ,ca2 ,ca3!0,ca4!1,state˜i),Ca2+(a!1),Ca2+(a!0)
4 PP2B(ca1!0,ca2 ,ca3 ,ca4!1,state˜i),Ca2+(a!0),Ca2+(a!1)
5 PP2B(ca1!0,ca2!1,ca3 ,ca4 ,state˜i),Ca2+(a!0),Ca2+(a!1)
6 PP2B(ca1 ,ca2!0,ca3 ,ca4!1,state˜i),Ca2+(a!0),Ca2+(a!1)
Now that we extracted molecular species composing the “all Ca*” ob-
servable, we can compare exactly the same trajectories of molecular species
between the two models by simulating the RB model with a set of new ob-
servables, defined precisely as these composing the “all Ca” observable in the
original ODE model (Figure 2.12A). To match this newly defined RB observable
of “all Ca*” to the original model, these 18 species were summed to obtain a
single observable (Figure 2.14B). In comparison to the unaltered species com-
position (Figure 2.14A), the result show that discrepancy between the ODE
and RB observable trajectories has diminished. Knowing that there is a higher
number of forms representing the half-active PP2B in the RB model, we can try
to obtain a closer match between the “all Ca” observables by superimposing
only one of six trajectories of the RB model. Figure 2.14C shows that the match
is close to perfect. It demonstrates that the differences between the “all Ca” ob-









































Figure 2.14: Comparison of variable compositions of molecular species containing
Ca2+ ions tracked in the system in both models with (B) unaltered observables; (B) all
molecular species containing Ca2+ ions selected exactly as indicated by names in the
original model and summed to obtain a single trace, where 13 molecular species in
the ODE model are represented by 18 species in RB model; (C) 13 molecular species
of ODE model matched to 13 of RB model, where only 1 of 6 molecular species of
inactive PP2B was selected.
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Figure 2.15: A half-active PP2B is a complex composed of PP2B and two Ca2+ ions.
The RB model simulation generates six different molecular species that represent this
complex, due to a combinatorial binding of Ca2+ ions to four identical sites of PP2B.
The plot shows a superimposed trajectories of these six variants of the half-active
PP2B. Neither of these six trajectories differentiates itself from others by a pattern of
dynamics nor an average level of abundances.
representations of the molecular species. To choose one of the six trajectories,
differences between them were examined in Figure 2.15. As they all have a
similar pattern of dynamics and the same average levels of abundances, the
choice of one of these forms is assumed as arbitrary. The distinction between
locations of two Ca2+ ions on the numbered sites of PP2B, as enforced by en-
coding of Kappa (Code 2.12), is irrelevant since all four sites are functionally
indistinguishable.
Figure 2.16 shows 13 pairs of traces of corresponding molecular species
of the two models. The largest discrepancy between trajectories can be ob-























Figure 2.16: Separated molecular species containing Ca2+, selected as in the original
model. The largest discrepancy lays in the “PP2BinactiveCa2” species, which is the
summation result of six entities representing an inactive form of PP2B in the RB model.
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obtained by summing six entities representing a half-active PP2B into one. If
we again choose one of the six trajectories and plot corresponding molecular
species in pairs (Figure 2.17M), though diminished, differences between them
remain. This time the trajectory of the RB model is lower then the one of the
ODE model.
These six forms of the half-active PP2B suggest that a better match
between the two models can be achieved by decreasing the constant rate of
rules that represent binding of Ca2+ to free PP2B. However, this could bring
the desired effect solely for the half-active PP2B (“PP2BinactiveCa2”) but not
for dynamics of other observables if their parameters were not adjusted si-
multaneously. In particular, the fully active PP2B (“PP2Bactive”), of which
the “PP2BinactiveCa2” is an intermediate form. With the current parameter
values, the fully active PP2B in the RB model is lower than in the ODE model
(Figure 2.11J). Decreasing the rate constant of its intermediate form would lead
to further decease of its copy numbers. It is important to observe that even
though there are more representatives of the half-active PP2B in the RB model
than in the ODE one, its fully active form has lower levels. It is so despite that
a rate constant that produces the fully active PP2B is three-fold higher than for
the inactive PP2B.
To further examine this paradox, we can return to the comparison of
model specifications (Section 2.4.1). The activation of PP2B in the rule rep-
resentation belongs to most divergent from the reaction representation. If
we recall the juxtaposition of reaction to rule counts per model component
(Table 2.3), the “PP2B activation” part is encoded with 24 rules, 4 reactions and
4 unique rate constants. Of these 24 rules (4 reactions), 12 (2) represent the first
step of binding and dissociation of two Ca2+ ions from PP2B. The Other 12 (2)
represent the second step of binding and dissociation of another two Ca2+ ions
from PP2B. The activation of PP2B in the rule representation is dissected to
a site-specific detail that include all combinations of positioning Ca2+ on four
sites of PP2B. This suggests that the larger number of rules defining transition
from inactive to active PP2B slows down this process in the rule representation.
To support this hypothesis that the number of rules activating PP2B
might be the reason for the lower level of “PP2Bactive*” in the RB model, we
can review the second example that required much larger number of rules,





















Figure 2.17: Separated molecular species containing Ca2+, selected as in the original
model. The trajectory of “PP2BinactiveCa2” of the RB model was obtained by se-
lecting one of six entities representing an inactive form of PP2B in the RB model. A
discrepancy between models is still present, but this time the trajectory is lower for the
one obtained with the RB model.
90 Chapter 2. Kappa model of DARPP-32 network
“PKA*” observable also reaches a much lower peak than its ODE counterpart.
Accordingly, values of rate constants of rules that number increased due to
the “combinatorial binding” notation in the RB model should be increased to
closely match the ones in the ODE model.
The above analysis is an example of how the RB modelling is a flex-
ible tool to explore complexes of species that appear during the simulation.
Molecular species defined in the ODE modelling belong to a fixed and definite
component of the model, whereas in the RB modelling, molecular species that
are formed during the simulation is a very much a subject of investigation.
By using samples of molecular mixtures obtained with snapshots, it can be
determined what molecular species are created and in what abundances. RB
model simulation results can be easily dissected the very fine detail by choosing
observables of interest to be tracked during the simulation. In the perspective
of reusing a model, the automation of collecting agglomerated time courses
of observables of interest renders the RB modelling as more advantageous in
comparison to ODE-based modelling. This automated procedure of defining
observables is less prone to errors and independent of variable names as it
happens in the ODE model.
On the other hand, this detailed and explicit notation offered by Kappa
might appear redundant as exemplified by enumerated locations of four Ca2+
ions on four indistinguishable sites of PP2B. This necessity to indicate all possi-
ble combinations of sites is a particular drawback of the Kappa language. The
other one is time necessary to simulate the model. In general, the length of sim-
ulation of stochastic models, compared to deterministic ones, has been always
an issue addressed by multiple optimisation strategies [161]. It is no different
in case of the two compared models. It takes almost 40min4 to simulate this
particular RB model with the KaSim simulator. Solution of the ODE model in
the COPASI environment in the deterministic setting is returned in an instance.
As the COPASI stochastic simulator is able to produce results in no more than
15sec, this difference in simulation time does not stem from the nature of the
stochastic simulation. This fact largely limits the use of KaSim and ought to be
considered in decision which formalism is most advantageous for a particular
problem.
4The total CPU time measured with the “time” command on Linux OS.
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2.4.2.1 Comparison of models with site-directed mutations
Up until this point, we saw the outcome of comparison performed on
models in the wild-type condition. The authors of the ODE model analysed
it in two other conditions of site-directed mutagenesis affecting the Ser137
site. The same type of perturbations, based on modifications of constant rates,
were applied to the RB model to establish if this perturbation would generate
similar results, and to obtain a broader view on differences between models.
Figure 2.18 juxtaposes simulation results of both models affected with the con-
stitutive Ser137 mutation. As exemplified by the six key observables showed
in this figure, there is a close match in initial conditions and general pattern of
dynamics between time courses of the two models. During the first minutes
of the simulation in both models, the Ser137 site completely depletes the un-
phosphorylated DARPP-32 as the site cannot be dephosphorylated. DARPP-32
phosphorylated at Ser137 reaches the maximal abundance level of 3000 copy
numbers. At the 400th second, the cAMP pulse is injected causing phosphory-
lation of DARPP-32 at Thr34 that reaches the same maximal level as DARPP-32
phoshorylated at Ser137. In the wild-type model variant, phosphorylation of
Ser137 significantly slows down dephosphorylation of Thr34. This occurs be-
cause the catalytic rate constant in the dephosphorylation reaction of Thr34 by
PP2B is 133 fold lower when Ser137 is also phosphorylated. Therefore, this
persistent phosphorylation of Ser137 strongly inhibited dephosphorylation of
Thr34 locking the effect of the cAMP pulse such that Ca2+ spiking had marginal
influence on the “D34” trajectory. A close match between models is confirmed
by a view on similarity between four paired curves in Figure 2.19. Selected
observables are the only ones among 15 that demonstrate the impact of the
mutation. Three of these four observables have been earlier mentioned as
bearing the largest discrepancies between models (Figure 2.19A, C, D), where
the copy-numbers at steady states in the RB observables are slightly lower.
The other site-directed mutagenesis is the Serine to Alanine mutation.
The results of comparison can be viewed on Figure 2.20. This mutation has
more subtle effect. Its major result is a deeper plunge of “D34” induced by the
Ca2+ stimulus and a slightly lower second peak in the relaxation phase than in
the “wild type” model variant. The same effects can be viewed in RB model
results.
Based on these two examples of site-directed mutations, the same per-
























Figure 2.18: Comparison of constitutive Ser137 mutation induced in (A) ODE model
in deterministic setting; (B) RB model in stochastic setting. The same ingeration per-














Figure 2.19: Closer look at traces of observables affected by the constSer137 muta-
tion. Both models were simulated in the stochastic scheme.
turbations used in the ODE model were successfully applied on the RB model
producing similar dynamics. It means that the RB modelling allows to emulate
experimentally observed perturbations in a similar manner as it is performed
in the ODE-based modelling.
2.4.2.2 Comparison of trajectories between competitive
and non-competitive variants of rule-based model
As discussed in Section 2.3.2.1, modifications of molecular binding
interfaces resulting with new complexes would require to enumerate addi-
tional molecular species and extend the model with additional equations in
the ODE-based framework. Contrary to this, the RB language allows for easy
modification of agents’ binding properties. Because DARPP-32 is an intrinsi-
cally disordered protein and the way it binds to partners is yet to be known,
two RB models with different variants of binding site specifications are com-
pared to test if dynamics of the RB model would be affected if DARPP-32 could
bind more partners at the same time. The first one, as defined in the origi-
nal model, constitutes a competitive version of the model with one binding
site of DARPP-32 (oBS). The second constitutes a noncompetitive version of
the model where partners of respective phosphorylation sites can bind con-
currently (three-binding-sites DARPP-32, tBS). This modification was made


























Figure 2.20: Comparison of the Ser137Ala mutation (A) ODE model in deterministic






















Figure 2.21: Comparison of two RB model variants where the agent representing
DARPP-32 had one binding site (oBS, red trace) and three binding sites (tBS, black
trace). Overlaid trajectories of corresponding agents demonstrate no effect of this
modification on the model trajectories.
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by changing the interface of DARPP-32 in the agent specification, and rules
defining behaviour of DARPP-32. The trajectories of two models were su-
perimposed in pairs of corresponding observables. Figure 2.21 demonstrates
that the modification of binding site properties has no effect on trajectories of
observables. A direct consequence of this modification was an increase of com-
plex sizes to more than two proteins. Therefore, it seems that larger complexes
are potentially rare to be formed during the simulation. An example of such
complexes can be seen in Code 2.13.
Code 2.13: Examples of DARPP-32 complexes composed of more than two proteins





6 # Two phosphatases :
7 D(ser137˜p!0,thr34˜p,thr75˜p!1),PP2A(ca!2,pSite˜u!1),
8 PP2C(a!0),Ca2+(a!2)
However, as mentioned in Section 2.4.1, the difference between one-
binding-site DARPP-32 (oBS) and models in the total number of molecular
species created during the simulation is quite considerable. There are 46 more
molecular species formed in the tBS (137) than in oBS (91). To examine the
increase of newly formed complexes of the simulation in the non-competitive
model variant compared to the competitive one, counts of unique molecular
species per timepoint are obtained from snapshots (described in Section 2.4.1).
In Figure 2.22A, we observe that the species set size is quite similar in both
model versions. Furthermore, the dynamics of forming complexes is dictated
by the stimuli input pattern (Figure 2.22B). The largest differences between oBS
and tBS also take place during the stimuli application.
The increase in the number of binding sites of DARPP-32 resulted with
unchanged dynamics. It should be noted that this was only established for a
single setting of parameters and initial conditions. As these three binding sites
do not counter each other’s binding properties, this lack of difference might
be caused by similarity in occupancy between a single site and all three sites


























Figure 2.22: Overlay of change in species counts over time for one-binding-site
DARPP-32 (oBS) and three-binding-sites DARPP-32 (tBS) model variants (A). The
change in the number of unique species counts is aligned with trajectories of the stim-
uli (B).
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reactants and strength of binding affinities. Reactions in the model are classified
as weak, with dissociation rates in the range of µM. Low affinity bindings
generally lead to lower levels of site occupancy. Moreover, the amount of
DARPP-32 molecules exceeds the total counts of all its interactors. Therefore,
with the current proportions of reactants, all three sites of DARPP-32 cannot
be saturated to expose the difference in binding capacity of DARPP-32. To
expose potential differences in dynamics between two binding scenarios, the
site occupancy should be targeted. The simplest test of this explanation could
be achieved by altering the size of reactant pools. For instance, a significant
decrease of the levels of DARPP-32 could increase the proportion of other
reactants. A prediction could be made that a similar dynamic response of
DARPP-32 could be achieved with its lower copy numbers.
2.5 Discussion
ODE-based modelling is a classical and most commonly used method
for creating detailed dynamic models of biological systems on many levels of
biological organisation [222–224]. It is often a point of reference or comparison
to newly proposed modelling methods [108, 136, 147, 225, 226]. Nevertheless,
modelling of signalling systems with ODEs poses particular difficulties due
to complexities underlying biomolecular interactions in cellular signalling that
occur transiently between multiple partners, forming complexes composed of
molecules that can exists in more than one functionally different state [30, 150].
The RB modelling was developed to address these difficulties by using for-
malisms originating in computer science, in particular graph transformations
and process algebras. Although a large body of reviews discussed advantages
of the RB modelling over the ODE modelling [106, 120, 124], to the author’s
knowledge, none of these studies presented a direct comparison of time courses
of one molecular system encoded in the two modelling formalisms. This chap-
ter presents a process of encoding reactions underlying an ODE model to the
RB language and comparison of the two models with respect to model speci-
fication and simulation results. This can provide a clearer view of differences
between the two formalisms and allow to answer such question as:
• how does encoding reactions into rules affects a system dynamics com-
pared to encoding them in ODEs?
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• does specification of a model in the RB language can facilitate process of
understanding and reusing dynamical models?
• what kind of biological processes are most advantageous to model in the
RB framework?
In the first step, models specifications were divided into components
such as reactions or rules, molecular species, and rate constants. Then, cor-
responding components were compared with respect to their overall counts.
Encoding reactions into rules slightly reduced the size of model specification
and increased counts of molecular species. This result confirmed a well known
advantage of encoding chemical reaction networks into rules. Translation of re-
actions into rules involves identification and removal of non-influential context
carried by reactants, such as their phosphorylation or binding state. Therefore,
by preserving only the context that conditions reactions allows to rewrite these
reactions into a generalised pattern, what in consequence shortens and simpli-
fies model representation.
As the drop in rule number was rather low, reactions were closer anal-
ysed by dividing them into subsets representing more general molecular mech-
anisms, such as activation and phosphorylation. This showed that reduction in
the reaction number is only true for reactions occurring between the same re-
actants, describe the same transformation, and are parametrised with the same
values of rate constants, but differ only with respect to binding or internal state
of reactants. In this type of reactions, the number of unique reaction rates was
equal to the number of rules that reactions were rewritten to. This is an exam-
ple of tackling combinatorial explosion by the RB modelling where multiple
reactions, parametrised with rate constants of the same value, are equivalent
to a single rule pattern.
Increase in the number of rules representing reactions occurred in cases
where the same partner binds an agent at multiple sites. To encode such
reactions, a much larger number of rules had to be encoded to represent all
possible positions and stages of binding process. This “combinatorial binding”
notation is not a general property of the RB language but only characteristic
to the Kappa syntax. In the BioNetGen Language (BNGL), an alternative
RB-language to Kappa, a rule can be defined with sites named in the same
way. It implies that a rule pattern defined for one of them applies to the others
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[154]. However, it would have to be empirically established how this simplified
representation in BNGL would affect trajectories of observables.
In the next stage of models comparison, trajectories of corresponding
observables were analysed. This shown an overall agreement between models
dynamics. By overlying 15 observable pairs, one from each model, discrepan-
cies between time courses were observed. The “all Ca” observable was exam-
ined closer as an example of such discrepancies. As molecular species are not
defined in the RB model specification, the exact composition of created molec-
ular species was obtained by taking snapshots of molecular mixture during the
RB model simulation. We learned that there are more molecular species with
Ca2+ in the RB model, than in the ODE model (24 vs. 13). Closer examination
revealed that 6 molecular species of the RB observable were not included in the
ODE observable as their name did not contain Ca2+. Of the total of 24 species,
18 represent exactly 13 species of the ODE model. This disproportion in the
number of molecular species was due to expanded representation of half-active
PP2B, where two Ca2+ ions can occupy 4 sites of PP2B in 6 variations. When
the simulation of the RB model was performed with observables consisting
of exactly the same species that composed the “all Ca” observable in the ODE
model, it appeared that all paired trajectories matched perfectly except for the
half-active PP2B. In the RB model, this observable is a sum of 6 variants of
molecular species that had much higher abundance than its ODE equivalent.
Interestingly, abundances of a fully active PP2B were lower for the RB observ-
able than for the ODE. A fully active PP2B is one of the two observables that
activation in rules required the “combinatorial binding” notation that specify
all combinations of binding positions of Ca2+. The second one was PKA. Pair-
ing ODE and RB trajectories of PKA demonstrated that this observable is also
present at the lower abundances in the RB model simulation. This observa-
tion suggests that in the RB model simulation, activation of proteins encoded
with the “combinatorial binding” notation are much slower processes than in
the ODE model. What follows then, these processes should be parametrised
differently if one wanted to obtain a perfect match to these two trajectories of
the ODE model. The observed discrepancies, specific to this particular group
of rules, ought to be taken into account when reactions and rate constants of
ODE models are reused to construct RB models.
A potential cause of such discrepancy between reactions and rules in
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terms of reaction speed could not be attributed to differences between the RB
model and the original model simulation procedures as both were simulated
with variants of the Gillespie’s Stochastic Simulation Algorithm (SSA). During
one iteration in the RB model simulation, a rule pattern is applied to one
rule instance found in the molecular mixture over time, what is called as an
“event”. Therefore, agents that activation is expressed with larger number of
rules, such as these with the “combinatorial binding” notation, require more
events that trigger these rules to be activated. This might have caused the
lower abundances of PKA and the active PP2B in the RB model, compared to
the ODE one.
Presented dissection of the “all Ca*” observable with application of snap-
shots demonstrated how one can explore in detail emerging molecular species
during the simulation of an RB model. Overlying trajectories of molecular
species that compose “all Ca*” and “all Ca” observables allowed to track the
source of differences between models. This detailed description of reactions on
the subprotein level offers precise view on interaction details. Emerging molec-
ular species are tractable, relatively easy to examine and analyse. Contrary to
these observations, the ODE model heavily relies on the complete knowledge
of the system and the model encoding.
Observables of the ODE model were obtained by identification of molecule
names in variables representing molecular species. This simplistic approach
omitted Ca2+ ions bound to PP2B and multiple copies of cAMP in complexes.
Therefore, retrieval of molecule counts hidden in individual molecular species
of the ODE model would require deeper deconstruction of the reaction system
to reuse and explore the model in an automated manner. Therefore, difficulty
in identification of molecular entities among molecular species impede also
correctness of reusing ODE models.
A simpler approach to correct identification of molecules in species
could be potentially performed by parsing the SBML file, that the ODE model
is also encoded with. This could be done because the model is deposited in
BioModels, a database of mathematical models, and it was successfully curated.
The curation process guarantees annotation of molecular species with common
resource identifiers, as defined by the Minimal Information Requested In the
Annotation of biochemical Models (MIRIAM) standard. In the Fernandez
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et al. [177] model web page in the BioModels website5, under the “Physical
entities” tab, it can be observed that an active PP2B is a composite species
having Ca2+ ions and therefore, this molecular species is annotated with two
common identifiers, one for the protein, one for the ion. However, based on
this information one will not learn that there are in fact 4 Ca2+ ions. Lastly,
the two identifiers are not always present in other complexes of PP2B (e.g.
CK1) although an active form of PP2B in this model denotes a protein complex
with ions. It can be concluded that automated identification of molecules in
the RB framework by defining observables is particularly advantageous, as it
offers a transparent framework with error-prone identification of molecules in
a modelled system. This feature is particularly vital when large number of
molecules is involved in the modelled system and their particular states are
important to be analysed in detail.
The model was tested with two types of site-directed modifications af-
fecting one of the phosphorylation sites of DARPP-32. The first one, common
for ODE, was based on a parameter modification and reproduced from the orig-
inal study. The results of the RB model matched closely the ODE model in all
conditions proving that the same method commonly used to perturb the ODE
models can be applied to the RB model. This is a particularly advantageous
regarding flexibility of a modelling framework to reproduce experimentally
conducted perturbations.
The second modification type was based on alteration of the DARPP-32
binding capabilities. This modification, on the other hand, is only specific to the
RB domain. Two variants of the model were introduced with varied numbers
of binding sites of DARPP-32. This binding site modification, that effectively
changed the model reaction network, did not affect the model response. This
might be caused by similarity in the average site occupancy between the model
variants in the current model conditions that could be altered by changing
proportions of reactants and binding affinities..
There are at two main routes alongside which the RB model could be
further explored. The first one is modification of parameters defining different
phases of combinatorially bound Ca2+ ions to PP2B, and cAMP to R2C2. A par-
ticular task would be to establish factors by which binding constants should
be changed to counterbalance the larger number of intermediate variants of
5http://www.ebi.ac.uk/biomodels-main/BIOMD0000000153
2.6. Conclusions 103
these complexes and lower copies of their final activated forms. The other
aspect worth exploration in future is to identify conditions under which a dif-
ference in dynamics caused by increase of the number of parallel binding sites
of DARPP-32 can be observed. As a starting point, the simplest modification
could be achieved by significantly decreasing the copy numbers of DARPP-32
compared to other interactors. As mentioned by the authors of the Fernandez
et al. [177] model, levels of DARPP-32 vary significantly between µM to tens
of µMs in the striatum. With the greater availability of single-cell techniques
for quantification of protein numbers [227] it would be worth to establish more
precisely the range of DARPP-32 even on the resolution of a dendritic spine
[228]. Estimation of variability between cells could also be used to compare the
level of noticeable variability of DARPP-32 phosphorylated at Thr34 observed
between repeated simulation runs in the stochastic framework.
Defining a model with rules allows to encode details of molecule inter-
nal states, binding sites and track changes in abundances of resulting molecular
species. Therefore, the process of encoding rules turns attention to questions
such as how many binding partners can bind a protein at the same time. Inter-
estingly, this question was not discussed in the Fernandez et al. [177] study re-
garding the DARPP-32 interaction network. The translation process has shown
that information about interfaces of interacting proteins and their alternative
states seems not only natural to include in a model build in the RB frame-
work but also would largely ease the process of its development as it could
support decision on agents signatures. One of the most studied protein states
happen through changes in post-translational modification (PTM) sites, among
which protein phosphorylation is most common [229, 230]. Information about
protein interaction interfaces can be based on protein domains which are im-
portant functional protein units mediating interactions. For instance, proteins
containing phosphatase catalytic domains are enzymes of dephosphorylation
reactions [229]. Therefore, among low-level data resources that could support
the RB modelling an important position can be allocated to resources of protein
domains and PTMs.
2.6 Conclusions
In this chapter, I showed that the RB model recapitulates the general
dynamics of ODE-based model. Analysis of the RB model in comparison to
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the ODE, proved its expressive and flexible syntax for encoding and study-
ing crucial aspect of signalling networks, such as complex formation. RB
modelling provides a framework for testing impact of perturbations on the
reaction network as well as offers tools for exploration and dissection of emerg-
ing molecular species during the simulation. However, increasing number of
such unpredicted molecular species of unknown importance might become in-
tractable. Particularly, in such commonly used methods of parameter analysis
to identify ones that have the largest impact on the model output. Select-
ing such model output might not be a straightforward task when molecular
species are created in the simulated system. It would be advantageous to sup-
port modeller’s assumptions and knowledge about the modelled system with
automated methods to differentiate between such species. Therefore, in the







It is a common practice when modelling molecular systems to reduce
the model simulation outputs to a handful of readouts that summarise some
specific characteristic of the response of interest [231, 232]. This simplification
is a crucial step to progress with the model analysis, such as visual examination
of the simulation output. Selection of biological readouts is commonly based
on the modellers knowledge of the system and the availability of experimental
data against which to compare model performance. This might become difficult
with the increase of model sizes, gradual automation of model construction and
when some aspects of modelled behaviour are impossible to experimentally
observe. What is more, new methods of modelling, such as RB modelling,
that show a different perspective on modelled systems, might require formal
approaches to support the knowledge of a modeller to select appropriate model
readouts.
As demonstrated in Chapter 2, a rule-based (RB) model is defined with
a rule patterns that are applied to multiple reaction instances. Therefore, in
contrast to the ordinary differential equation (ODE) modelling techniques, a
list of molecular species produced by such reaction instances is not defined a
priori in RB models but created over the simulation. Each simulation is also a
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sample of all possible molecular species that can be created and interact in the
system. Therefore, as opposed to ODE, the composition of species populating
the simulation requires new means to be carefully studied. If RB models gen-
erate a relatively large number of molecular species, it might become difficult
to decide which of these species are important and therefore, used as model
readouts. It would be particularly important to analyse changes in composition
of molecular species during the simulation with respect to variations in model
basal conditions designed to emulate disease conditions or drug-induced per-
turbations. For instance, by modelling and identification of shifts in importance
of interacting molecules, their configuration of states or involvement in com-
plexes, might help to study molecular mechanisms underpinning resistance
to pharmacological interventions observed in targeted cancer therapies [233].
In particular, how drug targeted pathway signal can be bypassed by rewiring
intracellular signalling in tumor cells as an adaptive stress response [234].
Selecting only a subset of created species is a crucial step in the model
analysis for example in application of sensitivity analysis (SA). SA is an ap-
proach to quantitatively evaluate how a change in model input parameters can
affect the model simulation output. It is a crucial step of every modelling task
as there are large number of sources contributing to uncertainty in parameter
values in mathematical models, such as difficulty in their accurate experimen-
tal determination and different experimental conditions they were measured
in [231, 235]. SA can help to answer such questions as: which parameters
reduce uncertainty in model output, which parameters do not contribute to
its variability, and which parameters have the largest effect on output under a
particular model setting [236]. Different simulation outputs can be sensitive to
change in different parameter subsets. Therefore, if we were able to cluster the
simulation outputs into subgroups that are strongly interlinked, then we could
separately subject each group to SA, that would identify parameters that are
most important to each subgroup of simulation outputs.
In this chapter, a pipeline for extended and automated analysis of RB
simulation results is proposed (Figure 3.1). It is performed on time courses
obtained from simulation of the RB model presented in Chapter 2. Main com-
ponents of pipeline are: a method for clustering and prioritisation of time
courses, followed by application of SA to calculate sensitivity scores of param-
eters with respect to the chosen subset of simulation outputs. The particular
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choice of SA method was guided by its potential application to larger and
more complex RB models than the model of DARPP-32 network and there-
fore, is scalable and model-independent. Prioritised model outputs and pa-
rameters are jointly presented as a network with edge weights derived from
sensitivity scores. The choice of network representation has two particular
justifications. First, as SA is performed on more than one model outputs, a
network structure can facilitate examination of relations between groups of
selected observables and parameters. Second, common experimental design
in modelling studies involves application of perturbations to a baseline model
and examination of outcomes of these perturbations in reference to the baseline
state. Investigation of differences between different modelled conditions can
be facilitated by representing them as networks as key simulation outputs and
control parameters are unified and summarised in a compact data structure. In
particular, measures contained in two networks representing different model
conditions are subtracted from each other. By taking the difference between
two model conditions, one can expose changes in sets of control parameters
and observables induced by perturbation in the model. In such setup, different
graph-based techniques can be applied to analyse such networks. To investi-
gate this approach, the pipeline is applied to two model phenotypes presented
in Chapter 2: the model with a baseline setting (wild-type), and the model with
constitutive Ser137 (constSer137) site mutation (perturbed).
This approach aims to extend the knowledge derived from analysis of
complex output of computer generated models that could facilitate and guide
laboratory experiments thus tightening interactive feedback loop between com-
putational modelling and experimental work.
3.2 Introduction
The pipeline for automated analysis of RB models is divided into three
stages (Figure 3.1). Each stage involves methods and tools that were previously
developed and applied in different studies. The first stage involves selection
of model simulation outputs. In the context of RB modelling these outputs
are trajectories of observables that are recorded during the simulation. The
second step identifies parameters that variation has the strongest impact on
selected observables. In the last step, results obtained in two previous steps
are integrated into a network representation.







Figure 3.1: Outline of the pipeline steps to automate the analysis of RB model simula-
tion results.
Before directly delving into details of the pipeline, each method com-
posing the pipeline is presented with the justification of choice. The method
for selection of model observables is introduced in Section 3.2.1. Section 3.2.3
flesh out details of selecting a method of SA that is most appropriate for RB
modelling. Next, in the methodology section (Section 3.3), the pipeline will
be presented as a whole procedure (Section 3.3.1), followed by explanation
of approaches and decisions required to be taken to perform methods used in
each of the pipeline step. The methodology section is followed by presenta-
tion of results from comparison of networks derived from the “wild-type” and
“perturbed” model simulations (Section 3.4).
3.2.1 Clustering and prioritisation of observables
Identification of communities or clustering was earlier discussed in the
context of network analysis (Section 1.3.1). In the field of data mining, cluster-
ing is a common data pre-processing step [237]. It is an exploratory technique
that partitions the data set into clusters, that members are highly similar with
respect to predefined objective. Dividing variables into similar subgroups re-
duces the complexity of the data set as smaller variable subgroups are easier to
analyse in separation. Clustering is one of unsupervised classification meth-
ods that partitions unlabelled data into clusters by learning from observations
rather than learning from examples of correct answers [238]. This type of clas-
sification is particularly important aspect for this study as there is no correct
examples that define a structure in the data composed of observable trajectories
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obtained with the simulation of a RB model.
There is no single formal definition what is a cluster and therefore, there
is a great variability between methods. The most popular methods of clus-
tering are variations of k-means, hierarchical, density-based, model-based and
graph-based clustering. The successful application of any method depends on
the data. Therefore, the choice of an appropriate clustering method should be
guided by data characteristics. Andreopoulos et al. [238] defines evaluation
criteria for clustering methods in a biomedical context: scalability, robustness
to outliers, insensitivity to the input ordering, minimum user-specified input,
mixed data types, arbitrary shape of clusters, insensitivity of results to dupli-
cates in data. In general, molecular dynamic models of signalling systems tend
to be complex, composed of different feedback and feedforward loops, man-
ifesting non-linear dynamics. Efficiency and scalability of clustering method
are criteria that can eliminate a method from the very start. The scalability
criteria is important aspect in this study if we consider to include all molecular
species produced during the simulation. As seen in Chapter 2, the number of
molecular species in the RB model of dopamine- and cAMP-regulated neuronal
phosphoprotein with molecular weight 32 kDa (DARPP-32) network generated
91 different molecular species in the competitive variant of the model in which
DARPP-32 can only bind one partner at a time. In its non-competitive variant,
this number was 137. With the increase of complexes and combinatorial mix-
tures of species it will be crucial to constrain the choice of clustering method to
the most efficient and scalable one.
Clustering methods using information theory measures appear to be
most appropriate for high-dimensional and complex patterns in data [239]. In-
formation theory is a study concerned with quantification of information con-
tent. Clustering methods based on information theory use measures extended
from mutual information introduced by Shannon [240]. Mutual information
quantifies dependency between random variables. In information-theoretic
clustering is based on maximisation of the mutual information between data
points and cluster labels [239]. The information theoretic approach offers a
formal and operational method for clustering that does not introduce a pro-
totypical cluster nor make assumption about the data distribution [239] and
it addresses such critical issues as sensitivity to outliers, present in commonly
used methods [241].
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Information theoretic frameworks for the clustering problem are in con-
stant development for finding a common theoretic ground and that success
has been mainly based on the evaluation against experimental results [241].
Still, it is a quite dynamic field [242, 243] with examples of applications in the
biosciences [241, 244].
For this study, Correlation Explanation (CorEx) was chosen as a highly
optimal method that leverages information-theoretic objective. From the point
of computational complexity, the algorithm scales linearly with respect to the
number of variables. Moreover, the algorithm can be parallelised on multiple
cores that speeds up the procedure.
Regarding the minimum user-specified input, the CorEx algorithm re-
quires input parameters to be specified by a user, such as the number of hidden
variables representing clusters. If this value is too high then only a subset of
clusters will have associated members [245]. Therefore, this number can be
optimally determined by starting from a relatively large value to the size of
clustered objects, e.g. smaller than their number, and then gradually reduce the
number of clusters up to some margin. Furthermore, the information-theoretic
objective used in CorEx is insensitive to missing values or noise [245]. One
major potential drawback of CorEx is that it does not arrive at the global op-
timum. Therefore, the analysis of results should be based on multiple runs of
CorEx.
CorEx has been mentioned by other studies but it has been system-
atically compared with other methods by the authors. As oppose to other
alternative methods, the authors showed that CorEx was able to partition a
synthetic data set with perfect accuracy in spite of a gradual increase in the
number of variables (Figure 3.2A). The method was also tested on a real data
set, the Big-5 personality test, and as the only one resulted with a correct answer
(Figure 3.2B).
The comparison of clustering methods is a nontrivial task as it requires
a selection of data sets, definition of correct clustering result and parameter
choice for each tested method. Wiwie et al. [246] compared 13 most popular
methods with 24 common bioinformatic data sets but did not include meth-
ods that are based on information theoretical objective. The largest data set
they used was from gene expression measurements in bone marrow compris-




Figure 3.2: Comparison of CorEx to other clustering methods performed by by the
authors. (A) Comparison of partitioning accuracy based on Adjusted Rand Index (ARI)
(see Section 3.2.2) with respect to increased number of variables. The data were
synthetically generated with a latent tree model. As oppose to other methods, CorEx
retrieved all clusters despite a gradual increase in the number of observed variables.
(B) Clustering results of the Big-5 personality test data set obtained with 13 methods
(CorEx+12). Results are presented as confusion matrices that compare predicted
to true clusters. CorEx correctly divided the data into 5 clusters. Source of figures:
Ver Steeg and Galstyan [245].
112 Chapter 3. Observable prioritisation and global sensitivity ...
is particularly challenging due to undersampling. The number of samples is
much smaller than the number of variables. CorEx has also been applied to
gene expression data from ovarian tumors but this data set was much larger
comprising 5371 genes across 420 tissue samples [248]. Pepke and Ver Steeg
[248] compared the results with outcomes from two most popular clustering
methods, k-means, hierarchical, and a method for dimensionality reduction,
Principal Component Analysis (PCA), showing the advantage of CorEx. In an-
other biological context, CorEx was used to cluster mixed data types composed
of different biological measures to search for the most informative biomarker
of cognitive decline and brain atrophy [249].
A decision to include CorEx into the pipeline presented in this chapter
is supported by results of a preliminary study where CorEx was applied to a
similar purpose and type of datasets, composed of multivariate time courses
obtained from simulations of RB models published in Suderman and Deeds
[123] (Appendix C).
3.2.1.1 Correlation Explanation method
The authors of CorEx link the algorithm with multiple domains of ma-
chine learning, placing the method in a context of hierarchical representation
learning and dimensionality reduction of high-dimensional datasets [250]. In
more precise words, CorEx is an unsupervised learning method for finding a
hierarchical structure of latent variables based on dependencies in data. Latent
or hidden variables, are variables that are not directly observed but inferred from
the relations between variables that are measured. In this context, measured
variables are molecular species set to be tracked over the KaSim simulation.
The CorEx algorithm aggregates measured variables into strongly correlated
and dependent subsets. Each group is assigned to one of hidden variables
whose number is lower than the set of measured variables. The procedure
of finding such partitions is based on optimisation of information theoretic
objective that maximises mutual information between grouped variables. In
other words, these variable subsets carry most information or best explain each
other. At the same time, latent variables become maximally independent from
each other.
Latent variables might not specifically refer to any particular meaning
but can simplify model structure by grouping measured variables to lower
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number of hidden variables that are highly similar to each other. That is,
the high dimensional space of measured variables is represented by lower
quantity of hidden ones. These latent variables can themselves be divided
between higher level and even lower number of hidden variables. In this way, a
hierarchical structure is formed providing reduced and abstract representation
of the measured data [245].
Strength of dependencies between multiple random variables are mea-
sured with multivariate mutual information, also called total correlation [251]. To
outline intuition behind the total correlation, first the entropy measure is pre-
sented, as a most fundamental measure in the field of information theory. The
entropy is a measure of uncertainty in the system or information gain. More




P(x) log2 1/P(x) (3.1)
where X is a discrete random variable represented as a set of all its possible in-
dividual outcomes, that is x ∈Ax = a1, ...,aN. Each of these outcomes is assigned
with a probability P(x). A set of probabilities form a probability distribution
over the random variable X, denoted as P(X). The minimal value of entropy,
H(X) = 0, occurs if P(X = x) = 1. It is understood as a complete certainty of the
outcome. The maximal value of H is reached when all possible outcomes are
equally probable [252].
The entropy definition provides foundations of higher order measures,
such as mutual information. Mutual information is quantification of dependency
between two random variables, X1 and X2, defined as follows:
I(X1 : X2) = H(X1) + H(X2)−H(X1,X2)
= H(X1)−H(X1|X2)
= H(X2)−H(X2|X1)
= I(X2 : X1)
(3.2)
In other words, the mutual information is a symmetric measure, I(X1 : X2) =
I(X2 : X1), of how much the entropy of one variable is reduced when the value
of the other is known.
Generalisation of mutual information to more than two variables is
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The total correlation is equal 0 if there is no relation between random variables.
Therefore, the entropy of individual variable Xi is equal to the joint entropy
of variables occurring together, H(X1, ...,XN). On the other hand, the total
correlation is maximised, if this joint entropy is equal 0 [245].






The conditional total correlation measures to what extend the variable Y ex-
plains the total correlation between variables X1, ...,XN.
The main objective of CorEx is to find a minimal number of hidden
variables Y, such that the total correlation between all variables (for simplicity
X = X1, ...,XN) decreases if conditioned on Y [248]. This principle is expressed
by the following equation:
TC(X;Y) = TC(X)−TC(X|Y) (3.5)
The expression in Equation 3.5 is maximised by the CorEx algorithm.
If the conditional total correlation, TC(X|Y), is equal 0, then TC(X;Y) is max-
imised. It means that Y explains all X. Therefore, an optimal Y minimises
TC(X|Y).
CorEx maximises this objective for more than one hidden variable, also
called explanatory factors. Each of these factors is a function of a subset of X.
For more than one explanatory factors, Y = Y1, ...,Ym, the optimised expression
can be defined as
maxG j,P(y j|xG j)
m∑
j=1
TC(XG j ;Y j) s.t.|Y j| = k G j∩G j′, j = ∅ (3.6)
where G j is a subset of indices of all N random variables, G⊆N = 1, ...,n and XG j
is the subset of the random variables that are grouped over latent variables Y j.
Each of the latent variables can take k discrete values. The algorithm maximises
conditional distribution P(y|xG) [245, 250].
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TC(XG j ;Y j) with respect to some Y j can reach high values when the
dependence between a small number of grouped variables is strong, or if
there is a weak dependence between a large number of variables [253]. The
number of hidden variables Y is a user-defined input that can be approximately
determined with respect to data by probing different values of Y [245].
As CorEx effectively partitions measured variables into clusters, each
represented by a hidden variable, the term “cluster” will be used henceforth
to denote the term “hidden variable” to simplify naming convention.
The authors use an iterative procedure to efficiently obtain the optimi-
sation of TC(X;Y). Details of applied implementation can be found in Ver Steeg
and Galstyan [250] and in Pepke and Ver Steeg [248]. The theoretic method
description of the algorithm can be found in Ver Steeg and Galstyan [245, 250].
The algorithm version used here is a most recent implementation of CorEx,
“bio corex”, that was developed for the study of Pepke and Ver Steeg [248].
3.2.2 Cluster similarity measure
To analyse the impact of different input parameters on clustering re-
sults obtained with CorEx, such as the number of clusters that represent the
data, similarity between two different CorEx runs is measured by evaluating
agreement in members allocation between pairs of clusters.
Comparison between pairs of clusterings are usually aimed to evaluate
validity of a clustering method by using validity indices. Variable methods
defining validity indices are used to compare paired clusterings [246]. These
indices are divided into internal and external validity indices. The internal
validity indices are based on a pairwise distances matrix derived from the
input data. Such properties as tightness and separation of clusters are rewarded
[246]. The external validity indices relay on a “ground-truth” clustering, that is
a clustering known to be a correct partition of dataset [246]. The external indices
are evaluated based on cluster labels. The internal indices additionally require
distance metrics between data points as for instance in popular Silhouette
Value method for calculating internal indices [254] that is based on between
and within cluster distances. To use the internal indices in this context of this
study, a sophisticated distance metric that captures complex and non-linear
relations existing between trajectories of clustered observables would have to
be chosen. It is a rather difficult task that would have to be addressed in a
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separate study. Therefore, the aim of cluster comparison is not to evaluate
the quality of clusterings but rather establish similarity between clusterings
obtained with CorEx. To this purpose ARI was selected as one of the external
validity measures that is commonly used for clusterings comparison.
ARI is an adjusted-for-chance version of The Rand Index that us a sim-
ilarity measure between a pair of clusterings [255]. In non-adjusted measures
similarity scores depend heavily on the cluster number to sample number
relation, where the score gradually increases with the number of clusters ap-
proaching the number of all clustered elements.
ARI can be defined as follows. For a set of elements n and a pair of
clusterings, X = X1,X2, ...,Xr and Y = Y1,Y2, ...,Ys, the overlapping membership
can be represented as contingency matrix (Table 3.2.2), where ni j is a number
of shared elements between Xi and Y j.
Y1 ... Ys Sums
X1 n11 ... n1s a1
... ... ... ... ...
Xr nr1 ... nrs ar
Sums b1 ... bs





















































ARI takes values within a range of 0.0 and 1.0. The index is equal to 1.0
if two clusterings are identical up to a permutation of cluster labels, and 0.0
otherwise. ARI is a symmetric measure that is independent from the ordering
of clustering pairs. In this study, computation of ARI was performed with
the Python “scikit-learn” package where the method is implemented in the
function “adjusted rand score” [256].
3.2.3 Sensitivity analysis for rule-based models
Sensitivity analysis is an quantitative approach to evaluate how the
model output is affected by changes in model parameters obtained with calcu-
lation of sensitivity indices. In the general field of modelling, SA is considered
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to be necessary for establishing the credibility of model-based analyses [257].
SA should support model generated predictions used for regulation, policy
and decision making [236]. It is so, because “[..] most simulation models will be
complex, with many parameters, state-variables and non-linear relations. Under the
best circumstances, such models have many degrees of freedom and, with judicious fid-
dling, can be made to produce virtually any desired behavior, often with both plausible
structure and parameter values”[258]. This is no different with systems biology
models as the study of Gutenkunst et al. [259] showed by analysis of 17 such
models. Behaviour of these models were characterised as insensitive to large
variations of many parameters, phenomenon called “sloppiness”. With such
uncertainty in parameter values and difficulty in obtaining direct experimen-
tal measurements for all parameter values, attempts to make predictions from
such biological models should be supported by methods for refinement and
analysis of parameter spectra, such as SA [259].
SA methods are generally divided into two classes, local sensitivity
analysis (LSA) and global sensitivity analysis (GSA). LSA was the first one
applied to quantitatively evaluate parameter sensitivity scores. LSA involves
measuring partial derivative of an output variable with respect to small pertur-
bations around nominal values of an input parameter [260]. Partial derivative
is a derivative of a multivariate function that calculates changes in the output
of function with respect to variation of one of its variables when the others are
kept constant [261]. LSA is the most common method for sensitivity analysis
in models of synaptic plasticity [203]. Particular shortcoming of this method
is that it assumes model linearity and it only allows small variation of a sin-
gle parameter at a time [236, 262]. Therefore, LSA might not be informative
enough regarding sensitivities of parameters that can have complex and higher
order interactions. Small parameter perturbations might not reveal the actual
parameter sensitivities, as they need not be aligned with real fluctuations in
the biological system [231]. To address these weaknesses GSA was proposed
as a new approach. GSA allows for variation of all parameters at the same
time across large ranges of values and therefore, enables assessment of sensi-
tivities in a broader parameter space. It has been shown for some models that
switching from LSA to GSA can reveal critical parameter values not seen with
LSA [231]. It has been demonstrated that GSA can be used to study system ro-
bustness to perturbations with a gradual increase in parameter variation levels
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[231]. In the context of this study, performing GSA is more preferable as the
Fernandez et al. [177] model was already analysed with LSA.
GSA is composed of several steps that involve [263, 264]:
1. specification of the study purpose
2. selection of parameter inputs of interest (whole or subset)
3. specification of variability range of selected inputs (folds or percentage
of nominal values)
4. specification of probability distribution for sampling values for selected
inputs
5. defining the number of samples
6. application of a sampling method to generate the defined number of
samples (step 5) drawn from chosen distribution (step 3) within the pre-
defined range (step 2)
7. evaluation of the model for each sample of parameter inputs
8. estimation of sensitivity indices for each parameter input based on model
output results (step 6)
The consideration of the study purpose is an important step as it can
determine the choice between different sensitivity indices and their estimation
methods. Therefore, it is commonly advised to first define what is the aim of
this study [260]. Among many purposes, GSA allows to identify parameters
that [236, 265]:
• drive model results by ranking model input parameters according to their
scored influence on the model output (parameter prioritisation)
• can be fixed to their nominal values during model calibration as they do
not contribute to reduction of output uncertainty (parameter fixing)
• are most important for given regime of the output value (parameter map-
ping)
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Of these three, the most common goal of sensitivity measure is parameter
prioritisation. Attainable information about relations between parameters and
model outputs can be constrained by the model dimensionality that is the
number of parameters involved. A model with higher than a few tens of
parameters is usually classified as high-dimensional [260]. It is often discussed
that the model size often constrains the method choice and the level of detail
obtained from SA. More detailed methods for SA are at the same time more
computationally demanding. For instance, compared to LSA, GSA is known
to be more computationally expensive but can offer more reliable information
on relations existing in the model. For large scale high-dimensional models,
the computational cost of GSA can be even prohibitive as the model has to
be evaluated a hundreds of times to obtain a sufficient number of samples.
However, assumption of linearity of LSA will only offer a partial information on
model parameters. To balance the efficiency of SA method and level of detail,
it is advised to examine complexity of relations within the model structure,
e.g. linearity and monotonicity of input-to-output relations in making decision
which SA method to choose [260]. It is known that in most realistic models this
assumption cannot be guaranteed. Therefore, selection of SA method is often
a trade-off between the amount of information gained from such analysis and
the model size.
To approach SA for large scale models, a preliminary screening step is
often advised, such as Morris method [265, s. 4.2]. This method can partition
model parameters to three groups that differ in characteristics of their effects
on the model output: (a) negligible, (b) linear and additive, (c) non-linear or
interaction effects indicating that a parameter interacts with others [265, s. 4.2].
In this way parameters with negligible effects can be excluded from SA [260].
As all parameter screening methods, the Morris method provides qualitative
ranking of input parameters with respect to their importance but does not
quantify the actual difference in importance between parameters [265, p.108].
GSA provides a quantitative measure for importance of parameters and is
directly used in this study, without the preliminary screening step.
Research on GSA methods is a vibrant field. Multiple books, reviews
and guidelines have been published on GSA methods, for a general modelling
domain [236, 262, 265, 266], specific to systems biology [267] and pharmacology
[235], offering guidance for good practices and methods comparisons. Here,
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I will briefly mention methods in the course of advocating the final choice of
an appropriate GSA method for RB models. Particularly applicable to the RB
modelling is a prominent study of Marino et al. [268]. The study offers thorough
analysis of two most notoriously used, robust and efficient sampling-based
methods for GSA, Partial Rank Correlation Coefficient (PRCC) and extended
Fourier Amplitude Senstivity Test (eFAST) [269]. Marino et al. [268] proposed
a methodology for deterministic and stochastic models based on analysis of
variable models from the biological domain. The authors compared results
obtained with both GSA methods, and provided methodology to perform and
circumvent problems that are common in application of these methods in both
deterministic and stochastic frameworks. The methodology presented for the
stochastic setting is of particular interest in the context of RB modelling.
Marino et al. [268] indicated two types of uncertainty in stochastic mod-
els. The first one, epistemic uncertainty, shared with deterministic models, and
aleatory uncertainty, specific only to stochastic models. The epistemic uncer-
tainty originates from lacking knowledge about the modelled system, whereas
the aleatory uncertainty refers to stochastic character of simulated time courses
that is their innate feature [268]. To tackle the aleatory uncertainty in stochastic
models and to be able to use GSA methods designed for deterministic setting,
Marino et al. [268] proposed that simulation of each parameter setting should
be repeated multiple times and obtained time courses should be averaged. The
study has been frequently used by modelling practitioners as a reference and a
guide to use GSA in systems biology [232, 267, 270, 271]. The methodology of
Marino et al. [268] has been also used in the context of RB modelling. Sorokin
et al. [272] proposed “RKappa” package implemented in R language, tailored to
perform GSA for RB models by using parallelised computation of sensitivity
scores on computer clusters. “RKappa” is an open source package hosted in the
GitHub platform [273]. The package will be used in this study as a ready to
use GSA framework for RB models.
Of the two methods for GSA analysed by Marino et al. [268], Sorokin
et al. [272] implemented PRCC. The authors noted that the “RKappa” frame-
work can be easily extended with other sensitivity methods. In fact, the PRCC
implementation used in the “RKappa” package comes from theR “sensitivity”
package, devoted to SA and containing a large selection of alternative methods
[274].
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As a guided use of PRCC and eFAST is presented in Marino et al. [268],
these are the first methods to be analysed to decide which of GSA methods is
most appropriate for RB model, based on the example of the Kappa model of
DARPP-32 presented in Chapter 2.
PRCC and eFAST are methods for importance measure [260] that rank
model inputs based on their influence on model output. Ranks for each input
are calculated with a chosen sensitivity measure. The first to concentrate on
is PRCC. It is a highly efficient method that does not require any specific de-
sign of experiment or parameter variation. PRCC belongs to a general class of
methods relaying on linear regression techniques, such as Pearson Correlation
Coefficient (CC), Standard Regression Coefficient (SRC) and Standard Ranked
Regression Coefficient (SRRC) [260]. PRCC is Partial Correlation Coefficient
(PCC) but applied to ranked transformed data. The ranking step allows to
apply this method when output-to-input relationships are non-linear. How-
ever, as Marino et al. [268] showed on an example of Lotka-Volterra model
[222], PRCC requires monotonicity in input-to-output relations to provide ac-
curate results. To observe if such non-monotonic relations are also present
in the Kappa model of DARPP-32, variation of a model observable (“Thr34”)
was examined against variation in two exemplary parameter values (“kon41”,
“kcat3”) with scatter plots (Figure 3.3), demonstrating that the model has
non-monotonic relationships. Therefore, PRCC cannot be used in this model
example.
In this case, Marino et al. [268] recommended use of eFAST. eFAST is
a model-independent variance-based method, free from assumption on input-
to-output relations [269]. Variance is a statistical measure of spread of random
variables from their average value. eFAST is an improved variant of FAST, the
very first variance-based method, proposed by Cukier et al. [276]. Variance-
based methods are a general class of methods that provides sensitivity indices
that express how much of variance in the output can be attributed to an input
parameter or their combinations [260]. Variance-based indices are believed to
be superior measures of uncertainty because of possibility of estimation of the
influence of individual parameters or their groups on the model output [277].
Variance-based indices allow to study different orders of interaction effects
between parameters by partitioning the output variance into orders of effects, so
called partial variances. The first order, or main effect, is individual contribution































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.3: Complexity of input-to-output relations, such as non-linearities and non-
monotonicities, can be assessed with scatter plots of observable-to-parameters [275].
Figures present results of such plots for the “Thr34” observable plotted against two
parameters for the 410th second of the simulation. The data was obtained with 400
simulations of 400 varied parameter sets sampled from the Sobol sequence. Copy
numbers of the observable trajectories were averaged over 6 repeats of 400 samples
(see Section 3.3 for methodology details). Scatter plots were produced for unpro-
cessed values: (A) “kon41”, (B) “kcat3”; and ranked values (C) “kon41” (D) “kcat3”.
According to the reaction set defining the model of Fernandez et al. [177], both param-
eters are strongly related to the output variable. The first one determines the speed of
rebinding “PKA” to “R2C2”, therefore removing the kinase from the system, that phos-
phorylates DARPP-32 at Thr34. The second chosen parameter, “kcat3”, is a catalytic
rate of Thr34 phosphorylation. The results show neither linear, nor monotonic depen-
dence between the input parameters and the output result. It should be noted that
the selected timepoint takes place at the start of the cAMP-stimulus that defines the
steepest gradient in the simulation. This affected the spread of data points that are
shown at its peak.
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of a parameter to the output variance. Second and higher order interaction
effects indicate contribution of interactions between two and higher number of
input parameters, respectively, to the output variance. Interaction effects are
interactions between parameters that effects are not the same as addition of their
individual first-order effects [265]. Calculation of higher order effects can easily
reach a combinatorial barrier with large number of parameters (2n − 1 for n
parameters) [269]. To circumvent this issue, total-effect indices were proposed as
a synergistic sensitivity score that include all interaction sensitivities of a given
parameter [278]. For instance, for three parameters X1,X2,X3, if Sx1 is a first
order sensitivity of parameter X1, then total order sensitivity of this parameter
can be represented as ST1 = Sx1 + Sx1,x2 + Sx1,x3 + Sx1,x2,x3 [269]. If ST1 > Sx1 then
the model is non-additive and therefore, interactions exists between X1 and
other parameters [268]. Existence of interaction terms is very likely if the
model has large number of parameters and the model is perturbed within a
larger range [269, 279]. In fact the classical FAST method was able to calculate
only the first order effect. eFAST, as its extension, was introduced to join two
aspects important the detailed decomposition of interactions between inputs
and computational efficiency of original FAST method. The eFAST method is
able to identify first-order effects and total-effects, as most important effects to
interpret sensitivity results [260].
Variance apportioned to a specific input parameter in the output result
is identified with Fourier analysis. Fourier analysis decomposes a periodic
function into component sinusoidal functions of different frequencies and am-
plitudes [280]. In eFAST each input variable is varied with a specific frequency
that are parameter identities detectable in the output signal with Fourier anal-
ysis [269]. How strong parameter frequency is propagated in the model output
is a measure of sensitivity [268]. eFAST requires a careful setting of additional
parameters relating to this procedure, such as frequencies and the interference
parameter. Therefore, the application of eFAST is more complex than PRCC as
it requires a specific sampling scheme of parameter inputs and frequency values
should be carefully selected to be correctly identified with Fourier analysis.
Application of eFAST to high-dimensional models poses certain draw-
backs. It is known to over-estimate sensitivity scores with high-dimensional
inputs [268, 281]. Major limitation of applying eFAST is that it has high compu-
tational costs when applied to models with a large number of parameters [268].
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For instance, analysed by Marino et al. [268] stochastic model with 12 parame-
ters required 53456 model calls. Despite continuous research on improvement
of variance based approaches, calculation of variance-based indices remain a
computationally intensive task for high-dimensional input parameters.
Variance summarises the entire probability distribution into a scalar
statistics (second-moment), and therefore is an incomplete statistics of un-
certainty in the model. As noted by Saltelli [257], if we use variance-based
methods for GSA, we “implicitly assume that this moment is sufficient to describe
the output variability”. Variance might not be sufficient to calculate global sen-
sitivity indices if the output distribution is multimodal or strongly skewed
[279]. This remark arguments a proposition of moment-independence index,
that is density-based index, by Borgonovo [279] that takes into account the whole
distribution of the output variable. Specifically, the density-based index is de-
fined as calculation of difference between unconditional output distribution,
where all parameters are varied, and conditional distribution, when one of the
input variables is fixed to a certain value. The author reported that the new
type of sensitivity indices can offer a different perspective on model sensitivi-
ties than then a variance based method as parameters were differently ranked
with respect to their importance when the entire distribution of output was
considered compared to the total sensitivity index and the first-order index
[279]. However, the approach appeared to be a very computationally intensive
task for high-dimensional models that require a specific design for sampling
scheme (e.g. double sampling loop) [279]. This lack of computational efficiency
locates indices proposed by Borgonovo [279] close to variance-based indices
that also have large computational cost. To circumvent this issue, Da Veiga
[282] proposed a new class of sensitivity indices based on different variants of
probabilistic dependence measures that generalise the density-based index by
Borgonovo [279]. These measures are particularly advantageous because they
can be efficiently calculated for high-dimensional models. These sensitivity in-
dices allows to use common methods for sampling minimising the complexity
of task.
The next section informally introduces the sensitivity index proposed
by Da Veiga [282].
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Method description The dependence-based sensitivity indices proposed by
Da Veiga [282] were developed from implications of the density-based sen-
sitivity index by Borgonovo [279]. Baucells and Borgonovo [283] proposed
that the impact of n independent input variables, X1, ...,Xn, on the output
model, Y = g(X1, ...,Xn) k = 1, ...,n, can be defined with a function that measures
dissimilarity, d(.), between probability distribution of Y (PY) and conditional
probability distribution of Y given Xk (PY|Xk). EXk is defined as expectation
with respect to Xk.
Sk = EXk(d(PY,PY|Xk)) (3.9)
Da Veiga [282] observed that this dissimilarity measure d(.) can be one
of a general family of dissimilarity measures called Csiszár f -divergences of
the form:








where pY denote the probability distribution function of Y and pY|Xk of Y|X
k.
There are different choices of the function f that denote different measures of
distance and divergence, such Kullback–Leibler divergence. Insertion of Equa-
tion 3.10 into Equation 3.9 yields a sensitivity index. By virtue of being Csiszár
f -divergences these indices are positive and equal 0 if Y and Xk are independent
[284]. By substituting different options of function f Da Veiga [282] was able to
represent previously proposed sensitivity indices and therefore, enclose them
with a general class of Csiszár f -divergences. Da Veiga [282] noticed further
that with specific choices of function f transforms the sensitivity index into well
known dependence measures, that in general, compare the joint distribution
and the product of the marginals. This result opened a possibility to consider
other, more recently developed dependence measures and propose new sen-
sitivity indices based on variable dependence measures that can be efficiently
computed for multivariate random variables [282].
This study will particularly concentrate on one of these dependence
measures, Hilbert-Schmidt Independence Criterion (HSIC). HSIC is a depen-
dence measure based on the Hilbert-Schmidt norm of the cross-covariance
operator between Reproducing Kernel Hilbert Spaces (RKHS), introduced by
Gretton et al. [285]. It is a sophisticated method that will be briefly outlined
her to draw an intuitive understanding underlying HSIC-based indices.
In the domain of machine learning and classification tasks, it is known
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that non-linearly separable data sets, if transformed into higher dimensions,
can be separated with linear methods. This separation can be performed with
a computational efficiency by using methods based on kernel functions. Ker-
nel functions are vary general class of functions that in the field of machine
learning are called “similarity” functions. They allow to map inner products
between variables to an inner product of these variables in higher dimensions,
procedure called as “kernel trick”. Generally, the inner product is an important
operation that allows to define distances between vectors. HSIC incorporates
the kernel trick through RKHS that allows to capture non-linear relationships
between inputs in higher dimensional space, like Hilbert space. Hilbert space
is mathematically defined space through possible operations, which is a gen-
eralisation of Euclidean space to potentially infinite number of dimensions. It
allows to use methods of linear algebra and calculus and is equipped with the
inner product.
RKHS is a Hilbert space of functions defining relations between func-
tions such that their closeness can be compared. The cross-covariance operator
generalises the covariance matrix between X and Y by representing higher
order correlations between X and Y through non-linear kernels. In this way,
non-linearities and non-monotonicities in the model are tackled [286].





The HSIC method is located in the topic of kernel embedding of distri-
butions in higher dimensions [287]. The formal presentation of the method is
provided in the original paper. The method description with more explanatory
information regarding Hilbert space and Reproducing Kernel Hilbert Space in
the context of Da Veiga [282] work was done by Sinha [284].
Da Veiga [282] compared the sensitivity index based on HSIC to first-
order and total indices applied on the Ishigami function. The Ishigami function
is non-linear, non-monotonic function with strong interaction term between
two parameters that is typically used to compare methods designed to calcu-
late sensitivity scores of models with complex input-to-output relations. Da
Veiga [282] observed that HSIC ranked variables with respect to their im-
portance as the total index, when the total index indicated different ranking
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from the first-order index. This means that it captures all interaction effects of
a parameter but with much lower number of parameter samples necessary to
calculate total indices that with the state-of-art variance-based sensitivity meth-
ods, such as Random Balance Design FAST (RBD-FAST) [282]. The results also
robustly detected non-influential parameters. The HSIC-based indices have
been successfully applied and compared in other studies. In the context of
modelling molecular pathways, Sinha [284] compared different implementa-
tions of variance-based indices (first and total) with the Da Veiga’s [282] method
on the Wnt signalling pathway in colorectal cancer and reported that the HSIC-
based indices are more robust and accurate in indication of drastic differences in
parameter importance between normal and tumor representing models. The
HSIC-based method with adjustments was also used for sensitivity analysis
of large spatio-temporal models of radionuclide concentrations [288] and for
parameter screening [286].
3.3 Methodology
The aim of this chapter is to propose a pipeline for prioritisation of
observables and parameters of RB model that application is presented on an
example of the RB model analysed in Chapter 2. The following sections will
chronologically discuss each step of the pipeline that incorporate the meth-
ods described in the previous section. Datasets analysed in the pipeline are
time traces of observables obtained with simulations of the RB model. These
time traces are analysed with CorEx that identifies subsets of most dependent
observables and possibly prioritise one of them as most intertwined. With
respect to chosen subset(s) important parameters are identified with the HSIC-
based GSA. Metrics obtained with CorEx and HSIC are integrated as weighted
network graphs.
In the first part of this section, I will outline the pipeline scheme. In
the next part, the choice of model observables that are input variables to the
CorEx step is discussed. The number of prioritised observables is reduced to a
subset when passed to the GSA step. At the final step, a network is constructed
integrating information from two previous steps. The following section will
also present and discuss method-specific settings.
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Figure 3.4: Overview of the pipeline steps. See main text for details.
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3.3.1 Pipeline overview
Figure 3.4 outlines a general skeleton of the pipeline. The pipeline
operates on the same model results in both CorEx (step 3) and GSA (step
5). Therefore, from the very first step the procedure requires to conform to
requirements of GSA. As the HSIC-based method for GSA does not require any
specific design to obtain parameter samples, the steps are reduced to general
stages of GSA. In the first stage, given nominal values of all rate constants,
called parameters X, a random vector N of parameter inputs is generated
with a selected sampling method over a chosen probability distribution and
drawn from specified range. In the next step, the model is simulated with each
parameter set N to obtain time-courses of observables as outputs Y for each
sample. The simulation of each parameter set is repeated s times and averaged
over repeated runs. These steps are already encoded in “RKappa” package [272]
that is used as a encompassing framework for performing GSA on RB models
in this study.
In the next (step 3), the averaged simulation results are passed to CorEx
to generate N different clusterings of observables. Based on aggregated score of
multiple metrics provided by CorEx, the 4th step involves selecting subgroups
of observables. In the 5th step, sensitivity scores are calculated between X
and a selected subset of observables Y′. In the 6th step, a three-dimensional
matrix associating sensitivity score to each parameter per time per observable
is reduced to two dimensions by integrating change of sensitivity score over
time. In the last 7th step, scores of parameters and observables are integrated
into a weighted network representing the model in a reduced form. This
integrated representation allows to analyse the model in a summarised form
with methods derived from graph theory.
The following sections present each of these steps in detail combined
with analysis and discussion on parameter settings used in each method. First,
however, I present different sets of observables selected to test the pipeline
with. The first observable set is aligned with the ones defined by the authors
of the ODE model, Fernandez et al. [177]. The second set is composed of
automatically generated observables obtained during the simulation of the RB
model with snapshots of molecular mixture.
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3.3.2 Observable sets
The pipeline is applied to time-courses obtained with the RB model of
DARPP-32 network in the competitive variant of the model where DARPP-32
has one binding site (Section 2.3.2.1). Two types of model readouts were se-
lected to be tracked over the KaSim simulation. The first one consists of 19
observables. 12 of these observables were defined as the first 12 in Table 2.1
(Chapter 2). The remaining 7 observables correspond to the last 3 in Table 2.1
(“D34”, “D75” and “D137”) with the difference that DARPP-32 species that are
analysed in this chapter, are represented with explicit enumeration of all possi-
ble combinations of phosphorylation states on three sites. In this way, selected
observables form disjoint sets of molecular species. For instance, molecular
species composing the observable “D34” in Table 2.1 are explicitly represented
by four observables in the observable set analysed in this chapter, that is:
“Thr34”, “Thr34:Thr75”, “Thr34:Ser137” and “Thr34:Thr75:Ser137”. In all these
19 observable expressions, the binding state of DARPP-32 is unspecified.
The other set of variables is retrieved in an automated manner with the
$SNAPSHOT command (see Section 1.5.1.5 for the snapshot definition), used
to record molecular species over the model simulation by taking snapshots of
current states of molecular mixture. The procedure of recording snapshots was
defined in Section 2.4.1 and encoded with Code 2.10, where the snapshot was
taken every 10000th productive event ([E+]). Application of this procedure
resulted in 9322 snapshots, that are parsed to retrieve a unique set of expressions
defining 91 molecular species. These expressions were transformed into an
input file that determines tracked observables during the model simulation.
3.3.3 Setup of CorEx input parameters
There are a few user-specified input parameters in CorEx that particular
choice should be elaborated with discussion. These are: (1) number of clusters
Y, (2) number of discrete states or dimensions of clusters (the same for each Y j),
(3) number of iterations during which TC(X;Y j) is optimised, and (4) number
of automated repetitions of CorEx runs. Among these are parameters that
determination require exploration of parameter ranges with multiple CorEx
runs (1,3), and parameters that determination can relay on interpretation of
previous studies in the context of this study (2,4). Except for the number
of clusters, setup of the other three parameters is discussed in this section.
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Outcomes of explorations of the number of clusters are presented and discussed
in the result section (Section 3.4.1) as they reveal important characteristics of
CorEx results with respect to the datasets. This exploratory approach was
supported with a convergence measure provided as a standard output of CorEx
execution. The convergence measure informs if over the course of iterations
CorEx successfully learned a fixed solution that does not oscillate between
disparate values at the final iterations. The convergence measure is based on
the sum of cluster strengths,
∑
TC(X;Y j), calculated for each iteration. To
calculate this measure,
∑
TC(X;Y j) from the last ten iterations are divided into
two groups of five and the absolute difference between their mean values define
the convergence measure. If the difference is smaller than some predefined ε,
by default set to 1e−05, then the algorithm converged.
The number of cluster dimensions was fixed to the default value of 2.
This particular values has an intuitive interpretation of Y j being either “high”
or “low” [253]. In all but one published study applying CorEx, the value for
the cluster dimensions was set to default [245, 249, 250]. The exception was the
study of gene expression dataset by Pepke and Ver Steeg [248], where dimen-
sions were set to 3, that is the highest number of dimensions that CorEx was
tested with [253]. This particular number of dimensions was chosen because of
its straightforward translation into levels of gene expression: “under”, “neu-
tral” and “over” expressed. These 3 labels were then used to divide expression
samples within gene clusters. As in this study there is no particular number of
bins or labels that clusters could be stratified with and convey biological mean-
ing; therefore, this value was left as default. It is worth noting that increase
of dimensions results with increase in computational cost. In the preliminary
screenings in this study, CorEx was executed with a set of higher dimensions
then default. It was observed that with higher dimensions, CorEx is less likely
to converge (data not shown). This additionally tips the balance against using
higher dimensions of Y j in this study.
Supported with examination of multiple CorEx runs, the number of
iterations is set to 500. It is 5 times the default number. Increase of the number
of iterations above 500 did not improve cases when CorEx runs resulted in
sustained and distinctive oscillations between
∑
TC(X;Y j) values indicating
impossibility of convergence. The setup of 500 iterations is a very safe margin
as learning process converges much earlier. This precociousness is dictated by
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uncertainty of perturbed model results.
Because CorEx is only guaranteed to arrive at local optimum, the CorEx
implementation provides a user-specified input for automated repetition of
CorEx runs that returns results of the largest
∑
TC(X;Y j). For this study, this
number is set to 3.
A particular asset of CorEx that was not put to use in this study is that
CorEx can learn multi-layered hierarchy of clusters, such that the data set can
be represented with gradually smaller number of clusters. In this study, only
a single layered clusters were learned as results of two layers produced one
significantly distinguished and strongest cluster that was disconnected from
others. Moreover, the multi-layered hierarchy of clusters would not serve the
purpose of this study.
3.3.4 Parameter sampling and model simulations
This section details first two steps of the pipeline that involve simulation
settings and data preprocessing to generate sets of random parameter samples
(step 1) and performing model simulations with these randomised parameter
sets (step 2). The implementation of both steps can be found in the “RKappa”
implemented in R language, and is used in this study. The package automati-
cally prepares the setup for GSA by generating N separate model specifications
each containing one of N sets of generated random parameter samples. Each
model is run multiple times according to the predefined number of replicates
per parameter sample. Simulations are performed with the KaSim simulator.
The biological time of simulation is set to 600 seconds, registering two time
points per second that results with time courses of 1200 steps.
As calculation of HSIC-based indices does not require any specific sam-
pling scheme, a sampling method predefined in “RKappa” is applied. Parameter
sets are sampled with a Quasi-Monte Carlo low-discrepancy sampling, Sobol
sequence, with addition of scrambling (randomisation) method of Owen, that
preserves the low-discrepancy between samples [289]. This sampling method
is implemented in the “randtoolbox” package [290]. Parameters sampled with
Sobol sequence and Owen’s scrambling result with a uniformly distributed
samples (Figure 3.5).
Parameter values are sampled within predefined ranges. To encompass
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Figure 3.5: Distribution of parameter samples of four parameters obtained with the
Sobol sequence and the scrambling method of Owen. Distributions of parameter sam-
ples are evenly dispersed with less frequently sampled values from both extremes of
indicated parameter ranges.
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baseline values. Though, the model of Fernandez et al. [177] has not been
tested for robustness with any of GSA methods, it has been observed in pre-
views studies that models of the DARPP-32 network are very robust [177, 201]
and therefore, stronger parameter variations might create a more appropriate
setting to expose important parameter relations. Moreover, variation of pa-
rameters in higher ranges reveals prominent importance of interaction effects
that become more dominating than first-order effects [269, 279]. Simulations
were run in parallel on the University of Edinburgh’s computer cluster, Eddie
Mark 3. The cluster uses the Open Grid Scheduler that is a batch-queuing
system on the Scientific Linux 7 operating system. The batch-queuing system
controls scheduling of unattended execution of programs run on a computer
cluster [291].
To evaluate a minimal number of required parameter samples, Marino
et al. [268] suggested Top-Down Coefficient of Concordance (TDCC). TDCC
measures agreement between two sets of ranked parameters emphasising
agreement between the top ranks. This sensitivity to agreement on the top
ranks is achieved by transforming parameter rankings with Savage scores
[292]. This is particularly advantageous in the context of SA as the top sensitiv-
ity scores indicate most influential parameters [268, 292]. Similarity between a
pair of transformed ranks is measured with correlation that scores one when
the top ranks are in complete agreement and zero otherwise. By using TDCC,
we can evaluate difference between two parameter rankings obtained with
varied numbers of parameter samples. The first step of TDCC requires to de-
fine a maximally large number of parameter sets that the model is simulated
with. Subsequently, sensitivity indices are computed from time courses and
parameter samples divided into subsets with gradually incrementing number
of included parameter samples in each consecutive subset. Obtained param-
eter sensitivity scores, separately for different sample groups, are ranked and
transformed with Savage scores to calculate correlation between pairs of subse-
quent subsets with gradually lower number of samples. If there is no distinctive
change between consecutive scores, the increase in number of samples has no
effect on the GSA scores.
The implementation of TDCC contained in the “RKappa” package is
used to evaluate decision on the final number of parameter samples. Figure 3.6
presents results of application of TDCC to the RB model of the DARPP-32 net-
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Figure 3.6: TDCC scores calculated between pairs of ranked HSIC sensitivity indices
calculated for ten subsets of gradually incrementing parameter samples. With rela-
tively low error, a convergence to an agreement between consecutive ranked sensi-
tivity indices can be observed. Based on these results, it can be assumed that 200
parameter samples is sufficient to calculate HSIC-based sensitivity indices for a model
with 60 parameters.
work, calculated for the time-course of the “Thr34” observable. The top number
of parameter samples was set to 400 and parameter sensitivities were calcu-
lated with HSIC. Results are divided into ten subsets, each with incrementing
number of samples. TDCC indicates that there is an acceptable level of agree-
ment between scores above the subset with 200 parameter samples. Despite
this result, the final number of parameter samples was set to 400 as compu-
tational burden implicated in performing model simulations was lowered by
parallelising model runs on the computer cluster.
As advised by Marino et al. [268], time courses obtained with each
parameter sample should be averaged over multiple model runs to remove
the alleatory uncertainty. The number of such repeated runs should be kept
above 3. However, automated batch simulations run on computer clusters
can be corrupted either due to an error related to the computer cluster or
the KaSim simulator, what results with missing data sets. Although CorEx
method is indifferent to missing data points, GSA step requires complete data
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sets. Therefore, measures to avert incomplete datasets were undertaken.
Simulation results can be affected in two ways. The KaSim simulation
can be interrupted that results with shortened time-series, or a lower number
of simulation repetitions per a parameter sample is executed than indicated.
One of the contributing factors to such interruptions is insufficient amount of
virtual memory allocated to a batch job submitted to the Open Grid Scheduler.
This can be easily avoided by rising job memory allocation above the default
level. In this study, the limit of virtual memory was set to 32G. In spite of testing
even higher limits, around 5% of simulations were still interrupted. Therefore,
to design simulations against such failures, the size of parameter sets and
the number of repeated model runs per parameter set has to be higher than
suggested minimal of three. This increased number of repetitions of model
runs can defend against loosing any parameter samples that would require
re-simulations of lost samples. Therefore, the number of repetitions is set to
6. The same number of repetitions was applied in calculation of TDCC. To
indicate the level of abnormalities in the data, simulation results are subjected
to tests and editing. In the first step, time courses shorter than 600 seconds
are detected and removed. In the following step, replicates of model runs per
parameter sample are counted to remove these ones that have ≤3 replicas. If
the simulation results show missing samples due to such removal, the model
is simulated with the lost ones. However, this problem did not occur as the
number of lost sample replicates was never higher than 1.
3.3.5 Selecting subsets of observables with CorEx
In this section, the 4th step of the pipeline is discussed that involve
grouping and prioritisation of observables based on analysis of times courses
with CorEx. Observables are selected with specifically developed scores for
this purpose. These scores decide which observables are progressed to the 5th
step of the pipeline, that quantifies the importance of parameters for selected
observables. These observable scores are defined through composite metrics.
First, I separately characterise each constituent metric, and based on these
descriptions, two variants of combined observable scores are proposed.
The constituent metrics are quantities resulting from the CorEx appli-
cation on averaged time courses obtained with all sampled sets of parameters.
These time courses are used to partition observables into groups, called clus-
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terings. The way observables are partitioned might reoccur despite parameter
variations. These recurring clusterings can define a clustering type. We can
assume that a clustering type that is more frequent then the others, is more
emblematic for the modelled system. Therefore, frequency of clustering types
is an important metric to examine. First, we have to ask if there are repeating
clusterings. If yes, then how many times a clustering of a certain type appears,
i.e. the frequency of clustering type. Clustering frequency can be detected by
calculating Adjusted Rand Index (ARI) (Section 3.2.2) for each pair of clus-
terings. Only pairs of clusterings that scored exactly 1 are taken into account.
This implies that a given clustering has to appear at least twice to obtain the
score. In the next step, all clustering pairs are divided into groups of the same
type. Assigning multiple clusterings to the same type is performed based on a
simple rule as follows: if clusterings c1 and c2 scored 1 with ARI, and therefore
are the same, and the same applies to clustering c2 and c3, then all three clus-
terings are declared as members of the same clustering type, Ck, defined by its
constituent members: c1, c2, c3. The frequency ratio calculated for each cluster





where N is the parameter sample size, and |Ck| is the cardinality of the clustering
set of type k.
CorEx reports strength of every cluster j within each clustering. This
cluster characterising metric is the total correlation score (TC j) defined in Equa-
tion 3.5 and further called TC j = TC(X;Y j). The cluster strength defines strength
of dependence between cluster members.
For each cluster member, CorEx gives also an observable characterising
metric, defined through its relation with the cluster it was assigned to. This
observable characteristic metric quantifying strength of dependence between
observable and the cluster it was assigned to, is defined with mutual infor-
mation, MIS ji = I(Xi : Y j), where j is a cluster index and i is an observable
index. TC j and MIS ji define the cluster strength and the observable strength,
respectively.
I propose two ways of understanding the observable score. The first one
is based on a premise that an observable is important within the group context
and its importance might change with variation of rate constants. Therefore,
the first score of observable is defined with respect to identified clustering
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types.
Definition of observable score with respect to the clustering of type k is
as follows:
ObsSck, j,i = Fk + med(TC′k, j) + med(MISk, j,i) (3.13)
Fk is a frequency of clustering type k. For all clustering type members,
med(TC′k, j) is median of normalised values of cluster strengths for each cluster
j, and med(MISk, j,i) is median of observable strengths for each observable i. The
median was chosen as a summarising statistics over all clustering type mem-
bers to make the score robust to outliers. As CorEx finds local optimum, some
of its executions might produce such outliers, what may heavily influence the
observable scores. TC′j denotes a normalised value of TC j. Normalisation is





The variable m is a number of cluster members that is very close to the theoret-
ically maximal cluster score. The maximal value of cluster strength is defined
as m−1 and it is valid only if dimensions of clusters Y j are equal 2 [253]. The
maximal value of cluster strength was not used in the normalisation equation
as the two element clusters then tend to be over-scored. The normalisation
of TC j with Equation 3.14 promotes clusters with high TC scores, relative to
the number of members. If the cluster member count is equal 1, TC′j is set to
0. This means that one element-clusters are understood as degenerate ones.
To equally treat the cluster and observable strengths, all MIS values for one-
element clusters are also set to 0.
To select the subgroup of observables, first the most frequent clustering
type is determined. To determine such clustering type, a matrix of Obskji scores
(Table 3.1) is summed over all observables. As all constitutive metrics take
values between 0 and 1 and each observable is classified to only one cluster
per clustering type, Fk value exposes such clustering type. Then, observables
are chosen that belong to the maximally scored cluster that belongs to this
highly scored clustering type. The observables selected based on this metric
are members of strongest and most frequent clusters. If there would be more
than one strong cluster, then each subgroup of observables could be separately




G0 G1 G0 G1
O1 ObsScC1,G0,01 0 ObsScC2,G0,01 0
O2 0 ObsScC1,G1,02 0 ObsScC2,G1,02
O3 ObsScC1,G0,03 0 ObsScC2,G0,03 0
Table 3.1: Matrix of observable scores obtained with application of Equation 3.13.
Each observable score (ObsSck, j,i) is composed of a frequency score of clustering type
(Ck) and cluster strength it was classified to (Gj) and observable strength defined by
relation of the observable (Oi) to the cluster (Gj).
By removing the term of the observable strength in Equation 3.13, we
can also define a cluster score as follows:
CluSck, j = Fk + med(TC′k, j) (3.15)
The second observable score is defined with Equation 3.16 as a more
generic term that include output measures derived from CorEx for all cluster-
ings of parameter samples without differentiating them into types.
ObsSc ji = med(TC′ji) + med(MIS ji) (3.16)
This alternative definition is prompted by the assumption that despite pa-
rameter perturbations, there might be a set of observables that importance is
persistent and therefore, these observables are always associated to the most
strongly dependent cluster. This score might be also preferred in case no
clustering type could be identified. Equation 3.16 is composed of two terms:
med(TC′ji) is a median value of all normalised strengths of clusters (TC
′
j) that the
observable i was associated to, and med(MIS ji) is a median value of observable
strengths (MIS ji) with respect to these clusters j across all clustering types. The
normalisation of TC′i is obtained as in the first observable score, with Equation
3.14.
3.3.6 Calculating and integrating sensitivity scores
In the 5th pipeline step, the parameter samples and the simulation
results obtained in steps 1th and 2nd (Section 3.3.4), are used to calculate sen-
sitivity scores with the HSIC-based sensitivity indices for selected observables
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in the 4th step. In this study timed-GSA is applied [268]. The timed-GSA
involves calculation of sensitivity indices for each time step per observable per
parameter. In usual practice, a single or at most a handful of time points is
chosen to perform GSA [231, 268]. Here, GSA is applied to a time slice from
the 402th time step, when the cyclic adenosine monophosphate (cAMP) pulse
is introduced, to the 1200th time step, that is the end of simulation. The choice
of this particular time-slice for evaluating sensitivity scores is dictated by the
fact that the steady state and the stimuli introduction are two different states
of the system that might confuse sensitivity profiles. Separation and selection
of one of the two system states might clarify the biological interpretation.
Based on sensitivity scores learned in the 5th step, in the 6th step,
the timed-GSA results are summarised by taking integral of the area under
sensitivity scores along the time axis. Integration was performed with the
composite trapezoidal rule. This is a technique for approximating the definite
integral of a region under the curve with trapezoids and calculating their area.
The parameter defining spacing between sample points was set to 0.5. The
composite trapezoidal rule is implemented in Python language in the “scipy”
package as the “numpy.trapz” function [293].
3.3.7 Score consolidation: weighted network of observables
and parameters
The scores learned in steps 4th and 6th are unified and represented as
a network graph in the 7th pipeline step. The network graph is composed of
two kinds of nodes, subset of observables and all parameters. For this reason,
network edges join two different kinds of nodes forming a bipartite graph.
Parameter sensitivity scores are represented as edge weights. As GSA is per-
formed on more than one model output, network representation can facilitate
examination of relations between groups of parameters and observables. With
such network representation, results can be viewed with different stringencies
on parameters from least to most sensitive with respect to groups of observ-
ables by applying cut-off values to edge weights. Moreover, we can compare
two varied conditions of the same model by analysis of two network structures
that represent these conditions. Because all non-zero parameters are included
in the network, the main focus of such analysis is placed on difference between
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Figure 3.7: Approach to analysis of differences between networks representing two
different model conditions. Each networks is constructed from observables and pa-
rameters connected with edges weighted by sensitivity scores. By subtracting edge
weights of a network representing condition “A” from a networks of condition “B”, a
new differential network is created that has positive edge weights for these relations
that gained importance in the condition “A”, negative edge weights for these that lost
importance, and zero-edge weights for unchanged relations.
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relatively small network, to observe such differences we can resort to a sim-
ple method based on taking the difference in edge weights between a pair of
networks representing two different conditions. The variability between condi-
tions is then defined by the gain or loss of edge weights. The 4th pipeline step,
where subsets of observables are scored and selected, different observable sets
can be excluded from the GSA step dependent on the condition. Therefore,
observable nodes can vary between these networks. To be able to compare
such networks that include different observables, first we need to reconstruct a
complete network containing all observables and assure that they all are con-
nected with each parameter. This is done by adding missing observables to
the list of nodes. Subsequently, network edges are drawn between missing
observables and all parameters with zero weights. Having two complete net-
works for two different model conditions, we can subtract edge weights in the
first graph from the ones in the second graph. In this way, we obtain a new
network, that has edges with positive, negative and zero weights. The positive
edge weight denotes that the relation between joint nodes gained importance
in the first condition. The negative edge weight means that this relation lost
importance in the first condition. The zero-edge means that there is no change
between conditions regarding joint nodes (Figure 3.7). All three conditions can
be visualised as separate networks.
The network view on relations between observables and parameters
allows to potentially shift the focus from liner rankings of most dominant model
elements, either parameters or observables, to networks of shared relations
between these elements. Moreover, by constructing a differential networks
between two conditions, we can ask how these relations change due to change
in conditions [294].
3.4 Results
Now that we learned details of the pipeline steps, we can progress to
presentation of results. The pipeline is applied to the base-line variant (“wild-
type”) of the DARPP-32 network model and one of two site-directed mutations,
the constitutive Ser137 (constSer137), presented in Chapter 2.
The pipeline is composed of two distinctive methods, CorEx and HSIC,
and divides into five distinctive stages: (1) clustering of time courses with
CorEx, (2) scoring of observables with developed metric, (3) parameter scoring
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with HSIC-based sensitivity indices, (4) analysis of combined metrics with a
network graph, and (5) comparison of two networks representing different
model conditions. Results obtained with these five stages require presentation
and analyses in separation.
First, I examine CorEx by running the algorithm with time courses
for each of two observable sets presented in Section 3.3.2. The first set was
composed of 19 observables and the other of 91 observables automatically
derived from snapshots of molecular mixtures taken during the simulation.
Application of CorEx requires decision on the number of clusters. Therefore,
first analysis of multiple CorEx runs with varied numbers of clusters for the
two observable sets is presented, to decide which one is most appropriate to
each set. When the number of clusters is decided, partitions of time courses of
the two observable sets obtained with CorEx are compared and analysed.
Following CorEx centred analyses, results of two types of observable
scores are shown for the 19-observable time-courses of the “wild-type” model
condition. Each composite metric of observable scores is separately demon-
strated. Designated subset of observables is progressed to GSA, where inte-
grals of HSIC-based indices that quantify observable-to-parameter relations
are analysed. These are then used to construct a weighted network of observ-
ables and parameters. The same procedure is applied to the constSer137 model
condition. Networks representing two different conditions, the “wild-type”
and constSer137, are joint into a “differential network” by subtracting edge
weights, on which network analyses are performed.
3.4.1 Determining number of clusters and characterising mul-
tiple CorEx runs
Among CorEx input parameters are ones that determination require
analysis of multiple CorEx runs with varied values. Such exploratory approach
is applied to find the appropriate range of the number of clusters. This value
is separately established for the 19- and 91-observable sets. Multiple CorEx
runs were performed on time courses obtained from a single model simulation
without averaging.
First, the number of clusters is determined for time courses of the 19-
observable set. The number of clusters was varied from 2 to 14, each with the
default number of dimensions. With these preliminary CorEx runs, alongside
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the determination of this input parameter, we can also learn about some general
characteristics of clustering results in application to this particular dataset.
Figures 3.8 reports results of variations in the number of clusters with
respect to three cluster characteristic values: cluster size (Figure 3.8A), cluster
strength (Figure 3.8B), and the normalised cluster strength with Equation 3.14,
defined as a ratio between the cluster strength and the cluster size (Figure 3.8C).
Figure 3.8A demonstrates that starting from 9 clusters , 8 of them are assigned
with at least one observable and this number remains constant up to the largest
number of clusters. The size of the largest cluster, located on 0th index, stays
of the constant cluster size of 8 between 3 to 12 clusters , except for 4 clusters.
Figure 3.8B shows that the drop in counts of members in the first cluster of the
clustering with 4 clusters is reflected in its strength, similarly to clusterings
with 13 and 14 clusters. It is worth noting that through all values of cluster
counts there is a distinctive discrepancy in the cluster size and strength be-
tween 0th index cluster and the other clusters. This difference is preserved
despite the normalisation (Figure 3.8C). In general, clusters with higher than
0th index drop to low values of the cluster strength, closely approaching 0,
that is particularly the case in one-member clusters. This clear domination of
one cluster indicates that there is a single cluster of observables that will be
prioritised to the next pipeline steps.
Knowing that such cluster characteristics as the strength and the mem-
ber count stabilise with the increase of the number of clusters, we can examine
agreement in member allocation between clusterings with earlier introduced
Adjusted Rand Index (ARI) (Section 3.2.2). Figures 3.9 show results of these
examination of paired clusterings as they were originally divided by CorEx
(Figures 3.9A), and transformed clusterings, each composed of two clusters,
where the first one consists of observables associated to 0th index cluster, and
the second is composed from members of all other clusters (Figures 3.9B).
Application of ARI to transformed clusterings is in fact a test of agreement
on the content of the largest and the strongest cluster with respect to change
in the number of clusters. The adjustment for chance of ARI guarantees in-
dependence between the number of clusters and the number of samples. In
non-adjusted measures, the more number of clusters is closer to the number of
samples, the higher is the score of agreement between clusterings [295]. The












Figure 3.8: To determine the most suitable number of clusters for the 19-observable
set, clusterings with variable numbers of clusters were obtained. Change in two char-
acteristic values of clusters are examined with respect to these variations: cluster size
(A), cluster strength (B). Despite increase in cluster counts to up to 14, maximally
8 clusters have at least one associated cluster member. Distinctive discrepancy be-
tween the 0th-indexed cluster and others indicates existence of a single dominating
one.















Figure 3.8: Cluster characteristic metrics shown in (A) & (B) are combined into a nor-
malised form of cluster strength, that is a ratio between cluster strength and cluster
size, and plotted against variation in the number of clusters (C). This ratio is a term
comprising the observable scores presented in Section 3.3.5, with the difference that
here the cluster strength of one element clusters were not set to 0. Examples of 3 to
5 clusters demonstrate that the cluster strength can have negative values. Negative
cluster strength is treated in the same way as the 0-cluster strength, and understood
as a failure of finding correlation between variables [253]. The ratio exposes the fact
that there are multiple observables associated to clusters with negative strength.
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Figure 3.9: Agreement in observable allocation between clusterings obtained for dif-
ferent and increasing numbers of clusters computed for time courses of the 19-
observable set. The agreement between pairs of clusterings was calculated with ARI,
for original clusterings (A), and transformed clusterings (B), composed of two clus-
ters, where the first cluster has members that belong to the largest and the strongest
cluster, and the second cluster contains members from all remaining clusters.
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Figure 3.10: Convergence of CorEx applied to time courses obtained with 19-
observable set through varied numbers of clusters. log10-transformed convergence
scores (Section 3.3.3) of clusterings are represented with bars that if crossed a blue
line are assumed as converged. The blue line is plotted on the level of log10(1e−05).
CorEx arrived at a stable solution for only four clusterings.
above the remaining clusters in almost all the clusterings. This suggests that
prioritised observables most likely will belong to this cluster. Moreover, com-
paring the consistency of member allocation in the largest and strongest cluster
can support the observed stabilisation of CorEx results and therefore, help to
establish the final choice of the number of clusters.
In Figure 3.9A, agreement between pairs of the original clusterings can
be observed between all clusterings in a rage starting from 7 to 12 clusters. This
agreement in contents of the strongest cluster can be noticed for even lower
numbers of clusters in the transformed clusterings (Figure 3.9B).
We can also examine the convergence metric (Section 3.3.3) over the
change of cluster number. Figure 3.10 shows that the distance between mean
values of last ten iterations visibly increases for more than 7 clusters. Despite
this lack of convergence, agreement between clusterings was observed for
clusterings with higher than 6 clusters.
We could observe that the number of clusters with at least one member
stabilised to 8 for clusterings indicated to have 9 and more clusters. However,
further examination of agreement in membership between clusterings showed
that the top ARI scores were achieved for clusterings with lower numbers
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of partitions, starting from 7 for the raw CorEx results, and already for the
clustering of 3 partitions, when the consistency in membership was compared
between the largest clusters. Although the safest value of clusters to choose for
the 19-observable set is above 8, a firm and reasonably satisfying result can be
obtained for 7 clusters.
The same analyses is also conducted for the 91-observable set. Fig-
ure 3.11 shows less stability in cluster size than observed in the 19-observable
set. The maximal number of clusters with at least one associated observable is
29 but this number occurred only once for the clustering of 39 clusters. Sim-
ilarly to the 19-observable set, there is a distinctive difference in the cluster
strength and size between the first and the other clusters. Though it might not
be that clear from the view on distribution of cluster sizes over varied number
of clusters (Figure 3.11), the cluster strength distribution demonstrates this pre-
vailing and wide discrepancy (Figures 3.12). Furthermore, for higher cluster
indices, the ratio drops to 0 and lower down to negative values that indicates a
lack of dependency between cluster members [253]. Therefore, despite sizes of
clusters are larger than in the 19-observable set, far greater number of clusters
has none or relatively low dependence between members, measured by the
cluster strength. At the same time, there is a particular similarity between
these observable sets as in both of them the normalised cluster strength of the
largest cluster in nearly all clusterings is equal 0.4 (compare Figures 3.13 &
3.8C). These observations can be explained by the fact that the 91 observable
set is composed of far more fined grained output than the 19-observable set,
drawn from the same system but with potentially higher level of noise. In
this particular dataset, the noise would denote these molecular species that
appear in very low quantities or very rarely over the simulation. In majority of
clusterings of the 91-observable set, the largest cluster has 15 observables with
the cluster strength of 8, whereas an equivalent cluster in the 19-observables
has 8 observables with the cluster strength of 4. Recalling that the maximal
value of the cluster strength is m− 1, where m is the cluster size, both cases
represent quite robust signals [253]. CorEx filtered out noisy and weakly de-
pendent observables from the time courses of the 91-observable dataset and
found proportionally the same amount of information in time courses of both
datasets.
Figures 3.14 shows agreement of cluster membership allocation mea-









































































































































































































































































































































































































Figure 3.14: Measurement of agreement in observable allocation between clusterings
with increasing numbers of clusters computed for time courses of the 91-observable
set. The agreement between pairs of clusterings was calculated with ARI, for original
clusterings (A), and transformed clusterings (B), composed of two clusters, where the
first one has members that belong to the largest and the strongest cluster, and the
second one contains members from other clusters.
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Figure 3.15: Convergence of the 91-observable set over varied numbers of clusters.
log10-transformed convergence scores (Section 3.3.3) of clusterings are represented
with bars that if crossed a blue line are assumed as converged. The blue line is
plotted on the level of log10(1e− 05). CorEx arrived at a stable solution for only one
clustering with 18 clusters. Compared to the 19-observable set, clustering of the 91-
observable set is highly unlikely to converge. This can be explained by higher level of
more fragmented representation of signal in the 91-observable set.
sured with ARI between pairs of clusterings with increasing number of clusters.
Figure 3.14A shows results for all paired clusterings and Figure 3.14B shows
results for transformed clustering determining consistency in the first cluster
membership across all clusterings. In the former figure, there is a very low
agreement between clusterings compared to the 19-observable set that can be
explained with the presence of molecular species with very low abundances.
Complete identity between clusterings can be found only when the first clus-
ters are compared, that is preserved fairly consistently over different numbers
of clusters. Suggested by these observations, the most reasonable choice of the
number of clusters for this observable set is above 15.
Convergence of CorEx was also recorded for the 91-observable set
demonstrated in Figure 3.15. Results show much larger distances between
learned values of
∑
TC(X;Y j) than observed in the 19-observable set. Similarly
to the 19-observable set, the lack of convergence did not hinder the ability of
CorEx to indicate the most tightly interlinked subgroup of observables. This
can be argumented by an example of clustering with 21-clusters, represented
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by the highest bar in Figure 3.15. Despite this clustering is most distant from
convergence, Figure 3.14B demonstrates that CorEx identified members of the
first cluster with a complete agreement with other clusterings.
To conclude, multiple CorEx evaluations of time courses with two dif-
ferent observables sets, performed with gradually higher number of clusters,
indicated that the most reasonable range of values for this input parameter for
the 19-observable set is above 6, and for the 91-observable set, above 15. These
values are inferred mainly on the membership agreement between clusterings.
As exemplified by the 91-observable set that contains trajectories characterised
with weak signals, the increase of cluster numbers did not bring stability in the
number of clusters filled with at least one observable. Therefore, the stability
of the largest cluster between clusterings seemed to be more indicative.
Analysis of obtained clusterings hinted on general characteristics of
CorEx results with respect to these particular datasets. As seen, the clustering
of time courses of the 91-observable data set is less stable over multiple runs
than the clustering of time courses of the 19-observable data set. This can be
explained by the amount of noise in the former data set. The 91-observable
data set is in fact a more fragmented representation of the model than the 19-
observable data set. The same prevailing value of normalised cluster strengths,
allocated for the strongest clusters, indicates that CorEx identified equal pro-
portion of signal in time courses of respective observable sets.
Procedure of learning dependencies within in a dataset by CorEx is not
deterministic as in a few clusterings a fixed value of total correlation between
iterations was not successfully found, even for the 19-observable data set. This
justifies application of CorEx to all time courses obtained with varied parameter
samples to prioritise observable sets, that is the main objective of this pipeline.
Despite being only guaranteed to converge to local optimum, CorEx is
able to identify a single and strongly dependent cluster of observables, that is
consistent over majority of multiple runs with increasing numbers of clusters.
This strongest cluster was successfully identified regardless learning conver-
gence. The other clusters have distinctively weaker dependence what suggest
that in further pipeline steps, the focus should be placed on the strongest clus-
ter that potentially harbour the most information within both observable data
sets. To confirm validity of this largest cluster, observables that are its members
should be examined with respect to their relations encoded in the model. This
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is the subject of the next section, where observables of the strongest clusters
found in both observable data sets are studied in details.
3.4.2 Comparison of clusterings between selected and sam-
pled observables
Having found suitable settings for both observable sets, we can ex-
amine and compare allocation of observables within clusterings of these sets.
CorEx executions were automatically repeated 3 times and the highest value
of
∑
TC(X;Y j) was subjected to analysis.
Automated visualisation of clustering are provided with tree graphs as
seen in Figure 3.16 and 3.17. A cluster is a circle node with outgoing edges to
observable names that are cluster members. The number placed in the middle
of nodes is the cluster index. The size of nodes is proportional to the cluster
strength (TC j). Thickness of outgoing edges between nodes and observable
names is proportional to the observable strength (MIS ji) defining strength of
dependence between a cluster and observable.
Figure 3.16 demonstrates outcomes of clustering performed on time
courses of the 19-observable set. The number of clusters was set to 7. The
largest 9-element cluster with the 0th index is also the strongest one, scor-
ing TC j = 4.428. The remaining 10 observables are scattered between other
6 clusters. Table 3.2a enlists names of these 9 members together with their
observable strength (MIS ji) in descending order. As seen, the values of MIS ji
are not distinctively different. The 9 observables can be represented with 6
observables denoting the same molecular species but in a more generalised
form (Table 3.2b). This reduction is achieved by removing redundant context
(binding or internal states of sites) in expressions representing observables of
the same agent. Molecular species in 3rd, 5th, 6th and 7th rows of Table 3.2a can
be replaced with an observable “D34”, denoting DARPP-32 phoshophorylated
at Threonine 34 (Thr34) with unspecified binding state and internal states of
two other sites. “D34” belongs to the list of 15 observables defined in Table 2.1
(Chapter 2), that represented species of DARPP-32 as overlapping sets. How-
ever, this list of 19 observables with the explicit and non-overlapping represen-
tation of DARPP-32 species demonstrates that species with phosphorylation of
the Thr75 site cannot be fussed in its general form (i.e. “D75”) as one of species
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(a)
Observable name Observable expression in Kappa language MIS ji
1. PKA PKA() 0.603
2. cAMP cAMP(c˜on?) 0.592
3. Thr34:Ser137 D(thr34˜p, ser137˜p, thr75˜u) 0.575
4. PDEP PDE(pSite˜p?) 0.572
5. Thr34:Thr75:Ser137 D(thr34˜p, ser137˜p, thr75˜p) 0.568
6. Thr34 D(thr34˜p, ser137˜u, thr75˜u) 0.567
7. Thr34:Thr75 D(thr34˜p, ser137˜u, thr75˜p) 0.566
8. D D(thr34˜u, ser137˜u, thr75˜u) 0.549
9. Thr75 D(thr75˜p, thr34˜u, ser137˜u) 0.478
(b)
Observable name Observable expression in Kappa language Row(s)
in Tab. 3.2a
1. PKA PKA() 1
2. cAMP cAMP(c˜on?) 2
3. PDEP PDE(pSite˜p?) 4
4. D D(thr34˜u, ser137˜u, thr75˜u) 8
5. Thr75 D(thr75˜p, thr34˜u, ser137˜u) 9
6. D34 D(thr34˜p) 3,5,6,7
Table 3.2: List of observables assigned to the largest and strongest cluster (TC j =
4.428) found with time series of the 19-observable set (A). This is the most visible clus-
ter on Figure 3.16. Molecular species in 3rd, 5th, 6th and 7th rows can be represented
with a single observable “D34”, denoting DARPP-32 phoshophorylated at Thr34 with
unspecified binding and internal states of other two site. Therefore, the list of 9 ob-
servables can be reduced to a 6-observable list (B). Species phosphorylated at the
Threonine 75 (Thr75) site cannot be similarly generalised as “D34”, because “D75”
implicitly includes “Thr75:Ser137” that is assigned to a different cluster.
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not present in the largest cluster. This missing species can be located in the
cluster with the index 1 (Figure 3.16), together with DARPP-32 phosphory-
lated only at the Serine 137 (Ser137) site (observable “Ser137”), and the bound
form of protein phosphatase 2C (PP2C) dephosphorylating Ser137 (observable
“PP2C ”).
All species of DARPP-32 phosphorylated at Thr34 appeared in the 0-
indexed cluster indicating on importance of events involving Thr34. Among
them are observables representing a negative feedback loop (cAMP–protein ki-
nase A (PKA)–PDE, Figure 3.16B) regulating the level of cAMP. This feedback
loop is directly involved in the phosphorylation of Thr34 site as are other clus-
ter members. This observable allocation indicates that CorEx separated major
effectors of the cAMP signal, from the ones. Presence of unphosphorylated
DARPP-32 in this cluster can be explained by the fact that the unphosphory-
lated DARPP-32 is mainly used for the phosphorylation of Thr34. This can be
supported by the observation of the opposite dynamics of the unphosphory-
lated DARPP-32 and the DARPP-32 phosphorylated at Thr34 that react to the
cAMP signal (Figure 2.10).
Similar analysis can be performed for clustering of time courses of the
91-observable set (Figure 3.17). The number of clusters was set to 18. The
largest 20-element cluster is also the strongest one. The content of the strongest
cluster with the index 0 is enlisted in Table 3.3 and presented together with
MIS ji values defined per observable in descending order. There is slightly
larger discrepancy between these values than in the cluster of 19-observables
set as the top scored observable (1st row) has a doubled value of the observable
that got the lowest score (the last row). The largest cluster strength is much
higher then its counterpart in the clustering of the 19-observable set, that is
TC j = 10.478. Similarly to the previous observable set, the list of 20 observables
in Table 3.3, can be reduced to 12 observables, as shown in Table 3.4.
As in the 19-observable set, majority of molecular species in the largest
cluster of the 91-observable set are directly related to the cAMP signal, such as
PKA, PDE, cAMP, R2C2 and DARPP-32 phosphorylated at Threonine 34 (D34).
In case of the 91-observable set, however, we have a view on explicitly de-
fined observables that gives us precise information what particular molecular
species, including complexes, are important and dependent on each other.
For instance, cAMP is found as both unbound and bound to R2C2. If four

































































































































Figure 3.17: Clustering of the 91-observable set visualised with a tree graph (A).
Graph nodes are clusters with edges outgoing to observable names. Node size is
proportional to cluster strength (TC j). CorEx assigned observables to 17 clusters,
with one particularly stronger than the others (B), composed of 20 observables with
similarly strong observable-to-cluster dependence (MIS ji) proportional to thickness of
edge strokes.
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Observable expression in Kappa language MIS
1. D(s!0, ser137˜u, thr34˜u, thr75˜u), PKA(a!0) 0.622
2. R2C2(camp1!0, camp2!1, camp3!2, camp4!3, pka1˜on, pka2˜on),
cAMP(a!0, c˜on), cAMP(a!1, c˜on),cAMP(a!2, c˜on),cAMP(a!3, c˜on)
0.616
3. R2C2(camp1, camp2, camp3, camp4,pka1˜off, pka2˜off) 0.616
4. PKA(a) 0.615
5. D(s!0, ser137˜u, thr34˜u, thr75˜p), PKA(a!0) 0.601
6. PDE(pSite˜u) 0.599
7. PDE(pSite˜p) 0.599
8. D(s, ser137˜u, thr34˜p, thr75˜u) 0.598
9. cAMP(a, c˜off) 0.598
10. D(s, ser137˜u, thr34˜p, thr75˜p) 0.598
11. D(s, ser137˜p, thr34˜p, thr75˜u) 0.597
12. D(s, ser137˜p, thr34˜p, thr75˜p) 0.587
13. D(s!0, ser137˜u, thr34˜p, thr75˜u), CDK5(a!0) 0.585
14. D(s, ser137˜u, thr34˜u, thr75˜u) 0.574
15. PP2B(ca1!1, ca2!2, ca3!3, ca4!4, state˜a!0),
D(s!0, ser137˜u, thr34˜p, thr75˜u),
Ca2+(a!1), Ca2+(a!2), Ca2+(a!3), Ca2+(a!4)
0.571
16. D(s!0, ser137˜u, thr34˜u, thr75˜u), CDK5(a!0) 0.503
17. D(s!0, ser137˜u, thr34˜p, thr75˜p), PP2A(ca, pSite˜u!0) 0.478
18. D(s, ser137˜u, thr34˜u, thr75˜p) 0.472
19. D(s!0, ser137˜p, thr34˜p, thr75˜u), PP2C(a!0) 0.428
20. D(s!0, ser137˜u, thr34˜u, thr75˜p), PP2A(ca, pSite˜u!0) 0.305
Table 3.3: List of observables assigned to the largest and strongest cluster (TC j =
10.478) found with time series of the 19-observable set. This is the most visible cluster
on Figure 3.17.
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Observable expression in Kappa language Row(s)
in Tab. 3.3






6. D(s, thr34˜p) 8,10,11,12
7. cAMP(a, c˜off) 9
8. D(s!0, ser137˜u,thr75˜u),CDK5(a!0) 13,16






Table 3.4: Reduced list of 12 observables assigned to the strongest cluster of the 91-
observable set. The reduction of the observables list is performed by representing
multiple observables as one generalised expression. Row numbers of combined ob-
servables from the complete list of 20 observables in Table 3.3 are enlisted in the third
column.
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molecules of cAMP are bound to R2C2, it can cause dissociation of two PKA ki-
nases. Furthermore, complexes of DARPP-32 with PP2C, protein phosphatase
2 (PP2A) and protein phosphatase 3/calcineurin (PP2B), cyclin dependent ki-
nase 5 (CDK5) and PKA are important only when DARPP-32 is in specific con-
figuration of phosphorylation sites. For instance, in the complex of DARPP-32
and CDK5 (the 8th row in Table 3.4), DARPP-32 is unphosphorylated on Ser137
and Thr75 sites. The state of Thr34 is irrelevant as in the table with unreduced
observable list it appears as unphosphorylated and phosphorylated (rows 13th
and 16th Table 3.4). The reason why DARPP-32 is unphosphorylated at the
Thr75 site in the complex of DARPP-32 and CDK5 is that CDK5 phosphory-
lates Thr75 site that has to be dephosphorylated to bind CDK5 as there is not
product rebinding. Similar explanation of explicit state indication of a par-
ticular phosphorylation sites applies in three other complexes that involves
DARPP-32 (1st, 8th, 11th rows in Table 3.4). In the largest cluster, there is
no observables of bound and fully phoshophorylated form of DARPP-32. In
particular the Ser137 site is in nearly all such cases unphosphorylated, except
for a complex of DARPP-32 and the phosphatase PP2C of Ser137 (12th row
of Table 3.4). Reasons why these specific forms of molecular species and site
configurations appeared in the dominating cluster but not the others with very
similar composition might be related to their much higher abundances or that
they are largely independent from each other. The larger abundances of cer-
tain species might be caused by a lower number of reaction steps necessary
to create these species, leaving more complex species in marginal abundances.
For instance, in the 11th row of Table 3.4 showing a complex of DARPP-32
and PP2A, PP2A is not bound to Ca2+ nor phosphorylated that would require
execution of two additional reaction rules. On the other hand, increase in
molecular species of PP2A bound to Ca2+ require the Ca2+ spiking, the signal
by which affected species seem to not be represented in the largest cluster. The
only observable that contains Ca2+ ions is the observable in the 10th row of
Table 3.4 that represents a complex of DARPP-32, phosphorylated at Thr34,
and PP2B, a phosphatase dephosphorylating Thr34. According to the rule
specification, only an active form of PP2B, bound to four Ca2+ ions, can de-
phosphorylate Thr34. Despite the presence of Ca2+ ions, abundances of this
particular species are very much dependent on the cAMP-triggered signal and
the phosphorylation of Thr34.
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Closer examination of observables assigned to the dominating cluster
in both observable data sets indicates that the cluster is constructed from mem-
bers directly affected by the cAMP signal. Differently to the hand-selected and
generalised 19-observable data set, the automatically generated 91-observable
set is a list of exact compositions and configurations of molecular species that
appeared during the simulation. Hence, the largest cluster derived from clus-
tering of time courses of the 91-observable set contains exact information on
species configuration that are strongly dependent on each other. We learned
that only particular configurations of species are found in the cluster and there-
fore, are strongly dependent on the cAMP-signalling events. This observation
suggests that not all closely matching species are present in equal abundances
during the simulation, or their dependence on other signal in the model is much
stronger than to the cAMP signal. Nevertheless, the original lists of observables
in both sets were reduced to more generic representation of observables by re-
moving redundant context in their expressions. This supports the assertion
that CorEx detected equally abundant and closely matching observables that
brings to the light another facet of CorEx application, that is dimensionality
reduction.
3.4.3 Observable scores
Acquiring a view on clustering results produced by CorEx application
on single time courses, we can delve into results obtained with the pipeline
(Figure 3.4), where CorEx is applied to 400 averaged time courses collected
from simulations of the model with varied parameter sets. This section presents
calculation outcomes of two observable scores to clusterings obtained with
CorEx. The first observable score is defined with respect to the clustering type
and therefore, contains a frequency term of clustering type. The second observ-
able score is calculated by using CorEx output measures form all clusterings of
parameter samples without differentiating them into types. As these observ-
able scores are sums of more than one CorEx output measures, results of each
one is analysed in separation. To simplify analyses, the pipeline is applied to
time courses of the 19-observable set. The parameters of the model are varied
10 folds from their fundamental values.
Averaged time courses obtained with model run performed with differ-




Figure 3.18: Distribution of ARI scores for pairs of clusterings obtained by applying
CorEx to time courses generated with all parameter sample sets. When clustering
pairs are compared in their original number of clusters as partitioned by CorEx, there
is weak agreement between 79800 clustering pairs except for one pair that scored 1
(A). When only content of the first cluster is compared between clustering, the number
of identical clustering pairs reaches 1377 comprising 1.73% of all clustering pairs (B).
This low fraction of repeated clusterings reveals absence of any types of clusterings
in time courses of the 19-observable set generated with 10 fold parameter variations.
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10. To determine whether any repeated clusterings types can be identified, Ad-
justed Rand Index (ARI) is calculated for each pair of clusterings. Figure 3.18A
shows that great majority of scores calculated between 79800 pairs have very
low similarity, located between 0.0 and 0.4, with the mean value slightly below
0.2. What is more, there are only two clusterings which scored 1 meaning
that only one pair of clusterings is identical. When comparison of only first
clusters between clusterings is performed, as in Section 3.4.1, the number of
identical clustering pairs that scored 1 is 1377, that comprises 1.73% of all pairs
(Figure 3.18B). This low fraction of identical clusterings seems to be found
rather by chance and therefore, does not convey existence of types among clus-
terings in the dataset that would divide clusterings into groups of identical
clusterings. This lack of distinctive agreement between groups of clusterings
might be caused by a relatively large range of 10 fold parameter variation that
significantly perturbed the modelled system. Therefore, following analysis
concentrates on constituents of Equation 3.16 that takes into account all clus-
tered samples without the frequency term calculated per clustering type. The
frequency term is excluded from the equation for the observable score as no
clustering types were identified.
Figure 3.19 shows distribution of observable counts per cluster. Clusters
included in the figure, are derived from clusterings of time courses generated
with all parameter sets. With the maximal number of clusters set to 10 and
clustering of 400 time courses, a total number of clusters is 4000. Figure 3.19
shows that nearly 2400 clusters, that is more than half of all clusters, have less
than two cluster members that classifies them to degenerate clusters.
Figures 3.20 show distributions of cluster strengths (TC) for all cluster-
ings. Figure 3.20A shows raw TC values that take values between 0 to above
6. Cluster strength of 2200 clusters is equal 0 denoting degenerated clusters.
Figure 3.20B shows normalised values of TC, TC′, enclosed within 0 and 0.6.
The normalisation is performed by dividing TC values by member counts if
their values are > 0 and cluster member count is > 1. Otherwise, TC′ values
are set to 0. After the procedure of normalisation, the number of clusters with
strength equal to 0 increased by 200 to the total of 2400 degenerate clusters.
Grouping together all degenerate cluster strengths under the 0 score reveals a
bimodal distribution of remaining cluster strengths with the first mode located
between 0.1 and 0.2 values of TC′, and the second above the value of 0.5.
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Figure 3.19: Distribution of member counts per cluster. Clusters that are included are
derived from clusterings of time courses generated with all parameter sets. Singleton
clusters, as non-member clusters, are classified as degenerate clusters in observable
score definitions what amount to almost 2400 clusters with 0 or 1 member.
Cluster strengths are parcelled into observables to separately examine
their allocation for each observable, for raw TC values (Figure 3.21) and nor-
malised ones (Figure 3.22). For each observable, TC and TC′ can take values
from the whole range. For TC between 0 and 7, and for TC′ between 0 and
0.6. In both cases, distribution of values is not uniform but tend to have uni-
modal or bimodal shape. In distributions of raw TC values, both types of
distributions have the mode between 0 and 1. In the bimodal ones the sec-
ond mode is located between 3 and 4. The observables that belong to the
bimodal group are “Thr34:Thr75” (A), “cAMP” (B), “D” (E), “Thr34” (F), “PKA”
(H), “Thr75” (J) “PDEp” (N). These 7 were among 9 located in the dominat-
ing cluster found by clustering of a single set of time courses generated with
the baseline parameter set (Section 3.4.2, Figure 3.16). Multiple clusterings
of time courses with parameter perturbations revealed that this earlier result
identifying the 7 observables as strongly dependent is rather a tendency. Nor-
malisation of values reduced broadness of variation and exposed more observ-
ables with bi- and tri-modalities in TC′ distributions (Figure 3.22). These three




Figure 3.20: Distributions of the cluster strength (TC) derived from all clusterings ob-
tained with time courses generated with varied parameter sets: (A) raw TC values, (B)
normalised TC′ values. Normalisation of TC values is performed by dividing TC values
by member counts if their TC values are > 0 and member counts is > 1. Otherwise, TC′
values are set to 0. Joining all degenerate cluster TC values under 0 score reveals a
bimodal distribution of remaining cluster strengths with the first peak located between












































































































































































































































































































































































































































































































































































modalities are mainly located around 0.0, 0.2 and 0.5, meaning that despite
broad range of cluster strength values to which an observable was classified,
there are three most commonly appearing cluster strengths that observables
are classified to. Observables can be grouped with respect to shape of dis-
tributions such as “Thr34:Thr75” (A) and “Thr34” (F); “cAMP” (B), “PKA” (H)
and “PDEp” (N); “Ser137” (G), “Thr75:Ser137” (L), “Thr34:Ser137” (Q) and
“Thr34:Thr75:Ser137” (S); “free Ca” (K) and “all Ca” (P). These groupings refer
to different forms of the same agent (P,K) or directly reacting agents (B, H, N).
Another metric to examine is distribution of observable strengths MIS.
Figures 3.23 show distribution of MIS for all clusters before (Figure 3.23A) and
after MIS scores for singleton clusters were set to 0 (Figure 3.23B). MIS score
is generally kept between the range [0,1] but can have an outlier values that
exceed this range. After removal of degenerated clusters, MIS values are kept
within the range. In Figure 3.23B, there are two most frequent scores with
means around 0.2 and 0.6.
In Figure 3.24, this distribution is parcelled into observables. Most of
the observables take the full range of values from 0.0 to around 0.75. Though
the same 7 observables tend to take values around the higher end of the range,
the view of MIS values per observable shows that other than 7 mentioned
observables have relatively higher scores, such as “Thr75:Ser137” (P), “Ser137”
(O), “Thr34:Thr75” (Q), that mean their dependence to the cluster they are
associated to is strong. There are also observables with high tendency to take
values around 0 (“CDK5 ”, E) or 0.25 (“free Ca”, B; “all Ca”, C; “PP2ACa”, H;
“PP2Bactive”, J).
As seen in Section 3.4.1, cluster indices are ordered according to their
TC scores, locating the strongest one on the index 0. Figure 3.25 shows dis-
tribution of cluster indices from 0 to 9 on a raw CorEx output dataset (before
any degenerated clusters had their TC or MIS values setup to 0). A “G-” suffix
means a group followed by the cluster index number to which observable was
classified. Again, the same 7 observables are discernible, as they are all located
in the “G0” cluster in at least half of the total of 400 clusterings (C, D, E, H, K,
L). Some other observables are more likely to be located in the “G1” or “G2”
clusters ( “free Ca”, F; “all Ca”, Q; “PP2ACa”, R; “PP2Bactive”, P). There is also
an observable, “CDK5 ” (J), with the opposite tendency to be located in the
weakest clusterings (e.g. “G9”).
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(A)
(B)
Figure 3.23: Distribution of observable strengths (MIS) defining dependence between
observables and their clusters, to the number of clusters. Clusters are derived from
clusterings of time courses obtained with all parameter samples. In general MIS take
values within range of [0,1], however, anomalous values are also encountered (A). By
setting MIS values of observables assigned to singleton clusters defined as degener-




















































































































































































































Figure 3.26: Comparison of two observable scores calculated from CorEx output mea-
sures derived from clustering of 400 averaged time courses obtained from executing
the model of DARPP-32 network with varied number of parameter sets. The first ob-
servable score, defined in Equation 3.13 and calculated per clustering type, is based
on CorEx output measures derived from only one identified clustering type, named
“pset243”, composed of two clusterings. Being such narrow representation of the
whole data set composed of 400 clusterings, the observable score with respect to
clustering type reference to the observable score defined in Equation 3.16 that include
CorEx output measures from all clusterings. Despite the difference in two observ-
able score definitions, the same 7 observables are enlisted as top ones, though with
different order. These 7 observables are found among 9 that were classified to the
dominating cluster found in clustering of a single set of time courses generated with
the model with the basal parameter set.
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At the final step, results of complete calculation of observable scores
are presented in Figures 3.26. The observable scores calculated with re-
spect to all clustered parameter samples (Figure 3.26A) are compared with
observable scores calculated per identified clustering type with Equation 3.13
(Figure 3.26B). Results of latter scoring are presented just for comparison, as
there was only one recurring clustering type (“pset243”) composed of 2 clus-
terings. Both scores indicate the same 7 observables as top scored ones, though
in different order (“Thr34:Thr75”, “cAMP”, “D”, “Thr34”, “PKA”, “Thr75” and
“PDEp”). All these observables are directly involved in the cAMP signal. In
case of score per clustering type, the 7 observables are located in the same
cluster, that has the highest score among the other clusters. For score based on
metrics collected from all clusterings, the 7 observables are distinctively sepa-
rated from the remaining 12. For these 7 observables, parameter sensitivities
are calculated and presented in the next section.
3.4.4 Parameter scores
62 parameter sensitivity scores are calculated for each of the 7 selected
observables, for each time point between 402 and 1200 interval of the simu-
lation. Based on an example of the “Thr34” observable, Figure 3.27 demon-
strates results of these calculations. The sensitivity scores take values between
[0,0.20]. Shapes of curves formed with sensitivity scores calculated over time
reflect three different phases of the simulation. These are the cAMP pulse is
introduced in the 200th second of the simulation, followed by the Ca2+ spiking
at the 250th second that lasts until the 300th second. The third phase is relax-
ation time that starts after the Ca2+ spiking ceases at the 300th second and lasts
until the end of the simulation. Based on the identification of these intervals
on sensitivity curves that bounced off the baseline level, parameters can be
divided into the ones that “Thr34” is sensitive to only at the cAMP pulse (e.g.
“k57”), during the Ca2+ spiking (e.g. “kon6”,“kcat6”, “kon33”, “kon41”), and
both at the cAMP pulse and the relaxation time (e.g. “kcat1”,“kon9”,“k58”).
Decision at which individual points of the simulation to calculate sensitivity
scores might be difficult to make as sensitivity scores even differ within these
three well defined intervals. For instance, these variations in sensitivity scores
are observed for the “k58” parameter during the relaxation phase, and for




















Figure 3.27: Sensitivity scores obtained with HSIC-based indices for the “Thr34” ob-
servable per each parameter and time step between 201 and 600 second. The sen-
sitivity scores take values between [0,0.20]. At the 200th second of the simulation,
the cAMP pulse is introduced. Next, at the 250th second, the Ca2+ spiking is initiated
that lasts until 300th second. A period passed the 300th second until the end of the
simulation defines relaxation time. Shapes of curves formed from sensitivity scores
calculated over time reflect patterns of these three different simulation phases. Pa-
rameters that sensitivity curves bounce off the baseline divide into ones that “Thr34”
is sensitive to only at the cAMP pulse (e.g. “k57”), during the Ca2+ spiking (e.g.
“kon6”,“kcat6”, “kon33”, “kon41”), and both at the cAMP pulse and the relaxation time
(e.g. “kcat1”,“kon9”,“k58”). Confronted with such diversity of parameter sensitivities
conditioned by the time point, it would be difficult to decide for which individual points
of the simulation the calculation of sensitivity scores should be performed as sensitivity
scores even differ within these three well defined intervals.













































Figure 3.28: Clustered heatmap of integrated parameter sensitivity scores for the 7 se-
lected observables. Clustering is performed with Ward’s method [296]. Values of the
integrals of sensitivity scores are within a broad range of [0,70]. Parameters with dis-
tinctively higher sensitivity scores divide into parameters affecting multiple observables
and parameters that variation only affects particular observables. Of 61 parameters
plus a negative control parameter (“kdummy*”), around 10 parameters per observable
have distinctively elevated sensitivity score exposing more than 80% of parameters as
weakly or uninfluential.
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these many sensitivity scores for more than one observable poses difficulties
in further analysis. Therefore, integral of area under the curve of sensitivity
scores define the final parameter scores. By taking the integral of the whole
time interval erases the stratification into three different phases of the simula-
tion but determines the overall magnitude of parameter impact. Figure 3.28
summarises results of integration of sensitivity scores for the 7 observables as a
heatmap clustered with the agglomerative hierarchical method of Ward. This
method applies a minimal variance criterion as a clustering objective function
[296]. The integrated scores take values from just above 0 to the maximal of
around 70. The top four parameters are “kon41”,“kcat1”,“kcat3” and “kon9”.
All four are important parameters for four molecular species of DARPP-32,
with the first one, “kon41”, having non-negligible impact on all observables.
This parameter is responsible for the speed of re-association of PKA to R2C2.
Therefore, “PKA” and the phosphorylated phosphodiesterase (PDE) (“PDEp”),
as a target of the “PKA” kinase, are most sensitive observables to this parameter.
The next parameter, “kcat1”, decides on the speed of the phosphorylation of
Thr75 by CDK5. Therefore, it is rather straightforward why this parameter
has an impact on such observables as “Thr34:Thr75” and “Thr75”. The same
parameter is also important for the “Thr34” observable as Thr34 cannot be phos-
phorylated by PKA if it is already phosphorylated on Thr75. Next in the line
is “kcat3”. It is a constant rate parametrising the phosphorylation of Thr34
by PKA, when Thr75 is unphosphorylated. The highest integral score for this
parameter is allocated for the unphosphorylated DARPP-32 (“D”). This might
be due to that the phosphorylation of Thr34 mainly occurs on the unphospho-
rylated DARPP-32 [177]. The second observable sensitive to this parameter is
“Thr34:Thr75”. Explanation for this importance relation can be seek in the or-
der of reactions, that is the Thr34 site has to be phosphorylated before Thr75 as
Thr75 blocks phosphorylation of Thr34 by PKA. The last on the list of the four
parameters is “kon9”. This is a binding parameter of the unphosphorylated
PP2A to DARPP-32. PP2A is the phosphatase of Thr75 and in this way, it is
important for all molecular species of DARPP-32 phosphorylated at Thr75.
Next to parameters affecting multiple observables, there are parame-
ter groups highly scored only with respect to a particular observable. For
instance, there is a group of three parameters, “kcat31”,“kcat32”,“kon54”,
that are highly scored with respect to “PDEp”. The first two parameters are rate
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constants of phosphorylation and dephosphorylation reactions of PDE, respec-
tively. A link with the third “kon54” parameter, is less straightforward as it is a
rate constant in a binding reaction of Ca2+ to PP2A. The reason why “kon54” is
important for “PDEp” can be explained in perspective of encoded dependencies
in the model. When Ca2+ is bound to PP2A, PP2A has a four times lower dis-
sociation rate from DARPP-32. Being the phosphatase of Thr75, PP2A has then
a greater chance to dephosphorylate its target. A more important aspect is that
PP2A competes with PKA for DARPP-32. When PKA is blocked from binding
to DARPP-32 by PP2A, then its availability for binding and phosphorylating
PDE is enhanced. Therefore, a connection of the phosphorylated PDE to PP2A
is mediated by PKA.
To examine if there is any artefactual level of sensitivities, a negative
control parameter was included in the sensitivity computation, “kdummy*”.
This parameter is absent in the model and therefore, neutral to the output
results [262, p. 74]. In theory, the sensitivity of such parameter should be
equal zero. However, Marino et al. [268] showed that with PRCC and eFAST
methods “dummy parameters” take non-zero sensitivity values. Whether such
artefactual sensitivities appear in the HSIC-based indices has not been tested
before. Figure 3.28 shows “kdummy*” parameter clustered at the bottom, among
least scored parameter. A more detailed view on a range of values that this
parameter can take can be seen in Figure 3.29. The figure shows distribution
of integrated sensitivity indices for each parameter. Indices are gathered from
all 7 observables. Distributions are divided into 1st, 2nd and 3rd quartiles to
demonstrate variability in parameter distributions. In an ascendingly ordered
dataset, the 1st quartile, equivalent to 25th percentile, is the median of the
range of values between the 2nd quartile and the fist value. The 3rd quartile,
equivalent to 75th percentile, is the median value of the range between the 2nd
quartile and the last value of this dataset. The 2nd quartile is the median of
the whole range of dataset values. In Figure 3.29, end sides of a box indicate
the 1st and the 3rd quarterlies with a red line denoting the median. Whiskers
reach is defined by 1.5 × Interquartile Range (IQR). IQR is a difference between
3th quartile (Q3) and 1st quartile (Q1). The value denoted of the left-hand
side whisker is defined as Q1− 1.5 ∗ IQR and the value of the right-hand side
whisker as Q3 + 1.5 ∗ IQR. Parameters are sorted according to the 3rd quartile.
The median value of “kdummy*” is 2.0 with the maximal value of 2.42. Conse-
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Figure 3.29: Distribution of integrated sensitivity scores for each parameter gathered
from all observables. Distributions are divided into quartiles to demonstrate scores
variations in the wild-type model. End sides of a box indicate 1st and 3rd quar-
tiles with red line denoting the median value. Spread of whiskers is defined with the
1.5×Interquartile Range (IQR). Parameters are sorted according the 3rd quartile. Re-
actions that the top 5 parameters are involved are dephosphorylation and phospho-
rylation of Thr75 (“kon1”,“kon9”, “kcat9”), phosphorylation of Thr34 (“kcat3”) by PKA,
and deactivation of PKA (“kon41”).
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quently, HSIC-based indices are not free from artefactual sensitivities. Though
reshuffled, the same four parameters can be identified at the top of the list as
in Figure 3.28.
Taken together, highlighted groups of influential parameters have indi-
rect relations to observables they have impact on. Why these key reactions have
been emphasised by identified parameters can be well-argued with respect to
encoded mechanisms in the model. Rather a small fraction of the total of 61
parameters has distinctive influence per a single observable. Among these, a
handful of parameters has significant effect on multiple observables. Lastly,
non-zero sensitivity scores gained by negative control parameter indicates that,
though with a very low magnitude, HSIC-based sensitivity indices are not free
from artefactual sensitivity scores.
3.4.5 Weighted network of observables and parameters
So far analysis of a linearly ordered or clustered lists of parameters
were shown. This section presents the alternative view on relations between
observables and parameters represented and analysed as a weighted network
graph. 62 parameters and 7 observables constitute a fully connected network
of 69 nodes and 434 weighted edges. Figure 3.30 shows this network but with
a subset of parameters and edges that integral of sensitivity scores reached
values above 4 to improve visibility of most affecting parameter sets. The net-
work is composed of 43 parameter nodes, 7 observable nodes, and 94 edges. A
common analysis of sensitivity scores discusses the top scored parameters. In
this study, though a cut-off of 4 may sound arbitrary, it was chosen to preserve
some distance from the maximal sensitivity score acquired by the dummy pa-
rameter. Different levels of stringency in selection of the threshold value can
be applied that allow for more clear exposition of observed results. Figure 3.31
presents the same network but with more stringent threshold of sensitivity
score set to 10. Higher stringency in weights emphasises bridging param-
eters (“kon41”,“kon41”) between observables representing different forms of
DARPP-32 and other 3 observables. Moreover, unphosphorylated DARPP-32
(“D”) is also a bridge between these two observable groups.
In the network graph in Figure 3.30, “PDEp”, “PKA” and “cAMP” observ-
ables are located in the corners, connected to parameters important to them





































































Figure 3.30: Network of observables (black labels) and parameters (red labels) joined
with weighted edges. Weights are defined by integrals of sensitivity scores and rep-
resented with edge colours with numeric values indicated by the colour map. The
network includes parameters that scores reached > 4. The network layout divides it
into four regions, a central one where molecular species of DARPP-32 share a great
number of parameters with each other and three other peripheral regions, occupied
by “PDEp”, “PKA” and “cAMP” observables.













































Figure 3.31: Network of observables (black labels) and parameters (red labels) joined
with weighted edges. Weights are defined by integrals of sensitivity scores and rep-
resented with edge colours with numeric values indicated by the colour map. The
network includes parameters that scores reached > 10. This high stringency in pa-
rameter scores emphasises bridging parameters (“kon41”,“kon41”) between observ-
ables representing different forms of DARPP-32 and other 3 observables. Moreover,
unphosphorylated DARPP-32 (“D”) is also a bridge between these two observable
groups.
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central part of the graph is occupied by observables representing 4 molecular
species of DARPP-32 that share most of their important parameters. Con-
nections between observables that lead through shared parameters allow to
examine relations between observables mediated by connections to the same
parameters. By following this observation, one could ask what is the maximally
connected subgraph or a network component. This question can be answered
by showing the main core of the network graph. Figure 3.32 shows the main
core of the network of parameters and observables with the integral sensitivity
threshold set to > 4. This subgraph contains nodes of degree ≥ 4, that is a score
of the main core for this graph network. This main-core perspective shows
the network in four layers, two representing observables and two, parameters.
This network preserves only these parameters that have distinctive impact
on observables and are shared between at least 4 of all 7 observables. There
are 7 such parameters, of which 3 belong to the top 4 parameters identified
in the clustered heatmap (Figure 3.28). The other 4 parameters are “kcat9”,
“koff40”, “koff27” in the second layer, and k58 in the last fourth layer. The
parameter defining the speed of dephosphorylation of Thr75 (“kcat9”) con-
nects 4 observables, among which are 3 observables representing DARPP-32
(“Thr34:Thr75”, “Thr34”, “D”) and a kinase of Thr34 (“PKA”). All 5 observables
in this main-core graph are connected with a constant rate of dissociation of
cAMP from R2C2 (“koff40”). It is one of important reactions leading to the
PKA activation by binding of cAMP to R2C2. Other highlighted reactions are
dissociation of PP2B, a phosphatase of Thr34, from DARPP-32 when all sites
of DARPP-32 are phosphorylated (“k27”) and Ca2+ degradation (“k58”).
Presented analysis of networks combining parameter and observable
scores only exemplify possible perspectives gained with application of different
graph-based techniques. This representation might be of an advantage when
GSA is performed with respect to multiple model outputs. The example of
the 7 observables shows how one can achieve an immediate view on groups of
parameters, significant with respect to certain groups of observables, next to
parameters and observables that connect separated groups. To take complete
advantage of the network representation of observables and parameters, in the
next section two different model conditions are contrasted and analysed based
on differences in parameter sensitivities.

































Figure 3.32: Main-core of the network of observables (black labels) and parameters
(red labels) joined with weighted edges. Weights are defined by integrals of sensitivity
scores mapped to colours as indicated by a colour map and shown as coloured edges.
The network includes observables and parameters connected with edges that scores
reached > 4 and have degree ≤ 4. This network view preserves only these parameters
that have distinctive impact on observables and are shared between at least 4 of all 7
observables.
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3.4.6 Studying changes induced by the constitutive Ser137
mutation
Parameter and observable rankings defined with GSA- and CorEx-
derived measures have found legitimate interpretation with respect to mecha-
nisms encoded in the wild-type model. To extend evaluation of these measures
and exploit their unified network representation, relations between multiple
observables and parameters are studied with respect to different model condi-
tions. The first one, analysed so far, is the wild-type model with the base-line
condition. The second is one of two models mimicking site-induced mutagene-
sis, constSer137. This mutation is designed to induce a sustained phosphoryla-
tion of DARPP-32 at Ser137. This mutation is implemented as inactivation of a
rule that dephosphorylates DARPP-32 at Ser137. This is achieved by switching
the constant rate parametrising this rule to 0 (see Section 2.3.2.1 for details).
The major effect of this mutation is an invertible phosphorylation of the Ser137
site. The phosphorylated Ser137 inhibits dephosphorylation of Thr34 thereby
also phosphorylation at the Thr34 site becomes permanent. As the phosphory-
lation of Thr34 mainly occurs on the unphosphorylated DARPP-32, this com-
pletely depletes the level of the unphosphorylated DARPP-32. In consequence,
after the cAMP pules leading to the phosphorylation of Thr34, DARPP-32 un-
phosphorylated at Thr34 and Ser137 is rarely encountered species. Comparison
of time courses of the wile-type and constSer137 models can be found in Sec-
tion 2.4.2.1 (Figure 2.19. A closer view of observables affected by the mutation
can be found in Figure 2.19.
Until now, results of measures obtained with CorEx and GSA were pre-
sented only for the wild-type model. Therefore, before the actual comparison
between conditions is performed with differential networks, results of mea-
sures established for importance of observables, parameters, and their amal-
gamated representation as networks are briefly demonstrated for the model of
constSer137. This will also extend evaluation of consistency and significance
of both methods.
3.4.6.1 Observable scores
Observables scores are based on time courses of 19 observables obtained
with simulations of the constSer137 model. As in the wild-type model variant,
the scores are calculated from CorEx output measures derived from clustering































Figure 3.33: Observable and cluster scores calculated from CorEx output measures for
the constSer137 variant of the DARPP-32 network model. The output measures are
derived from clustering of 400 averaged time courses obtained by simulating the model
with varied number of parameter sets. The observable score is calculated with Equa-
tion 3.13 for each of 7 identified types of clusterings (A). Observables are ordered with
respect to scores of the “pset113” clustering type. Variability of observable scores be-
tween different clustering types can be observed. In particular, between “pset113” and
“pset166”. There are also pairs of clustering types with similarly scored observables,
e.g. a pair of “pset113” and “pset140”, and a pair of “pset166” and “pset268”. Compar-
ison of cluster scores for these 7 identified types (Equation 3.15) shows dissimilarity
in cluster scores between these pairs (B). As these clustering types are composed of
up to 3 clusterings, they constitute a narrow representation of the whole data set of
400 clusterings and therefore, the alternative observable score that include measures
from all clusterings is used for observable prioritisation (Figure 3.34B).
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of 400 averaged time courses resulting from execution of the constSer137 model
with randomised parameter sets. Two types of observable scores were defined.
The first one calculated per repeated clusterings (ObsSckji) with Equation 3.13.
Recurrence of the same partitions of observables into clusters determine a clus-
tering type. Clustering should reappear at least once among 400 clusterings to
establish a type. Figure 3.33A presents results of this scoring method applied
to the constSer137 model. There are more clustering types identified in the
constSer137 model than in the wild-type one. The observable scores are sepa-
rately calculated for each of 7 identified types of clusterings. Despite disparate
scores of observables between clustering types, types of clustering with simi-
larly scored observables are identifiable. For instance, a pair of “pset113” and
“pset140” clustering types assign hight scores to “Thr34”, “Thr34:Thr75”, and
“PP2C ”, that in other types are zero or close to zero. The other two observ-
ables that expose variability between clustering types are “D” and “Thr75”. Not
only scores for these observables distinctively vary over clustering types but
also in other two highly similar clustering types (“pset166” and “pset268”), the
two observables have distinctively highest scores than the other ones. As each
clustering type is defined by time courses obtained with variable parameter
sets, the gain of importance by particular subsets of observables over the others
is determined by a particular configuration of parameters. Therefore, observ-
able scoring with respect to the clustering type can potentially indicate specific
parameter setup that influence the importance of particular observables. Nev-
ertheless, the identified clustering types constitute a narrow representation of
the whole data set of 400 clusterings as each clustering type is composed of
no more than 3 clusterings. Despite presence of similarities between pairs
of clustering types, comparison of cluster scores for these 7 identified types
(Equation 3.15) shows that scores allocated per each cluster in these pairs are
dissimilar (Figure 3.33B). In general, mainly strongest clusters across all cluster-
ing types have resembling scores, a tendency already observed with repeated
evaluations of CorEx with varied numbers of clusters (Section 3.4.1).
Seeing that the number of clusterings partitioned into types is low and
to permit for direct comparison between the two model conditions, the al-
ternative observable score (ObsSc ji), defined in Equation 3.16, is favoured for
observable prioritisation as the same score is used to select observables of the
wild-type model. This observable score is calculated with CorEx output mea-











































Figure 3.34: Observable scores defined in Equation 3.16 calculated from CorEx out-
put measures for the wild-type model (A) and the constSer137 model (B). The output
measures are derived from clustering of 400 averaged time courses obtained by simu-
lating the model with varied number of parameter sets. Differences between modelled
conditions are reflected in variable ordering of observables what is found as consistent
with the predominant effect of the mutation. For instance, observables representing
DARPP-32 phosphorylated at Ser137 scored higher in the constSer137 model rank-
ings compared to the wild-type model. Moreover, the top observable of the wild-type
model, representing DARPP-32 phosphorylated only at Thr34, dropped to the 16th
position in the constSer137 model rankings.
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sures derived from all clusterings disregarding clustering types. Figures 3.34
represent a juxtaposition of scored observables with respect to the wild-type
model (Figure 3.34A) and the constSer137 model (Figure 3.34B). Difference
between the two models can be observed by comparing orderings of observ-
ables between these figures. According to the constSer137 ranking, “Thr34”
and “Thr34:Thr75” observables are located at the bottom of the list, at 16th and
17th positions, whereas in the wild-type ranking, these two observables are at
the 1st and 3rd positions, respectively. The loss of importance regarding these
two observables is consistent with the major effect of irreversible phosphory-
lation of Ser137. Abundances of molecular species matching observables of
DARPP-32 solely phosphorylated at Thr34 (“Thr34”), and phosphorylated at
Thr34 and Thr75 (“Thr34:Thr75”) are marginal, as they are rapidly phosphory-
lated at Ser137. For this reason, observables composed of molecular species of
DARPP-32 phosphorylated at Ser137 (“Thr34:Thr75:Ser137”, “Thr34:Ser137”,
“Thr75:Ser137” and “Ser137”) are among the top 7 highly scored observables
in the constSer137 ranking but not among the top 7 of the wild-type list. There
are two observables that are located on the boundary in the two rankings.
These are “Thr75” and “D”, both in the pool of the top 7 observables on the
wild-type ranking but dropped below this pool in the constSer137 ranking.
They are still located in the upper half of the constSer137 ranking, at 8th and
9th positions (Figure 3.34B). In the other type of observable scoring per clus-
tering type, these two observables reach two towering scores in the “pset166”
clustering (Figure 3.33A). However, compared to others, scores for these two
observables are distinctively diverse across clustering types. Both observables
stand in contrast to persistently and highly scored observables like “PDEp”,
“PKA”, “cAMP”, “Thr34:Thr75:Ser137” and “Thr34:Ser137”. Of these 5 observ-
ables, “PDEp”, “PKA” and “cAMP” are situated at the top of rankings in both
modelled conditions.
Based on the observables ranking and in coherence with the wild-type
model analysis, the top 7 observables ranked with respect to the constSer137
model are progressed to the next steps of the pipeline. To sum up, among
these 7 are observables representing molecular species of DARPP-32 phos-
phorylated at Ser137, i.e. “Ser137”, “Thr34:Ser137”, “Thr34:Thr75:Ser137” and
“Thr75:Ser137”. These 4 observables are absent in the prioritised list of the
wild-type model. Among prioritised observables of the wild-type model but
192 Chapter 3. Observable prioritisation and global sensitivity ...
absent in the constSer137 model are “D”, “Thr34”, “Thr34:Thr75” and “Thr75”.
Three observables that are analysed in both conditions are “PDEp”, “PKA”,
“cAMP”.
It is worth noting that when results of a single run of the constSer137
model in the base-line parameter setup is clustered, these 7 prioritised observ-
ables are not located in the same cluster (Figure 3.35), contrary to prioritised
observables of the wild-type model (Figure 3.16). These 7 observables are
found in two clusters that consist of 7- and 2-elements. The 2-element cluster
with index 2, contains “Thr75:Ser137” and “Ser137” observables. They both
have similar and hight observable strengths (MIS ji) signified by edge thickness
connecting observables to the cluster (Figure 3.35). The 7-element cluster with
index 0 that has the other 5 prioritised observables, contains “Thr75” and “D”,
observables that are located just below the top 7 observables according to the
constSer137 ranking.
3.4.6.2 Parameter scores
This section outlines results of calculation of HSIC-based parameter
sensitivities with respect to the selected observables of the constSer137 model.
The aim is to present key reactions highlighted by top scored parameters.
Sensitivity scores are calculated for 61 parameters for each time point between
402 and 1200 interval of the simulation. As the “kcat13” parameter is set to
zero to reproduce the constSer137 mutation, it is excluded from calculation of
sensitivity scores.
Figure 3.36 shows parameter distributions of integrated sensitivity
scores gathered from all observables. Parameters are ordered according the
3rd quantile. Among the first 5 observables, 3 are found in the analogous fig-
ure presented for the wild type model (Figure 3.29, “kon41”, “kon9”, “kcat1”).
The other 2 parameters of the top 5 of the mutated model, are on the 62nd
(“kon10”) and 44th (“kon36”) positions in the analogous figure for the wild-
type model. These two parameters manifest the most prominent effects in-
duced by alteration of the Ser137 function. “Kon10” determines a binding rate
of the phosphorylated PP2A to DARPP-32. PP2A binds DARPP-32 to dephos-
phorylate it at Thr75. “Kon36” defines activation of PP2B that occurs through
binding of two Ca2+ ions at a single reaction step. PP2B has two roles in the
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Figure 3.36: Distribution of integrated sensitivity scores for each parameter gathered
from all 7 observables. Distributions are divided into quartiles demonstrating scores
variations in the constSer137 model. End sides of boxes indicate first and third quar-
tiles with red line denoting the median value. Spread of whiskers is defined with
the 1.5×Interquartile Range (IQR). Parameters are sorted according the 3rd quar-
tile. The top 5 parameters are involved in dephosphorylation and phosphorylation



































































Figure 3.37: Clustered heatmap of integrated parameter sensitivity scores for the 7
selected observables of the constSer137 model. Clustering is performed with Ward’s
method [296]. Values of the integrals of sensitivity scores are within a range of [0,100].
A handful of parameters with distinctively higher sensitivity scores divide into param-
eters affecting multiple observables, and parameters that variation only affect a single
observable. Similarly to parameter sensitivities of the wild-type model, around 10 pa-
rameters per observable have distinctively elevated sensitivity scores exposing more
than 80% of parameters as weakly or unimportant.
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activated, catalyses phosphorylation of Ser137. Increase of importance of this
parameter is in agreement with the increase of importance of molecular species
of DARPP-32 phosphorylated at Ser137 in the mutated model. Examination of
relations between parameter sensitivities and particular observables can clar-
ify importance of these parameters. Figure 3.37 shows integrated sensitivity
scores for the 7 observables as a heatmap clustered with the method of Ward.
Figure 3.28 is a corresponding figure for the wild-type model. Integral of sen-
sitivity scores of “kon10” is highly elevated for “PDEp”, “cAMP” and “PKA”.
Non of these observables take part in the reaction parametrised by “kon10”,
where the phosphorylated PP2A binds DARPP-32. However, a link joining
this particular reaction with these three observables is PKA, a binding parter
of PP2A and DARPP-32. It is a sufficient tie as “PDEp”, “cAMP” and “PKA”
observables bind themselves. Moreover, all these three observables directly
interact with each other forming a negative feedback loop regulating levels
of cAMP (Figure 3.16). cAMP is introduced in the simulation as a large and
steeply increased pulse that activates PKA. Elimination of cAMP from the
simulation is catalysed by the phoshophorylated PDE. The phosphorylation
of PDE is catalysed by PKA. As defined in the rule specification, when PDE is
phosphorylated, then the constant rate of binding, unbinding and deactivation
of cAMP is doubled. PKA binds to PP2A to catalyse its phosphorylation that
increases binding likelihood of PP2A and DARPP-32. As binding between all
these proteins is mediated by a single site, PKA is then less likely to bind to
PP2A or DARPP-32, what enhances its availability to bind and phosphorylate
PDE. These is a setup that is also in force in the wild-type model but “kon10”
has not been detected as influential. What causes importance of this particular
parameter in the mutation of the Ser137 site? As in the constSer137 model
the phosphorylation of Thr34 is close to permanent, PKA is effectively blocked
from biding to DARPP-32 when it is phosphorylated at Thr34 due to a general
assumption of no product rebinding. Therefore, the link with this particular re-
action involving DARPP-32 is rather related to PP2A, at least in the later stages
when Thr34 is already phosphorylated. Not being able to bind permanently
phosphorylated Thr34, PKA becomes more likely to bind other interactors.
These are PP2A, cAMP and PDE. In this way, not only PDE, but also PP2A
is more likely to be phosphorylated. “kon10” parametrises reaction where
the phosphorylated PP2A binds to DARPP-32, phosphorylated at Thr75. This
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phosphorylated form of PP2A is particularly important for “PDEp”, “cAMP”
and “PKA”, as the rate constant parametrising analogous reaction but with the
unphosphorylated PP2A (“kon9”) is a parameter of distinctive impact only for
observables representing various forms of DARPP-32 in both modelled con-
ditions, but not for these three considered observables. Lastly, since all three
observables are tracked in unspecified binding state, each of these observables
contains trajectories of molecular species that are complexes. For instance, the
“PKA” observable is a sum of time courses of all molecular species containing
PKA. When PKA is a part of a complex it is less likely to be re-associated
to R2C2. In fact a parameter determining the speed of re-association of PKA
to R2C2 (“kon41”) appears as the most important for all three observables
regardless the model variant.
The second parameter that was exposed as particularly influential in the
constSer137 model is “kon36”. Its sensitivity scores are raised for “Thr34:Ser137”
and “Thr34:Thr75:Ser137”. Its impact on these particular observables has a
clear connection with direct outcome of reaction parametrised by “kon36”
as DARPP-32 would not be phosphorylated at Ser137 without activation of
PP2B. These two observables are also sensitive to the same most influential
parameters that are also among the top 5 (“kon9”, “kcat9”, “kcat1”). All three
parametrise reactions involving the state of DARPP-32 at the Thr75 site. Impor-
tance of reactions deciding on this particular phoshorylation site can be linked
to dependence between Thr75 and Thr34, the last one being phosphorylated in
both considered observables (“Thr34:Ser137”, “Thr34:Thr75:Ser137”). This de-
pendence determine that Thr34 is blocked from phosphorylation when Thr75 is
phosphorylated. Therefore, there is a certain order how these sites can be phos-
phorylatated to produce “Thr34:Ser137” and “Thr34:Thr75:Ser137”. The same
4 parameters (“kon36”,“kon9”, “kcat9”, “kcat1”) have elevated integrated
sensitivity scores with respect to “Thr75:Ser137”. Compared to “Thr34:Ser137”
and “Thr34:Thr75:Ser137”, these scores are quite low that emphasise impor-
tance of these parameters in relation to the phosphorylated Thr34. Interestingly,
variation of the same 4 parameters is insignificant for the fourth observable
representing DARPP-32 phosphorylated at Ser137 alone (“Ser137”). Two most
important parameters for “Ser137” are only shared with “Thr75:Ser137”. The
first one determines how often PKA binds DARPP-32 when it unphosphory-
lated at Thr34 (“kon3”), and second, parametrises phosphorylation of Thr34
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when DARPP-32 is unphosphorylated at Thr34 and Thr75 (“kcat3”).
3.4.6.3 Differential networks of contitutive Ser137 and wild-type models
Analyses of what observables and parameters are important in the
constSer137 model have been based on ranked lists so far. Measures collected
from results of CorEx and GSA are used to construct a weighted network of pa-
rameters and observables for the constSer137 model (Figure 3.38), comparable
to the wild type network (Figure 3.30). After preserving only the edges that in-
tegral of sensitivity scores reached values above 4 to improve visibility on most
affected parameter sets, the network of the perturbed model is composed of 35
parameter nodes, 7 observable nodes, and 72 edges. The same cut-off applied
to the corresponding wild-type network yields a slightly smaller network of 43
parameter nodes, the same number of observable nodes, and 94 edges.
To analyse parameters and observables that gained and lost importance
due to invertible phosphorylation of Ser137, edge weights of the wild-type
network are subtracted from the edge weights of the constSer137 network. As
both networks contained different subsets of observables, missing observables
were added and connected to all parameters with edges of zero-weights. The
procedure of weight subtraction yields a difference network with positive,
negative and zero weights. To facilitate analysis of this difference network, it
is divided into two networks with respect to edge weights. The first network
has only positive edges exhibiting parameters that gained importance in the
mutated model, further called the gained-importance network. This network
is shown in Figure 3.39A. To increase clarity of the visualisation, only edges
with difference in weight values above 4 are drawn. The second network
has only negative edges exposing parameters that lost importance due to the
perturbation, further called the lost-importance network. This network is
visualised in Figure 3.39B. Similarly to the gained-importance network, only
edges with weights below −4 are shown. This network has slightly larger
(nodes: 43, edges: 74) than the gained-importance network (nodes: 35, edges:
60). This can be explained by the smaller size of the constSer137 network
compared to the wild-type model.
The gained-importance network has all 7 observables indicated as im-
portant for the mutated model (Figure 3.38). In analogy, the network of


































































Figure 3.38: Network of observables (black labels) and parameters (red labels) joined
with weighted edges for the constitutive Ser137 model variant. Weights are defined by
integrals of sensitivity scores and represented with edge colours with numeric values
indicated by the colour map. This network plot includes parameters that integral of
sensitivity scores is > 4. Parameters can be divided into ones that affect multiple ob-
servables and ones that have distinctive impact on a single observable. Analogous to
the wild-type model, the network layout is partitioned into two regions that can be de-
termined by the number of connections between observables. The first one allocated
to molecular species of DARPP-32 phosphorylated at Ser137 and the other occupied
by “PDEp”, “PKA” and “cAMP” observables.
































































































































Figure 3.39: Differential networks of observables and parameters between the
constSer137 and the wild-type model that (A) gained importance (edges with weights
> 4) (B) lost importance (edges with weights < −4) with respect to the model with
mutation at Ser137. Marked in green are parameters shared between observables
representing different state configurations of DARPP-32 regardless the model pheno-
type.
3.4. Results 201
type model (Figure 3.30). In the gained-importance network, a group of pa-
rameters that connects 4 observables only present in the mutated network
(“Ser137”, “Thr34:Thr75:Ser137”, “Thr34:Ser137”, “Thr75:Ser137”) is the same
as in the network of the mutated model (Figure 3.38), as edge weights be-
tween these observables and parameters are 0 in the wild-type network. As
anticipated, similar holds for the network of lost importance for the 4 ob-
servables present only the wild-type network (“D”, “Thr34:Thr75”, “Thr34”,
“Thr75”) (Figure 3.30). In the gained-importance network, there are clearly
three parameters (“kon41”, “koff41”,“kon10”) that are connecting observables
representing 4 various forms of DARPP-32 to observables forming a negative
feedback loop (“cAMP”, “PDEp”, “PKA”). Comparison of parameters shared
between these 4 observables representing DARPP-32 shows that the same 8
parameters can be identified in both networks of gained and lost importance
(Figure 3.39). Despite of difference in composition of phosphorylation sites of
DARPP-32 and regardless the model phenotype, 8 parameters, that constitute
around half of all shared parameters in both networks, are the same. Among
these ones, most prominent are: “kon3”,“kcat3”,“kcat1”, “kon41”, “kcat9”
and “kon9”. Meaning of these parameters was elaborated earlier in analyses of
heatmap plots in the context of the wild-type and the constSer137 models (Sec-
tion 3.4.6.2). More interesting are changes of parameters among observables
shared by both conditions that form the negative feedback loop, i.e. “PDEp”,
“PKAa” and “cAMP”.
Figure 3.40 shows adjacent parameters to each of the three observables
in perspective of three different types of networks. The first type is the wild-
type network (Figure 3.40A), and the two others show parameters that gained
(Figure 3.40B) and lost (Figure 3.40C) importance in the constSer137 model.
For all three observables, the number of neighbours in the wild-type network
is higher then the total number of neighbours in both negative and positive
networks. It is because among parameters in the wild-type network are ones
that difference in sensitivity scores between two conditions is below 4 in the
positive networks, and above −4 in the negative networks. Adjacent parame-
ters to all three observables in the networks of parameters that lost importance
in the constSer137 condition (Figure 3.40C) are contained in the set of parame-
ters found in the general wild-type network for each of three observables. This
is different in the network of parameters that gained importance for respective
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observables in the constSer137 model (Figure 3.40B), as these networks contain
parameters absent in the wild type network. These parameters become impor-
tant due to alteration of the Ser137 function that affected the three observables.
Among these parameters are “kon10”, found in all three observables, “koff50”
in the “cAMP” network, and “koff54”, “koff41” in the PDEp network.
The first three parameters (“koff50”, “kon10”, “koff54”) define rate
of reactions with PP2A as one of the reactants. “koff50” is a constant rate
of a dissociation reaction of a phosphorylated PP2A from DARPP-32, when
PP2A is also bound to Ca2+. “koff54” defines dissociation of Ca2+ from the
PP2A, regardless its phosphorylation state. Earlier presented “kon10” deter-
mines a rate of binding between the phosphorylated PP2A and DARPP-32.
Extended elaboration on potential reasons of this shift towards importance of
PP2A in the constSer137, in particular in the phosphorylated form, was pre-
sented in the context of “kon10” in Section 3.4.6.2. The two other parameters
(“koff54”,“koff50”) confirm increase of importance of the phosphorylated
PP2A for the observables of the negative feedback loop. This claim can be
supported by analysis of parameters in the negative networks of “PKA” and
“PDEp”. Among parameters that lost importance for these two observables
there is “kcat9” that parametrises dephosphorylation reaction of DARPP-32 at
Thr75 by the unphosphorylated PP2A. The most distinctive lose of importance
of this parameter occurred with respect to “PKA”.
Shift in importance of these parameters demonstrate that, unlike the
wild-type model, parameters involved in reactions of the phosphorylated PP2A
gain greater control in the constSer137 model. This can also mean that the phos-
phorylated PP2A is more abundant than the unphosphorylated one, that is a
result of increased availability of PKA due to nearly irreversible phosphoryla-
tion of Thr34.
Parameters determining reactions where PP2A is involved in, has al-
ready appeared in analysis of the top scored parameters of the wild-type model
(Section 3.4.4). In particular, “kon54” was identified as important parameter
for the “PDEp” observable. “kon54” is a rate constant defining speed of a bind-
ing reaction between Ca2+ and PP2A. According to the rule specification, when
Ca2+ is bound to PP2A, PP2A has 4-times lower dissociation rate from one of its
binding partners, DARPP-32. Therefore, a complex of PP2A and Ca2+ hinder
binding of PKA to DARPP-32. What is more, as PP2A and PKA are binding
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partners themselves, when PP2A has a free binding site, it can also compete
with PDE to bind PKA. All together, when PKA is less likely to bind PP2A
or DARPP-32, then availability to bind and phosphorylate PDE is enhanced.
However, in the constSer137 model, the importance of “kon54” clearly dropped
with respect to “PDEp” (Figure 3.40C) but a parameter of the reverse reaction,
“koff54”, became important for the same observable (Figure 3.40B).
Beyond the PP2A context, high difference in integral of sensitivity in-
dices between parameters exposed other two reactions being in reverse to each
other and parametrised by “koff41” and “kon41”. These two are most crucial
parameters for PKA in the wild-type network, that gained even greater control
over this observable through the mutation of Ser137. “kon41” and “koff41”
are constant rates of re-association and dissociation of PKA from R2C2, respec-
tively. As inactive PKA is a heterotetramer that consists of two regulatory and
two catalytic subunits denoted by R2C2, activation and deactivation of PKA
takes place by dissociation and re-association reactions. As PKA is among re-
actants, these two reactions directly influence abundances of “PKA”. Therefore,
there is a clear and obvious relation between “PKA” and parameters of these
reactions, “koff41” and “kon41”. Other observable sensitive to changes in
these reactions is “PDEp”. However, only in the constSer137 model “PDEp” is
sensitive to both parameters. The wild-type model, though with a high level,
the observable is sensitive only to “kon41”, that is even more elevated in the
constSer137 model.
Taken together, two types of observable scoring systems were tested
on the perturbed model. Because the number of identified clustering types
was low, and to preserve consistency in applied measures between two model
conditions, the observable score that included measures derived from all clus-
terings was used to prioritise observables of the perturbed model. Ordering
of observables with respect to the score exposed shift in importance of ob-
servables between conditions that are consistent with the major effect of the
perturbation. Among top scored observables, 3 were identified as important
despite the perturbation. All together, 7 observables were prioritised for which
integrated sensitivity indices were calculated with the HSIC-method. Different
parameters were indicated as important with respect to different observables or
their groups. Shift in controlling parameters between the two model conditions
revealed growth of importance in the perturbed model of the phosphorylated
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PP2A with respect to the observables forming a negative feedback loop reg-
ulating cAMP. Another indicative of the perturbation is activation of PP2B
with respect to observables representing DARPP-32 phosphorylated at Ser137.
Regardless the model condition, a parameter determining rate of PKA deacti-
vation received the highest score with respect to observable representing PKA.
To compare two model conditions with respect to obtained measures of im-
portance, parameter and observable relations are summarised in a network
structure for each condition. Parameter sensitivity scores are represented as
edge weights joining observables and parameters. To find divergences between
conditions with respect to multiple model outputs, edge weights of the per-
turbed model are subtracted from corresponding edge weights in the wild-type
condition. Obtained in this way differential networks represent gain and lose of
importance due to mutation of the Ser137 site. Examination of these networks
revealed that for observables representing various forms of DARPP-32, half
of parameters that were also highly scores in the wild-type model preserved
importance in the perturbed model but for a set of observables representing
different configurations of DARPP-32. For 3 observables that were commonly
present in the two model conditions, analysis of differential networks has fur-
ther emphasised the increase of importance of parameters defining reactions
related to a phosphorylated PP2A. This result can be interpreted with mecha-
nisms encoded in the model and the major effect of the constSer137 mutation.
3.5 Discussion
Practical exploitation of modelling studies in clinical application should
allow to combine work of experimentalist and computational biologists in an
iterative feedback loop. This could not be achieved without in-depth examina-
tion of control parameters and exploration of molecular mechanisms encoded
in the model [232]. In particular, advent of new modelling techniques ought to
be accompanied with novel methods of their analysis to guarantee use of their
potential. RB modelling approach remains a niche in the domain of molecular
modelling [129]. Extending ways of how RB models can be explored, what
often defines strength of ODE-based modelling, could increase its application.
This motivation has led to propose an extended and automated analysis
of RB models that results are presented in this chapter in form of a pipeline. The
pipeline aims to partition and score observables, either defined by the modeller
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or gathered from snapshots during the simulation. Selected observables are
passed to GSA to identify groups of parameters that are important to them.
RB modelling offers a new perspective in modelling of molecular systems.
It was created to address the character of signalling systems, understood as
parallel transient interactions between autonomous agents. Molecular species
and complexes that are created during the simulation is one of particularly
eminent novelties introduced by RB modelling. Not all molecular species are
equally abundant and therefore, not all are important or informative. As seen,
importance of particular species can be swung by perturbations applied to the
model. Though with a great potential to accommodate detailed protein inter-
action data, results analysis and interpretation of such precise models might
become problematic. In particular with growing scales of molecular models,
what is an ultimate goal of automated model assembly. The question is then
whether any groups of species can be prioritised as representative for the mod-
elled system based on simulation results? Can we learn from the model what is
worth to observe? These questions were a point of departure to use relatively
recent approach of CorEx. Internal workings of CorEx relay on information
theoretic objective that is optimised to learn a hierarchy of clusters that best
explain dependencies between measured variables, i.e. observables. Results of
clustering of single time courses showed that CorEx partitioned time courses
of observables in justifiable way. Repeated CorEx executions with variable
cluster numbers revealed that the major and strongest clusters have a stable
set of members despite lack of convergence. Selection of members composing
these strongest clusters can be interpreted as dominance of observables that
respond to the sharp increase in the cAMP abundance. The impact of this
cAMP pulse on copy numbers of proteins is much stronger compared to the
Ca2+ spiking, as observed in selected time courses of the model (Figure 2.10).
This interpretation was drawn from application of CorEx to time courses with
two differently specified observable sets. These are hand-picked 19 observables
and automatically collected 91 observables. The last ones being a total number
of molecular species created by the model and established with recordings of
molecular mixture during the simulation. As time courses of these observable
sets are generated by the same model but differ in signal fragmentation, they
should contain similar quantity of signal. As seen, CorEx identified equal pro-
portion of signal in time courses for the two observable data sets as evidenced
3.5. Discussion 207
by the prevailing score of normalised cluster strength allocated for the strongest
clusters observed in the two observable data sets. As 91 observable definitions
are exact compositions and configurations of molecular species that appeared
during the simulation, the largest cluster of this data set reveals that only partic-
ular configurations of species are strongly dependent on the cAMP-signalling
events or are present in equal abundances during the simulation.
In both observable sets, among observables of the strongest clusters are
ones with closely matching expressions that could be represented with a single
aggregated and generalised expression. Such observables were combined into
one expression thereby reducing lists of original observables. This results
with dimensionality reduction of the model output, another aspect of CorEx
application often evoked by the authors of CorEx.
To incorporate measures produced during the CorEx evaluation of mul-
tiple time courses obtained with randomised sets of parameters, two types of
observable scores were introduced. The first one is calculated with measures
collected from all clustering. The second, with measures derived from identi-
fied clustering types and contains the clustering frequency term. As such, this
observable score is reserved for results with distinctive proportion of cluster-
ing types found among all clusterings. No distinctive division into clustering
types has been observed in time courses of randomised parameter sets, as there
was only one recurring clustering type composed of 2 clusterings. This lack of
agreement between clusterings could be due to the relatively hight variation
of parameters (10-folds). To verify this interpretation, the same evaluation
would have to be performed with time courses generated with lower param-
eter variability (5%, 10%, 30%). If this hypothesis is confirmed, then CorEx
could be applied to test model robustness, alternative to what was presented
in the context of GSA by Kent et al. [231].
Both observable scores indicated the same 7 observables as top scored
ones that are directly involved in the cAMP signal. The same set of observables
was indicated in the largest cluster when CorEx was applied to a single set
of time courses of the model with the base-line parameter values. For this
particular data set, large range of variability of parameters did not alter this
particular clustering result. As the preliminary results yielded similarly par-
titioned observables, CorEx could be used for a single set of time courses to
select a subset of observables, before the model is simulated with randomised
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parameter sets. It would be especially advantageous for large RB models as the
simulation time can be also computationally expensive when a large number
of observables is tracked.
For the 7 identified observables, parameter sensitivity indices are cal-
culated with HSIC. This method is a highly efficient importance measure
of parameters that was introduced here as a model-free alternative to PRCC,
proposed as sensitivity indices in the RB modelling framework by Sorokin
et al. [272]. HSIC-based sensitivity indices are calculated for each time step
of the simulation after the cAMP stimuli. The final sensitivity scores are ob-
tained by taking definite integral of areas under sensitivity curves as a compact
measure of parameter sensitivities. Though indirect, relations between high-
lighted groups of reactions with highly scored parameters are explicable with
encoded mechanisms in the model. Analysis of sensitivity scores per observ-
able revealed that less than a handful of parameters has significant effect on
more than one observable. Moreover, less than 10 parameters, constituting a
fraction of all 61 parameters, were found to have distinctive influence per a
single observable. Addition of a negative control parameter revealed that the
HSIC-based sensitivity indices are not free from artefactual sensitivity scores,
evidenced by non-zero sensitivity scores gained by the dummy parameter. This
aspect of the HSIC sensitivity indices has not been tested before, neither by the
author of indices [282] nor in the study by Sinha [284], the first-time application
of these indices in the context of molecular modelling. In consequence, as the
HSIC sensitivity indices yield low levels of artefactual values, ones should not
assume that every value of sensitivity above 0 reflects a real sensitivity. As it
was suggested by Marino et al. [268] in the context of eFAST, sensitivity score
of a dummy parameter could be used as a control group to statistically asses
sensitivity of other parameters. By defining statistical significance of sensitiv-
ity scores in the pipeline, one could avoid using arbitrary cut-off for parameter
selection in the network of integrated observables and parameters, and include
only significantly scored parameters. One caveat is that this approach would
require even more simulations of randomised parameter sets, a requirement
that might become prohibitive with a large number of sampled parameter sets.
Next to definition of statistical measure of significance for parameter scores, a
similar need refers to observable scores. In practice however, with the large
number of observables only the top ones can be considered in GSA.
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Parameters and observables were combined into a compact network
representation to facilitate analysis of parameter sensitivities with respect to
multiple observables. As shown on the example of the 7 observables, one can
have an immediate view on groups of parameters that are significant with re-
spect to certain groups of observables, or parameter nodes and observables that
connect otherwise separated groups, i.e. minimum cut nodes. Such commonly
used measures and techniques defining relations in network graphs as cen-
tralities and clustering were not applied here as the size of analysed network
was small enough to be visually examined. Network analysis is a dynamic
research domain that studies relations in large data sets and therefore, it is
a potentially notable advantage to apply graph-based techniques to analyse
dynamical models. Weighted network representation was particularly chosen
to define a method to investigate effects of perturbation induced in the based-
line model. Comparison between different model conditions is an essential
part of modelling-based studies. Moreover, application of the same measures
composing the pipeline to two model conditions aimed to extend evaluation
of consistency and significance of both techniques. Constitutive mutation of
Ser137 was selected as an exemplary model perturbation. Ordering of observ-
ables with respect to the observables score calculated with measures collected
from all clustering exposed shift in importance of observables towards molec-
ular species of DARPP-32 phosphorylated at Ser137 that is consistent with
the major effect of the perturbation. Among top scored observables, the ones
composing a negative feedback loop were identified as persistently important
despite the perturbation. Similar composition of the top scored observables
was recorded for the observable score calculated with respect to a clustering
type. Though the number of identified clustering types was higher than in the
base-line model, counts of member clusterings in each type remained very low.
Therefore, the other scoring method was used to prioritise observables to the
next pipeline step.
Calculation of integrated sensitivity indices with the HSIC-method re-
vealed growth of importance of a phosphorylated PP2A with respect to the
observables forming the negative feedback loop regulating cAMP (“kon10”).
For observables representing DARPP-32 phosphorylated at Ser137, a parameter
indicative of the perturbation determines the rate of reaction activating PP2B
(“kon36”). In both conditions, a parameter determining rate of PKA deacti-
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vation received the highest score with respect to observable representing PKA
(“kon41”). Growth of importance of the three parameters is consistent with
size of impact of the cAMP pulse on abundances of other proteins, common in
both model conditions, and domination of the DARPP-32 phosphorylated at
Ser137.
These observations were derived from analysis of separate heatmap
plots of sensitivity indices with respect to multiple observables, constructed
for both model conditions. To study divergences between these conditions in a
structured and unified way, differences in parameter sensitivities were defined
as differential networks representing gain and lose of parameter importance
due to mutation of the Ser137 site. Examination of these networks revealed
that for observables representing molecular species of DARPP-32, different in
each model condition, half of parameters preserved importance regardless the
condition. Analysis of differential networks of observables shared by networks
of both conditions has further emphasised the increase of importance of param-
eters defining reactions where the phosphorylated PP2A is a reactant. Another
observation was that constant rates involved in activation of PKA gained even
higher sensitivity scores in the perturbed model with respect to observable
representing PKA and a phosphorylated PDE. This gain of greater control by
parameters involved in the PKA activation caused by the constSer137 mutation
can be interpreted by stronger dependence between these interactors due to
increased availability of PKA to bind other partners.
Representing measures of relations between parameters and observ-
ables as network graphs demonstrated that they can be studied with differ-
ent means than commonly applied clustered or ranked heatmaps. However,
this particular method of analysis of differences between model conditions is
an example relevant only to small networks and therefore, would not scale
well for larger ones. More advanced methods for larger network compar-
ison could be developed from methods already available in the domain of
differential network analysis [294, 297]. Techniques of comparison between
biological interaction networks defined for more than one condition, regard-
ing different time-points, tissues, species or drug induced perturbations, have
been commonly applied to protein-protein interactions and gene co-expression
networks. These methods are mostly focused on measuring changes in the net-
work topology caused by gain or loss of edges. This approach would not be
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suitable in this study, as networks of observables and parameters are fully con-
nected unless a measure of statistical significance of sensitivity indices would
be provided to drop insignificant edges from the network. Nevertheless, there
are also methods that are based mainly of weight statistics [297, 298] that could
find a direct application in this study. For instance, a potential measure that
could be used in further development of this pipeline is the Generalised Ham-
ming Distance (dGHD) developed for weighted networks by Ruan et al. [299].
It has recently been improved by Mall et al. [300] and implemented as the
“DiffNet” package in the R programming language. The proposed metric for
measuring difference between two networks with the same number of nodes
is enclosed within a normalised sum of squared differences of mean centred
edge-weight between two clustering types. As this method was developed
for the particular domain of genomic studies, one would have to examine if
statistics applied in this method are also appropriate to capture the important
regions of change in the observable-to-parameter networks. Therefore, though
promising, application of this method in the context of this study requires to
be evidenced by future research.
To improve the approach presented in this study, the difference network
could be also applied not only to edges but also to node weighs defined by
proposed observable scores. Calculation of the HSIC-based scores for all ob-
servables to obtain a complete network of weights between all observables and
parameters might give a more complete view on alterations in modelled mech-
anisms caused by perturbations. However, the size of observable list defines
the constraint of this approach.
Parameters of the RB model were equally varied over a range of ± 10
folds. Ideally however, prior knowledge about ranges of parameter uncer-
tainty and their probabilistic distributions should be incorporated in the study
design. For the model of Fernandez et al. [177], the domain of parameter vari-
ation could be defined within physiologically plausible bounds for the 35% of
parameters that were based on experimentally characterised reactions by using
error bars of replicated measurements. In case of fitted parameters, the spread
of variation could be established by examination of the model behaviour un-
der wide parameter ranges and setting the boundaries of parameter space that
excludes these values under which the model fails to reproduce any charac-
teristic features of behaviour. This approach would be particularly important
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in parameter prioritisation to indicate most crucial parameters to be precisely
measured in future. This would not be the case if the purpose of GSA was to
measure the model robustness as this aims to establish the scale of perturbation
necessary to abolish characteristic model behaviour. These aspects are worth
to include in the procedure of GSA in the presented pipeline.
To improve the final part of the pipeline, where relations between crit-
ical parameters and observables are represented as networks, only indirectly
linked rate constants could be preserved. These are constants that parameterise
reactions where an observable is not present as a product or a reactant. This
would allow for easier exploration of non-trivial relations.
Although the pipeline was particularly designed for the stochastic agent-
based models, it is also appropriate for ODE-based model analysis as the par-
ticular method used for GSA is designed for deterministic models and used on
averaged time series. Moreover, the RB model was refactored from the ODE
model that represent an accurate approximation of these particular molecular
behaviour.
3.6 Conclusions
In this chapter, I proposed a pipeline of automated exploration and
analysis of RB models. Both presented measures of parameter and observ-
able importance, HSIC and CorEx, provided sensible and justifiable results
with respect to mechanisms encoded in two model conditions representing the
wild-type and the perturbed phenotypes. Application of differential networks
to compare two different model conditions offered an unified and compact rep-
resentation of alterations in parameters and observables due to perturbation of
the base-line model condition. Proposed method is limited to small networks
and practical application would require more advanced methods for differ-
ential network analysis. Despite this limitation, this study provides a proof
of concept to support analysis of complex dynamic models with graph-based
techniques.
Having established that an automated pipeline for model analysis can
offer legitimate results summarising different model conditions and pheno-
types, now I would like to ask if model construction can be facilitated by
recent advances in the domain of bioinformatics. As the RB language offers a
molecule-centred perspective, it is aligned with bioinformatics data resources
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that are concentrated on mostly protein- and gene-centred information. There-
fore, in the next chapter, I examine what resources are available and relevant
to RB modelling, and whether they could accelerate the process of building








A common way of dynamic model construction requires extensive liter-
ature reading to assemble necessary details and evidence. The amount of effort
involved in building models in such a manner is a limiting factor that restricts
the model size and its subject of inquiry. Molecular models are composed of
lists of biomolecular entities, reactions and parameters. From the bioinfor-
matics perspective, these lists can be found in thematic databases cataloguing
gene or protein-centred information that aggregate results from numerous ex-
perimental studies. Having at disposal a repository composed of reliable and
relevant resources to dynamic modelling could accelerate the process of defin-
ing such models for potentially wider scope of biomedical inquiries such as
identification of disease mechanisms. Therefore, identifying and assembling
these resources beforehand could simplify and advance the process of mod-
elling that target disease mechanisms. This assumption can be realistic in the
light of recent advances in unification and standardisation of data formatting,
access and annotation that are provided in machine-readable formats. To asses
the validity of such assumption, first we need to identify such datasets and
evaluate their coverage. This assessment is the main purpose of this chapter,
performed with respect to an exemplary subject of biomedical inquiry. Having
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a list of genes associated to a disease of interest, the question is how we would
build a dynamic model by which mechanisms involved in this disease could
be investigated?
As the relevance of data sources depends on the modelling framework
of choice, this assessment will be performed with respect to the rule-based (RB)
modelling framework. As elaborated in Section 1.4, the choice of this particular
framework is not arbitrary as the RB modelling offers a modular, formal and
concise method to capture protein interactions in a scalable way. Moreover,
the protein and gene-centred focus of bioinformatics data resources stands in
analogy to the molecule-centred perspective of the RB language.
In Chapter 2, based on an exemplary model, we learned what particular
aspects of molecular mechanisms could be efficiently represented with a RB
model. In Chapter 3, an approach to analysis of potentially large RB models was
proposed. This chapter aims to clarify if up-to-date efforts in bioinformatics
domain can facilitate such large model construction.
4.2 Introduction
The most important biomolecular entities in the cell signalling are pro-
teins that are conducting the signal through interactions with other proteins,
DNA, RNA and small molecules. Interactions between proteins has been a sub-
ject of intensive studies propelled by the development of a large range of exper-
imental detection methods. This places the protein-protein interactions (PPIs)
resources in the special interest of this study. PPIs provides evidence of existing
associations between protein lists at different levels of directness. Identification
of such associations is an important step as biological processes and functions
are conveyed by interacting proteins. More detailed information regarding the
actual mechanism of interactions requires a closer look at functional blocks of
proteins, such as domains, motifs or repeats, and interactions between these
protein subunits. As seen in Chapter 2, the RB framework is particularly de-
signed for modelling complex interactions with site-specific details. Although,
the RB language is flexible enough to define a model without explicitly stating
what protein interfaces mediate the interaction, the site-specific information
can clarify the exact mechanisms of reactions and impute hypothetical reac-
tions.
Bringing site-level information and dependencies between protein in-
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terfaces to the first plan allows to explicitly model impact of genomic variants,
point mutations and deletions. Alteration of residues in motifs and domains,
influence recognition and binding properties of these protein subunits [5].
This is particularly applicable in studies of disease-related mechanisms. For
instance, Single Nucleotide Polymorphism (SNP) in the DNA sequence coding
for a domain can lead to disturbance of interactions that the domain is involved
when it is non-mutated [5]. This example locate the information about protein
domain architecture and domain interactions in a special interest of this study.
One of the domain functions is to recognise and bind to amino acids
with post-translational modifications (PTMs) [5]. PTMs are another important
mechanisms employed in signalling systems. Among many variants, phos-
phorylation is the most abundant type of PTMs [230], with phosphoserine and
phosphothreonine as the top two most frequently observed PTMs [301]. The
ubiquity of this particular type of peptide modification could have been also
observed in the limited example of the DARPP-32-network model that con-
sists chiefly from reactions between phosphorylation sites and their enzymes.
With respect to information availability, identification of phosphorylation sites
and kinase-substrate relations belong to most frequently studied aspects of
phosphorylation [16].
Having the model of DARPP-32, defined and explored in two previous
chapters, the focus of this chapter could have been placed on reproduction of
the system with use of variable primary resources. However, the DARPP-32
interaction network is an example of well studied system. The level of cov-
erage of proteins in the pathway data resources, based on the example of
REACTOME Pathway Database (REACTOME), can be expressed by the fact
that out of 71785 proteins in the Human proteome1, 10996 proteins can be
found in any molecular pathway of REACTOME2. Therefore, concentrating
on DARPP-32 network might not reflect the realistic availability of datasets
for other biological mechanisms of interest. A more pertinent question would
be if the assembly of relevant elementary data sets, related to any biologi-
cal question, would bring us closer to the construction of a dynamic model.
Therefore, with an attempt to recreate a common scenario of biological inquiry,
this chapter is concentrated on a question regarding molecular mechanisms
1According to UniProtKB. Proteome identifier: UP000005640.
2According to the Version 63 released on December 18, 2017.
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underpinning Attention Deficit Hyperactivity Disorder (ADHD), an example
of highly heritable and complex disorder. The staring point of this inquiry is
an assembled list of genes associated with the disorder. I present here a walk
through the data sets that could be supportive in the RB model definition.
First, the essential data sets are presented. Among these are: protein-protein
interactions (PPIs), protein-domain interactions (PDIs), domain-domain inter-
actions (DDIs), and kinase-substrate interactions (KSIs). Necessary mappings
between resources and their coverage is examined from broader perspective of
the Human proteome and the ADHD-associated genes that are assembled from
three data resources of different provenance. To identify relevant functional
modules in the ADHD-associated gene list, clustering and gene-set enrichment
analysis is performed.
4.2.1 Protein interactions
Information of protein interactions can be derived from low and high
throughput experimental methods that provide variable levels of details, speci-
ficity, sensitivity and types of interactions they report. The interaction types
range from binary to co-complex, from transient to stable, from weak to
strong. Among commonly used high-resolution methods are X-ray crystal-
lography and nuclear magnetic resonance (NMR) [302]. Less detailed but
more commonly used detection methods are yeast two-hybrid (Y2H) [303], co-
immunoprecipitation of protein complexes (Co-IP), protein-complex affinity
purification-mass spectrometry (AP-MS), tandem affinity purification (TAP),
pull-down and protein chip technology [302]. Reliability of these methods
varies significantly [304]. Comparative studies of the two most popular high-
throughput experimental approaches, Y2H and Co-IP, report very small over-
lap between the two methods [305]. This poses general difficulties in compari-
son, integration and validation of reported interactions.
To ameliorate this situation, computational approaches for interaction
prediction has been proposed independently, or as a support for experimental
methods [306]. These computational interaction detection methods leverage
different aspects of biological information, among which are protein sequences,
structures, homology and protein-domain interactions [306, 307].
The PPI data resources can be divided into primary databases that col-
lect and collate information directly from published PPIs detection experiments
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(e.g. DIP, BIOGRID, IntAct), and meta-databases that integrate information
from multiple primary databases and individual studies, e.g. Human Inte-
grated Protein-Protein Interaction rEference (HIPPIE) [308].
Integration and functioning of such aggregated databases is largely de-
pendent on compatibility and unification of data formats, annotation standards
and curation systems. To address these multiple facets, the Human Proteomics
Organisation (HUPO)’s Proteomics Standards Initiative (PSI), jointly with PPI
data providers, proposed a community standard data model to facilitate the
exchange, integration, analysis and verification of molecular interaction data
between multiple resources [309]. This standard data model includes accepted
data attributes and controlled vocabularies contained in the PSI-Molecular In-
teractions (MI) ontology. The ontology provides structured and unique iden-
tifiers to denote variable categories3. Among others, the ontology terms des-
ignate interaction detection methods (e.g. experimental interaction detection,
X-ray crystallography) and interaction types (e.g. genetic interaction, phospho-
rylation reaction). Ontology terms are hierarchically ordered in parent-child
and sibling relations to each other. A parent term designates more generic
term than its children terms. For instance, the category of “interaction type”
(id: MI:0190) is a parent term to “molecular association” (id: MI:2232), that is
a parent term to even more specific “carboxylation reaction” (id: MI:1139). To
guarantee data compatibility, the MI standard vocabulary is accompanied by
guidelines for reporting experimental results, e.g. Minimum Information about
a Molecular Interaction eXperiment (MIMIx). These all standards are enclosed
in the PSI-MI database-independent data format. Among the PSI-MI stan-
dards compliant data providers are BIND, DIP, HIPPIE, BIOGRID, IntAct and
MIPS. PSI-MI became a widely recognised standardisation initiative that has
extended its facilities to encode other than PPIs forms of molecular interaction
data, like nucleic acids, chemical entities, and molecular complexes [310]. The
development of PSI-MI was followed by establishment of the International
Molecular Exchange Consortium (IMEx), cooperation between large public
protein interaction data providers to unify standards for data curation and
collect non-redundant records of interactions in the PSI-MI format. To support
computational accesses through web services and query languages to a number
3Molecular Interaction ontology website on Ontology Lookup Service (OLS): https://www.
ebi.ac.uk/ols/ontologies/mi
220 Chapter 4. Exploring current resources ...
of interaction repositories in the PSI-MI format, the HUPO-PSI introduced the
Proteomics Standard Initiative Common QUery InterfaCe (PSICQUIC) service
[311].
The PSI-MI interaction data format does not impose the use of com-
mon interactor identifiers. PPIs records are reported in multiple identifiers,
not always overlapping between databases and referencing either to genes or
proteins. A commonly acclaimed and used gene identifier across many data re-
sources comes from Entrez Gene database of National Center for Biotechnology
Information (NCBI). It is a database for gene-centred information providing
unique, stable and tracked numeric identifiers for gene sequences and gene
symbols [312]. As for the protein identifiers, the Universal Protein Resource
Knowledgebase (UniProtKB) is a widely used resource of protein-centred in-
formation. UniProtKB consists of two sections: TrEMBL with automatically an-
notated proteins (unreviewed annotations) and Swiss-Prot with expert-curated
annotations (reviewed annotations). These two types of identifiers for genes
and proteins are used to cross-map PPI resources used in this study.
4.2.2 Protein domains and their interactions
The study of Schuster-Böckler and Bateman [7] found that interactions
between domains are present more often in experimentally detected protein
interactions than expected by chance. This finding suggests that some domain
interactions are likely mediators of these interactions. Domains and their inter-
actions have been used as indicators of potential interaction between proteins
[7, 306, 313]. Identification of domains in proteins has led development of the
protein classification system that divides proteins into families based on their
domain architecture, providing means for protein characterisation. This clas-
sification system allows to functionally characterise newly sequenced proteins
[3]. The domain identification and classification process is based on protein
signatures. They are predictive models build on similarity between fragments
of peptides that share local features (e.g. conservation at different positions)
known to be associated with a function or structure [314]. There are multiple
computational approaches that detect such patterns and define types of signa-
tures, either based on the amino acid sequence or the 3D structure of a protein
[3].
Major integrated resource of the protein-to-domain mapping is the Inter-
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Pro Consortium database [315, 316]. It is a federation amalgamating multiple
protein signature databases (CATH-Gene3D, CDD, HAMAP, PANTHER, Pfam,
PIRSF, PRINTS, ProDom, PROSITE, SFLD, SMART, SUPERFAMILY, TIGR-
FAMs). InterPro provides an additional curation layer of member database
records. Detected anomalies are reported back to federated databases [316].
These databases differ in methods and purposes of defining protein signatures.
These differences obstruct mapping between signatures and complete integra-
tion of datasets. Methods relaying on the 3D structure, like CATH-Gene3D,
are based on classification of known protein structures deposited in the Protein
Data Bank (PDB) [316]. The sequence-based methods share the same baseline
step of protein multiple sequence alignment that is used to build model of
protein signatures. Searching for signatures is a major diagnostic method for
analysis of novel sequences, protein families definitions as well as domain and
functional site identification. Each protein in the database can be matched to
multiple signatures. The examples of signature methods are position-specific
scoring system (Hidden Markov Models, e.g. Pfam) [317], fingerprints, pro-
files (scoring matrix, e.g. PRODOM), and patterns (regular expression, e.g.
PROSITE). In all member databases, the similarity in signature between pro-
teins is used to define hierarchies of protein and domain families. On a monthly
basis, InterPro analyses and annotates all protein sequences of UniProtKB with
signatures of member databases with the InterProScan software package [318].
In this study, the major focus is on details of protein interactions and
therefore, domain-domain interactions (DDIs) resources are of particular inter-
est. Among multiple existing domain identifiers, the only one used in the DDI
resources are accessions of the Pfam database. Therefore, this database is a
main focus of this study. The Pfam database of protein families is continuously
active since its establishment in 2003.
Th most reliable methods for the DDI identification are based on known
3D structures of protein complexes. This information is accessed from the PDB
repository of 3D structures of proteins, nucleic acids, and complexes [319]. The
DDI datasets derived in this way are collectively called gold standard domain-
domain interaction (GSDDI) datasets [320]. Constituent datasets gold standard
domain-domain interaction (GSDDI) are iPfam [321], 3did [322, 323] and PiNS
[324]. The high-resolution structural information derived from 3D protein
crystal structures does not provide significant coverage for existing proteomes.
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Therefore, computational methods for domain predictions has also been in
development [325]. What follows, there have been initiatives to integrate these
two different data sources, with support of scoring systems helping to evaluate
predicted data sets with respect to GSDDI. Among them are DOMINE [326],
UniDomInt [327], DIMA 3.0 [328] and IDDI [320]. IDDI is the latest of four that
aggregated data sets of its predecessors. The database integrated 23 datasets,
including the three GSDDI and 20 computationally predicted DDI. IDDI was
reused by other studies, e.g. for protein scaffold prediction [329] and in analysis
of domain interactome of virus-host relation [330]. In this study, IDDI is used
as a baseline of DDI information being the largest DDI dataset known to the
author.
4.2.3 Phosphorylation sites and kinase-substrates
Although, data has been gathered on a range of PTM sites, most studies
are focussed on protein phosphorylation (phosphoproteomics) [331]. It is the
most ubiquitous and conserved type of PTM [14]. Rapid increase in amount
of available data is mainly a result of advances in high-throughput methods
based on mass spectrometry (MS), coupled with novel enrichment techniques.
This has had a significant impact on the field of signal-transduction research
[14, 332]. Experimental studies are also devoted to discover kinase-substrate
relationships, mainly based on in vivo kinase assays and perturbation experi-
ments [333]. The experimental techniques needed to obtain phosphorylation
data are either expensive (based on MS [230]) or low-throughput (antybody-
based western blots [334]). To address such experimental difficulties and low
coverage of kinase-substrate relationships, there have been efforts to develop
prediction algorithms for kinase-specific phosphorylation sites or phospho-
binding motifs. These methods are chiefly based on pattern recognition [230].
For a review of computational techniques see Trost and Kusalik [335].
Though, the above picture suggests abundance of information on pro-
tein phosphorylation, there is incomplete representation and bias towards well
studied proteins [331]. Furthermore, although a fairly complete picture of
phosphorylation processes is composed of phosphorylated substrate, kinase
and phosphatase enzymes that catalyse the reaction, and phospho-binding
proteins that bind to the phosphorylated residue of the substrate protein, abun-
dances of information on the two latter are rather scarce [16]. The progress and
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research interest in the substrate-kinase networks is more evolved [336–338].
This study concentrates only on the substrate-kinase relation. This is particu-
larly motivated by the fact that it can give us a view on proteins associated by
concrete reactants, as opposed to phosphorylation sites alone. Moreover, from
the perspective of dynamic modelling, a view on coverage of phosphorylation
sites to proteins might be misleading as there are non-functional phosphoryla-
tion sites that do not have any regulatory role [16]. Identification of functional
phosphosites was recognised as one of challenges of phosphoproteomics data
sets [16].
Most of persistently updated repositories of PTMs are mainly concen-
trated on phosphorylation sites. However, alongside the PTM information,
there are data sets of kinases-substrate relations. Among the largest and stably
developed ones are PhosphoSitePlus [339], PHOSIDA [340] and Phospho.ELM
[341]. To the author’s knowledge, available sources are immature and scattered
across multiple repositories. An effort would have to be put forward to inte-
grate these datasets before working with them in a high-throughput manner.
Therefore, this study concentrates on a single repository of PhosphoSitePlus R©
as a representative dataset. It is a database of manually curated resources of
experimentally observed PTMs. The database mainly contains Human and
Mouse proteins [339]. The release used in this study covers 53928 UniProtKB
accessions4. Datasets are updated every six months.
4.2.4 Molecular pathways
Molecular pathways have been traditionally organised as diagrams of
pathway maps composed with extensive curation and expert knowledge. To
make possible programmatic analysis, other formats have been introduced
such as Biological Pathway Exchange (BioPAX) [98] and Simple Interaction
Format (SIF). The former encapsulates all details in a rich eXtensible Markup
Language (XML) data structure whereas the latter, simplifies pathway informa-
tion to represent it as graphs. Even simpler format than SIF is often employed in
bioinformatics analyses, that is as gene sets, where each pathway is associated
with a list of gene or protein identifiers [62].
Molecular pathway knowledge-bases are important resources for dy-
namic modelling as pathway maps contain the first layer of information re-
4Accessed 2018-01-24.
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quired to construct a dynamic model. Pathway maps represent a topological
network structure defined with detailed qualitative information about reac-
tions that occur between molecular entities. The importance of information
stored in pathway databases as a starting point of model construction can be
reflected by the study of Büchel et al. [342] and Wrzodek et al. [343]. Büchel
et al. [342] automatically generated kinetic, logical and constraint-based models
from pathway representations stored in KEGG and MetaCyc [344] (Path2Model
[342]). Kinetic models were only created for metabolic pathways, with the
support of additional databases to identify kinetic reaction parameters, e.g.
System for the Analysis of Biochemical Pathways - Reaction Kinetics (SABIO-
RK) [345]. Signalling pathways were translated to qualitative logic models
that does not contain mechanistic details [129]. Though, more information is
available for metabolic pathways, the authors reported that kinetic data col-
lected from SABIO-RK only exists for 12.2% of all Human metabolic reactions
[342]. Similar attempt to translate signalling pathways from the KEGG-specific
pathway format to the Systems Biology Markup Language (SBML) modelling
format was performed by Wrzodek et al. [343] but without supplementation of
kinetic parameters. In both cases, pathway databases provided a step forward
towards automated generation of models.
Section 1.3.2 mentioned difficulties in unification of pathway databases
caused by multiple factors. Even for extensively studied pathways, e.g. Wnt
signalling pathway, agreement between databases in constituent pathway el-
ements were found as very poor [103]. Reason for these observed variations
between databases cannot be unequivocally designated, as lack of shared vo-
cabularies or other such technical reasons and biological variation could be
equally considered factors [103]. As no unified pathway database exists, this
study relays on a single but important pathway reference dataset, REACTOME
Pathway Database (REACTOME). It is an open source, publicly available
and manually curated database [346]. The database provides annotations of
molecular entities to terms representing biochemical reactions and pathways.
Pathways in REACTOME are hierarchically structured terms. A pathway can
be composed of other pathways and itself be a constituent of higher order
and larger ones. On the lowest leaf-level are reactions or reaction-like events,
among which are binding, complex formation, transport or polymerisation.
Molecular entities included in a pathway can appear in other parallel path-
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ways and are extensively cross-referenced with other databases, such as PDB,
UniProtKB, Gene Ontology (GO) and gene expression in tissue samples [346].
Among biological processes included in REACTOME are signal transduction,
metabolism, chemical synaptic transmission, gene transcription and disease
affected pathways [346].
To other category of resources containing molecular pathways are databases
dedicated to mathematical models, mentioned in the review of signalling path-
way databases by Khatri et al. [55]. The growing number of models in the
past years has put pressure on development and use of standardised mod-
elling languages paired with the establishment of model repositories. Among
these initiatives that gained general acceptance are ModelDB [347], BioMod-
els [184], Database of Quantitative Cellular Signaling (DOQCS) [212] and the
CellML repository [348]. Common functions to all these databases are storage,
of models that contributes to availability to the wider research community.
In particular interest of this study is the BioModels database. BioModels is a
public repository of quantitative models of biochemical and cellular systems.
The database is unrestricted by the biological subject and stores physiological
and biochemical models [349]. The database has been continually released
since 2005. Deposited models are divided into curated and non-curated. The
former originate from peer-reviewed publications and successfully passed the
curation procedure. The latter are derived from published studies that ei-
ther failed to pass the manual validation aiming to reproduce results provided
by the original publication, or were generated from automated procedures
(Path2Models [342]). Models are provided in numerous model encoding for-
mats, e.g. SBML and BioPAX. Moreover, curated models in BioModels are com-
pliant to the Minimal Information Requested In the Annotation of biochemical
Models (MIRIAM), introduced to standardise annotation and curation of com-
putational models [349]. As the only such model database, constituents of
models deposited in BioModels are annotated with unique identifiers from
other resources, e.g. UniProtKB, GO and REACTOME. This is an important
and unique feature of this database that bridges bioinformatics resources and
dynamic modelling. As exampled by a study of 30 models of synaptic plastic-
ity by Heil et al. [45] (Appendix D), modelled molecules are often referred with
commonly used names that does not refer to concrete experimentally defined
protein sequences with known reference identifiers. Moreover, they tend to
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denote protein families or protein multimers. Identification of molecular enti-
ties in such models can be performed only in non-automated way that hinders
their use and analysis.
Another advantageous aspect of the BioModels database is that it is a
member of the European Bioinformatics Institute (EBI) Resource description
framework (RDF) Platform [350]. The platform provides unified access to
query federated resources with the W3C SPARQL language [351]. Thanks
to this unification of resources, a pathway in REACTOME can be annotated
with BioModels identifier if there is a model of the pathway (for details see:
BioModels Linked Dataset, Wimalaratne et al. [351]).
4.3 Data sets
This section introduces the major data sets used in this study, alongside
necessary resources and procedures to map identifiers across different data
sets. Data sets used in this study are composed of the list of genes associated to
a chosen biomedical inquiry, that is ADHD, protein-protein interactions (PPIs),
protein-domain interactions (PDIs), domain-domain interactions (DDIs), and
kinase-substrate interactions (KSIs). Cross-reference datasets are used to map
genes to proteins, and proteins to domains. Genes are represented as symbols
and Entrez Gene identifiers (Gene IDs).
Firstly, it is established if there are direct PPIs between members of
the ADHD-associated gene list. The integrated data set of PPIs with only
direct interactions are collected from 3 databases and assembled into a single
set. Next, to learn more details about protein interactions found among the
ADHD-associated genes, they are mapped to DDIs resources. In this step,
a comparison between PPI and existing potential interactions resulting from
domain-level information is performed. The DDIs are collected from the IDDI
database, updated with resources that have ongoing releases. Because DDIs
are encoded with a specific type of accessions derived from the Pfam database,
the final results are exclusively based on the contents of this database. Another
data set that the list of ADHD genes is examined with is kinase-substrate
relations deposited in PhosphoSitePlus R©. These dataset is no presented in this
section as the dataset does not require processing and is used in its original
form.
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4.3.1 Disease gene set
ADHD is a neurodevelopmental disorder that mechanisms are investi-
gated as an example of biomedical inquiry. ADHD is a chronic, complex and
polygenic disorder. It has relatively high worldwide prevalence (children 5-8%,
adults 3-5% [352]). Though, multiplicity of variable etiologies is involved in
ADHD, including neurobiological and environmental factors, it is thought to be
predominantly caused by biological factors (heritability estimation – 76%) [353],
with an autosomal dominant mode of inheritance [354]. ADHD is characterised
by clinical and etiopathogenic heterogeneity where underlying genetics has yet
to be understood [355]. ADHD is composed of two main subtypes: inattention
and hyperactivity-impulsivity. Although the only “biomarkers” of ADHD are
behavioural tests, a range of animal models exists that mimic multiple deficits
characteristic to ADHD. They are successfully attenuated by psychostimulant
administration, similarly to affected Human individuals [356, 357]. Among
rodent models of ADHD are knockout (DAT gene), tansgenic (SNAP-25 gene,
TRbeta1 receptor) and inbred strains. Compared to other disease of CNS, in
particular neurogenertive disorders like Altzheimer’s and Parkinson’s disease,
ADHD does not have a clear molecular correlate that would easily indicate
molecular-level mechanisms worth to be closely studied. As such, the choice
of ADHD potentially avoids bias towards well studied diseases. In any case,
ADHD is an exemplary disorder with known list of susceptible genes indicated
by multiple studies (candidate gene, genome-wide common variants, genetic
linkage and pharmacogenetics [358]) that effects could be explored in a larger
pathway context and then mechanistically modelled, what mainly motivated
this choice. Moreover, a popular theory about genetic etiology of ADHD is
dopamine deficit in multiple brain regions that involve cortico-striatal circuits
[359]. This is a particular link to the model of Fernandez et al. [177] that locates
it as a potential component of a larger modelling project.
A list of candidate disease genes for ADHD is consolidated from three
data resources. The first one is the ADHDgene database5. It is a high-quality
manually curated community database assembled through extensive literature
screening [86]. The list of genes is contained in the Core Data set, that is
composed of full-text literature reading of ADHD studies retrieved from the
5ADHDgene website: http://adhd.psych.ac.cn. Accessed 2014-08-03 (not updated since
then).
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PubMed database, published between 1995 and 2014. Of the total of 364
studies included in the database, 16 are meta-analyses and 348 are marked as
others6. Among the latter are genome-wide association studies, candidate-gene
association studies, linkage studies, mutational studies, and genome-wide copy
number variation analyses. The database enlists the total number of 359 genes,
each assigned with 4 scores: a total number of studies, a number of statistically
significant studies that confirm a gene-disease relationship as reported by a
publication, a number of insignificant studies for this relationship and a number
of trend studies that locates the significance values between these two threshold
values. The significance value is dependent on the type of study. In the general
candidate-gene association study and meta-analysis a significant gene have
p-value < 0.05. In genome-wide association studies (GWAS), a significant
association is assigned for p-value < 1e−7, non-significant for p-value > 1e−5
and trend for p-value between 1e−5 and 1e−7 [86].
To define the highest confidence set of ADHD candidate genes, the
number of significant studies per gene is chosen as a quality criterion. It is
dictated by examples of genes like CACNA1C that though intensively studied,
are not confirmed by any statistically significant test result. With respect to the
number of significant studies, out of 359 genes, 38 are confirmed in at least two
significant studies (10% of the whole set) and 137 by at least one such study
(38% of the whole set). These two gene subsets are used as high quality subsets
and further referred as the 38-seed genes and the 137-seed genes.
The other two datasets used in this study are based on automated text-
mining methods. The first one is MalaCards [360], a disease-centred meta-
database that collects variety of information on more than 16000 diseases,
represented as “disease cards”. MalaCards is a curated and automatically as-
sembled platform gathering information from around 72 resources on different
topics related to a disease. Among these topics are symptoms and phenotypes,
drugs and therapeutics, publications and disease-associates gene sets. Disease
gene sets for ADHD are derived from such resources as ClinVar [361], Online
Mendelian Inheritance in Man (OMIM) [362], the University of Copenhagen
DISEASES database [363]. ClinVar is a database of Human gene variations to
medically important phenotypes [361]. OMIM is a database of high-quality and
manually curated gene-to-disease associations [362]. The DISEASES database
6According to the search tab on the ADHDgene website.
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contains disease-gene associations extracted from biomedical abstracts using
text-mining techniques [363]. The total number of ADHD associated genes
found in MalaCards is 837. Each gene is associated with at least one of the three
sources, OMIM (6 genes), DISEASE (73 genes) and ClinVar (4 genes). Provided
gene scores were not taken into account.
The second dataset based on text-mining technologies is a gene-to-
disease annotation dataset derived from the automated framework for creation
of ontology-based annotations, OntoSuite-Miner [364]. The disease ontology
used here is Disease Ontology (DO). The datasets of gene-disease associa-
tions are derived from publicly available datasets of gene-disease associations:
OMIM [362], Gene Reference into Function (GeneRIF) [365] and Ensembl varia-
tion [115]. These three databases represent different approaches to disease-gene
annotations. EnsemblVariation relies on genetic mutations like SNP, whereas
OMIM and GeneRIF contain text annotations describing disease-gene associ-
ations. As mentioned earlier, OMIM is internally curated and high-quality
database of relations between genes and phenotypes, whereas GeneRIF is a
simple online tool that allows scientists to add the textual annotation of genes
described in a publication. Annotation data in OntoSuite-Miner are processed
using concept recognisers: MetaMap [366] and NCBO Annotator [89, 367] to
identify terms found in ontologies, such as DO [368, 369]. To obtain a list of
genes associated to ADHD, the OntoSuite-Miner annotation dataset is filtered
with the DO identifier for ADHD (DOID:1094) with the result of 665 associated
genes8. Majority of these retrieved genes is confirmed by Ensemble Variation
(555). Much smaller fraction of genes is reported GeneRIF (115) and OMIM
(7). There is a very low overlap between these three datasets: 9 genes are
shared between Ensemble Variation and GeneRIF, 3 genes between GeneRIF
and OMIM, and 1 gene between OMIM and Ensemble Variation. The union
of the three resources is composed of 886 genes and constitutes the final list of
ADHD-associated genes used in this study.
Figures 4.1 visualise an overlap between the three resources of ADHD-
associated genes. Each diagram shows a different subset of the ADHDgene set,
varied with respect to the number of significant studies that confirm association
7ADHD gene card website: https://www.malacards.org/card/attention_deficit_
hyperactivity_disorder_2. Accessed 2018-01-18.
8OntoSuite-Miner github address: https://github.com/statbio/OntoSuite-Miner/
tree/master/annotation_sources. Accessed 2017-02-11.
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(A) Complete ADHDgene set
(B) 1 ≤ significant studies
(C) 2 ≤ significant studies
Figure 4.1: Representation of an overlap between three data sources for ADHD-
associated gene lists with various subsets of the ADHDgene set, differentiated by
the number of significant studies: (A) full set of 359 genes; (B) 137 genes confirmed
by 1≤ significant studies; (C) 38 genes confirmed by 2 ≤ significant studies. MalaC-
ards and OntoSuit-Miner gene lists are mainly based on text-mining methods, whereas
ADHDgene relays on deep literature reading and curation.
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of gene to the disorder. Figure 4.1A demonstrates that a lot of genes in the
ADHDgene dataset cannot be found in either OntoSuite or MalaCards. This
suggests that more than 50% of genes in the ADHDgene set are not commonly
supported by other resources. When the list of genes in the ADHDgene set is
constrained by gradually increasing requirement of the number of significant
studies (Figures 4.1B&4.1C), the proportion of genes that are not found in
either OntoSuite or MalaCards decreases reaching nearly complete coverage of
manually curated genes by automatically assembled ones, for 2 ≤ significant
studies.
4.3.2 Protein interactions
Having assembled the list of genes connected by their association to
ADHD, the next step is to ask if there are any direct interactions between them
that would uncover more general biological contexts these genes are involved
in. Therefore, the next essential step is to screen the list of genes with the PPI
dataset.
The HUPO-PSI standardisation initiative for PPI datasets facilities the
integration process of databases. There are three leading primary databases
compliant with these standards: IntAct [370], BioGRID [371] and Database of
Interacting Proteins (DIP) [372]. These databases provide data in two standard
formats, PSI-MI XML and PSI-MITAB (tabular). Leveraging the convenience
of the standard format for PPI datasets, PPIs are assembled from the three
databases and unified within the PSI-MITAB format9. Although PSICQUIC
provides a single-point access to all these resources, retrieval of interactions for
more than a few hundred proteins appeared as inefficient and required flawless
connection to the server and therefore, was not used in this study.
The PSI-MITAB format guarantees unified column contents and use of
controlled vocabularies. Before consolidation of the datasets was possible, the
database tables had to be parsed and cleaned individually with separate pro-
cedures. Of 15 obligatory columns, 7 were preserved. These columns report
identifiers of an interactor pair, the PubMed database identifier of publication
where the interaction was reported, taxonomies of interactors, an interaction
detection method, and an interaction type. The last two identifiers are defined
with unique MI-terms specified in the MI ontology. As interactor identifiers
9Datasets of individual databases were retrieved on 2018-02-07.
232 Chapter 4. Exploring current resources ...
vary between databases, first they had to be converted to a common type of
identifier to integrate the tables. DIP and IntAct databases use UniProtKB
accessions (UniProtKB ACs) as their primary identifiers, e.g. P49418. On the
other hand, BioGRID uses numeric Gene IDs, e.g. 1134. For the reason that
UniProtKB protein sequences are used as reference for mapping domain in-
formation, UniProtKB AC was selected as a common identifier for the unified
PPI dataset. To combine all three databases, BioGRID Gene IDs are mapped
to UniProtKB AC. The mapping procedure was preformed with combined
cross-references of Gene IDs and UniProtKB ACs, obtained directly from their
primary providers, that is NCBI10 and UniProtKB11, respectively.
UniProtKB AC are divided into two sections, manually annotated Swiss-
Prot and automatically annotated TrEMBL. As the former guarantees the high
quality and non-redundant protein sequences, these are only preserved in the
NCBI and UniProtKB final mapping files. The list of Swiss-Prot accessions was
retrieved for the Human taxon from the UniProtKB database. It is composed of
20258 unique UniProtKB ACs12. After removing TrEMBL accessions, the NCBI
mapping file has 20053 protein accessions mapped to 20007 genes. The map-
ping file provided by UniProtKB has 18935 proteins mapped to 19125 genes.
Union of both mapping files constitute the final bimap file composed of 20063
proteins and 20140 genes, with the total number of 20482 gene-to-protein pairs.
Unification of both mapping files revealed that there are 1461 gene-to-protein
pairs that are present in only one of the two mapping sets. Among these, 1169
pairs are in the NCBI-derived file, and 292 pairs in the mapping file obtained
from UniProtKB. This difference between cross-references identifiers confirms
the insufficiency of using only the mapping data sets provided by one of the
two databases.
Although DIP and IntAct databases use UniProtKB AC as primary iden-
tifiers for pairs of interactors and despite multiple identifiers supplied per inter-
action pair as aliases, not all have associated UniProtKB AC. These interactions
had to be dropped in the process of table parsing.
10Gene ID to protein accessions mapping file: ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/
gene2accession.gz. Accessed 2018-02-07. VALIDATED and REVIEWED positions were only
selected as these are manually verified.
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As the only one of the three, IntAct database provides information in an
additional column if a binary interaction was generated by a spoke expansion
of co-complex interactions. These interactions are retrieved as constituents of
a protein complex [370]. The spoke expansion, next to the matrix expansion,
is a method of converting n-ary interactions to a tabulated binary format. N-
ary interactions are protein complexes that are identified in such experiments
like tandem affinity purification (TAP). The spoke-model pairs a bait protein
with each prey protein and therefore, a single complex is spoke-expanded
into multiple interactions. As this procedure may generate false positives,
interactions denoted as originating from spoke expansion were removed from
IntAct records to obtain the most refined dataset.
The number of unique interaction counts for each dataset is 98085 for
IntAct, 5508 for DIP and 281867 for BioGRID. A combined set of the three
databases has 332190 unique interactor pairs between 31909 proteins. Fig-
ure 4.2 shows an overlap of interactions between the databases. The largest
contribution is brought by BioGRID. This contribution could be lower if, sim-
ilarly to IntAct, spoke-expanded interactions were identifiable and dropped
from the dataset. Despite this large contribution, the overlap of BioGRID with
other two databases is very low. The total percentage of non-overlapped in-
teractions that comes from only one of the three databases is 84.63%. The
intersection between the three databases is as narrow as 0.67%.
To obtain most refined data set of PPIs, only experimentally determined
and direct interactions are included in the final dataset. The selection procedure
was facilitated by the standard vocabulary of the MI ontology. It is worth noting
that an interaction can be assigned with one or more interaction types and
detection methods. This results in more records than actual unique interactions
in PPI data sets.
The MI ontology provides two general terms to denote types of “direct
interactions” (MI:0407) and types of “experimental interaction detection meth-
ods” (MI:0045). According the ontology, the definition of the former category
is: “Interaction between molecules that are in direct contact with each other.”13.
The definition of the latter is: “Methods based on laboratory experiments to
determine an interaction.”14. Both categories have multiple child-terms that
13Definition of direct interaction term in the MI ontology: https://www.ebi.ac.uk/ols/
ontologies/mi/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FMI_0407
14Definition of experimental interaction detection term in MI ontologies: https:



















Figure 4.2: Overlap of interactions between three resources of PPIs: BioGRID, IntAct,
DIP represented as: (A) counts; (B) percentages of the total number of unique inter-
actions (332190). The largest contributing dataset is BioGRID with the total of 281867
unique interactions, then IntAct with 98085 unique interactions and the smallest set
belongs to DIP, 5508 unique interactions. The overlap between all three datasets is
very narrow.
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Record counts Interaction counts
Human
Database Raw Non-spoke Genes Proteins
BioGRID 1 517 681 - 365 586 378 903 281 867
IntAct 794 921 500 881 - 186 225 98 085
DIP 288 612 - - 19 665 5 508
Table 4.1: Representation of gradual reduction of dataset sizes before consolidation
of the data sources. Columns are divided into record counts that represent rows in
respective datasets and interaction counts. Starting from the left, the progression
of columns shows the results of application of further modifications or filters on the
datasets. Record counts imply duplicated interactions as one interaction can be asso-
ciate with more than one identifier in other columns.
denote more specific concepts. The set of MI-terms representing each of the
categories was obtained by parsing the MI ontology file15. Each set consists of
the parent term and children terms. The total number of terms classified as “di-
rect interations” is 69, whereas the total number of terms in the “experimental
interaction detection methods” is 293. The terms were used to drop interactions
that were annotated with terms different than in the set. The combined set of
332190 interactions has 74006 direct interactions, of which 73115 interactions
are experimentally confirmed.
As established by the example of IntAct database, interactions annotated
with terms that belong to the set of “direct interactions”, were also annotated as
spoke expanded. Therefore, one could have limited trust to the remaining two
databases, as they do not differentiate between spoke expanded and non-spoke
expanded interactions. However, the databases were not further scrutinised
as they represent leading resources in the field and contain the most current
information available.
Table 4.1 demonstrates a gradual reduction of dataset sizes through the
process of merging the three data sources. The first four numeric columns
represent record counts, where an interaction between two the same proteins
could be associated with more than one identifier denoting the publication,
//www.ebi.ac.uk/ols/ontologies/mi/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%
2Fobo%2FMI_0045
15The MI ontology file source: http://www.ebi.ac.uk/ols/index; version: 10-01-2018
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the interaction type and the interaction detection method. Starting from the
left, each next column is a result of applying further modifications or filters
on the datasets. The first column presents the count of raw records before
any filter was applied. The “Non-spoke” column represents the record counts
after removal of interactions resulting from application of the spoke-expansion
model. The “Genes” column represents the number of records of Human
interactions represented with gene identifiers in the BioGRID database after
converting the identifiers to UniProtKB ACs. The “Protein” column presents
records after removing other than Human interactions and represented with the
unifying type of protein identifiers. The last column represents unique counts
of Human interactions represented with UniProtKB ACs. The consolidation of
resources results in 578443 records of 332190 unique interactions.
4.3.3 Protein domain interactions
A major compendium of information about protein domains is Inter-
Pro. It joins 14 signature databases that apply different predictive models for
identification of protein characteristics. Though DDIs are not represented with
InterPro identifiers, reference to InterPro resources can serve as an overview of
overall domain information.
Table 4.2 presents database-wise statistics reported on the 66.0 release of
InterPro. The largest number of signatures belongs to the PANTHER database
(90742). However, the most integrated database with InterPro is the Pfam
database (16109). Table 4.3 shows counts of types of entries present in the
release mapped to all UniProtKB sequences. Although the data set contains
also information about other characteristics of proteins, e.g. binding sites and
PTMs, the database is predominantly a source of information about protein
families and domains. The percentage of reported counts of all UniProtKB
proteins matching any signature in InterPro is 88.3%. Within UniProtKB data
set, TrEMBL accessions are covered in 88.3% with any signature and in 80.9%
with integrated signatures. Swiss-Prot is covered in 97.9% with any signature
and 96.6% with integrated signatures.
The above statistics are reported across all species and types of UniProtKB
accessions. The current release of Pfam (31.0), that provides unifying accessions
for DDIs, covers 75.48% of sequences of reference proteomes in the UniProtKB
database. Reference proteomes are composed both of reviewed and unre-
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Signature Database Version Signatures Integrated Signatures
CATH-Gene3D 4.1.0 2737 1366
CDD 3.16 12805 2535
HAMAP 2017 10 2216 2216
PANTHER 12.0 90742 7387
Pfam 31.0 16712 16109
PIRSF 3.02 3285 3223
PRINTS 42.0 2106 1974
ProDom 2006.1 1894 1307
PROSITE patterns 2017 09 1309 1289
PROSITE profiles 2017 09 1194 1161
SFLD 3 303 143
SMART 7.1 1312 1263
SUPERFAMILY 1.75 2019 1595
TIGRFAMs 15.0 4488 4445
Table 4.2: InterPro member database information for the 66.0 release. Source: Inter-










Table 4.3: Types of entries in the InterPro database of the 66.0 release for all protein
sequences in the UniProtKB database, with the total number of 32568 entries. Source:
InterPro release notes (23-11-2017)
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viewed UniProtKB accessions. Proteomes used as a basis for the last Pfam
release originate from the 2016-10 release of UniProtKB. Number of matched
proteins between InterPro resources and Pfam resources are not directly com-
parable as InterPro uses all UniProtKB accessions, whereas Pfam only reference
proteomes. The number of all UniProtKB protein sequences is 161521 for the
Human taxon, whereas the Human reference proteome used to map Pfam ac-
cessions has 70891 sequences. To asses the information gain obtained with
InterPro, one would have to limit protein accessions used in mapping InterPro
signatures to the same version of the Human proteome as used in the Pfam
dataset.
Similarly to PPIs, proteins expressed in Human are the main focus of
this study. Therefore, the Human reference proteome annotated with Pfam
accessions was retrieved from the Pfam database16. The total number of 6116
unique Pfam accessions are mapped to 49717 proteins of Human reference
proteome. The number of protein in the proteome is 70891 composed of Swiss-
Prot (˜30%) and TrEMBL (˜70%) accessions. Of the 49717 protein accessions
mapped to at least one Pfam accession, 37% are reviewed (18473)17. The number
of Pfam accessions found in these protein subset is 6084. Similarly to InterPro,
not only protein domains are in the database, though they comprise the majority
of entries (Figure 4.3).
The Integrated Domain-Domain Interactions (IDDI) dataset is used as
the source of DDIs. The dataset has not been updated since 2011. However,
two included sources that belong to GSDDI datasets, are regularly updated,
3did18 and iPfam19. These two resources were updated with preservation of
the IDDI data format. The number of interactions in each GSDDI after the
update is: 2898 (PINS), 11200 (3did) and 9561 (iPfam). The reliability scoring
system proposed in IDDI for reported interactions was not updated here and
excluded from the dataset.
After adding the two updated GSDDI sources to IDDI, the number of
non-redundant DDIs is 209941, with 9126 unique Pfam accessions. Before the
update, the IDDI dataset had 204705 DDIs. Therefore, the update increased
16The file with the Human proteome annotated with Pfam accessions (release 31.0): ftp:
//ftp.ebi.ac.uk/pub/databases/Pfam/current_release/proteomes/9606.tsv.gz
17The list of reviewed UniProtKB accession was retrieved from the UniProtKB database on
08-02-2018. The same list was used for filtering the PPI dataset
18The 3did dataset File name: 3did flat.gz. Version: 2017 06.
19Accessed 2014-07-22.
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Figure 4.3: Pfam entry types that were found in the Human reference proteome. “Dis-
ordered” and “Coiled-coil” are most recently added types [373].
the number of interactions by 5236. The original IDDI version had 7351 Pfam
domain accessions from the Pfam version 24.0, where the total number of
signatures was 11912 (current 31.0 version: 16712). Pfam accessions in the
updated IDDI dataset was filtered with 6116 Pfam accessions found in the
Human reference proteome. These reduced the final non-redundant list of
interactions to 130843, with 4271 unique Pfam accessions. The drop in the
number of interactions and Pfam accessions was also caused by withdrawal of
Pfam accessions by the database or by the fact that they were not found in any
protein of the Human reference proteome. There was additional slight decrease
of IDDIs by 47 interactions, as they were no longer supported by the updated
data sets. The total number of interactions that are reported by at least one
GSDDI is 7461 (5%). The number of interactions in each GSDDI data set is: 1650
in PINS, 6037 in 3did, and 5297 in iPfam. The number of domain interactions
per source comprising the final IDDI is shown in Figure 4.4. Figure 4.5A
demonstrates the number of sources per an interaction. Great majority of these
interactions is confirmed by a single source. Figure 4.5B shows the same aspect
of DDIs but for the subset of IDDI limited to the GSDDI resources.
The IDDI database did not differentiate between intra- and inter-chain



















































































Figure 4.4: Number of protein domain interactions per resource that compose the IDDI
dataset of DDIs. Golden standard resources are 3did, iPfam and PINS. Compared to
computationally inferred datasets, e.g. INTERDOM, overall number of GSDDIs is very
low.
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Figure 4.5: Distribution of sources per protein domain interaction, for (A) all 23 sources;
(B) GSDDI sources: 3did (6037), PINS (1650) and iPfam (5297).
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domain interactions. Though this distinction exists in two GSDDI databases
(3did and iPfam), it is not taken into account in this study. This differentiation
between intra- and inter-chain domain interactions is limited to existing exam-
ples of the PDB-derived crystal structures of molecular complexes. Following
the example of the study by Schuster-Böckler and Bateman [7], it is assumed
that the modular assembly of domains in evolution of proteins, that happens for
instance through gene fusion/fission, can swap domain interactions between
two categories. Therefore, first the accent is posed more on potentially existing
interactions, leaving their refinement to later steps.
4.4 Methodology
Presented datasets were chosen to indicate functional links between the
ADHD-associated genes. This section outlines steps undertaken to combine
these datasets together with intermediate procedures to map between identi-
fiers. Identified associations are represented with network graphs that are clus-
tered to partition gene or protein nodes into strongly related subgroups. This
section presents particularities of the selected clustering method. Enrichment
analysis is performed with respect to library of pathway categories to deter-
mine if subsets of the ADHD-associated genes or proteins are overrepresented
in any of these categories. Among many techniques of enrichment analysis,
this study employs a special type of over-representation analysis (ORA) that
take into account hierarchical relations between pathways.
4.4.1 Outline of steps
Figure 4.6 presents a diagrammatic representation of steps undertaken
in this chapter. Gene IDs of the assembled list of genes associated to ADHD
are mapped to UniProtKB ACs. These ADHD-associated proteins are used to
filter the in-house PPIs to identify direct and experimentally confirmed protein
interactions where both interactors are in the set of ADHD-associated pro-
teins. Identified pairs of interactors are represented as a graph network that
is subjected to clustering and clique identification. Aside from PPIs, the set
of ADHD-associated proteins is also mapped to three other datasets. These
are kinase-substrate interactions (KSIs), BioModels and proteins mapped to
domains (PD). The latter dataset is combined with DDIs to identify interaction
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Figure 4.6: Outline of steps undertaken in Chapter 4, that include mapping the ADHD-
associated genes to various resources with biological relations (white rectangles), in-
termediate steps of cross-referencing identifiers of different datasets (grey rectangles),
and used techniques on these datasets (pink and green rectangles). The intersection
icon denotes integration of two datasets, where a subset of shared entries is pro-
gressed to further analyses with clustering and enrichment techniques. White rect-
angles, representing datasets, contain information on types of identifiers used in the
respective datasets. Abbreviations: DDI – domain-domain interactions; PD – proteins
mapped to domains; PDI – protein-domain interactions; PPI – protein-protein interac-
tions; BioModels – database of models; KSI – kinase-substrate interactions.
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Figure 4.7: Schematics representing of enriching PPIs with DDIs. This procedure is
applied to examine the number of potential domain-based interactions that could exist
between proteins.
are represented as a network graph that is subjected to a clustering procedure.
Intersection between PDI and PPI networks is taken to preserve these pro-
tein interactions that are mediated by at least one pair of interacting domains.
This strictly limited subnetwork is subjected to clustering. In the last step,
the original list of genes, associated with ADHD, is subjected to enrichment
analysis with respect to gene-to-pathway annotations. The same procedure is
performed on protein nodes of the stringent PDI network. Results of enrich-
ment into pathway categories are reported for the whole set of network nodes
and for each subset of these nodes, obtained with the network clustering.
Alongside presentation of coverage of the datasets with respect to the
ADHD-associated genes, the coverage with respect to the Human proteome is
also reported for selected datasets.
4.4.2 Network analysis
Network analysis allows to examine relations between numerous en-
tities represented as abstract nodes or vertices. Differentially expressed or
disease-associated genes are mapped to PPI resources to identify binary in-
teractions proving close associations between identified molecules. PPIs are
commonly represented as networks, with vertices denoting proteins and edges
associations between them. Identification of densely connected components
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or clusters among these molecules can point to important modules, involved
in a common pathway or biological function. There are diverse approaches
to cluster identification that often produce different clustering results for the
same network. Computational complexity and running time are crucial aspects
that are taken into account in method evaluation and selection. Scalability of
clustering algorithm is particularly important in large-scale network cluster-
ing. Variable network structures, sizes and evaluation metrics prevent from
categorical decision which clustering method is superior to others [79, 81]. At-
tempts have been performed to provide guidelines which clustering algorithm
is most efficient and accurate in most circumstances [79, 81]. In particular,
the study of Yang et al. [79] compared 8 state-of-art algorithms implemented
in “igraph” package of R language with respect to accuracy and efficiency as
most important aspects of successful algorithm. Comparison was performed
on a benchmark generative network model of Lancichinetti-Fortunato-Radicchi
(LFR) with a wide range of network sizes and values defining the mixing pa-
rameter µ of the network. This parameter, equally defined for each network
node, is formulated as a ratio between the number of edges that connect a node
to other clusters, to the total number of its adjacent edges [79]. The larger the
number of edges shared with other communities, the task of community iden-
tification becomes more difficult as the community structure becomes obscured
[79, 81]. Additional aspect found to influence the reliability of algorithms is
the network size. In larger networks it is more difficult to correctly identify
communities [79, 81]. Yang et al. [79] investigated dependencies between ac-
curacy and computing time with increase of the mixing parameter and the
network size. In general, all tested algorithms performed well with µ ≤ 0.5
and with the number of nodes ≤ 1000. In networks with more demanding
community structures (0.5 ≥ µ0.6 ≤ 0.6) and the higher number of nodes but
≤ 6000, the “multilevel” algorithm outperformed other tested algorithms. This
was found despite that algorithms based on modularity optimisation suffer
from resolution limits [374]. As in this study variable network structures are
clustered with different levels of separation between communities, the more
flexible the algorithm is with respect to this property, the more favourable it is.
The “multilevel” algorithm was proposed by Blondel et al. [82], and it is more
commonly known as Louvain [81, 82]. The algorithm is a scalable method of
modularity maximisation, that was originally prosed by Newman [80]. The
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Louvain algorithm is a hierarchical approach with agglomerative strategy us-
ing greedy optimisation of modularity score [78, 82]. Initially, each network
node is considered as a singleton community. The number of communities is
gradually decreased as neighbouring nodes are aggregated. Aggregation of
nodes is only possible if the modularity of the whole graph is increased as a
result of such aggregation. When further increase in modularity score cannot
be achieved, in the next phase the algorithm contracts identified communities
into single nodes and repeats the same procedure on the reduced graph until
modularity score cannot be further gained [82].
The Louvain method was also mentioned in the review of Javed et al.
[78] as the one that outperformed other greedy algorithms for modularity
maximisation. Emmons et al. [81] compared Louvain to other 3 algorithms with
respect to different cluster quality metrics, and found that Louvain generally
outperformed other popularly applied InfoMap.
In this study, this algorithm was favoured among others as it does not
require the network to be fully connected, and scales linearly with number
of nodes [82]. The Python implementation of the algorithm in the “igraph”
package as the “community multilevel” method was used in this study. Argu-
ments of the method were left to default, meaning that the community structure
that has the best modularity score is returned.
4.4.3 Enrichment analysis
A commonly used method to identify associations between lists of genes
is an enrichment analysis, briefly presented in Section 1.3.2. Enrichment anal-
ysis informs if a set of genes of interest contains a significantly high number
of genes associated to the same annotation in chosen category. This approach
allows to gain a better understanding of underlying common biological pro-
cesses found in the list of genes. Reference datasets supplying annotations are
commonly organised as ontologies with hierarchical organisation of terms as
direct acyclic graphs. The hierarchical organisation implies certain relations
between terms, where the most generic terms are located at the top, and the
most specific ones at the bottom. Moreover, the higher the term is located in
the hierarchy, the more genes are associated to it as the parent term aggregates
all genes from its child terms. Hence, a single gene can be found on different
levels of annotation specificity. Depending on the purpose of the analysis, it
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is important to be able to choose the level of retrieved terms. In the dynamic
modelling context, the most preferable level is the most specific one, as it allows
to retrieve relatively small and cohesive group of genes.
This problem has been addressed by the algorithm proposed by Alexa
et al. [375] for GO, that allows to identify the most specific terms among
significantly enriched ones. Alexa et al. [375] improved scoring of GO terms by
including the underlying GO graph topology in term scoring. This approach
removes strong correlations between neighbouring terms, a common feature
of standard methods for the GO enrichment analysis.
Assuming that a child term is potentially more interesting than its more
generic ancestors, significance of a term is calculated depending on the signif-
icance of its child terms [375]. In this way the enrichment of a more generic
term is ignored, and less frequent low-level ones that are more specific and
potentially more interesting to surface. The algorithm leads to more refined
results than a set-based enrichment analysis that ignores the ontology struc-
ture. The algorithm is implemented as the “topGO” package in the R language
but only for the GO reference database. For the purpose of identification of
important disease mechanisms that could be dynamically modelled, pathway
reference datasets are more informative as intensively studied and verified
pieces of molecular mechanisms. They are also a usual commencing point in
the process of construction of molecular models. Therefore, it is of interest to
apply the same approach to the pathway-related gene annotation sets. This can
be achieved with the “topOnto” package written in the R language [376] that is
based on the “topGO” tool developed by Alexa et al. [375]. The package extends
the advantage of the Alexa et al. [375]’s method to any hierarchically structured
dataset, such as REACTOME. Pathways in REACTOME can be composed of
other pathways. On the lowest leaf-level are reactions or reaction-like events,
such as binding, complex formation, transport or polymerisation.
These hierarchically organised terms are transformed into a simplified
ontology standard format, the OBO file. “topONTO” implements various test
statistics and methods to eliminate local similarities and dependencies between
ontology terms that are implemented in the “topGO” package by the follow-up
studies [377]. In this study, the “elim” algorithm by Alexa et al. [375] is used,
paired with Fisher’s exact test as a measure of significance. The decision to
select the “elim” algorithm was based on clarity of the number of comparisons
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performed by the algorithm. This number was further used to correct for the
false discovery rate with the Benjamini and Yekutieli multiple testing correction
[378]. In the “elim” approach, enrichment analysis starts at the bottom of the
ontology graph. If a child term is significantly enriched amongst the genes of
interest, this influences the number of genes annotated to its ancestor terms.
All genes associated to the enriched child term are removed from the ancestor
terms leaving most specific ones with the minimal indicated significance.
A background dataset (N) is composed of genes of the Human genome.
each associated with a set of REACTOME terms. The REACTOME terms
were retrieved from the REACTOME database and filtered for the Human’s
Gene IDs20. The total number of terms is 1845, annotating 10045 genes.
4.5 Results
4.5.1 Protein interaction network
PPIs between the ADHD associated genes are assembled from the di-
rect and experimentally identified dataset of PPIs (Section 4.3.2). To match
the identifier type of the PPI dataset, the ADHD Gene IDs are translated to
UniProtKB ACs. This mapping between identifiers is performed with the
same dataset that was used to unify BioGRID with the other two PPI databases
(Section 4.3.2).
Of the total number of 886 genes associated to ADHD, 746 Gene IDs
are converted to 760 protein UniProtKB ACs. There are 140 genes that are
not mapped to proteins. Almost all these genes (134) are non-coding DNA
sequences that are not transcribed into proteins, with an exception of 6 that
have unknown or withdrawn Gene IDs. Great majority of non-coding genes
are non-coding RNA (ncRNA) (127), that are transcribed into functional RNA
molecules. They can potentially have a regulatory function in various aspects
of gene expression [379]. Among them, are 2 short nuclear RNAs (snoRNAs)
that might play role in modification of other RNA forms [379]. There are also 7
pseudo-genes among the ADHD-associated genes. These are DNA fragments
similar to existing protein-coding genes but with a modified open reading
frame (ORF) that prevent their translation to proteins [380]. There are various
types of pseudo-genes, some known to have a functional role in gene expression
20Entrez Gene ID to REACTOME term annotation file source: http://reactome.org/
download/current/NCBI2Reactome_All_Levels.txt. Accessed 2016-11-19.
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[379]. These pool of identifiers could be included in analysis; however, research
on ncRNA is rather scarce and the information regarding the role of ncRNA
might not be detailed enough to include it in the dynamic model.
Filtering of the integrated PPI dataset with the ADHD protein list re-
sulted with 721 records representing individual pairs of potentially duplicated
protein interactions. An interaction can be duplicated in this set if it has more
than one publication identifier, type or detection method. The number of
unique interactions is much lower, 371. They are composed of 270 proteins, of
which 101 are self-interactions.
As all constituent PPIs resources report the type of interaction encoded
with MI terms, the extend of information content on interaction details is ex-
amined in the ADHD dataset. Figure 4.8A shows types of interactions existing
in the PPI in-house dataset. Nearly all interactions are associated with the
most generic “direct interaction” term, showing negligible representation of
the remaining child terms. Figure 4.8 shows the same type of information but
for protein interactions between the ADHD-associated proteins. Among iden-
tified interactions, there are 9 interactions of more specific type than the general
“direct interaction”, of which 4 are self-interactions. These are 4 “phosphoryla-
tion reactions”, 4 “dephosphorylation reactions” and 1 “disulfide bond”. The
subset of ADHD-associated interactions demonstrates a similarly predominant
level of generality in information content describing individual interactions as
in the full PPI dataset. As such, the PPI datasets can be classified as a prelimi-
nary sieve.
Figure 4.9 shows the top 50 interaction detection methods of 125 terms
associated with the full PPI dataset. Figure 4.10 shows all 47 interaction detec-
tion methods associated with the ADHD-associated PPI dataset. Both figures
present a similar domination of two types of experiments, the “two hybrid”
and the “pull down”. The “two hybrid” method is a variant of transcrip-
tional complementation assays. The “pull down” method belongs to affinity
chromatography technology generally classified to biochemical methods.
The binary set of ADHD protein interactions is represented as a net-
work graph. The network consists of 270 nodes (proteins) and 371 connecting
them edges (interactions). After removing self-interacting nodes, the network
consists of 243 nodes connected with 270 edges. As mentioned in Section 4.3.1,
genes derived from the ADHdgene database have associated two levels of
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Figure 4.8: Distribution of “direct interaction” terms allocated per interaction for (A) all
PPIs (29 terms); (B) PPIs for ADHD associated genes (4 terms). Datasets include
duplicates of interactions if an interaction was assigned with different identifiers for
interaction type. For ADHD associated genes, the number of interaction entries is
376, of which 371 are unique interactions.
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Figure 4.9: Distribution of the top 50 terms of the total 125 terms in the set of “ex-
perimental interaction detection methods” of the whole PPI dataset. Counts include
duplicated interactions if an interaction was assigned with more than one interaction
detection method.
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Figure 4.10: Distribution of the terms in the set of “experimental interaction detection
methods” in the ADHD protein list (47 terms). Counts include duplicated interactions
if an interaction was assigned with more than one interaction detection method. The
number of data entries is 528 of which 371 are unique interactions. On average, there
are 1.42 interaction detection methods assigned per each unique interaction. However,
of 371 unique interactions, 295 (79.5%) are associated to only one method. A closer
look at this subset shows that 150 interactions (40.4%) are confirmed solely by “two
hybrid” and 87 interactions (23.5%) by “pull down” detection methods.
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confidence, based on the number of studies that reported a significant gene-to-
disorder relation. There are 38 genes confirmed by > 2 significant studies and
137 genes by> 1 significant study. The former 38 genes are mapped to the same
number of proteins and 15 are found in the node list of the ADHD-associated
PPI network. Of 137 genes, 135 are mapped to 145 proteins and 40 of them
appeared in the node list.
Figures 4.11 and 4.12 present two perspectives of the network connec-
tivity with removed self-interacting nodes for visualisation purpose. Node
sizes in Figure 4.11 are proportional to the eigenvalue centrality scores. This
centrality measure exposes nodes that are connected to a group of important
nodes as the score is measured with respect to importance of neighbouring
nodes determined by their degrees. Figure 4.12 demonstrates the location of
cliques in the network. The minimal number of fully connected nodes is 3
with the maximal number reaching only 4. The network has few disconnected
pairs of nodes and sparsely connected number of edges. This explains a still
relatively high number of clusters that from 60 dropped to 33 after excluding
self-interactions.
4.5.2 Protein-domain interaction network
Direct protein interaction networks presents rather sparse connectivity
between the ADHD-associated proteins. They also does not offer a higher
resolution view on interaction details, nor protein interaction interfaces, such
as protein subunits that could hint on protein binding patterns. To include this
information, proteins associated with ADHD are enriched with information
on protein subunits collected from the Pfam database. Identified subunits of
ADHD proteins are used to screen IDDI for protein-domain interactions. The
obtained list of interacting domains is mapped back to proteins associated
to ADHD. A new network is build with multiple edges denoting presence
of interactions between protein components. It is important to note that the
network represents a hypothetical view on interaction capabilities existing
between proteins based on their characteristic subunits.
Table 4.4 reports the coverage of Pfam accessions and domain interac-
tions with respect to the Human reference proteome and the ADHD proteins.
Counts of DDIs are presented for a full set of DDIs and a subset of DDIs con-
firmed by at least one of the GSDDI datasets. Among domain interactions of
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Proteome ADHD proteins
Data types Counts Counts
Genes – 886
Proteins 70 891 760
Proteins with Pfam Acc 49 717 723
Pfam Acc mapped to proteins 6 116 723
Protein to Pfam Acc pairs 98 236 2 065
Domain interactions
Domain interactions 130 843 11 294
Pfam Acc 4 271 595
Proteins – 666
Domain interactions in GSDDI*
Domain interactions 7 461 1 147
Pfam Acc 3 353 523
Proteins – 623
Table 4.4: Counts of Pfam signatures and Human-specific domain interactions with
respect to the Human reference proteome (2016 10) and the ADHD associated genes.
*Interactions confirmed by at least one GSDDI.
the Human proteome, 5.7% is confirmed by at least one of the three GSDDI,
whereas among the ADHD protein set, it is 10%. Nearly doubled domain inter-
action coverage can be explained by the character of ADHD-associated genes,
that are often more studied than the average protein of the Human proteome.
Moreover, the genes are mapped to canonical reviewed UniProtKB ACs (Swiss-
Prot), whereas proteome is composed of both types of accessions, TrEMBL and
Swiss-Prot.
A protein identifier can be mapped to more than one Pfam accession.
In consequence, the number of protein interactions on the domain-resolution
for ADHD grows combinatorially to 368117 potential protein-domain inter-
actions. If only GSDDI are included, the number of hypothetical protein-
domain interactions is reduced to 65196. An example of such combinatorial
growth in domain interactions are the ones between “CUB and sushi domain-
containing protein 3” (Q7Z407) and “CUB and sushi domain-containing protein
2” (Q7Z408). These proteins are connected with 1680 edges denoting domain
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interactions. The first one has 42 domains, the second has 40 domains. As
their names suggest, these proteins are composed of repeats of two the same
domains, Sushi domain (PF00084) and CUB domain (PF00431). Both domains
not only interact with each other but also interact with themselves. Therefore,
the number of all possible combinations of interacts is equal to 1680 (40×42).
With domain interactions mapped to proteins, a network of potential
protein interactions is constructed. The network can be viewed with two
different levels of stringency, dependent on the included resources of DDIs,
as a full set of DDIs or confirmed by at least one of the GSDDI databases.
The network is clustered with the same “multi-level” algorithm used for the
PPI dataset. The algorithm partitioned the network to 3 and 33 communities
for the DDI- and the GSDDI-based networks, respectively. As the number of
vertices and edges in these networks render visualisation difficult to analyse,
Figure 4.13 shows the most numerous cluster (142 proteins) among the 33
communities that demonstrates various density regions.
Table 4.5 collates counts of the two networks. Networks are processed
in two ways, by removing isolated nodes and by merging multiple edges into
one between pairs of nodes and preserving the removed number of edges as an
edge weight. Alongside the number of edges and nodes, the change in coverage
of the 38- and 137-seed genes are reported. The drop in the seed gene coverage
and the number of protein nodes between DDI and GSDDI is rather low. This
allows to first concentrate on the GSDDI-based dataset in the next steps of the
network reconstruction. The argument against the use of less stringent DDI
dataset is also the lack of certainty in correctness of prediction-based sources
of DDI.
Domain-based protein interaction networks includes far more protein
nodes in comparison with the PPI-based network composed of 243 nodes. It
is true even with the most stringent network variant. We can compare the
number of edges between the DDI-based and the PPI-based networks after
edge simplification. The edge simplification involves replacing multiple edges
of the preliminary domain-based network with a single edge between a node
pair weighted with the sum of multiple edges. The domain-based network has
still much larger number of edges (9685) than the protein-interaction-based
(270). The number of edges, being hypothetical interactions in the protein-
based PPI network, increased 36 folds alongside the number of interacting

















































































Data types Counts Counts
Preliminary network
Protein nodes 666 623
38-seed nodes 38 37
137-seed nodes 136 131
Edges 368 117 65 196
Merged edges 62 253 9 685
Isolated nodes 13 78
Network without isolated nodes
Protein nodes 653 545
38-seed nodes 38 33
137-seed nodes 133 116
Merged edges 62 253 9 685
Clusters 3 33
Table 4.5: Counts of network components represented for two categories of stringency
in separate columns: all sources of DDIs and interactions confirmed by at least one
GSDDI. The network is processed in two ways, by merging multiple edges between
node pairs into one and by removing isolated nodes.
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proteins included in the network. Distribution of weights per edge for the
ADHD-associated PDI network limited to GSDDI is visualised in Figure 4.14.
For the network including all IDDI interaction sources in Figure 4.15. In both
cases, the most common number of interacting sites is 1 with the most extreme
weights reaching 1764.
4.5.3 Kinase-substrate interaction network
PhosphoSitePlus R© is used as an exemplary resource of kinase-substrate
interactions (KSIs). These dataset has not been presented in the previous sec-
tions as this dataset was used in its original form. The data were extracted from
the PhosphoSitePlus R© database21 and screened with the ADHD genes. Of the
total 17255 KSIs reported by the database, 10188 have both Human interactor
proteins. In this Human-specific subset, 102 interactions between 45 ADHD-
associated proteins were found. Neither of them is in the set of significant
ADHD genes (Figure 4.16). The network has 14 genes that are kinases and
45 are substrates. This means that these 14 play both roles. This mechanisms
is not a surprise as many substrates are themselves kinases. Similarly, many
proteins are auto-phosphorylated.
The kinase-substrate pairs are screened unilaterally, by either mapping
the ADHD genes to substrates or kinases. There are 121 ADHD genes that are
substrates among the 547 kinase-substrate pairs, where kinases are outside of
the ADHD gene set. On the other site, 19 ADHD proteins are involved in 1283
substrate-kinase interactions, when substrates are outside of the ADHD gene
list.
4.5.4 Proteins in models
A common approach to parametrisation of new models is to use kinetic
rates from previously modelled systems. To find out if any of the ADHD genes
have been included in modelled systems, the proteins were screened through
the resources of the BioModels database. The database, as oppose to CellML or
DOQCS model repositories, offers unprecedented cross-referencing with other
common biological collections of data and therefore, is used in this study.
Of 760 ADHD proteins, 40 were modelled in at least one model and 13
of them belong to the gene set confirmed by at least one significant study (the
21Accessed 2018-01-20.
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Figure 4.14: Distribution of edge weights of the ADHD-associated PDI network limited
to GSDDI.
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Figure 4.15: Distribution of the top 60 edge weights of the ADHD-associated PDI net-
work with all DDIs included.
4.5. Results 263
Figure 4.16: The kinase-substrate network of the ADHD-associated genes. The net-
work is composed of 102 interactions between 45 ADHD-associated genes. Neither of
the proteins belong to the set of genes confirmed by at least one significant study (the
137-gene set). The network is clustered with the “multi-level” algorithm. Clusters are
designated by distinctive node colours.
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137-gene set). There are 72 models with at least one ADHD protein. However,
model identifiers point to 56 unique publications meaning that there are more
than one model reported by a single publication. These models represent dif-
ferent variants or conditions of the same molecular system and were separately
submitted to the BioModels database. Among 72 retrieved models, some are
associated with multiple ADHD proteins. There are maximally six proteins
that were modelled together in a single publication of the α-synuclein-based
model of Parkinson’s disease by Sass et al. [381]. The top modelled protein, Pro-
epidermal growth factor (P01133), appeared in 9 publications and 11 models
of the epidermal growth factor receptor (EGFR) signalling. Of the 56 publica-
tions, 38 modelled exactly one ADHD protein. Table B.1 in Appendix B enlists
ADHD proteins with names of models they were found in.
4.5.5 Pathway enrichment analysis
Pathways represent grounded information about molecular mecha-
nisms. Though limited in coverage, pathway information can serve as a
basis of model development. In this section, the ADHD associated genes
are subjected to pathway-based enrichment analysis, in particular its variant
of ORA (Section 1.3.2). ORA is preformed on pathway data retrieved from
the REACTOME database with the “topONTO” package (Section 4.4.3). Ob-
tained p-values were corrected for the false discovery rate with the Benjamini
and Yekutieli multiple testing correction [378]. Among the total of 886 ADHD
genes, 439 are annotated to REACTOME terms. Table 4.6 shows enriched path-
way terms in the ADHD-associated genes that scored with p-values< 0.01, after
the correction was applied. Before the correction, 33 terms were found with
p-values < 0.01. Terms with at least one annotated gene found among the
ADHD-associated genes were included in calculations.
Figure 4.17 shows a hierarchical representation of reduced ontology
graph with the significantly enriched nodes in the ADHD-associated genes.
All 9 terms listed in Table 4.6 are leaf-level terms, as intended by applica-
tion of the “topONTO” package. Found pathways are biologically related and
centred around processes involving three neurotransmitters: serotonin, nore-
pinephrine and dopamine. The last two neurotransmitters are catecholamines.
In fact, norepinephrine is derived from dopamine, and their synthesis can be

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































other enriched pathways, localised in the presynaptic terminal, are neurotrans-
mitter release cycles to synaptic cleft. Lastly, pathways involving receptors that
are targeted on the postsynaptic membranes by the three neurotransmitters are
enriched.
Sharing of genes between pathways can be observed in Figure 4.18,
depicting a network of pathway terms connected to their gene members, rep-
resented as symbols. Pathway identifiers are marked in blue, whereas the
subset of genes associated to ADHD, in red. The network is clustered with the
“multi-level” algorithm. Clusters are designated by distinctive node colours.
The largest green cluster concentrates terms around the “G alpha (s) signalling
events” pathway (R-HSA-418555), which shares genes with “Dopamine recep-
tors” (R-HSA-390651), “Adrenoceptors” (R-HSA-390696) and “Serotonin recep-
tors” (R-HSA-390666). The most entangled pathways regarding shared genes
are “Dopamine Neurotransmitter Release Cycle” (R-HSA-212676), “Serotonin
Neurotransmitter Release Cycle” (R-HSA-181429) and “Norepinephrine Neu-
rotransmitter Release Cycle” (R-HSA-181430) (bright green cluster).
4.5.6 Protein interactions enhanced with domain informa-
tion
If self-interactions are excluded, the PPI network is composed of 243
nodes and 271 edges, whereas the domain-based interaction network has 545
proteins and 9685 edges. This large increase of potential interactions hidden in
the domain-level, might not correspond to the actual interactions. The domain-
level interactions does not include structural constraints of interaction inter-
faces that might render two domains as non-interacting. On the other hand,
experimentally confirmed protein interactions have various level of certainty
regarding limitations of detection methods. Majority of protein interactions
is detected with the “two hybrid” method that is known to have a high false-
positive rate [382]. Combined information from PPI and DDI datasets can
limit protein interactions to the ones of higher confidence, though with the
risk of false negatives, as protein domains are not the only means of protein
interactions.
The number of PPI, including self-interactions (271 nodes, 371 edges),
that has at least one domain-domain interaction is 165 (44.5%). In a network
without self-interactions (243 nodes, 271 edges), 69 (25.5%) interactions be-
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tween 94 (38.7%) proteins has at least one domain-domain interaction. The
network has 28 detached components that divide the network into clusters. To
learn if any of these clusters represent a known biological pathway, 28 clus-
ters are subjected to pathway enrichment analysis based on the pathway set
deposited in REACTOME. Of 28, 3 rendered results that passed the threshold
of p-value < 0.01, after the Benjamini and Yekutieli multiple testing correction.
Two clusters resulted with an enrichment of a single pathway. Both pathways
have relatively large number of associated genes (“V18” and “V27” Table 4.7)
and 4th level on the REACTOME pathway tree. The third “V1” cluster resulted
with 10 pathways, with all 5 cluster members associated with the first 6 path-
ways located on the lower 5th level of the pathway diagram (Table 4.7). These
6 pathways are siblings, grouped under a common ancestor pathway term,
“Neurotransmitter release cycle” (R-HSA-112310). Among pathways, not indi-
cated in the enrichment of the whole ADHD-associated gene set (Table 4.6) are
the “GABA synthesis, release, reuptake and degradation” pathway (one of the
6 sibling pathways), the “Regulation of insulin secretion” and three pathways
of the toxicity of botulinum toxin, each of the three annotated with only 3 genes.
Figure 4.19 show network representation of pathways enlisted in the
“V1” cluster in Table 4.7.
To examine if enrichment on the full set of 94 proteins results with a
different set of enriched pathways, that is if division into clusters might occlude
enrichment of other pathways, the list of 94 proteins is subjected to pathway
enrichment. Table 4.8 presents results of the enrichment of the undivided
protein set. The first 6 pathways are among 6 pathways in the “V1” cluster
in Table 4.7. These are “GABA synthesis, release, reuptake and degradation”
and 5 pathways of neurotransmitter release cycles of acetylcholine, serotonin,
norepinephrine, dopamine and glutamate.
The “Nuclear Receptor transcription pathway”, located at the bottom in
Table 4.8 of enrichment results for the undivided protein list, can be found in
the enrichment results of the “V18” cluster (Table 4.7). This pathway does not
share any of its members with other enriched pathways (Figure 4.20). Pathway
enrichment analysis of the unclustered protein indicated the “Adrenoceptors”
pathway (R-HSA-390696) that was missed in the cluster-based enrichment.
Similarly to the “Nuclear Receptor transcription pathway” (R-HSA-383280), the
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ter in the network representation of enriched pathways (Figure 4.20). On the
other hand, the cluster-based enrichment indicated the “Regulation of insulin
secretion” pathway (R-HSA-422356) as significantly enriched, that is missed in
the enrichment of unclustered proteins. In Figure 4.19, showing the network
representation of enriched pathways of the “V1” cluster, enriched pathways
share their members in larger degree, expected by the underlying protein in-
teraction module.
4.6 Discussion
The realm of biological data is ever-changing environment that require
the constant process of verification. There is a limited fraction of confirmed and
stable datasets that forces ventures to include and integrate datasets obtained
with high-throughput experimental methods and computational predictions.
These, on the other hand, suffer from uncertainty, errors and redundancy. Op-
erating between different data sources, implied by an integrative approach, in-
troduces another layer of difficulties regarding the control for errors in datasets.
Even process of merging resources of similarly understood biological entities,
like domains and pathways, is problematic. However, ongoing community
efforts and distinctive progress to tackle these issues is observed.
The aim of this chapter was to identify aspects and difficulties that
assembling of a RB model from molecule-centred datasets might imply. To
reflect a potential biomedical inquiry, this exploration sets off from a list of
genes associated with an exemplary complex disorder, that is ADHD. The list
of genes is assembled from three variable datasets that represent high-quality
curated and automatically assembled resources. Different types of knowledge-
bases and association datasets were employed to learn on biological meaning
represented by the list of ADHD-associated genes.
The first association datasets are physical interactions between proteins.
They are commonly used in molecular studies of diseases [383–387]. To limit
interaction to direct and experimentally detected ones, an in-house dataset
of PPIs was assembled by merge of three primary databases, standardised
with the common PSI-MI data format. To select direct and experimentally
detected protein interactions, PPIs with appropriate MI ontology terms were
only preserved. However, as identified in the IntAct dataset, co-complex in-
teractions, binarised to a tabular form with the spoke expansion model, are
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in fact also categorised as “direct interactions”. Given that only the IntAct
database explicitly tags these interactions, classifying an interaction as direct
that is reported by other databases, might introduce false positive records. In
spite of this uncertainty, all three PPI resources were merged, preceded with
removal of spoke-expanded interactions from IntAct. Overlap between the
three datasets is negligible (0.67%). The overlap between two largest datasets
(BioGRID and IntAct) is higher, though it is still quite low (14.69%). Exact
mechanisms of interactions are not provided in PPI and therefore, using them
alone will not allow to encode realistic interaction rules that emphasise bind-
ing interfaces. Therefore, another data types that were reached for were pro-
teins annotated with domains and domain-domain interactions (DDIs). The
protein-to-domain annotations were retrieved from the Pfam protein signa-
ture database. A network of PDIs was constructed from the updated IDDI
database of DDIs composed of Human proteins. IDDI combines 23 datasets
including 3 gold standard domain-domain interactions (GSDDIs). Mapping
DDIs between ADHD genes revealed that there is 36-fold increase in the num-
ber of potential site-specific interactions (9685 edges) than found by mapping
the same genes to the PPI dataset (271 edges). Furthermore, a much higher
number of the ADHD-associated proteins was included in the PDI network
than when PPIs were only considered. This domain-based protein interaction
network reflect only potential interactions. A proof of the actual existence of
these interactions would require further studies supported by other resources
and statistical methods to eliminate conflicting domain interactions.
As PPIs might contain false positive records and a narrow overlap be-
tween databases was observed, the PPI network of the ADHD-associated pro-
teins was intersected with DDIs. 38.7% of proteins of the ADHD-associated
PPI network were found to be involved in at least one DDI (excluding self-
interactions). The number of PPIs mediated by at least one DDI were 25.5%
of the same PPI network of the ADHD-associated proteins. As reactions po-
tentially mediated by domains cover less than 40% of proteins identified as
directly interacting, other resources should be also employed to gain greater
coverage and understanding of reaction details.
The ADHD-associated gene set was also mapped to kinase-substrate
interaction (KSI) obtained from the PhosphoSitePlus R© database. This mapping
resulted with a network of sparse connections that included most studied
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proteins but non of the proteins that association to ADHD was confirmed by
at least one significant study. However, interactions in this network could
be directly encoded as rules of a dynamical model, as they represent direct
physical interactions. Moreover, these reactions belong to a particular class that
could be parametrised with generalised reaction constants for phosphorylation
reactions. Different strategy could be acquired to slightly increase coverage in
phosphorylation reactions of genes associated to ADHD. When only substrates
were mapped to the ADHD-associated genes and kinase proteins were outside
of this set, 13.6% of these genes were found among substrates of KSIs, compared
to 5% when both interactores were contained in the ADHD gene set.
PhosphoSitePlus R© is only an example of existing resources of kinase-
substrate interactions. Other databases could be examined and potentially
integrated to evaluate coverage of this type of interactions. For instance,
the PhosphoNetworks dataset includes a large Human dataset of phospho-
rylation sites and kinase-substrate relations [338]. Hu et al. [338] integrated
high-throughput phosphorylation data and provided a high-resolution phos-
phorylation dataset. However, the dataset has not been updated since 2014.
To other potential sources of kinase-substrate interactions is the Eukaryotic
Kinase and Phosphatase Database (EKPD) [388]. Similarity to the Pfam fami-
lies, the database contains defined families of eukaryotic protein kinases and
phosphatases, for which position-specific scoring system based on the Hidden
Markov Models, the HMM profiles, were generated. Based on these profiles, a
genome-wide identification of kinases and phosphatases can be achieved [388].
Enrichment analysis with respect to the REACTOME pathway terms
was performed to identify pathways that could be used as a starting point
to develop dynamic models of disorder-related mechanisms. The pathway
enrichment analysis was performed with the “topONTO” package. Unlike usual
ORA methods, the one implemented in “topONTO” takes into account ontology
structure to produce enrichment results. Consequently, more specific but still
significantly enriched pathway terms were identified.
It is worth noting that around a half of the ADHD-associated genes was
found as significantly enriched in any pathway term. The highest number of
genes allocated to the same pathway was 20, in the largest pathway of “G alpha
(s) signalling events”. In other pathways, this number was not larger than 7.
Pathways enriched in the ADHD-associated genes were identified as
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closely related, located in pre- and postsynapses. These pathways involve
processes of synthesis, release cycle and interactions with receptor targets of
5 major neurotransmitters. A visualisation of pathways as clustered network
graphs allowed to easily observe extensive sharing of genes between three of
these pathways. These pathways appeared to be sibling-terms on the ontology
tree, parented by the more general pathway of neurotransmitter release cycle.
Enrichment performed on proteins derived from the intersection of PPIs and
DDIs of the ADHD-associated genes revealed three other pathway members
of neurotransmitter release cycles that involve glutamate and acetylcholine
release cycles, and the GABA synthesis, release and degradation pathway.
To convey any distinctive conclusions regarding the disease mecha-
nisms from the performed analyses, the obtained results would have to be
consulted with the specialist in the ADHD domain. Therefore, I refrain from
a discussion on potential disease mechanisms that could possibly be derived
from the identified pathways. However, it is worth noting that indication
of neurotransmitter-related process by the enrichment analysis is cohesive
with generally known symptoms of ADHD. Disruption of levels of multi-
ple neurotransmitters in ADHD is commonly admitted [389]. Typically used
pharmacotherapies involve medications that increase extra-synaptic levels of
dopamine and norepinephrine (methylphenidate and amphetamine) [390]. Im-
portance of GABAergic inhibitory neurons in the child ADHD, particularly in
the upregulation of GABA inhibitory function, was experimentally evidenced
by Nagamitsu et al. [391]. In other study by Edden et al. [392], reduced level
of the GABA neurotransmitter concentration was observed in ADHD children
compared to a control group.
Regarding the type of method for enrichment analysis that was used
in this study, there are certain limitations in the ORA-based approach, in par-
ticular with respect to the pathway enrichment analysis. Firstly, pathways in
the ontology-base ORA approach are considered as terms connected with each
other to form parent-child relations. A parent is a more generic term that con-
tains one or more children terms. Each term harbours a list of genes that are
not connected within the list nor to other pathways. This representation ne-
glects a vital information regarding pathway topology. Therefore, a potentially
more adequate enrichment approach to pathway datasets is to combine the
gene set-based scoring system with the pathway network topology. Methods
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implementing such approach include information about a position of gene in a
pathway topology diagram. For instance, CePa uses different centrality mea-
sures corresponding to diverse biological functions to weight pathway nodes
found as differentially expressed genes [393]. Another proposition is EnrichNet
[394] that overlays target genes and reference datasets onto a molecular interac-
tion network combined with information about tissue-specific gene expression
and computes network-based gene set enrichment scores.
Although very detailed, information enclosed in pathway datasets lack
quantitative data characterising reactions they represent. There are multiple
resources with quantitative data that are commonly used in modelling pro-
cess. For instance, one of commonly used resources are public databases,
such as SABIO-RK [345], BRENDA [395], IntEnz [396] and MetaCyc [397].
These databases are focused on enzyme kinetics, relevant for instance to pro-
tein kinases and phosphatases. Other quantitative information like protein
concentration, binding affinities and reaction rates could be extracted from
the literature either manually or by using natural language processing (NLP)
techniques to find relevant publications and references in a high-throughput
process of document screening [398]. If not from exact processes, quantita-
tive measurements could be obtained from related processes. Other sources of
kinetic information can be obtained from existing models published in reposi-
tories such as BioModels, CellML or DOQCS. These resources are rather scarce
and limited to most popularly modelled molecular systems (e.g. EGFR) as seen
on example of ADHD-associated proteins found in at list one model deposited
in BioModels (5.3%). If quantitative data are nowhere to be found, a com-
mon approach is to create a parameter value window around default rates for
particular classes of reactions [174].
An important source of information on how to automate the process of
RB model construction are frameworks and infrastructures developed to ad-
dress the ordinary differential equation (ODE) modelling, such as KiMoSys, a
web-based repository for experimental data and model exchange [399]; SBML-
squeezer for semi-automated and integrative process of the ODE modelling
that addresses assignment of kinetic rate laws, integrable with any modelling
pipeline [111]; and Path2Models, a generator of kinetic, logic or constraint-
based SBML-encoded models of metabolic processes from the KEGG pathway
dataset [342].
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Protein-centred associations, in form of PPIs, were used as an essential
source of deriving functional links between disease genes in this study. There
are other associations that could be used to relate genes and that have been
used in disease studies, such as gene interactions, sample-specific gene tran-
scripts and gene co-expression networks [400–402]. Genetic interactions point
to functional relations between genes that affect each other and produce a phe-
notype that is not observed with their individual effects [403]. However, these
interactions are most commonly studied with low-level model organisms (e.g.
Fruit fly and Yeast) as genetics of these organisms can be easily manipulated,
and effects of mutations are quickly observed due to these organisms short
life cycles. The other mentioned data source are gene expression correlations.
Pairs of differentially co-expressed genes are linked by virtue of similarity in
their activity measured across multiple conditions [404]. Neither of these two
datasets provide information on direct and causative relations between these
proteins or genes and therefore, cannot be used in building mechanistic models.
However, these types of datasets could be included as auxiliary resources to




High-throughput experimental techniques combined with new hypotheses re-
garding the character of molecular processes have been developed side-by-side
with novel computational techniques to model these processes and capitalise
on available datasets. In the light of this development, this thesis aimed to iden-
tify components and examine challenges of a framework for semi-automated
rule-based (RB) modelling in neuroscience research. The RB approach that was
placed at the centre of this thesis was selected as an advantageous method to
dynamically model interactions between molecular entities on a subunit level.
5.1 Rule-based vs. ordinary equation-based mod-
elling
The RB notation captures properties of subcellular signalling networks
that are difficult to model with other frameworks such as most popular and
commonly applied ordinary differential equations (ODEs). Although advan-
tages of the RB modelling in comparison to the ODE modelling have been
extensively presented and discussed in numerous reviews, no direct compari-
son of time courses of one molecular system encoded in the two frameworks
have been presented before. Therefore, in Chapter 2, I directly compared the
same molecular system of the immediate interaction network of dopamine-
and cAMP-regulated neuronal phosphoprotein with molecular weight 32 kDa
(DARPP-32) encoded in the two modelling approaches. Comparison of models
was performed on two levels, model specification and time courses of selected
observables.
281
282 Chapter 5. Discussion & Conclusions
5.1.1 Differences in model specification
The number of reactions was reduced with the rule encoding. This
result was expected by virtue of the advantage of the RB language where
multiple precisely defined reactions are represented by a single rule pattern.
A closer look at representation of particular mechanisms revealed that this
advantage is not always at play. Increase in the number of rules compared
to reactions was noted for very detailed encoding of activation reactions of
protein phosphatase 3/calcineurin (PP2B) and protein kinase A (PKA), termed
here the “combinatorial binding” notation.
5.1.2 Comparison of time courses
The models were stochastically simulated to compare their agreement
on the level of dynamics. Agreement between the models was observed re-
garding general characteristics of trajectories of selected observables. Direct
comparison of the two model dynamics was performed by overlaying paired
time courses of 15 designated observables. This revealed that for these ob-
servables that activation required the “combinatorial binding” notation (PP2B
and PKA) the same reactions encoded and simulated with rules output slightly
lower copy numbers than with the original ODE model. These lower abun-
dances might be caused by the fact that activation of these observables required
larger number of events in the simulation than in the original reaction nota-
tion. The number of intermediate steps between inactive and active forms of
PP2B and PKA is much higher than in the ODE model. This explanation can
be supported by much higher copy numbers of different half-active variants
of PP2B than in its ODE equivalent observable. This observation suggests
that during the simulation, activation steps “diffused” into intermediate steps.
Nevertheless, additional studies are recommended to identify the exact rea-
son of observed discrepancies between ODE and RB model dynamics, despite
application of the same rate constants and kinetic law defining elementary
reactions. Conclusion of this finding is that modelling the same molecular re-
action system in these two formalisms might require different parametrisation
of some reactions.
These differences are in fact an outcome of very detailed and explicit
notation of molecular complexes and molecular species compositions in the RB
modelling. This allows for exploration and observation during the model sim-
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ulation as showed by employment of snapshots taken during the simulation to
dissect molecular species composing the “all Ca” observable. This transparency
in the model simulation proves that the RB framework can facilitate process of
model understanding. Automated specification of observables that are sums
of selected time courses allows for less error-prone identification of molecular
entities among molecular species and more accurate reuse of the model.
5.1.3 Modification of models
Models in the RB notation are easily modifiable as demonstrated by
application of two types of model perturbations. Effects of the perturbation
type that is commonly used in the ODE models, were reproduced by the RB
model. For practical reasons, the second type of perturbation is only possible
in the RB modelling domain. This modification involved alteration of the
number of binding sites of DARPP-32 presented in two variants. In the first
one, interactors of DARPP-32 bound to one site. In the second one, interactors
bound to three parallel sites for each phosphorylation site. No change in
dynamics was observed between the two variants of the model. This result
requires further investigation. A potential modification that could change
model dynamics is to significantly decrease the copy numbers of DARPP-32
compared to other interactors. An important note is that inducing this type of
modification was a trivial task in the RB model. This opens a way to study
effects of perturbations on a protein subunit level, dynamics of multiple binding
sites with different properties, and interactions between them.
5.1.4 What kind of mechanisms to model in the RB frame-
work?
Rules enforce explicitness of assumption about the number of simul-
taneously bound interactors. Exploration of more complex dependencies be-
tween individual molecular sites can be easily accomplished with different
means, such as by varying their binding affinities, defining rules where bind-
ing of sites is exclusive or cooperative. Other investigations enabled by RB
modelling revolve around complex formation, influence of molecular states
on their function, and how local features of binding properties influence the
overall system dynamics. This investigation confirmed the RB framework as
suitable for dynamic modelling of signalling networks as it allows for flexible
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expression of such molecular-level phenomena as distinctive functional char-
acteristics of protein subunits, allosteric regulation, cooperative binding and
cross-talks between pathways, formed by promiscuously interacting kinases
and phosphatases.
In the light of these observations, two routes of investigation were un-
dertaken in this thesis. The first one addressed the question how to analyse
models that are characterised by multiplicity of molecular species generated
during the simulation and determine their shift in importance due to model per-
turbation. The second route involved exploration of molecule-centred repos-
itories in various biological categories that match expressibility of the Kappa
language, to facilitate and accelerate process of model construction with respect
to a defined biomedical inquiry.
5.2 Pipeline for analysis of RB models
The first question is addressed in Chapter 3 by proposition of a pipeline
for extended and automated analysis of RB models. The RB model of DARPP-32
network, presented in Chapter 2, is used to demonstrate results of the pipeline.
In the pipeline procedure, observables are partitioned and scored based on sets
of their time courses generated from the RB model with varied parameter sets.
Selected observables are passed to global sensitivity analysis (GSA) to score
impact of parameters on these observables. Scores obtained for observables
and parameters are represented as a weighted network graph. The compact
and unifying network representation is used to extract differences between two
model phenotypes.
5.2.1 Clustering and prioritisation of observables with CorEx
Partition and scoring of observable sets were performed with CorEx,
a method based on optimisation of total correlation of groups of observables
assigned to hidden variables that represent clusters. Preliminary examination
of CorEx was performed on repeated runs with different numbers of clusters.
This demonstrated stable composition of the largest cluster regarding allocated
observables. These observables are linked by the impact of the cyclic adenosine
monophosphate (cAMP) signal on their abundances. These observations were
made for the largest cluster of the 19-observable set. Other tested observable
set with CorEx was composed of 91 automatically collected molecular species
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from snapshot recordings. The largest and strongest cluster for this observable
set showed complete information on composition of most dependent species
driven by the cAMP signal. In both observable sets, composition of members
of the largest cluster allowed to represent the same set with aggregated and
generalised observable expressions. As the largest cluster was assigned with
exceedingly high value of total correlation compared to other subgroups, it
could be claimed that its members represent the most distinctive information
content of this modelled system.
5.2.2 Observable scores for multiple time courses
Within the presented pipeline procedure, CorEx was executed on a set
of time courses generated with randomised sets of parameters, as prepared to
perform GSA. To aggregate CorEx-derived measures from multiple time-series,
two observable scores were introduced. The first one was designed to score
observables per clustering type. The second, to score observables based on all
clustering measures derived from CorEx outputs. The latter scoring method
was used as no distinctive clustering types emerged. The same subgroup of
observables gained the top 7 scores that was earlier classified to the largest
cluster among the 19-observable set.
5.2.3 Global sensitivity analysis with HSIC-based indices
and network representations
These 7 observables were progressed to the next step of the pipeline
where timed parameter sensitivity indices are calculated with the Hilbert-
Schmidt Independence Criterion (HSIC)-based method. Integrals of area un-
der curves defined by sensitivity scores calculated per time points served as
unified sensitivity measures. Parameters and observables were combined into
a weighted network with weights defined by the integrals of sensitivity mea-
sures. This representation was chosen to facilitate analysis of parameter sensi-
tivities with respect to multiple observables. Moreover, this also enables easier
representation of relations within one model and between different model
conditions, e.g. induced by parameter modification. Potential of the latter
was demonstrated by subtracting edge weights of the base-line model from
the perturbed model to investigate the effect of the latter. Based on this op-
eration, two types of networks were defined, a network of parameters that
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gained importance and a network of parameters that lost it due to change in
model conditions. The two model phenotypes were the wild-type model of
DARPP-32 network and its variant with the constitutive mutation on Serine
137 (Ser137). Reordering of observable scores obtained with measures derived
from CorEx demonstrated promotion of observables of DARPP-32 phospho-
rylated at Ser137. This result was consistent with the main effect of the per-
turbation where Ser137 was permanently phosphorylated. In the next step,
HSIC-based sensitivity indices were calculated for the prioritised observables
of the perturbed model.
5.2.4 Pipeline results agree with encoded mechanisms
Outcomes of HSIC-based sensitivity indices that reported driving pa-
rameters per observable were consistent and justifiable by the mechanisms en-
coded in both models. Analysis of the networks of lost and gained importance
showed that a half of parameters preserved importance regardless the condi-
tion for observables representing molecular species of DARPP-32, different in
each model condition. The same analysis but regarding observables present
in networks of both conditions demonstrated gain of importance of parame-
ters involved in mechanism that were first observed with the heatmap-based
analysis of sensitivity scores.
5.2.5 Future perspectives
Presented in this study analysis of differences between model conditions
by subtracting edge weights between two networks is a rudimentary approach
that could be replaced by other more sophisticated methods from domain
of differential network analysis scalable to larger networks [294, 297]. The
choice of an appropriate method would depend on acquired strategy regarding
decision whether to preserve or drop edges and nodes denoting observables
and parameters. In this study, subsets of parameters and observables were
included in the networks based on their scores. If a method for evaluation of
statistical significance of parameter sensitivities and observable scores would
be developed, then methods that take into account node removal and edge
weights in measuring the difference could be considered in this application.
In another possible setup, all parameters and observables could be included
in the network and ranking of differentiated components between networks
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would be performed with respect to edge weights and observable node weights
defined by CorEx-derived observable scores. Calculation of sensitivity scores
per each observable might be computationally expensive and in some cases
even infeasible.
Although results of HSIC application were justifiable with mechanisms
encoded in the model, importance of identified parameters with respect to
certain observables should be subjected to further verification, in best case
scenario, with experimentally-obtained evidence.
This was a first demonstration of the pipeline results that constitute
a proof-of-concept and therefore, further studies with other model examples
and different choices of constituent metrics would be necessary to verify and
improve this approach.
5.3 Exploration of molecule-centred repositories
for an ADHD-related Kappa model
The second route of investigation, undertaken in this thesis and con-
tained in Chapter 4, explores molecule-centred repositories, compliant with
expressivity of the Kappa language, that would facilitate and accelerate process
of model construction. Contents and coverage of these datasets were studied
with respect to a example of Attention Deficit Hyperactivity Disorder (ADHD),
a complex neurodevelopmental disorder of relatively high prevalence and a
strong genetic contribution. A list of the disorder associated genes was com-
piled from three resources representing different quality and types of studies.
Among molecular-centred repositories, main focus was laid on protein-protein
interactions (PPIs) and interactions between their subunits, DDIs. Three
other resources were also employed, kinase-substrate interactions (KSIs), the
BioModels database, and the REACTOME Pathway Database (REACTOME).
5.3.1 Protein and domain interactions
An in-house PPIs assembled from three databases limited to direct
and experimentally obtained interactions, as reported by Molecular Interac-
tions (MI) terms assigned to each interaction entry. A weak overlap between
three leading PPI databases was observed. Moreover, spoke-expanded in-
teractions were not marked and tagged as direct despite commonly known
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uncertainty regarding directness of these interactions. A complete informa-
tion regarding these interaction details could help to refine the PPI datasets
with a desired level of stringency. Identifying domains in ADHD-associated
proteins and linking these proteins with domain-domain interactions revealed
that there is 36 times more hypothetical interactions than reported by PPIs. As
existence of DDIs embedded in two proteins might not necessarily point to
an actually existing interaction, obtained protein-domain interactions (PDIs)
would have to be refined with other resources to eliminate conflicting do-
main interactions. In the study by Kim et al. [167], a structural interaction
network (SIN) was defined for Yeast’s PPIs based on identified 3D structures
of protein complexes deposited in Protein Data Bank (PDB). The database
currently stores > 130000 macromolecular structures [405], of which around
half are protein complexes [406]. Information on protein binding interfaces de-
rived from this dataset is limited to proteins that 3D structure can be obtained
therefore excludes, for instance, intrinsically disordered proteins. Prediction
methods for protein binding interfaces are also based on co-crystal structures
of homologous complexes (the Inferred Biomolecular Interaction Server, IBIS
[407]) or domains [408, 409]. Construction of a high-quality and structurally
resolved PPIs is highly desirable for RB model definition and therefore, it is
an important direction in future research. Currently, as seen on an example of
the INstruct database, the coverage of structurally resolved PPIs is low (6585
Human interactions) [409].
A high rate of false positive records in PPI is a common issue observed on
the level of experiments [405]. A network of PPIs between ADHD-associated
proteins were augmented with domain-level interaction information. Less
than 40% of interactions between these proteins were potentially mediated by
domains. This observation suggests that other resources for reaction details
should be employed to gain greater coverage.
5.3.2 Kinase-substrate interactions
Coverage of other source of reactions was also examined with reactants
of phosphorylation reactions, KSIs. Phosphorylation reactions are abundantly
present in processes of cell signalling. 13.6% of all ADHD-associated genes are
phophorylated by kinases that are outside of the gene list. If both kinases and
substrates were among the ADHD-associated genes, only 5% of these genes
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were included in the ADHD KSI network. Other resources with phosphatases
could supply information on reactants of the reverse dephosphorylation reac-
tions of identified substrates. Though PhosphoSitePlus R© that KSIs were used
here, does not provide similar network of phosphatases and substrates, there
are other resources worth exploration and integration [388, 410].
5.3.3 Pathway gene sets
Other resources important in the dynamic modelling are pathway maps.
Supported with other datasets, these were used in the past to automatically gen-
erate kinetic models encoded in the Systems Biology Markup Language (SBML)
format [342, 343]. Identification of pathways where disease-related genes are
overrepresented is one of essential methods of finding disease underlying pro-
cesses. However, pathway databases are limited in gene-coverage and repre-
sented processes. A half of ADHD-associated genes were found in pathways
of the REACTOME database. Enrichment analysis demonstrated that at most
20 of them can be found in a single pathway (“G alpha (s) signalling events”).
A handful of these same genes is shared by other pathways of smaller sizes,
all being subpathways of neurotransmitter release cycle and sharing the same
5 genes. This demonstrated an immense discrepancy between all explored
resources, where proportion of interactions included in pathway maps is much
lower than reported by high-throuput PPI datasets. These in turn appear to be
much lower than the number of potential protein interactions inferred on the
protein subunit level, as shown by identification of DDI among proteins.
5.3.4 Future perspectives
In the continuation of this study, identified associations between the
ADHD gene set could be assembled with a rich intermediate data format to
identify most information enriched subnetworks of ADHD candidate genes.
Based on these modules and possibly with a pathway or connected pathways
as a starting point, construction of a RB model could be attempted. However,
building dynamical models requires more detailed datasets on an exact reac-
tion network, stoichiometry of reactants and products, their copy numbers, and
rate constants. Though direct measurements of rate constants for enzymatic
reactions are performed on a high-throughput level [411, 412], rate constants
for binding reactions (e.g. ligand-receptor, complex formation) are still tech-
nically challenging to obtain on a large scale (e.g. Surface plasma resonance,
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saturation, association and dissociation binding experiments) [413, 414].
Similarly important to rate constants are time-courses recording changes
of molecular species, in particular these that originate from perturbation ex-
periments [415]. They not only allow to estimate unknown parameter values
but also verify the model dynamics [416]. For instance, levels of DARPP-32
phosphorylated at Th34 and Thr75 in the Fernandez et al. [177] model, though
not explicitly mentioned, were most likely estimated to match results of assays
involving immunoprecipitation and immunoblotting, performed for multiple
time points on neostriatial slices incubated in either dopamine (DA) [417] or
glutamate (Glu) [418]. The slices were treated with various activators (forscolin)
and inhibitors (e.g. roscovitin, okadaic acid, cyclosporine A) of DARPP-32 ki-
nases and phosphatases. These not only reported changes of phosphorylated
DARPP-32 but also showed what impact phosphatases and kinases have on
each other and on two phosphorylation sits of DARPP-32. This allowed to
infer the reaction network that underlies the model.
Immunoblotting is a common standard to measure levels of proteins
in cell for multiple time points but it is a very low throughput [419]. A
promising technology, similarly based on antibodies, are microwestern arrays
that can quantify protein abundances for multiple time points and conditions
with reduced experimental complexity and much higher throughput [420, 421].
Though mass spectrometry (MS) methods are known to be limited with respect
to the number of samples [421], targeted MS based on selected reaction moni-
toring appears to circumvent this issue and quantifies proteins below 50 copies
per cell [422]. Nevertheless, the cost, availability and labour intensiveness of
such methods will not be easily circumvented to generate high-quality and
high resolution time courses for large number of molecular interactions. An
ideal scenario for automated model generation would be to directly and auto-
matically build models from experimental assays and background knowledge.
Such frameworks have yet to be created in the realm of dynamic and mecha-
nistic modelling but exists for boolean modelling that require far less detailed
information to construct a model. PHOsphorylation Networks for Mass Spec-
trometry (PHONEMeS) [423] is an example of such framework among wider
research interest [424–426]. It was particularly designed to construct and train
boolean logic models based on revised kinase or phosphatase-substrate inter-
actions and phospho-MS perturbation data.
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Boolean modelling is an example of a formal method that can be ap-
plied to high-throughput proteomic datasets. However, RB modelling is an-
other such example, though much more requiring one. Even with lack of the
detailed and high quality dynamic perturbation data, Stites et al. [173] con-
structed RB models to study recruitment of signalling proteins to epidermal
growth factor receptor (EGFR) using high-throughput MS-based proteomics
datasets. These datasets contained identification and quantification of protein
abundances [427, 428], and equilibrium dissociation constants (KD) derived
from large-scale fluorescence polarization (FP) study of interactions between
SH2 domains and ErbB receptor phosphosites [429]. The authors build 11 dif-
ferent HeLa cell-specific RB models by combining specific to these cell-lines
data. Only site-specific interactions were included between 6 EGFR Tyrosine
residues and 19 proteins containing either or both Src homology 2 (SH2) and
phosphotyrosine-binding (PTB) domains. Early EGFR signalling is a well stud-
ied system and each of these models is not larger in size than the Fernandez
et al. [177] model. It might be difficult to find similarly detailed information on
the level of kinetic interactions for other less studied processes and cell-lines.
Nevertheless, Stites et al. [173] demonstrated that though incomplete, pro-
teomics datasets can be quickly translated and studied with a dynamic model
that account for mass action kinetics and competition between sites [173]. With
future increase of studies kinetically characterising interactions [429, 430] in
other possibly neuronal-cell lines, the same models could be created to study
disease-related mechanisms in neurobiology.
5.4 Conclusions
In the first step of this thesis, RB and ODE-based models were com-
pared demonstrating expressiveness and opportunities lying in the former
framework. A downstream pipeline was proposed to determine important
observables and parameters dependent on modelled condition, that relay on
two highly efficient methods for observable clustering (CorEx) and evaluation
of parameter sensitivities (HSIC). Existing bioinformatics resources, suitable
for development of RB models, are described and evaluated on an example
of investigation of ADHD-involved mechanisms. This exploration suggested
multiple obstacles relating to quality and coverage in using high-throughput
datasets in detailed dynamic modelling and necessity to reach for other, more
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detailed and kinetic resources to bridge the gap between mechanistic and high-
throughput systems biology. Moreover, a persisting factor that limits any form
of automation is lack of consensus and continuous integration of multiple re-
sources. Solution to this can be delivered through long-term, community-based
efforts towards standardisation and integration of heterogeneous datasets. Fi-
nally, I discuss future perspectives and improvements regarding proposed
resources and methods, followed by example of an immediate use of RB mod-
elling with proteomics datasets.
Appendix A
Automated translation of ODE
model with Atomizer
BioNetGen (BNG) is a family member of rule-based formalisms that most
closely resemble Kappa. The BNG framework is supported by an SBML-to-
BNGL translation with Atomizer [176]. It is an automated translator from
the Systems Biology Markup Language (SBML) model format to BioNetGen
Language (BNGL). Atomizer defines molecular binding structures, implicit in
reaction-based models, by relaying on molecular species naming conventions
and reaction stoichiometry. This method potentially could offer an easy way to
obtain a rule-based (RB) model from the original ordinary differential equation
(ODE) model. The performance of Atomizer was tested on the Fernandez et al.
[177] model to compare results of this automated translation to the manual
translation presented in Chapter 2.
The automated translation was successful, though simulation of the
obtained model resulted with errors, regardless application of all available op-
tions for the model simulation . The standard error output reported multiple
cases of conflicting definitions and inconsistencies in naming. Notation-wise,
complexity and redundancy of the resulted model encoding seemed not to
be designed to be editable by human and thus, it was difficult to evaluate
correctness without simulating the model. The generated model was exam-
ined with respect to definitions of agents and rules. The rule examination
showed fully contextualised reaction instances (Code A.3). All combinations
of dopamine- and cAMP-regulated neuronal phosphoprotein with molecu-
lar weight 32 kDa (DARPP-32) states where represented as separate species
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(Code A.1, l.2 and l.3).
These results supported the necessity of the manual translation of the
ODE model into the Kappa language.




Code A.2: Example of agent manually formulated in Kappa
1 %agent: CK1(pSite˜u˜p)
2 %agent: D(s, thr34˜u˜p, ser137˜u˜p, thr75˜u˜p)
Code A.3: Example of rules in BNGL for a two-step phosphorylation generated with
Atomizer









@Spine -> D75(ck1,pka,pp2)@Spine + CDK5(d,d137,d34,d34_137)
@Spine r3_kcat1
Code A.4: Example of rules for a two-step phosphorylation manually encoded in Kappa
1 D(s, thr75˜u),CDK5(a) <-> D(s!1, thr75˜u),CDK5(a!1)
2 @’kon1’,’koff1’
3 D(s!1, thr75˜u),CDK5(a!1) -> D(s, thr75˜p),CDK5(a) @’kcat1’
Appendix B
Supplementary material
Table B.1: ADHD-associated proteins can be found in published models de-
posited in the BioModels database. Proteins represented with UniProtKB acces-
sion (UniProtKB AC) are listed with model names that they were found in. There are
13 proteins that association to ADHD was confirmed by at least one significant study.
These are marked with asterisk.
UniProtKB Acc Model name
P37840 Sneppen2009 - Modeling proteasome dynamics in Parkinson’s disease
Ouzounoglou2014 - Modeling of α-synuclein effects on neuronal homeostasis
Sass2009 - Approach to anα-synuclein-based BST model of Parkinson’s disease
Morris2009 - α-Synuclein aggregation variable temperature and pH
Cloutier2012 - Feedback motif for Parkinson’s disease
Kuznetsov2016(II) - α-syn aggregation kinetics in Parkinson’s Disease
Proctor2010 - UCHL1 Protein Aggregation
P18510* Palmer2014 - Effect of IL-1β-Blocking therapies in T2DM - Disease Condition




Q13163* Pathak2013 - MAPK activation in response to various biotic stresses
Pathak2013 - MAPK activation in response to various abiotic stresses
P46734 Pathak2013 - MAPK activation in response to various abiotic stresses
Mol2013 - Immune Signal Transduction in Leishmaniasis
P18754 Görlich2003 RanGTP gradient
Continued on next page
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UniProtKB Acc Model name
P06858 McAuley2012 - Whole-body Cholesterol Metabolism
P14778 Proctor2013 - Cartilage breakdown, interventions to reduce collagen release
P32121* Coggins2014 - CXCL12 dependent recruitment of beta arrestin
O43318 Mol2013 - Immune Signal Transduction in Leishmaniasis
Q9Y2T1 Goldbeter2008 Somite Segmentation Clock Notch Wnt FGF
O60260* Sass2009 - Approach to anα-synuclein-based BST model of Parkinson’s disease
Proctor2010 - UCHL1 Protein Aggregation
P04150 Kolodkin2013 - Nuclear receptor-mediated cortisol signalling network
P01133 Chen2009 - ErbB Signaling
Schoeberl2002 - EGF MAPK
Borisov2009 EGF Insulin Crosstalk
Sivakumar2011 - EGF Receptor Signaling Pathway
Jenkinson2011 EGF MAPK
Mol2013 - Immune Signal Transduction in Leishmaniasis




Bidkhori2012 - normal EGFR signalling
Bidkhori2012 - EGFR signalling in NSCLC
O15055* Weimann2004 CircadianOscillator
Leloup2003 CircClock DD REV-ERBalpha
Leloup2003 CircClock LD
Leloup2003 CircClock LD REV-ERBalpha
Leloup2003 CircClock DD
Vasalou2010 Pacemaker Neuron SCN
P28562 Chen2009 - ErbB Signaling
Nakakuki2010 CellFateDecision Core
Proctor2011 ProteinHomeostasis NormalCondition
Proctor2013 - Cartilage breakdown, interventions to reduce collagen release
Birtwistle2007 ErbB Signalling
Bidkhori2012 - normal EGFR signalling
Bidkhori2012 - EGFR signalling in NSCLC
P08913* Thomsen1988 AdenylateCyclase Inhibition
Continued on next page
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UniProtKB Acc Model name
Thomsen1989 AdenylateCyclase
P45983 DallePezze2014 - Cellular senescene-induced mitochondrial dysfunction
Koo2013 - Integrated shear stress induced NO production model
Mol2013 - Immune Signal Transduction in Leishmaniasis
Proctor2011 ProteinHomeostasis NormalCondition
Koo2013 - Shear stress induced eNOS expression - Model 3
Proctor2013 - Cartilage breakdown, interventions to reduce collagen release
O15516* Hong2009 CircadianClock
Locke2008 Circadian Clock
P25445 Kallenberger2014 - CD95L induced apoptosis initiated by caspase-8, CD95
HeLa cells (cis/trans-cis/trans variant)
Neumann2010 CD95Stimulation NFkB Apoptosis
Kallenberger2014 - CD95L induced apoptosis initiated by caspase-8, CD95
HeLa cells (cis/trans variant)
Kallenberger2014 - CD95L induced apoptosis initiated by caspase-8, wild-type
HeLa cells (cis/trans variant)
Kallenberger2014 - CD95L induced apoptosis initiated by caspase-8, wild-type
HeLa cells (cis/trans-cis/trans variant)
P61812 Schmierer 2008 Smad Tgfb
P49593 Li2012 Calcium mediated synaptic plasticity
P20711* Sass2009 - Approach to anα-synuclein-based BST model of Parkinson’s disease
Q9NZN5 Ung2008 EGFR Endocytosis
P49841* Proctor2010 - a link between GSK3 and p53 in Alzheimer’s Disease
Proctor2013 - Effect of Aβ immunisation in Alzheimer’s disease (deterministic
version)
Proctor2013 - Effect of Aβ immunisation in Alzheimer’s disease (stochastic
version)
Sivakumar2011 WntSignalingPathway
Kim2007 - Crosstalk between Wnt and ERK pathways
Goldbeter2008 Somite Segmentation Clock Notch Wnt FGF
Sivakumar2011 NeuralStemCellDifferentiation Crosstalk
O14974 Maeda2006 MyosinPhosphorylation
P19367 Sengupta2015 - Knowledge base model of human energy pool network (HEP-
Net)
Continued on next page
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UniProtKB Acc Model name
P07332 Sengupta2015 - Knowledge base model of human energy pool network (HEP-
Net)
P07101* Sass2009 - Approach to anα-synuclein-based BST model of Parkinson’s disease
P53597 Sengupta2015 - Knowledge base model of human energy pool network (HEP-
Net)
P21397* Sass2009 - Approach to anα-synuclein-based BST model of Parkinson’s disease
O15534 Leloup2003 CircClock DD REV-ERBalpha
Leloup2003 CircClock LD
Leloup2003 CircClock LD REV-ERBalpha
Leloup2003 CircClock DD
Vasalou2010 Pacemaker Neuron SCN
P06733 Sengupta2015 - Knowledge base model of human energy pool network (HEP-
Net)
P01100 Nakakuki2010 CellFateDecision Core
Mol2013 - Immune Signal Transduction in Leishmaniasis
Swat2004 Mammalian G1 S Transition
Proctor2013 - Cartilage breakdown, interventions to reduce collagen release
P18089* Thomsen1988 AdenylateCyclase Inhibition
Thomsen1989 AdenylateCyclase




Q9Y6D9 Ibrahim2008 MCC assembly model KDM
Ibrahim2008 Cdc20 Sequestring Template Model
Ibrahim2008 - Mitotic Spindle Assembly Checkpoint - Convey variant
Ibrahim2008 - Mitotic Spindle Assembly Checkpoint - Dissociation variant
Q9UD71 Li2012 Calcium mediated synaptic plasticity
Fernandez2006 ModelA
Fernandez2006 ModelB
Q05940 Sass2009 - Approach to anα-synuclein-based BST model of Parkinson’s disease
P18825* Thomsen1988 AdenylateCyclase Inhibition
Thomsen1989 AdenylateCyclase
Appendix C




I chose a biological context of this study based on RB models of Suder-
man and Deeds [123]. I simulated the models and prepared time courses for
further analysis, wrote a great part of this report with an exception of CorEx
description and fragments of choice rationales that was written by S. Garg and
fragments of “Introduction” and “Chaos Time Series Analysis” by V. Dzut-
sev. S.Garg proposed CorEx as a method for dimensionality reduction and
run it with provided time courses. V. Dzutsev performed nonlinear time series
analysis. L. Condon proof-read the report.
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1 Introduction and project motivations
Extensive development of technologies and methods related to data acquisition,
sharing and storage have made analysis and knowledge discovery unprecedentedly
challenging. For instance, big data has become increasingly common in social
sciences and requires new techniques of analysis, including non linear time series
approaches. One of such recent examples of a challenging dataset is the data on
rebel violence in the volatile Russian North Caucasus region [26]. The dataset has
recordings of incidents of rebel violence on weekly basis for every town and village
of the region. Overall, this resulted in over 1 million observations with nearly 200
variables, approximately 200 million data points.
An important task for many if not all the scientific domains is efficient
knowledge integration, testing and codification. It is often solved with model
construction in a controllable computational environment. In spite of that, the
throughput of in-silico simulation-based observations become similarly intractable
for thorough analysis. This is especially the case in molecular biology, which
served as a subject for this study.
In this project, we aimed to test some approaches developed to deal with the
curse of dimensionality. Among these we found dimension reduction techniques
especially appealing. They can be used to identify irrelevant variability and help to
understand critical processes underlying high-dimensional datasets. Additionally,
we subjected our data-sets to nonlinear time series analysis, as those are well
established methods for results comparison.
To investigate the usefulness of dimension reduction methods, we decided
to base our study on a concrete sample set. The example was taken from the
domain of systems biology concerning dynamic evolution of subcellular signalling.
Particularly, the dataset relates to the yeast pheromone pathway and is studied
in-silico with a stochastic model. The model reconstructs signal propagation
stimulated by a mating pheromone.
In the following sections we will elaborate on the reason of multidimensional
analysis problem in the context of molecular signalling. Next, we will introduce
the model of choice, simulation details and obtained time series dynamics. A
description of used methods followed by a discussion of results and their biological
interpretation will finalise this report. This study is a preliminary analysis of the
dataset, future work will expand on the results presented here.
2 Working with example
2.1 Problem view: combinatorial explosion of cell
signalling systems
As with all signal processing systems, cell signalling is characterised by
signal related functionalities, such as input fidelity, output specificity, signal
amplification, the sensitivity and diversity of response or the flexibility of
3
reaction [1]. These highly sophisticated functions produce complex systems
embodied by the combinatorial explosion of molecular interactions and states [12,
2].
On the lower level, cell signalling depends on formation and interactions
of multi-subunit complexes, mainly formed by interacting proteins. They are
composed from often numerous and autonomously folding blocks called domains,
acting as protein functional interfaces. Importantly, protein activity is determined
by multiple post-translational modification sites (phosphorylation, acetylation,
ubiquitination), transitionally changing their states. For example, lets consider
an ubiquitously present Epidermal Growth Factor Receptor (EGFR), which has
9 sites resulting in 512 possible states (29 = 512 , on- and off-state). Furthermore,
each site has at least one binding partner rising the value of single receptor protein
states to 19,683 possibilities (39 = 19, 683). The large number of possible
states, even within this relatively simple system is one of the key challenges for
mechanistic modelling of signalling networks. Traditional equation-based models
are capable of representing only extensively studied and limited size signalling
circuits. Any larger integrative models become intractable, impossible to reuse or
even proofread [19]. These problems have been addressed by rule-based modelling
methods embodied by flexible languages such as Kappa [3] and BioNetGen [6],
facilitating the creation of large and complex dynamical models. In contrast to the
other modelling techniques, in rule-based models the system emerges with time,
often showing unpredictable behaviour arising from elementary reaction rules.
However, their construction and analysis often limit their potential application.
For instance, even though provided with visualization tools for static and causal
analysis, a modeller has to resort to a self-assembled battery of tests trying to unfold
the complexity of results [24].
2.2 Yeast pheromone response pathway model
In the domain of molecular biology the yeast pheromone cell cycle is an
extensively studied example, both in-vivo and as a computational model. It’s often
used to test hypotheses and investigate details related to mechanisms of signalling
processes, such as dynamical pathway adaptation to demanding environmental
conditions [20], evolutionary preserved functional units (G-protein coupled
receptor signalling [4], mitogene-activated protein kinase [17]), signal-noise
decoupling [4] and information transmission [29].
Saccharomyces cerevisiae yeast, is a model species, capable of sexually
reproducing in pairs of opposite sexes (type a and α). The mating signal is
communicated by either of the cell type through pheromone release (a-factor) [20].
The model used in this study relates to a subcellular signalling activated in the other
cell in response to the stimulus [24].
The pathway represents canonical mechanisms of the subcelluar signal
propagation, such as G-protein activation via a GPCR, which is stimulated by
pheromone ligands. The scaffold protein (Ste5) is recruited to the cell surface.
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Figure 1: A: Usual scheme of hierarchically structured molecular machines B:
Potential combinations of complexes appearing over the simulation. The red-arrow
path represents the possible way of construction of decamer complex. Source: [24]
Its major role is to insulate the kinase phosphorylation cascade from activating
other related pathways. Ste5 dimerizes and aggregates five more proteins that
phosphorylates each other forming an activation cascade. The last one is doubly
activated mitogene-activated protein kinase (MAPK, Fus3) that travels to the
nucleus and releases the transcription factor (TF) from its inhibitors. In this way
TF transcribes genes regulating yeast mating behaviour.
The study is examining the established hypothesis that signals in cells are
propagated via well defined complexes of molecular machines rather than loosely
assembled and polymorphic ensembles.
As it was shown, even though a conserved structure of decameric complex
was hardly present in the ensemble model over repeated simulations, the signal
was uninterrupted leading to St4 synthesis. Furthermore, contrary to the machine
model, the ensemble model was able to replicate the experimental observation of
combinatorial inhibition of phosphorylated Fuss3 (Fus3pp), when a copy-number
of St5 was increased 60 fold. Models were built with the rule-based formalism
that allows us to sample the sets of possible protein complexes the model can
produce, without explicitly imposing the set of species that are formed [24]. More
details about the formalism are in the next section. The code with the models’
implementation is in the public domain and can be found as one of the attached
files to this paper.
2.3 Rule-based modelling
The subject of signalling pathways and networks has already been addressed
by many modelling formalisms. However, one significant advantage of the
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rule-based (RB) modelling is that it is able to express an infinite number of
reactions with a small and finite number of rules, i.e. a single reaction rule and its
parameters generalize a class of multiple interactions. In all of the other modelling
methods every chemical species has to be specified in advance which is highly
problematic for species with dozens of phosphorylation sites and many possible
states. This limiting factor makes these methods inappropriate for modelling
large-scale complex dynamical systems.
RB modelling is a method for the formal representation of combinatorially
complex signalling systems in both a qualitative and quantitative way. The major
idea is to replace equations with interaction rules. A rule representation is a
graph-rewriting, where a graph specified on the left-hand-side is a pattern to be
matched to instances in the current “mixture” of graphs and transformed into
graphs specified on the right-hand-side. Matching should satisfy embedding,
i.e. injections on agents (graphs) with the preservation of names, sites, internal
states and edges [3]. In the rule-based language nomenclature, “agents” are most
elementary molecules and “species” are agent complexes having particular states.
A model can be translated into a system of ODE equations or simulated with a
stochastic algorithm. In the latter case, system trajectories are created by rule
selection at each time step, which is applied probabilistically, based on reaction
rates and the initial/current copy number of agents [12]. Immediate consequences
of this formulation are different levels of rule contextualisation (“don’t care don’t
write”), without obligation of ad hoc assumptions about the system, modularity,
reusability and extensibility of the modelling process [19]. Furthermore, the ability
to capture a protein as a graph with (binding) sites (e.g. domains) that have internal
state(s) (e.g. phosphorylated) gives a sufficiently expressive system to capture all
of the principal mechanisms of signalling processes (e.g. dissociation, synthesis,
degradation, binding, complex formation [18]) as well as insight into site-specific
details of molecular interactions such as affinities, dynamics of post-translational
modifications, domain availability, competitive binding, causality and the intrinsic
structure of interactions.
RB modelling originates from concurrency system representations and as
such has the ability to capture dependencies, causality and conflicts in biological
interactions (overlooked by concentration-based ODEs). In other words,
precedences occurring along trajectories (stories) reveal competing events leading
to a final state [3]. In the Kappa language, this feature is supported by the
syntax for graphical analysis provided in the simulation tool. Among these are
diagrams with causal flows, flux and influence maps as well as contact maps
[Figure 2] that facilitate the process of modelling. The causal flow diagram
shows dependencies and conflicts in tracking indicated species and the flux maps
[Figure 13], negative/positive activity transfers between rules with the quantitative
contributions on edge weights, both generated on the fly during a simulation [7].
At any time of a simulation, a snapshot can be taken to record the collection of
species existing at that time.
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Figure 2: Contact map defined without running the simulation with KaSa software
accompanying KaSim4.0 simulation tool. Yellow circles denote agents sites, green
circles agent states, and edges all potential connections between species.
Figure 3: Flux map for pheromone pathway model in steady state simulated with
KaSim4.0
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2.4 Datasets and simulations
Our time series datasets report changes of indicated molecular species’
copy-number over 13,800 time points. Stochastic simulations were run for 4,600
sec with 3 time points recorded per second. The system was first simulated over
1,000 sec to reach a steady state and the initial mixture of protein complexes.
Afterwords, a pheromone stimulus was introduced and the system was simulated
for another 3,600 sec.
Variables in the rule-based syntax are called “observables” ( %obs:) and are
specified in a separate code block. A single observable can be mapped to one
or more rules conditioned on the level of its particularity. Hence, all the types
of created species not indicated as observables, become intractable. For instance,
the observable %obs: Fus3PPFus3(T180~p,Y182~p), which is a double















However, as it is with the model specification, as it is infeasible to observe all
potentially important variations of species, we have to resort to what we know we
want to observe.
Therefore, the considered dataset consists of standard 31 variables, patterned
after the original paper. There is also an extended 977 variable set but it has yet to
be explored with parallel computations. This number was dictated by the snapshot
of all existing species at the pick of the simulation (~1,000 sec after the stimulus
appearance) used then as a list of observables in the simulation.
2.4.1 Perturbed model
To compare the outcome of applied methods, the model was simulated in two
states, which are called here “perturbed” and “unperturbed”. By the unperturbed
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model we call the standard “wild type” pathway dynamics. The perturbed one
relates to an experimentally observed phenomenon of combinatorial inhibition.
It occurs when the copy-number of protein scaffold is largely increased and
impossible to fully assemble the complex that doubly activates Fus3 because all
available members of the complex are used up on too many scaffold proteins.
2.4.2 Simulator
Models written in Kappa language are supported by KaSim simulator. By
default, reaction rates are computed applying the law of mass action [2] but can
easily be adjusted to follow any kinetic law (e.g. Michaelis-Menten, Hill’s Law).
What can be found under the hood is a direct particle-based variant of Gillespie’s
method. A general version of Gillespie’s method, also called exact stochastic
simulation algorithm (SSA) or kinetic Monte Carlo is a common simulation
method for modelling time-evolution of stochastic chemical reaction systems.
Numerical stochastic simulations are known to be computationally intensive and
a lot of efforts have been made to improve their efficiency [10]. The most popular
and effective solution, implemented in KaSim, is called “network-free” because
rules transforming reactant into products are applied directly at runtime to advance
the state of a system. As a result, it does not have to generate the full reaction
network beforehand and is therefore independent of its size [13].
3 Applied methods and results
3.1 Correlation Explanation
3.1.1 Choice rationales
Since a rule representation may vary in generalization, it can be applied to
more then one reaction that satisfies it. In other words rules serve as the reaction
and species generator. It results in the unpredictability of species types and their
importance emerging over time. Especially, if the model is of a large magnitude.
On the other hand, the intrinsic modularity of Kappa syntax opens the path
to large integrative models, gradually assembled from the collections of reusable
rule-based syntactic modules.
However, models are currently built in a fully controllable and stringent
fashion. It leaves the notion of modularity and its experimental aspect risky and
unexplored. Thinking ahead, the rule notation can be understood as an updatable,
machine readable and executable knowledge representation and storage, replacing
the usually manual revision of papers required in the model construction [15]. We
could allow for uncontrollable, collective model growth in a form of rule stacks
and then verify inner links and hierarchies in the system. That could guide an
automatic trimming of the model size. Hence, the question is whether and how we
could restrict a model to only these rules which are most informative.
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Figure 4: Model dynamics in unperturbed and perturbed states for characteristic
protein species. The perturbed ensemble model showed a decrease in Fus3
activation (Fus3PP) being a key observation of the combinatorial inhibition. As we
can see, the synthesis of St4, which happens in the nucleus, was inhibited under
perturbed state (plot with a flat line).
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Likewise the question lies what exactly does it mean to say a species is
“important” or “informative” and what do groups of biologically important species
share with each other? Are they strongly interlinked modules of the system?
Could they guide the rule-based modularity idea? The last question is especially
important, since the scope of elementary parts of RB model is not yet clear. Are
these three, four, five reaction rules? Is there any other measure of mechanisms
granularity?
Facing these kind of questions, we opted to test one of recently realised
methods Correlation Explanations (CorEx) that applies information theoretic
objective to learn a hierarchy of more abstract representations of the data.
Having the hierarchy of latent variables, we can pose more precise questions,
such as:
• What subset of species has common underlying dynamics?
• How strong is the correlation between species grouped under the same latent
variable?
• How many underlying hidden causes can be identified out of the observed
high-dimensional species dynamics?
and finally:
• What could be the meaning of these “hidden causes” for molecular
signalling?
The algorithm was previously applied in a biological context for identification
of targets for a cancer therapy [23]. Furthermore, a similar method mentioned
in CorEx paper, called the information bottleneck, was previously applied for
trimming of gene ontology (GO) [14] to compress the data into a smaller
representation. In contrast, in CorEx the redundant information is preserved
ignoring uncorrelated random variables [27].
3.1.2 Method description
In this section, we discuss an information theoretic approach for building a
model on dynamics of the species concentrations. This method, proposed recently
for a general domain [27, 28], learns a hierarchy of latent variables that maximally
inform correlation between the observed species dynamics. Herein, correlation
refers to mutual information between a set of variables, and not just a linear
correlation.
Before we delve into the details of the method for our specific settings, it should
be noted that we disregard the time series nature of species copy-number dynamics
in this method application.
Let G be a set of random variables representing copy-numbers for all the
species. Then, XG is a joint random variable on G. For a species i, all the
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copy-number values of the time series are assumed to be independent samples of
a random variable Xi. As such, we can see that there is a contradiction since
consecutive samples in the time series would have a correlation (not i.i.d.). For
obtaining uncorrelated samples, one can take sub-samples of the time series, either
at uniform interval or using any other relevant technique.
Following the notations in [27], total correlation TC(.) between a set of





TC(XG) = I(X1; · · · ;Xg) (2)
HereH(Xi) is entropy on a random variableXi; andH(XG) is a joint entropy
on XG. Another interpretation of TC(XG) is that it is mutual information, I(.),
between all the variables in the set G. Typically mutual information is expressed
between a pair where each element of the pair can be a set of random variables.
Here, we are instead expressing mutual information between a g dimensional triplet
of random variables, where g is a number of random variables in the set G.
In our problem of learning a model of species dynamics, evaluating mutual
information (or total correlation) between all random variables would not be of
much value. We are instead interested in evaluating mutual information between
some subsets of species. However there are two problems along these lines:
i) we do not know for which subsets of species we should evaluate mutual
information and there can be a large number of permutations to explore (depending
on the size of a subset and the G set); ii) non-parametric estimation of mutual
information between random variables is a hard problem [16, 25, 22, 9]. To tackle
these, we formulate our algorithm such that; i) we assume the individual species
copy-number variables Xi to be Gaussian; however, we do not assume that the
set of variables has to be Gaussian (the later is a stronger assumption); ii) we
are interested in only those subsets where variables have low mutual information
conditioning on a latent variable (or high mutual information between variables
explained by a latent variable).
Along these lines, let us define a new information theoretic quantity
TC(XG;YF ).
TC(XG;YF ) = TC(XG)− TC(XG|YF ) (3)
TC(XG;YF ) is a total correlation (or mutual information) in the set of random
variables XG explained by a set of latent variables YF . TC(XG|YF ) is a total
correlation between the random variables XG that can not be explained by YF ,
i.e. conditional total correlation (conditional mutual information). If the latent
variables YF can explain the total correlation inXG perfectly, then TC(XG|YF ) =
0. Ideally, we would like to learn YF if exists. Thus intuitively, optimal Y would
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correspond to minimum of TC(XG|YF ). In our formulation, we can express
optimization of YF as optimizing conditional distributions PY |X .




TC(XG;Y ) s.t. |Y | = k (4)
Here Y is a discrete random variable; xG is a sample of the random variable XG
and y is sample of Y . We optimize Y by learning the conditional distribution
p(y|xG). Now, we further extend it for multiple latent variables, where each latent
variable explains total correlation in a subset of the species concentration variables.
arg max




We have introduced m latent variables here with Yj explaining correlation
between random variables in the corresponding subsetGj ⊂ G. Here these subsets
can have an overlap.
Optimizing the above objective function seems hard. However, as explained
in detail in [27, 28], it can be solved very efficiently for practical purposes. We
omit these optimization details and refer readers to the original papers introducing
this algorithm for the first time [27, 28]. Computational complexity of the method
is linear with respect to the number of samples and number of variables in the set
G. Furthermore, as an unsupervised method, it requires no assumption about the
learned model. The code implementation for this algorithm is publicly available
from the original authors 1.
3.1.3 Results
The CorEx algorithm was applied both to perturbed and unperturbed datasets
and yielded two results with a single layer of hidden variables. In both cases,
presented results were the maximal values the data sets could be divided to. Further
increase of the number of hidden units did not change their values.
For both sets [Figures 6 & 5] CorEx found 6 latent variables, where 8-9 out of
31 biologically plausible variables were expected.Biologically plausible variables
were thought to be all these observables that contained Ste5 scaffold protein,
known to be a nucleation point of the system [24]. However, the preliminary
intuitions did not align perfectly with the algorithm results.
In the unperturbed data tree we can distinguish two important groups, ‘0’ and
‘1’. They are recognisable in the perturbed data tree as they preserved half of their
members from the former set. However, contrary to the unperturbed data tree,
1https://github.com/gregversteeg/CorEx
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where the members of both groups have similarly balanced strong relations, the
perturbed set shows far uncertain correlations, mostly concentrated in the group
‘0’.
3.1.4 Interpretation and analysis
The interpretation of the results was conducted on two levels. The first one is
based on the biological knowledge about the process. The second one is supported
by the dynamic analytical tools provided by the KaSim simulator.
Generally speaking, the CorEx algorithm successively subsets data into a
defined number of latent variables guided by species dynamics. Results appears
to be consistent with the differences between perturbed [Figures 9 & 10] and
unperturbed models [Figures 7 & 8]. The group ordering, referring to the strength
of inter-correlations, shows which event takes the lead in two cases. Earliest events
upstream to the formation of signalling cascade appeared to be the leading ones
in the perturbed simulation. This is consistent with the fact that phosphorylation
of Fus3 kinase distinctively drops when the amount of Ste5 protein scaffolds
competing for binding kinases increases [Figure 4 in Section 2.4.2]. As the Fus3
phosphorylation was not entirely blocked, the second latent variable relates to
events leading to Fus3 phosphorylation. Thus it is more consistent with the group
‘0’ apart from transcription in the nucleus, which was inhibited in the perturbed
data.
Owing to the static causal analysis provided by the simulation software,
we can ask whether important observables relate to frequently executed rules.
The most powerful visualization output is a flux map, which tracks the overall
influence of rule applications on each other [7]. It is a directed and weighted
graph with rules as vertices and edges annotated with positive or negative weights
[Figure 13]. Dependent on simulation parameters (selected time or number of
events), a flux map might vary in structure (for details of our simulation parameters
see section 2.4).
Both untrimmed graphs for unperturbed and perturbed models had 233 vertices
but they differ from each other in the edge number (unperturbed- 2,753, perturbed-
2,422). Weights range from 0 to 407,172,203. An important note is that vertices
are rules. Hence, to compare them with the output of CorEx, thus subsets of
observables, first observables had to be mapped to rules they referred to [Figure 11
& 12]. The weight cutoff varies with inverse proportion to the number of
observables in flux map subgraphs. Therefore, we compared different subgraphs
by gradually removing less and less vertices given a set of thresholds for weight
values. The aggregated results are presented in the Figure 13. As we can
observe, the frequency of rule application relates to subsets obtained with the
CorEx algorithm but cannot explain them fully.
We stated some questions in the Section 3.1.1, which we would like to
comment on or even answer to in the following part. We have learned that the

















































































































































































































































































Figure 7: On the left, a fragment of unperturbed data-tree with Group ‘0’. On
the right, the process diagram for a comparison. A biological interpretation of the
strongest group ‘0’ refers to the most important steps indicating critical events in
the successful signal propagation. As the authors argued, the assembly of decamer
involving Ste5 dimerization does not belong to the most crucial events guaranteeing
the signal transfer.
over the entire course of time series, with results depended from the outcome of
signalling process. Hence, it did not inform us about intrinsic modularity of the
system, what would relate to more “horizontal” division of time courses (when
looking at the process diagram). Perhaps the considered system is far too small
thus interlinked to observe invariable modules among species (encapsulations).
Hence, the result might be then more correctly named as a form of “compression”.
Furthermore, given the limited number of experiments and the model size and
its character, we are not yet ready to precisely answer the question of biological
meaning related to the importance and informativeness indicated by the algorithm.
3.2 Chaos Time Series Analysis
To compare results with the outcome of CorEx algorithm and discover other
aspects hidden in our data, we applied methods of nonlinear time series analysis
[11]. Similarly, we used both the perturbed and unperturbed datasets (for more
details about used datasets see Section 2.4). To bypass an obvious division into
a pre- and post-pheromonal stimulation, we cut the beginning 1,000 sec and used
17
Figure 8: On the left, a fragment of unperturbed data-tree with Group ‘1’. On
the right, the process diagram for a comparison. The second highly scored group
indicates less vital events, related to dimerization, and the impact of Kss1 kinase
on the Ste4 activation.
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Figure 9: On the left, a fragment of perturbed data-tree with Group ‘0’. On
the right, the process diagram for a comparison. The strongest group indicates
the earliest events located upstream to the Fus3 poshorylation (observable called
Fus3PP), preceding the complexation step
19
Figure 10: On the left, a fragment of perturbed data-tree with Group ‘1’.
On the right, the process diagram for a comparison. The second strongest
group of perturbed data tree reflects weak correlation between members and the


















































































































































































Figure 13: Three top-scored groups of latent variables (G0, G1, G2) found with
CorEx, both for perturbed (red) and unperturbed (blue) simulations and five flux
map subgraphs with weights above (starting from left on x-axis) 10 000 000, 1 000
000, 100 000, 10 000, 1 000 units (two last sets in the perturbed set overlap). The
comparison of changes in the number of intersecting observables with decrease of
stringency in rule importance shows that perturbed system gives seemingly higher
overlap between compared groups than the non-perturbed dataset.
only the part after the stimulation. Furthermore, to cap the computation time, we
cut the data from original 10,801 (three events per second) observations to 3,600
(one event per second).
First we examined our data by creating recurrence plots for dynamical systems
[5]. The recurrence plot is an array of dots in a NxN square, where a dot is
placed at (i, j) whenever x(j) is sufficiently close to x(i). For the purposes of
this study we selected an embedding dimension of 10 and time delay 5 to keep the
computational time within reasonable limits.
In general, the recurrent plot shows the times at which a phase space trajectory
visits roughly the same area in the phase space [21]. The authors [5] defined
small and large scale patters, textures and topologies respectively, to ease their
interpretation.
The resulting figures [16 & 15] are densely grey without distinctive textures
or patterns. However, the unperturbed set is seemingly brighter away from the
diagonal and distinctively darker along it. This gradient is interpreted as the
occurrence of a progressive decorrelation at large time intervals involving a linear
trend or drift. The perturbed model presents dynamics pushed a bit more towards
randomness.
Next, we created plots, showing the average mutual information index (AMI)







































































































Figure 15: Unperturbed model Figure 16: Perturbed model
Figure 17: Unperturbed data Figure 18: Perturbed model
The larger time lag the smaller is the value of AMI. In case of Figure 19
AMI drops down almost diagonally, as opposed to the Figure 20. Thus, the
perturbed model is far more unpredictable, showing randomized dynamics and less








Next, we created a sample correlation integral plot [11]. The correlation
integral can be approximated by the correlation sum. The correlation sum counts








Θ(ε− ‖−→x (i)−−→x (j)‖),−→x (i) ∈ Rm (7)
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Figure 19: Unperturbed data Figure 20: Perturbed data
As the perturbation involved a single parameter and demonstrated naturally
occurring phenomenon (not randomised), differences between these two plots were
not expected to be extreme. Nonetheless, the results are coherent both with the
understanding of process and the CorEx algorithm. However, for our purposes,
these methods present a more distanced view on the system dynamics, missing a
decoupling problem of individual species relations.
4 Conclusions
Overall, this project offered a fruitful chance for an exploration of multivariate
time series analysis. We have learned that the approach offered by the CorEx
method might be very promising in analysis of rule-based models. However, it
requires further testing with models that incorporate multiple randomly modified
parameters and represent larger advanced processes. Further, we applied some
nonlinear time series methods to our dataset. Though powerful, they offered a
bird’s-eye view understanding of system dynamics missing species-related details.
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Abstract
The desire to explain how synaptic plasticity arises from interactions between ions,
proteins and other signalling molecules has propelled the development of biophysical
models of molecular pathways in hippocampal, striatal and cerebellar synapses. The
experimental data underpinning such models is typically obtained from low-throughput,
hypothesis-driven experiments. We used high-throughput proteomic data and
bioinformatics datasets to assess the coverage of biophysical models.
To determine which molecules have been modelled, we surveyed biophysical models
of synaptic plasticity, identifying which proteins are involved in each model. We were
able to map 4.2% of previously reported synaptic proteins to entities in biophysical
models. Linking the modelled protein list to Gene Ontology terms shows that modelled
proteins are focused on functions such as calmodulin binding, cellular responses to
glucagon stimulus, G-alpha signalling and DARPP-32 events.
We cross-linked the set of modelled proteins with sets of genes associated with
common neurological diseases. We find some examples of disease-associated molecules
that are well represented in models, such as voltage-dependent calcium channel family
(CACNA1C ), dopamine D1 receptor, and glutamate ionotropic NMDA type 2A and 2B
receptors. Many other disease-associated genes have not been included in models of
synaptic plasticity, for example catechol-O-methyltransferase (COMT ) and MAOA. By
incorporating pathway enrichment results, we identify LAMTOR, a gene uniquely
associated with Schizophrenia, which is closely linked to the MAPK pathway found in
some models.
Our analysis provides a map of how molecular pathways underpinning neurological
diseases relate to synaptic biophysical models that can in turn be used to explore how
these molecular events might bridge scales into cellular processes and beyond. The map
illustrates disease areas where biophysical models have good coverage as well as domain
gaps that require significant further research.
Author summary
The 100 billion neurons in the human brain are connected by a billion trillion structures
called synapses. Each synapse contains hundreds of different proteins. Some proteins
sense the activity of the neurons connecting the synapse. Depending on what they sense,
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the proteins in the synapse are rearranged and new proteins are synthesised. This
changes how strongly the synapse influences its target neuron, and underlies learning
and memory. Scientists build computational models to reason about the complex
interactions between proteins. Here we list the proteins that have been included in
computational models to date. For good reasons, models do not always specify proteins
precisely, so to make the list we had to translate the names used for proteins in models
to gene names, which are used to identify proteins. Our translation could be used to
label computational models in the future. We found that the list of modelled proteins
contains only 4.2% of proteins associated with synapses, suggesting more proteins
should be added to models. We used lists of genes associated with neurological diseases
to suggest proteins to include in future models.
Introduction 1
Activity-dependent synaptic plasticity is necessary for learning and memory [1]. Since 2
the discovery of long term potentiation (LTP) and long term depression (LTD) [2, 3], it 3
has been shown that synaptic plasticity can depend strongly on patterns of pre-and 4
post-synaptic firing [4] and neuromodulators [5]. Forms of plasticity vary between types 5
of synapses and brain region [4], which could be explained by the local proteome, 6
i.e. the expressed proteins and their abundances; PSD-95 knock-outs demonstrate the 7
influence of the proteome on synaptic plasticity [6]. Synaptic plasticity underlies 8
behaviour, as evidenced by the effect of antagonising NMDA receptors [1], and synaptic 9
proteins underlie disease [7]. 10
Synapses have been modelled computationally at various levels of detail. Models at a 11
phenomenological level, such as spike-timing dependent plasticity (STDP) models, link 12
firing patterns in the pre- and postsynaptic neurons to changes in synaptic strength 13
with little or no reference to the underlying molecules [8]. Biophysical models refer to at 14
least some known molecular actors in synaptic plasticity. In 2009 there were at least 117 15
biophysical postsynaptic signal transduction models [9] and the number is 16
growing [10, 11]. 17
Recent advances in tissue and cell extraction techniques and sample processing allow 18
localised proteomes to be determined, e.g. the synapse including the smaller presynaptic 19
or postsynaptic proteomes [12, 13]. The most recent analysis of 37 published synaptic 20
proteomic datasets contains 1,867 presynaptic genes, 5,053 postsynaptic genes and 5,862 21
synaptic genes (with human EntrezID identifiers) respectively. These numbers are large 22
compared to results from individual studies. Nevertheless, data inclusion was highly 23
restrictive and the augmented numbers can be partly explained by higher experimental 24
sensitivity and the broad use of high-throughput techniques (a manuscript containing 25
detailed analysis of the synaptic proteome is in preparation). 26
These synaptic protein lists make it possible to compare systematically proteins 27
contained in computational models of synapses with those proteins likely to be in the 28
synapse. In this paper we: (1) survey a selection of biophysical models of synaptic 29
plasticity, identifying which proteins are involved in each model, and describing the 30
complexity and detail of description of signalling pathways within the models; 31
(2) compare the proteins in models with synaptic protein lists, thus showing what 32
fraction of synaptic proteins have been considered in models; (3) identify the functional 33
classes of proteins in models; and (4) compare the proteins in models with those involved 34
in neurological diseases. This work should help inform what proteins and pathways 35
should be considered in new modelling efforts. While new datasets offer possibilities for 36
models of greater scope and detail, it is important to understand the foundations that 37
have been laid by existing computational models of synaptic plasticity, which we do 38
thematically before moving to the identification of proteins in models and the discussion 39
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of implications of our findings for future synaptic models and model annotation. 40
Biophysical models of synaptic plasticity 41
To set the scene for our analysis of proteins in biophysical models of synapses, we first 42
give an overview of how the questions addressed in models of synaptic plasticity have 43
shaped the development of simulation methods, and describe the main hippocampal, 44
striatal and cerebellar pathways that have been modelled. We categorise simulation 45
methods as non-spatial, spatial or multiscale and as deterministic or stochastic. Table 1 46
shows examples of simulation packages and associated studies that fall into each 47
category. Rather than using simulators, some studies use bespoke code in languages 48
such as Java, or generic mathematical environments such as MatLab. 49
Table 1. Overview of simulation environments.
Deterministic Stochastic


















Multiscale E-Cell 3 ode [33]16
NEURON + E-Cell 3 ode [34]
Simulation environments listed according to whether they support deterministic or
stochastic simulations, and non-spatial, spatial or multiscale simulations (ordered
alphabetically by simulator). URLs for the simulation environments are indicated by












Many of the simulation methods and issues associated with models of signalling 51
pathways are found in models of calcium/calmodulin dependent kinase II (CaMKII) 52
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and the intricate dynamics of its phosphorylation states and interactions with 53
calcium-bound calmodulin (CaM). 54
Mean field models of CaMKII In 1985 Lisman [35] advanced the hypothesis, 55
expressed as a mathematical model, that memories could be stored in bistable molecular 56
switches comprised of auto-phosphorylating kinases. Following the discoveries that 57
CaMKII is an autophosphorylating holoenzyme [36] and is a major component of the 58
postsynaptic density (PSD) [37], Lisman and Goldring [38] proposed that CaMKII 59
could form the basis for the auto-phosphorylating switch. Their ordinary differential 60
equations (ODEs) described how the probability of a CaMKII holoenzyme being “on” – 61
the “mean field” – could depend on the calcium concentration and the number of 62
phosphorylation sites required to switch the CaMKII holoenzyme on. Solving these 63
equations demonstrated that the number of CaMKII holoenzymes activated could 64
depend on the duration of the calcium stimulus, thus allowing CaMKII to act as graded 65
rather than binary switch. Furthermore, the time taken for the switch to turn on could 66
be modulated by changing the threshold number of sites that needed to be 67
phosphorylated before the holoenzyme entered an auto-phosphorylated state. 68
Analysis of mean field models Mean-field ODE models allow stability analysis to 69
be undertaken, which can show, for example, that a model of CaMKII has two stable 70
states – almost fully phosphorylated or almost fully dephosphorylated – within a wide 71
range of calcium concentrations [39]. Stability analysis has also been used to inform how 72
parameters should be set to give a biphasic calcium-synaptic strength curve, with LTD 73
at moderate concentrations of calcium and LTP at high concentrations [22]. 74
Stochastic models of CaMKII In a volume containing N reacting molecules of a 75
species, there will be fluctuations of the order of 1/
√
N in the concentration of the 76
species predicted by the mean-field solution. For large volumes it follows that stochastic 77
effects can be neglected, but in the ∼1 fl volume of the spine head the number of 78
CaMKII holoenzymes is considerably finite – an average of 30 are seen in electron 79
microscopy (EM) images of immunuogold labelled PSDs [40] – so there will be 80
significant variability between experiments in the same conditions. In order to 81
determine the accuracy of the encoded information for a given number of holoenzymes, 82
Lisman and Goldring [38] used the binomial formula to compute the mean and standard 83
deviation of the number of fully phosphorylated CaMKII holoenzymes, which suggested 84
that graded information could be stored to an accuracy of around 10%. 85
Rather than deriving variability from mean field simulations, stochastic 86
(“Monte-Carlo”) models can be built. Each run of a stochastic model is generated by 87
drawing random numbers to decide when bonds are made or broken, and when changes 88
in state occur; the variability of the model is obtained by analysing multiple runs. A 89
simple method to simulate chemical reactions accurately is Gillespie’s stochastic 90
simulation algorithm (SSA) [41], as used in some simulations [42]. 91
Combinatorial complexity in models of CaMKII One challenge in modelling 92
CaMKII is that each CaMKII holoenzyme comprises multiple subunits; initial estimates 93
were of 8–14 subunits, but EM and X-ray crystallography show that there are 12 94
subunits [43–45] arranged in two hexamer rings. Since a phosphorylated subunit can act 95
as a kinase to its neighbour, the multiple subunits give rise to a combinatorially large 96
number of meaningful configurations (states) of the holoenzyme. For example, a model 97
with 6 subunits, each of which can be in one of 12 states, can be in 498,004 98
configurations according to the necklace function [46] and would therefore need the 99
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same number of ODEs to simulate. To simulate the dodecamer ring would require 100
∼ 1012 states, an impractical number of states to model with ODEs. 101
This combinatorial problem can be alleviated by model simplification, for example 102
by (i) reducing the number of subunits to 4 and (ii) lumping together states that are 103
invariant to rotations and adjusting the reaction rates between states according to their 104
multiplicities [47]. These strategies are used in other deterministic and stochastic 105
models of CaMKII [22, 48,49]. A further simplification can be made by lumping 106
together states with the same number of phosphorylated subunits, and weighting the 107
transition rates between these states [39]. 108
Agent-based simulation Combinatorial complexity can also be dealt with using 109
agent-based simulation, in which the states of individual molecules rather than 110
populations of molecules are followed through the simulation [50]. For example, in 111
simulations of a 10-subunit CaMKII holoenzyme [51], there was one variable per 112
subunit, each of which described which of 5 states the subunit was in. The state of each 113
holoenzyme was therefore described by 10 state variables, giving 976,887 states of the 114
holoenzyme. Transition probabilities between a subunit’s states depended on its own 115
state and that of its neighbouring subunit. Transitions were generated in 100 ms time 116
steps in each subunit in turn, based on the state of the holoenzyme in the previous time 117
step – similar to the τ -leap algorithm later formalised by Gillespie [52]. As this method 118
is based on a fixed time step it can be combined with deterministic simulation of some 119
elements of the system, as in a model of CaMKII activation in a dendritic spine [53]. 120
Rule-based simulation Agent-based simulation alone does not solve the problem of 121
how to represent the states and the transitions between states clearly and concisely [50]. 122
To specify transitions in agent-based simulations “rules” are specified in which the state 123
of a fragment of system is mapped to the transitions that can occur within that 124
fragment. For example a CaMKII monomer may be phosphorylated when both it and 125
its neighbour (the fragment) are bound to Ca2+-CaM complex [24]. The StochSim 126
agent-based simulator [54] describes rules by using flags to represent phosphorylation 127
and binding states to be attached to molecules. However, the StochSim description of 128
binding of CaM to CaMKII, phosphorylation states of CaM and trapping of CaM by 129
CaMKII [24] is, arguably, unwieldy, requiring 1,209 lines of code. 130
Second generation rule-based modelling languages such as Kappa [55] or BioNetGen 131
(BNGL, [56]) have a well-defined, general syntax to specify binding sites and states of 132
proteins and interactions between protein binding domains. The interaction rules can be 133
expanded to generate the “biological network”, i.e. the full set of complexes and 134
reactions needed to simulate the system [56]. These reactions can be converted into 135
ODEs or stochastic differential equations (SDEs), or simulated using a stochastic 136
simulation method [41,52]. In another approach – dubbed “Network Free” [56], since no 137
biological network is generated – simulators, such as KaSim [55] or NFSim [57], create 138
the complexes that exist throughout a simulation dynamically. Network-free methods 139
avoid the prohibitive memory requirements needed to store all possible states in a large 140
network [57], and even allow simulations with infinite numbers of potential species [55]. 141
This form of “on-the-fly” simulation is intrinsically stochastic, with transitions 142
occurring one rule at time, similar to Gillespie’s SSA [41]. For smaller networks, ODEs, 143
SDEs or the SSA are faster, but because the simulation speed of these methods scales 144
roughly with network size (i.e. the number of reactions), for larger networks these 145
conventional methods are slower than network-free simulation [57]. 146
Varying model structures Authors devise differing descriptions of the same 147
pathway. For example Byrne et al. [58], Stefan et al. [59] and Faas et al. [14] all describe 148
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the binding of calcium to CaM, but each model has a distinct structure. The models of 149
Byrne et al. and Faas et al. assume cooperativity within the N and C lobes of CaM: the 150
rate at which a calcium ion binds to a lobe with one calcium bound is different from the 151
rate at which calcium binds to the lobe in the apo, unliganded, state. In contrast, Stefan 152
et al. assume that the affinity of each of the four positions on CaM is independent, but 153
that these affinities depend on whether the entire CaM molecule in the “tense” or 154
“relaxed” conformation [60], which is an allosteric mechanism [61]. The two positions 155
within each lobe are assumed to be equivalent by Faas et al., but not by Byrne et al. 156
The model of Faas et al. has been fit against kinetic data, which is richer than the 157
binding curves fit by Byrne et al. and Stefan et al., but it has not been investigated 158
whether the parameters of these earlier models could be adjusted to fit the kinetic data. 159
There is also diversity in the number of states monomers in models of CaMKII may 160
assume, and how the multimeric structure of the molecule is represented. An additional 161
variation in particle-based simulations of CaMKII is that once the CaM N or C lobe is 162
bound to a CaMKII monomer, it becomes much more likely that the other lobe on the 163
same CaM molecule will bind to a neighbouring CaMKII monomer on the hexamer 164
ring [58]. This necessary to fit Ca-chelator-induced dissociation curves [62] and 165
steady-state CaM-CaMKII binding curves [43]. A result of this assumption is that the 166
rate of CaM binding to CaMKII is dominated by the more affine N-lobe. 167
Biophysical constraints on parameters A number of strategies are used to 168
reduce the considerable number of reaction coefficients in molecular models. For 169
example, the reactions in Byrne et al. [58] are parameterised by 2 sets of 24 parameters, 170
but the forward reaction coefficients are all set to be equal, reducing the number to 2 171
sets of 13. The principle of microscopic reversibility [61] is used to link reaction 172
coefficients that are in loops, taking the number down to 2 sets of 9. Microscopic 173
reversibility applies generally, though some ion channels are exceptions to this rule [61]. 174
Other linkages between parameters can be postulated; for example in the allosteric 175
model of Stefan et al. [59], the ratio between the affinities of each site for calcium in the 176
tense and relaxed conformations is assumed to be the same for each of the four sites. 177
Data used to constrain parameters Various types of data have been used to 178
constrain the parameters of single pathway models. To obtain equilibrium binding 179
curves, equilibrium dialysis with radioactively labelled ligands can be used, as by 180
Crouch and Klee in their determination of Ca2+-CaM binding. More recently, 181
stopped-flow fluometry [43] has been used for the same purpose. This method has the 182
disadvantage of a relatively long dead time of the order of 2 ms, which hinders 183
determining fast dynamics, e.g. of the N lobe of CaM. A faster method is calcium 184
uncaging, which can lead to a sub-0.1 ms change in calcium concentration, and 185
measurement with a fast fluorescent calcium indicator [14]. 186
Spectroscopic analysis can be used to infer conformational changes, e.g. the tense to 187
relaxed conformation change upon binding of a calcium ion to CaM [60]. 188
Phosphorylation states, e.g. of CaMKII, can be measured using radioactively labelled 189
ATP [43] which can be coupled with immunoprecipitation and gel electrophoresis [63]. 190
Optimisation of free parameters Even after reducing the number of parameters 191
there are typically a number of free parameters in a model, and a number of 192
optimisation techniques are used to fit them to data, for example particle swarm 193
optimisation [58]. Latin hypercube sampling can be used to determine global parameter 194
sensitivity [20]. 195
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Hypothesis-driven and simplified modelling In one combined 196
experimental-modelling study [63], the authors engineered a monomeric form of 197
CaMKII. This allowed them to measure the CaM-dependent phosphorylation properties 198
of CaMKII and produce a simplified computational model, which predicted that the 199
amount of CaMKII activation would depend on the frequency of a presented train of Ca 200
pulses: CaMKII could thus act as a frequency decoder. A number of CaMKII models at 201
various levels of detail have been formulated to explain the dependence of CaMKII 202
activation on the frequency of calcium pulses [47, 48, 64]. 203
Data-driven rule-based modelling Proteomic studies of the synapse (Table S2) 204
show that there are many proteins in the synapse not included in the models described 205
thus far. The challenges of combinatorial complexity, already encountered in models of 206
CaMKII, are magnified as more proteins are added. Rule-based modelling has been 207
applied to simulate a network containing 54 proteins, with interactions were described 208
by 136 rules [23]. This model makes predictions about the molecular composition of 209
complexes that could occur in the PSD. 210
Spatial models 211
The modelling methods described so far assume that molecules are within a well-stirred, 212
spatially homogeneous environment. However, the cellular environment is not 213
homogeneous; for example, calcium enters through N-methyl-O-aspartic acid 214
receptors (NMDARs) on one side of the spine head. It can react with buffers on a 215
shorter timescale than it takes to diffuse through the spine, and can exist within 216
microdomains around the NMDARs briefly at high concentrations. Thus, to address 217
some questions, it is necessary to model space explicitly. 218
Deterministic reaction-diffusion Deterministic diffusion is modelled by splitting 219
cellular space into compartments and formulating ODEs to describe how reactions 220
within compartments and fluxes between compartments affect the concentrations of 221
species within each compartment. Deterministic diffusion along one dimension has been 222
used in models of calcium and other intracellular signalling in spines [65–67]. Whilst 223
these models do not model LTP and LTD explicitly, they give insights such as that the 224
combination of calcium pumps and buffers can confine calcium and activated CaMKII 225
to the synaptic spine head [67], or that the temporal ordering of input at weak and 226
strong synapses with NMDARs determines the concentration of calcium in the spine, 227
which will then influence the intracellular pathways underlying LTP and LTD [66]. The 228
NEURON simulator, used widely in models of electrical activity of neurons, also 229
supports reaction-diffusion, with recent work to extend these capabilities [68]. 230
Deterministic reaction-diffusion can be simulated in 3D by splitting cellular space into 231
tetrahedral or cubic compartments, as implemented in the STEPS simulator [69]. 232
Compartmental stochastic reaction-diffusion The numbers of molecules in each 233
compartment of a mesh is often small enough to warrant stochastic simulation methods. 234
Gillespie’s SSA can be extended to a compartmentalised volume by replicating the set 235
reactants in each compartment, and treating diffusion of reactants between each 236
compartment as a type of reaction [41]. This “Spatial SSA” method and more efficient 237
approximations [70] have been used for a number of simulations of medium spiny 238
projection neurons in the striatum [28–31] and is implemented in the simulators 239
NeuroRD [28] and STEPS [69]. 240
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Compartmental agent-based stochastic reaction-diffusion The Spatial SSA 241
requires one variable in each compartment to describe the number of molecules in every 242
possible state in the system, and therefore is ill-adapted to deal with models of 243
molecules with many states, such as CaMKII. A custom extension to the Spatial SSA 244
has been used to study the relative effects of the stochastic opening and closing of 245
NMDARs and of stochastic binding between CaMKII holoenzymes and CaM in a spine 246
head [27]. The results showed that NMDARs were a greater source of noise, due to their 247
smaller numbers than the CaMKII holoenzymes. The agent-based, rule-based simulator 248
SpatialKappa [71] extends the Kappa language syntax and the KaSim algorithm to 249
allow diffusion of complexes between voxels in regular meshes. 250
Particle-based stochastic reaction-diffusion In particle-based simulation 251
methods, each molecule has a location in 3D space or on a 2D membrane and moves in 252
Brownian leaps. Reactions may occur when particles come within an interaction radius 253
of each other. Simulators implementing this method include MCell [72] and 254
Smoldyn [73]. MCell has been used to model diffusion of glutamate molecules in the 255
synaptic cleft and their binding to NMDARs and 256
α-amino-3-hydroxy-5-methyl-4-isoxalone propionic acid receptors (AMPARs) [27, 74], 257
and influx of calcium into the spine head and its interaction with calcium binding 258
proteins [75, 76]. The most recent version of Smoldyn supports the rule-based BNGL 259
language, but only to generate reaction networks, not to perform network-free 260
simulation. 261
Modelling diffusion measurements Khan et al. [32] used a spatial model built 262
with Smoldyn to interpret their fluorescence recovery after photo-bleach (FRAP) 263
measurements of CaMKII diffusing in a spine head before and after glutamatergic 264
stimulation. Eleven bidirectional reactions described binding of phosphorylated CaMKII 265
to the PSD, binding of non-phosphorylated CaMKII to the actin cytoskeleton, and 266
CaMKII self-aggregation. All these reactions contribute to keeping stable CaMKII 267
concentrations in stimulated spines, providing an explanation of sequestration of 268
CaMKII in dendritic spines. 269
Multiscale modelling It is possible to simulate reaction-diffusion and the membrane 270
potential using the same spatial mesh, but these simulations are likely to run very slowly 271
because of the unnecessarily fine mesh in parts of the model, such as the dendrites, 272
where concentration gradients are lower. Multiscale modelling, defined as the process of 273
using multiple models at different scales simultaneously to describe a system [77], can 274
allow for the desired level of detail with tractable simulation times. To demonstrate a 275
multiscale algorithm to integrate detailed models of signalling networks within electrical 276
models of neuron, Mattioni and Le Novère [34] used a model of a striatal medium spiny 277
projection neuron (MSPN) with 1,000 synaptic spines attached. The electrical activity 278
and calcium accumulation in the dendrites and soma of the neuron were simulated using 279
the NEURON implementation of the compartmental modelling method. Within each 280
spine, the calcium flux through AMPARs, NMDARs and voltage gated calcium 281
channels (VGCCs) calculated by the electrical model is fed to instances of a molecular 282
simulator (in this case E-CELL3), in which the calcium binds to CaM, which then 283
participates in a biochemical network typical of striatal MSPNs. A similar effort has 284
incorporated the rule-based SpatialKappa simulator into NEURON [78]. 285
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mGluR/MAPK circuit CaMKII phosphorylation/dephosphorylation circuit
Fig 1. Partial block diagrams comparing essential elements of the
hippocampal biochemical circuit. Each small box represents an ion, monomer or
multimer. Red arrows indicate activating interactions. Blue lines ending in circles
represent inhibiting interactions. Within each box, the molecules can be one of
potentially many binding or phosphorylation states. The circuit is split into two
sub-circuits: the CaMKII phosphorylation/dephosphorylation circuit and the
mGluR/MAPK circuit.
Models of hippocampal synaptic signalling pathways 286
In tandem with the extensive experimental study of LTP and LTD in the hippocampus, 287
computational models of hippocampal synaptic plasticity have been developed. 288
The CaMKII phosphorylation-dephosphorylation circuit Lisman [79] 289
proposed a model to account for how LTP and LTD could be mediated by postsynaptic 290
calcium acting as a second messenger (Fig 1). A high concentration of calcium, caused 291
by coincident pre- and postsynaptic activity, leads, via binding to CaM, to 292
phosphorylation and then auto-phosphorylation of CaMKII. At moderate 293
concentrations calcium binds to calcineurin (PP3), which is also known as PP2B; we 294
use PP3 for consistency with gene identifiers. The calcineurin-calcium complex 295
dephosphorylates protein phosphatase inhibitor 1 (I1), thereby deactivating it. The 296
inactive I1 then unbinds from protein phosphatase 1 (PP1), allowing it to 297
dephosphorylate phosphorylated CaMKII. At high Ca2+ levels this pathway is 298
inhibited via Ca2+-CaM activated adenylate cyclase (AC), which then catalyses 299
production of cyclic adenosine monophosphate (cAMP) from adenosine 300
triphosphate (ATP). The cAMP then binds to the regulatory subunits of 301
cAMP-dependent protein kinase (PKA), releasing its catalytic subunits which then 302
phosphorylate I1, thereby allowing it to sequester PP1. The Ca2+-CaM complex also 303
activates phosphodiesterase (PDE), which hydrolises cAMP into adenosine 304
monophosphate (AMP), thus reducing the rate of activation of PKA. 305
Lisman formulated this biochemical circuit as a simplified steady-state mathematical 306
model of the net phosphorylation rate of CaMKII, and showed that a set of parameters 307
existed that would allow unphosphorylated (“off”) CaMKII molecules to be 308
phosphorylated (activated) by high Ca2+ levels, and phosphorylated (“on”) CaMKII 309
molecules to be dephosphorylated (inactivated) by low Ca2+ levels. Lisman 310
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hypothesised that, ultimately, CaMKII activation increases the non-NMDA component 311
of the synaptic response. The biochemical circuit of Lisman is included in a number of 312
dynamical biochemical models of postsynaptic signal transduction [80–84]. In some 313
cases PKA is assumed to be tonically active rather than released from inhibition by 314
cAMP, [83,85] and other features may be included such as sequestering of CaM by 315
neurogranin and SAP97 [83]. 316
AMPA receptor phosphorylation Models have been formulated in response to 317
the developing understanding of AMPARs [86]. AMPARs comprise four subunits, each 318
of which is one of GluR1–4. The phosphorylation at two sites on GluR1 affects the 319
function of the AMPAR multimer. In synapses in a “naive” state, i.e. those which have 320
not been exposed to any plasticity protocols, phosphorylation of Serine 831 (Ser831), by 321
CaMKII or protein kinase C (PKC), is associated with LTP [87,88] and 322
dephosphorylation of Serine 845 (Ser845) is associated with LTD [89]. In synapses that 323
have already experienced LTD, “dedepression” caused by a theta-burst stimulus is 324
associated with Ser845 phosphorylation, and in a synapse that has potentiated, the 325
Ser831 site is dephosphorylated during “depotentiation” [88]. 326
These findings led to the four state model of AMPARs by Castellani et al. [90], in 327
which potentiation is caused by phosphorylation of the Ser831 and Ser845 sites, and 328
LTD caused by dephosphorylation of the sites. The activation of the phosphatases and 329
kinases was set up in the model so that the phosphates were more activated than the 330
kinases at low concentrations, and vice-versa for high concentrations. Steady-state 331
analysis of the set of 4 bidirectional reactions gave a typical biphasic Ca2+-synaptic 332
strength curve in which there is LTD at moderate concentrations of calcium and LTP at 333
high concentrations. Furthermore, control of Ca2+ levels via adaptation of NMDARs 334
allowed modification of the threshold level of Ca2+ at which LTP rather than LTD 335
occurred, as in the Bienenstock-Cooper-Munro (BCM) rule [91]. 336
AMPAR trafficking Blocking AMPAR exocytosis causes run-down of synaptic 337
strengths, and inhibiting endocytosis of AMPARs causes an increase in AMPAR 338
responses [92]. This discovery lead to the idea of a stable distribution of receptors at the 339
synapse being replaced by a highly dynamic picture, with continuous exocytosis and 340
endocytosis of AMPARs [93]. The trafficking to synapses comprises three steps [94]: 341
(1) AMPARs bound to Transmembrane AMPA receptor regulatory protein (TARP) 342
proteins such as stargazin are inserted into the dendritic shaft or spine by 343
phosphorylation events caused by PKA, PKC, extracelluar regulated kinase (ERK) 344
(part of the mitogen-activated protein kinase (MAPK) family) or Phosphoinositide 345
3-kinase (PI3K), or myosin-V; (2) the AMPARs diffuse through the membrane to the 346
synapse; and (3) phosphorylation events (triggered by active CaMKII targeting 347
stargazin) increase the affinity of the AMPAR-stargazin complex for PDZ-containing 348
scaffolding proteins such as PSD95, PSD93, SAP97 and SAP102. AMPAR trafficking 349
away from synapses is thought to be an inverse process, whereby AMPARs are released 350
from PDZ proteins and diffuse from the synapse back to the dendrite, where they are 351
endocytosed. There is a link between trafficking and the phosphorylation states of 352
AMPARs, with phosphorylation of Ser845 on the GluR1 subunit needed to incorporate 353
GluR1 subunits into synapses [95], although it is not clear how strong this link is [96]. 354
Integrated modelling of CaMKII phosphorylation circuit and AMPAR 355
trafficking Urakubo et al. [84] explored whether a model that integrated AMPAR 356
trafficking with the CaMKII-phosphorylation-dephosphorylation biochemical circuit 357
first formulated by Lisman and implemented by Bhalla and Iyengar [80] could account 358
for spike-timing dependent plasticity (STDP). They embedded the circuit in a spine 359
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containing NMDARs, AMPARs and VGCCs in a simplified soma-and-dendrite 360
compartmental model with conductances used in models of CA1 hippocampal 361
cells [97, 98]. In their first model LTP resulted from pre-before-post spiking, but LTD 362
did not result from post-before-pre spiking. To cause LTD in this situation, it was 363
sufficient that the NMDARs were blocked by binding of Ca2+-bound CaM. This 364
biochemical detection circuit was linked to AMPAR phosphorylation and 365
dephosphorylation by the activities of the kinases CaMKII and PKA and the 366
phosphatases PP1, PP3 and protein phosphatase 2 (PP2) (commonly known as PP2A). 367
AMPAR trafficking was modelled by having four pools of AMPARs: (1) cytosolic; (2) in 368
the dendritic or spine shaft membrane; (3) at the synapse but not anchored by PDZ 369
proteins; and (4) at the synapse, anchored by PDZ proteins. The phosphorylated LTP 370
and LTD states were used to control the rates of endo- and exocytosis, and binding to 371
the PDZ proteins. 372
The MAPK circuit and metabotropic glutamate receptor (mGluR) 373
signalling To the CaMKII phosphorylation-dephosphorylation circuit the modular 374
model of Bhalla and Iyengar [80] adds the MAPK cascade, activated by mGluRs 375
(Fig 1). Input to mGluRs activates G-proteins, which then go on to activate 376
phospholipase C-β (PLC-β), leading to production of diacylglycerol (DAG) and 377
inositol (IP3) and phosphorylation of PKC. This activates the cascade of Ras, Raf, 378
mitogen-activated protein kinase kinase (MAP2K) and MAPK. In turn, MAPK 379
activates phospholipase A2 (PLA2), which cleaves arachidonic acid (AA) from 380
phospholipids. The AA binds to PKC, activating it, which in turn leads to more Ras 381
activity, completing the loop. The G-proteins also activate the 382
Ras–Raf–MAP2K–MAPK pathway via up-regulation of guanine exchange factor (GEF). 383
The parameters in the system were such that the persistent up-regulation of PKC was 384
enough to catalyse AC production in the CaMKII circuit, and thus up-regulate PKA 385
and down-regulate PP1, leading to prolonged CaMKII activation. There was also 386
inhibitory crosstalk from the CaMKII to the MAPK via inhibition of Raf by PKA. 387
Late LTP, synaptic tagging and gene expression The models described so far 388
all deal with the induction of early-LTP, which occurs up to 4 hours after induction and 389
does not depend on protein synthesis [99]. In contrast, late-LTP depends on protein and 390
mRNA synthesis. In order to solve the conundrum of how AMPAR proteins, which 391
were assumed not to be synthesised close to synapses, get to the synapses, Frey and 392
Morris [99] proposed that a “synaptic tag” is set when activity has potentiated the 393
synapse. Smolen et al. [100] formalised this concept into an ODE model containing four 394
pathways: (1) the MAPK cascade; (2) PKA activated by cAMP; (3) CaMKII; and 395
(4) Ca2+-activated calcium/calmodulin-dependent protein kinase kinase (CaMKK), 396
which activates calcium/calmodulin-dependent protein kinase (CaMKIV). The CaMKII, 397
MAPK, and PKA pathways are all required to set a synaptic tag. CaMKIV, assumed 398
to be in the nucleus, and MAPK are assumed to activate unknown transcription factors. 399
The input to the model was the assumed time courses of Ca2+, Raf and cAMP. The 400
CaMKII phosphorylation circuit was not modelled. 401
To induce late-LTP, translation and synaptic tags need to be active simultaneously. 402
Smolen et al. [16] devised a distinct model at a similar, relatively low, level of detail 403
containing notional synaptic LTP tags activated by Ca2+-CaM-CaMKII, LTD tags 404
activated by the Raf-MAPK pathway, local protein translation mediated by 405
autonomously active isoform of atypical protein kinase C ζ (PKMζ) (after a chequered 406
history, back in favour as a memory molecule [101]), and movement of PKMζ and 407
notional plasticity related proteins from the cytoplasm to synapses. The model was used 408
to explore how strong potentiating or depressing stimuli at one synapse can promote 409
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Fig 2. Incomplete block diagrams comparing essential elements of striatal
biochemical circuit. Greyed nodes and edges denote shared elements with
hippocampal models. See Fig 1 for explanation.
protein synthesis that allows, at other synapses, weak stimuli to cause plasticity. 410
Models of striatal synaptic signalling pathways 411
The striatum integrates multiple inputs to the basal ganglia, such as glutamatergic 412
excitatory afferents from the cortex and dopaminergic inputs from the midbrain [102]. 413
Around 95% of striatal cells are MSPNs, in which signalling cascades activated 414
simultaneously by glutamatergic and dopaminergic stimuli is a necessary condition for 415
the LTP that underlies reinforcement learning [103]. Models of striatal MSPNs share 416
some pathways with hippocampal synapses and include striatum-specific proteins. 417
Multistate DARPP-32 An abundantly expressed protein in MSPNs is phosphatase 418
1 regulatory subunit 1B (PPP1R1B), known as dopamine- and cAMP-regulated 419
neuronal phosphoprotein with molecular weight 32 kDa (DARPP-32). As a homologue 420
of I1, it has the same major role of PP1 inhibition. It is a hub protein that is regulated 421
by multiple neurotransmitters and phosphorylation sites. There are at least 8 422
modification sites known in the DARPP-32 amino acid sequence, and 4 of them are 423
known to have a regulatory impact on DARPP-32 [104]. The threonine sites (Thr34 424
and Thr75, as positioned on the rat protein sequence) have a major regulatory role in 425
signal processing. Thr34 inhibits PP1 and is phosphorylated by PKA, which Thr75 426
inhibits. The serine sites (Ser137, Ser102, as positioned on the rat protein sequence) 427
regulate Thr34 positively. Ser137 inhibits dephosphorylation of Thr34 on Ca2+ 428
stimulation and Ser102 enhances phosphorylation of Thr34. A number of models of 429
dopamine (DA) and Ca2+ signal integration have included only Thr34 and Thr75 as 430
major switching factors between LTP and LTD [17,18,29, 105]. A few models 431
incorporate all four phosphorylation sites [19, 106]. 432
Glutamatergic and dopaminergic signal integration Lindskog et al. [105] 433
created an ODE model of interacting cascades activated by DA and Glutamate (Glu) 434
signals stimulating dopamine receptor D1 (DRD1) and Ca2+ influx through NMDAR, 435
respectively. The glutamatergic signalling cascade shares the general network structure 436
of the CaMKII circuit with hippocampal models (Fig 2), with a few major differences. 437
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Firstly, the inhibition of PP1 does not occur via I1 but rather via DARPP-32 438
phosphorylated at Thr34. Secondly, as the DRD1 is a G-protein-coupled 439
receptor (GPCR), DA input adds to the network G-protein activation events. On DA 440
stimulation, Gαβγ dissociates into Gα,olf and Gβγ subunits. Subsequently, Gα,olf binds 441
to AC and ATP, synthesising cAMP. The last event, which results in activation of 442
PKA and the cascade inhibiting PP1, is shared by both hippocampal and striatal 443
models. However, in contrast to hippocampal models, in Lindskog’s model [105], Ca2+ 444
inhibits AC, leaving its activation to DA input. Furthermore, Ca2+-activated PP3 445
dephosphorylates Thr34 counteracting the DA, but not the Ca2+ signal. 446
In the model Thr34 is both activated and inhibited by a Ca2+ feedforward signal, 447
which is conveyed by the PKA–PP2–Thr75 double negative feedback loop. PP2 448
dephosphorylates Thr75 but its action is enhanced by Ca2+ and PKA. The model 449
showed that the loop does not exclusively reinforce PKA pathway stimulated by DA but 450
instead acts as a competitive inhibitor for PKA. 451
The detailed model of Nakano et al. [15] demonstrated that the loop can have a 452
major role in LTP induction. They extended the network upstream of DARPP-32 and 453
added AMPAR phosphorylation and trafficking as a direct readout of plasticity. Their 454
model required activation of both CaMKII and PKA to reach striatal LTP. They also 455
included the downstream pathway of mGluR activation that represented mainly the 456
bi-directional effect of Ca2+ on IP3 receptor located at the endoplasmic reticulum. 457
STEP-mediated crosstalk between glutamatergic and dopaminergic 458
signalling cascades Gutierrez-Arenas et al. [18] developed a signalling model of two 459
main signalling pathways activated by DA and Glu inputs in MSPNs: AC–cAMP–PKA 460
and NMDAR–Ca2+–Ras. The AC-pathway was built on the model of Lindskog [105] by 461
adding a NMDAR-cascade, in which the dissociated Gβγ subunits activate Fyn which 462
phosphorylates a NMDAR subunit, thus enhancing the Ca2+ influx. Ca2+ activates the 463
MAPK pathway phosphorylating mitogen-activated protein kinase 1, also known as 464
ERK2 (MAPK1) at two sites. In striatal plasticity, MAPK1 activation is known to 465
require both DRD1 and NMDAR stimulation, as shown by the negative impact on 466
MAPK1 phosphorylation in the DARPP-32-knockout mouse model [107]. DRD1 467
activation by the DA-signal also enhanced the Ca2+ current through NMDAR, e.g. by 468
the phosphorylation of NMDAR by activated PKA. This particular reaction network 469
was chosen to allow for examination of various scenarios that could explain the results 470
of behavioural experiments showing distinctive segregation of behaviours of two animal 471
types representing Gα,olf -deficiency and DRD1-deficiency. The former exhibited 472
disruption of phosphorylation of the GluR1 subunit of AMPAR and the latter disrupted 473
phosphorylation of MAPK1 after acute psychostimulant administration. This effect was 474
present despite known crosstalks between two cascades mediated by striatal enriched 475
tyrosine phosphatase (STEP), which could balance the sensitivity in both pathways. 476
The model reproduced the segregation with an assumption that there are two 477
DRD1/Golf signalling compartments for each pathway distributed from common pools 478
of DRD1 and Golf . These compartments differ in DRD1 and Golf distribution 479
determined by the opposite affinity strengths for these molecules in each compartment. 480
These settings resulted in a competition between the two compartments for Golf/DRD1 481
resources, giving a ‘winning hand’ to the one with a stronger affinity to a given molecule. 482
Interactions between G-protein-coupled receptors DRD1 is a subfamily of 483
dopamine receptors and one of multiple types of GPCRs expressed in MSPNs, including 484
serotonin (5-HT2C receptor [108]), noradrenaline (α2-adrenoceptor, 485
β1-adrenoceptor [109], acetylcholine (muscarinic M4 receptor; M4R), adenosine (A2a 486
receptors; A2aR) and dopamine receptors of D2-like family. The last three, alongside 487
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DRD1, were modelled by Nair et al. [17], who simulated the reward prediction error 488
(defined as the difference between the received and expected reward). They modelled 489
two types of MSPNs, expressing either DRD1 and M4R (striatonigral projections) or 490
DRD2 and A2aR (striatopallidal projections). These two types of neurons process 491
DA-signals in two opposing manners by stimulating (DRD1-expressing) or inhibiting 492
(DRD2-expressing) the signalling cascade resulting in phosphorylation of DARPP-32 at 493
Thr34. In both models neuromodulators interact through Gi/o and Golf signalling, 494
inhibiting and activating AC5 respectively. Also in both models, AC5 is inhibited by 495
Gi/o at the basal state. In the DRD1-expressing neurons, Gi/o is coupled with the 496
M4R–tonic ACh signal; and in the DRD2-type of neurons with the DRD2–tonic DA 497
signal. In DRD1-neurons, the high PKA activation level was achieved with a 498
simultaneous DA-peak and ACh-dip. These neurotransmitter signals realise an 499
AND-gate, sensitive but noise-prone to a positive reward. In DRD2-neurons it is the 500
DA-dip that increases the PKA activation, even without Adn signal. This suggests that 501
in this type of neurons the cAMP–PKA cascade mainly detects reward omission. 502
Spatial specificity in synaptic plasticity The model of Oliveira et al. [29] 503
studied the mechanisms of spatial restriction of PKA activation by A-kinase anchoring 504
protein (AKAP). The problem required a multi-compartmental stochastic 505
reaction-diffusion approach. To evaluate distinct functions of anchoring, the 506
experimental protocol consisted of four spatial variations in localisation of AC and 507
PKA, either locating them in the spine head or at dendritic submembrane area. The 508
signalling network was adopted from Lindskog [105] and the stimulating signal was 509
either dopamine alone, corresponding to the reward response, or the combined DA and 510
Ca2+ influx used for LTP protocols. The results showed that for the induction of LTP 511
the colocalisation of PKA near the source of cAMP is more important than its 512
colocalisation near its target substrates (e.g. DARPP-32, PP2, PDE). 513
Kim et al. [31] used the NeuroRD algorithm to model 19 molecules in the 514
postsynaptic signalling pathways of the dendrites of striatal MSPNs with multiple 515
spines. The model investigated the hypothesis that temporal patterns, linked to Ca2+, 516
determine LTP or LTD induction, via PKC or endocannabinoid 517
2-arachidonoyl-glycerol (2AG) production respectively. The ratio between the number 518
of activated PKC and 2AG molecules was used as an indicator of the direction of 519
plasticity. It describes Gq-coupled pathways, the temporal pattern of Ca
2+ stimulation 520
and Gα,q activation. In the simulations LTP was specific to spines, whereas LTD was 521
more diffuse. This suggested that spatiotemporal control of striatal information 522
processing uses Gq-coupled pathways for decision-making. 523
Cerebellar synaptic models 524
Despite the historical importance of cerebellar granule cell to Purkinje cell plasticity, at 525
least 9 types of synaptic and non-synaptic plasticity are known [110]. The classical LTD 526
at cerebellar granule cell to Purkinje cell synapses occurs when there is simultaneous 527
climbing fibre and granule cell (parallel fibre) firing. At the heart of the model of 528
Kuroda et al. [111] is the MAPK positive feedback loop found in hippocampal and 529
striatal models [18, 80], which here comprises Raf–MAP2K–MAPK-PLA2–AA–PKC. 530
Parallel fibre activity both activates and inhibits the loop. Parallel fibre glutamatergic 531
input to AMPARs causes Na+ influx, which triggers the Na+/Ca2+ exchanger causing 532
Ca2+ influx which, in turn, activates PKC and PLA2. PKC is also activated via 533
mGluR and AMPARs also activates Lyn tyrosine kinase directly, which activates Raf in 534
the MAPK loop. Parallel fibre input also releases NO, which, via the guanylate 535
cyclase–cGMP–PKG pathway, activates PP2, which inhibits MAP2K. Climbing fibre 536
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inputs also activate the MAPK link via Ca2+, and via Raf which is activated 537
corticotropin releasing hormone receptors (CRHR) activated by corticotropin releasing 538
factor. When the loop is active, activated PKC phosphorylates AMPARs, but in 539
contrast to hippocampal models phosphorylated AMPARs are internalised, leading to 540
LTD. 541
Antunes and DeSchutter [112] model LTD in cerebellar granule cell to Purkinje cell 542
synapses in the cerebellum using Gillespie’s SSA, as implemented in the STEPS 543
simulator. The model includes a version of the PKC-MAPK circuit (Fig 2), but with an 544
undetermined “Raf-activator” between PKC and Raf. This Raf-activator could be Ras 545
itself or indirect activation of Ras via complex Src/Proline-Rich Tyrosine Kinase 2 546
(PYK2). PP5 tonically inhibits Raf and MKP (DUSP) inhibits MAPK. Activated PKC 547
promotes endocytosis of AMPARs, thus causing LTD. The stochastic nature of the 548
model leads to LTD being stochastic and binary at individual synapses, but over the 549
ensemble of synapses this results in a graded relationship with the magnitude of the 550
activating Ca2+ signal. Increasing the number of molecules makes the system less 551
stochastic, and makes the resulting macroscopic signal less graded. 552
Antunes et al. [42] extend this model by incorporating CaMKII and PP3 to 553
implement LTP. They use the rule-based BioNetGen system to generate stochastic 554
reactions that are simulated using Gillespie’s SSA. In contrast to hippocampal models, 555
calcineurin promotes LTP by preventing endocytosis of AMPARs. RKIP is also 556
incorporated as an additional activator of Raf. 557
Summary 558
In summary, the development of biophysical models of synaptic plasticity has been 559
propelled by: (1) hypothesis-driven physiological and molecular biological discoveries; 560
(2) the need to formalise informally expressed hypotheses; (3) the intrinsic fascination 561
and intellectual challenge of complex biomolecules such as CaMKII; and (4) increasing 562
compute power, which makes it practical to model stochastic and spatial aspects of 563
synaptic signalling cascades. Challenges in the field have included dealing with 564
combinatorial complexity and finding appropriate sets of parameters. Recent 565
computational modelling methods, such as agent-based and particle based simulation, 566
address the problem of computational complexity. Depspite being an active field of 567
research, the perennial problem of inferring parameter values remains more intractable. 568
Analysis of proteins in synaptic models 569
Computational models of synaptic plasticity are important tools for understanding 570
synaptic and neural function. When they include molecular entities and phenomena 571
they can also be used to study dysfunction, and potentially model pharmacological 572
interventions. Clearly the coverage of synaptic molecules found in the existing ‘model 573
space’ is going to be very incomplete given the intense amount of effort required to 574
develop each model but here we sought to explore systematically molecular coverage to 575
identify significant gaps that might offer new opportunities. 576
Computational models contain a diverse cast of players, including proteins, second 577
messengers, reporters, ions and others. Models vary in how precisely they specify 578
proteins; for example Bhalla and Iyengar [80] specify AC1, AC2 and AC8, whereas 579
Castellani et al. [82] and Oliveira et al. [28] specify AC, which could, in principle, map 580
to any of the adenylate cyclases expressed in the synapse. This presents a problem when 581
mapping models to molecular identifiers, which we addressed by developing a mapping 582
from what we refer to as model “entities” to gene families. For example a protein such 583
as Calmodulin 1 can be mapped onto a single gene (CALM1 ), but a family of proteins 584
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such as metabotropic glutamate receptors maps onto more than one gene 585
(GRM1–GRM8 ). By definition, second messengers or ions do not map onto gene 586
symbols. 587
The concept of entities allows each model’s constituents to be catalogued faithfully 588
and then mapped onto identifiers according to the steps shown in Fig 3: (1) select 589
models to analyse; (2) determine all entities (e.g. proteins, protein multimers or families, 590
ions and second messengers) that are contained in each model; (3) map these entities 591
onto gene identifiers and higher level families; and (4) use the lists of entities in each 592
model and the mappings to undertake comparative analyses. These analyses include: 593
comparison of modelled proteins with pre- and postsynaptic proteomic datasets; 594
identification of properties of modelled genes, in particular cellular pathways, gene 595
ontology terms and disease; and comparison of models with each other. 596
List of entities in model
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Fig 3. Overview of the modelling paper analysis process. Sets of data are shown in boxes with black rectangular
borders. Processes are shown in boxes with blue backgrounds and curved corners. Final analyses are shown in boxes with
dashed borders. “ID” refers to the modelled entity. Boldface type refers to column headers.
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Selection of models 597
We selected a number of published computational, biophysical models of synaptic 598
plasticity or related pathways (Table 3). Models that we regarded as phenomenological 599
or descriptive, i.e. models describing a function with no explicit reference to an 600
underlying mechanism, were excluded. For example, models of spike-timing dependent 601
synaptic plasticity are phenomenological, since they contain an empirical function that 602
maps spike times onto changes in plasticity with no reference to proteins. 603
The process of identifying the model constituents can be time-consuming, especially 604
when machine-readable descriptions are not available. In order to address our questions 605
regarding the molecular coverage of synaptic models, it sufficed to select a set of models 606
that we were reasonably confident gave good genetic coverage, rather than to identify 607
entities in every model. We assessed molecular coverage of pre-2010 models from the 608
tables in Manninen et al. [9] and we screened models published between 2010 and 609
December 31st 2015. 610
Sources of models 611
A number of the models we selected are written in standardised modelling languages and 612
hosted in large scale repositories such as ModelDB [113], BioModels [114], DOQCS [115] 613
and the CellML repository [116]. ModelDB is a curated database of computational 614
neuroscience models at the molecular and electrophysiological levels, written in a 615
number of languages. BioModels hosts models which focus on biochemical and cellular 616
systems at the physiological and biochemical levels, unrestricted by the biological 617
subject [114, 117]. In the curated branch of BioModels, models have to be annotated 618
according to the minimal information requested in the annotation of biochemical 619
models (MIRIAM) standard [118], thus meaning that model constituents are mapped to 620
external identifiers. CellML is both a model format and a repository. The repository 621
hosts a wide range of biological models, which have documentation pages generated 622
from the meta-data supplied by model authors. DOQCS (Database of Quantitative Cell 623
Signalling) is a database tailored for storing chemical kinetics and reaction level 624
information [115]. The chemical-level description of each model corresponds to the 625
GENESIS/Kinetikit simulator and reflects reaction diagrams or ODE equations. 626
Table 2 summarises the numbers of models we analysed that are stored in 627
repositories and other locations, and the format of the model descriptions. Three of the 628
7 models deposited in the BioModels database were curated to MIRIAM standards. 629
Around half of all catalogued models (14) had non-machine readable descriptions. 630
Models in this group are often difficult to explore and extract information proves 631
challenging. There were 18 machine-readable models available from publication 632
attachments, on institute or lab servers and the four public modelling databases; some 633
models are deposited in more than one database. With two exceptions models were not 634
duplicated in ModelDB and BioModels; the Bhalla and Iyengar [80] model was present 635
in all four public modelling databases, and the Nakano et al. [15] model was found in 636
ModelDB and BioModels. We did not test the functionality or reproducibility of models; 637
only the availability and relative ease of exploration was examined. 638
Features of models 639
We extracted a number of features from each model to highlight their similarities and 640
differences (see Table 3). To quantify the model size, we counted the number of entities 641
that appear in the model. We also extracted information on numbers of dynamic 642
variables per compartment (“Vars/comp.”). Variables are values describing quantities 643
that change in the model. A compartment is defined as a spatial subsection within the 644
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Table 2. Overview of locations of models and their formats.
































Fractions refer to the number of models in the category relative to the total of
annotated models. Each machine-readable model can be part of several categories. See
text for details.
model. Since the number of compartments varies with the fineness of the spatial mesh 645
used, the number of variables scales with the number of compartments, but the number 646
of variables per compartment will be a constant, independent of the spatial 647
discretisation used to simulate the model. To provide a measure of model complexity, 648
we used the ratio of thethe number of variables per compartment and the number of 649
entities (“Vars./Comp./Entities”, Table 3). 650
For example, in a model of calcium binding to a buffer in a single compartment, 651
there are two entities: calcium (an ion) and the buffer (a protein). There are three 652
variables, namely the concentrations of free calcium, free buffer and calcium-buffer 653
complex. To model diffusion of calcium, buffer and calcium-buffer complex, space could 654
be divided into 100 compartments. The number of variables would then be 300, but the 655
number of variables per compartment would be 3. There would still only be two entities 656
in this model – calcium and the buffer – and the variables per compartment per entity 657
ratio would be 1.5. 658
A high ratio of variables per compartment to entities reflects a detailed description 659
of a small pathway. For example the model of Byrne et al. [58] – whose stochastic model 660
describes binding of calcium, calmodulin and CaMKII – has 82 variables per 661
compartment and 3 entities, making a ratio of 27.3. The 82 variables correspond to the 662
combinations of calcium bound to the N and C lobes of calmodulin and whether or not 663
these complexes are bound to CaMKII. Dealing with this complexity in the simulation 664
is achieved by using an agent-based Gillespie method (Section “Non-spatial models” in 665
“Biophysical models of synaptic plasticity”). Agent-based simulation also allows the more 666
extreme example of Zeng and Holmes [27], whose model of the Ca2+-CaM-CaMKII-PP3 667
pathway (with calbindin and neurogranin; 6 entities in total) has 14,296,081 possible 668
complexes (i.e. variables), making a ratio of 2,382,680 variables per compartment per 669
entity. At the other end of the spectrum, a low variable to entity ratio indicates larger 670
pathways with each interaction modelled in less detail. For example, the ODE-based 671
model of Bhalla and Iyengar [80], with 44 entities and approximately 100 variables per 672
compartment, has a ratio of 2.3 variables per compartment per entity. 673
PLOS 18/53
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/254094doi: bioRxiv preprint first posted online Jan. 28, 2018; 
In Table 3 we also indicate the region or cell type the model applies to. 674
Hippocampal CA1 cells are most frequently modelled, followed by striatal MSPNs and 675
cerebellar Purkinje neurons. In some models the location is not specified. 676
Table 3. Summary of models.
Paper Vars./comp. Entities Vars./comp./
Entities
Region
Antunes and De Schutter (2012) [112] 103 19 5.4 Cereb. Purk.
Antunes et al. (2016) [42] 17 Cereb. Purk.
Bhalla and Iyengar (1999) [80] 100 42 2.4 Hipp. CA1 Pyr.
Byrne et al. (2009) [58] 82 3 27.3 Hipp. CA1 Pyr.
Castellani et al. (2001) [90] 36 5 7.2 Cortex**
Castellani et al. (2005) [82] 33 13 2.5 Ex. glut. syn.**
Graupner and Brunel (2007) [22] 16 5 3.2 Hipp. CA1 Pyr.
Gutierrez-Arenas et al. (2014) [18] 188 34 5.5 Striatal MSPN, D1R expressing
Hernjak et al. (2005) [26] 9 5 1.8 Cereb. Purk.
Khan et al. (2011) [32] 12 1 12.0 Hipp. CA1 Pyr.
Kim et al. (2010) [21] 54 18 3.0 Hipp. CA1 Pyr.
Kim et al. (2011) [30] 16 17 1.0 Hipp. CA1 Pyr.
Kim et al. (2013) [31] 10 18 0.6 Striatal MSPN, mGluR1
expressing
Kötter (1994) [119] 12 striatal MSPN
Kuroda et al. (2001) [111] 20 Cereb. Purk.
Li et al. (2012) [33] 95 8 11.9 Generic excitatory spine
Mattioni and Le Novère (2013) [34] 13 9 1.4 Striatal MSPN
Miller et al. (2005) [49] 58 4 14.5 **
Nair et al. (2015) [17] 80 16 5.0 Striatal MSPN, D1R and D2R
expressing*
Nakano et al. (2010) [15] 189 28 6.8 Striatal MSPN, D1R expressing
Oliveira et al. (2010) [28] 31 9 3.4 HEK293 cells
Oliveira et al. (2012) [29] 113 28 4.0 Stratial MSPN
Pepke et al. (2010) [20] 156 3 52.0 **
Qi et al. (2010) [19] 115 13 8.8 Stratial MSPN
Smolen et al. (2006) [100] 23 9 2.6 Hipp. CA1 Pyr.
Smolen et al. (2012) [16] 14 6 2.4 Hipp. CA1 Pyr.
Sorokina et al. (2011) [23] 1, 000, 000 55 18, 181.8 Ext. glut. syn.
Stefan et al. (2008) [59] 49 3 16.3 **
Zeng and Holmes (2010) [27] 14, 296, 081 6 2, 382, 680.2 Hipp. DG
Zhabotinsky et al. (2006) [83] 58 11 5.3 Hipp. CA1 Pyr.
“Paper” refers to the analysed model. “Vars/comp.” is the number of molecular variables per compartment, a measure of the
complexity of the model; this was not assessed for all papers. “Entities” is the number of entities in the model, and
“Vars./Enties” is the ratio between the number of variables per compartment and the number of entities. This roughly
corresponds to the level of detail of the model. “Region” refers to the brain region or cell type where the model is situated (**
– no cell specified). Abbreviation: Cereb. Purk., cerebellar Purkinje cell; Ex. glut. syn., excitatory glutamatergic synapse;
Hipp. CA1 Pyr., hippocampal CA1 pyramidal cells; Hipp. DG, hippocampal dentate gyrus cell; MSPN, medium spiny
projection neuron; * – denotes that there is more than one model presented in a study and numbers in this table refer to the
one with the larger number of “Entities”.
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Table 4. Frequency of entity types found in models.
Type Frequency Examples
Ion 2 Magnesium, Calcium
Neurotransmitter 5 Adenosine, Dopamine
Others 2 ATP and PIP2, intermediates in the IP3/DAG pathway
Protein 95 Neurogranin
Protein family 52 calmodulin, which may correspond to one of calmodulin-1, calmodulin-2 or
calmodulin-3
Protein multimer 8 AMPA receptor, which comprises a tetramer of GluR1, GluR2, GluR3 and GluR4
proteins.
Reporter 1 AKAR3
Second messenger 8 GTP (Guanosine triphosphate) or cAMP (cyclic AMP).
Total 173
Identifying entities in models 677
To identify the entities in each model, the publication describing the model and, if 678
available, an electronic description of the model were examined by one of the authors. 679
For each entity, we recorded the name used in the model publication and our standard 680
entity identifier. Models do not always specify the entities involved precisely. We 681
discussed ambiguous cases together and erred on the side of not imputing the identity of 682
a protein; for example a “Plasticity related protein” [16] was not mapped to an entity 683
identifier. 684
We identified 178 distinct entities across the 30 catalogued models (see S1 Table for 685
full list). As well as an identifier, each entity has a long name and a type which can be 686
one of: “ion”, “neurotransmitter”, “others”, “protein”, “protein family”, “protein 687
multimer”, “reporter” or “second messenger”. Table 4 shows how many of each type of 688
entity were identified, and gives examples. The most frequent entity type is “protein”, 689
followed by “protein family” and then “protein multimer”. 690
The rationale for having three protein types – “proteins”, “protein families” and 691
“protein multimers” – was to allow us to record as precisely as possible what was meant 692
in each computational model. A “protein” is a specific protein e.g. neurogranin, 693
encoded by a specific gene (NRGN ), so it is unambiguous as to which gene is implied by 694
the model. The same gene may produce multiple isoforms due to gene duplicates or 695
alternate splicing. For example PRKCZ produces two isoforms, PKCζ and PKMζ [120]. 696
A “protein multimer” is a multiprotein complex, e.g. an AMPA receptor, which 697
comprises a tetramer of a selection of GluR1, GluR2, GluR3 and GluR4 proteins. In 698
this example, if the model only specified “AMPAR” there would be ambiguity about 699
which of the GluR1–4 subunits are implied by the model. Coding AMPAR as a “protein 700
multimer” allows this ambiguity to be recorded and resolved as desired. A “protein 701
family” is a protein from a family of proteins, e.g. calmodulin, which may correspond to 702
one of calmodulin-1, calmodulin-2 or calmodulin-3. Again, it is not clear which protein 703
is implied by the model, though later we will use information about the synaptic 704
proteome to narrow down the possibilities. “AKAR3” is the only entity that was 705
classified as a reporter [17]. The FLIM-AKAR reporter was included in the model to 706
reflect the experimental setup where it is used to measure PKA dynamics. “Ions”, 707
“neurotransmitters” and “second messengers” were assigned to individual classes. They 708
are not proteins, but carry out crucial functions in the cell. 709
ATP and PIP2, both intermediates in the IP3/DAG pathway were classified as 710
“other”. ATP itself can produce a second messenger and is often referred to as a 711
precursor or “coenzyme”. Similarly, PIP2 is frequently acting as a precursor of a second 712
messenger [31]. 713
PLOS 20/53
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/254094doi: bioRxiv preprint first posted online Jan. 28, 2018; 
The full catalogue of all model entities for all models is shown in matrix form in 714
Fig 4. The models are ordered according to hierarchical clustering (Ward’s 2D method, 715
as implemented in R’s hclust function with the Ward.2D method). This catalogue is 716
































































































































































































































































































































































































Fig 4. Matrix of entities in models. The occurrence of an entity in a model is
indicated by open circles. Entity IDs are staggered for readability.
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Mapping entities to gene identifiers 718
In order to compare synaptic models with the synaptic proteome, we needed to map 719
each protein entity onto the proteins to which it might correspond. The construction of 720
this mapping is shown in Fig 5. Based on common practice in bioinformatics we decided 721
to use HUGO Gene Nomenclature Committee (HGNC) gene symbols and NCBI Entrez 722
Gene IDs to identify proteins/genes. The one-to-one mapping from HGNC gene 723
symbols to NCBI human Entrez Gene IDs [121] allowed this approach. 724
As presented in Fig 5, entities of type “protein” were mapped directly to HGNC 725
gene symbols. Entities classified as “protein family” and “protein multimer” required an 726
intermediate mapping step. We searched for ontologies that could be used to identify as 727
many of these entities as possible and map them to HGNC gene symbols. After 728
thorough analysis of available bioinformatic resources (see Methods) we decided to use 729
HGNC gene families to map entities of type “protein family” and “protein multimer” to 730
genes. For each such entity, we tried to identify a corresponding HGNC gene family, 731
and used manual NCBI mapping (see Methods) to check if the genes contained in this 732
family seemed likely to be what was meant in the models. For example, we mapped the 733
entity “Dopamine receptors” (DRD) to the HGNC family “Dopamine receptors”, which 734
contains the genes DRD1, DRD2, DRD3, DRD4 and DRD5. Since this seemed a 735
reasonable set, we accepted the mapping. 736
For some entities no one HGNC family gave a reasonable set of proteins, but the 737
intersection between two or more families did. For example the genes corresponding to 738
SHANK, by which we mean the family of proteins encoded by SHANK1, SHANK2 and 739
SHANK3, may be selected from the gene families list by choosing all genes that are in 740
the “Ankyrin repeat domain containing” (ANKRD) and “PDZ domain containing” 741
(PDZ) gene families. When we could not find a corresponding HGNC family or a 742
combination of HGNC families, we constructed our own mapping (see Methods). Since 743
“ions”, “neurotransmitters”, “others”, “reporters” and “second messengers” are not 744
proteins, we excluded them from the mapping to gene names. 745
Once gene families corresponding to 61 ”protein families” and “protein multimers” 746
were identified we could map each family or multimer onto a set of genes (S3 Table and 747
S4 Table). 331 unique HGNC gene symbols were identified based on protein families 748
and multimers. The union of this set of symbols with the 96 genes mapped directly from 749
type “protein” in the “full set of HGNC gene symbols in models” dataset. It contains a 750
total of 386 HGNC gene symbols. A number of “protein families” mapped onto the 751
same genes; for example the families PDE and PDE1 both contain PDE1A and PDE1B. 752
Comparison with proteomic data 753
HGNC families are general gene classes and do not contain information about tissue 754
specificity or expression patterns. To identify proteins found in the synapse, we used a 755
meta-analysis of published proteomic datasets of the presynapse, postsynapse and 756
synaptosome that we are preparing for another publication. The individual references, 757
as of July 2017, can be found in S2 Table. 758
The synaptosome is the largest data subset and extracted from brain homogenate. 759
The term synaptosome refer to the complete presynaptic terminal including 760
mitochondria, synaptic vesicles and the postsynaptic membrane together with the 761
PSD [122,123]. The PSD is a tightly connected, dense region of the postsynaptic 762
membrane which hosts a number of different receptors and regulatory units. The 763
presynapse and postsynapse are subsets of the synaptosome, and can be separated 764
through experimental steps. 765
The union of these three datasets, which we refer to as the “synaptic proteome”, 766
comprises 6,706 genes and is based on data obtained from 37 publications and 39 767
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Fig 5. Overview of entity to Gene Symbol mapping process. Sets of data are shown in boxes with black rectangular
borders. Mappings are shown in boxes with blue backgrounds and curved corners. Dashed lines indicate additional
information, and the key outcome is highlighted in a box with green background. Bold font refers to column headers.
datasets (data as of July 2017). The extracted proteome was used to filter the “full set 768
of HGNC Gene symbols in models” (see Fig 5 and “Identifying entities in models”). We 769
found that every “protein family” (S3 Table) and “protein multimer” (S4 Table) in our 770
list contains at least one gene overlapping with the synaptic proteome. Genes not 771
expressed in the synapse (“OUT SYNAPSE” in S3 Table and S4 Table) were excluded 772
from further analysis. This filtering step reduces the 331 genes in families to 239 HGNC 773
gene symbols. Together with directly mapped proteins this leaves us with 294 unique 774
HGNC gene symbols describing all mapped genes in models, where families and 775
multimers were screened for the presence in the synapse. From now on we refer to this 776
gene set as “genes in models” (see green box, Fig 5). 777
The overlap between the final set of “genes in models” and the synaptic proteome, 778
as well as its subsets (presynaptic, postsynaptic, and synaptosome) is visualised in the 779
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Venn diagram in Fig 6. It can be seen that 46% of “genes in models” (135 genes) are 780
found in all three synaptic proteome datasets. Significantly lower numbers are expressed 781
in individual sub-datasets. These are 3, 14 and 21 genes for the presynapse, postsynapse 782
and synaptosome respectively (representing 1.0%, 4.7% and 7.1% of genes in models). 783
When disregarding “genes in models” present in the intersection of all three datasets, 784
more modelled genes are found in the postsynapse or synaptosome (143 genes) than the 785
presynapse or synaptosome (27 genes). Thus, postsynaptic genes appear to be the most 786
highly modelled subset. However, relative to the total size of the respective proteomes, 787
only 5.1% of postsynaptic genes (258 “genes in models” out of 5,053 postsynaptic genes) 788
versus 7.6% of presynaptic genes (142 “genes in models” out of 1,867 presynaptic genes) 789




















Fig 6. Relationships between the sets of genes in postsynaptic, presynaptic,
synaptosome datasets and the sets of genes possibly present in models.
Postsynaptic genes in red, presynaptic in blue, the synaptosome in purple and genes in
models in green. Numbers refer to the number of genes in each subset and shading
shows how many sets a region belongs to (white – none; red – all four). It can be seen
that the number of genes in the proteome but not included in models is an order of
magnitude bigger than the number of proteins included in models and the proteomic
datasets. There are only 9 genes (listed in Table 5) found in models and none of the
proteomic datasets.
Nine modelled genes, all of type “protein” are not present in the synaptic proteome 791
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datasets (see lower right of the circle in Fig 6). Further investigation shows evidence for 792
all of them being expressed in the synapse (Table 5), so these 9 genes remained in the 793
set of “genes in models”. These cases illustrate how proteomic datasets still seem to be 794
slightly incomplete. 795
Table 5. Proteins in models and not to be found in synaptic datasets.
Entity ID Gene Reason for inclusion
ADORA2A ADORA2A Adenosine A2a receptors (A2aR) are expressed with D2R receptors
[17]
CALM2 CALM2 Unpublished dataset
CHRM4 CHRM4 Muscarinic cholinergic receptor shown to be expressed in go-
nadotropin releasing hormone neurons [124]
CRH CRH Corticotropin-releasing factor, regulating the release of adrenocorti-
cotropin in synapses [125]
DRD1 DRD1 D1 subtype of the G-protein coupled dopamine receptor - the most
abundant in the central nervous system. [126] confirms the presence
in neurons.
DRD2 DRD2 D2 subtype of the G-protein coupled dopamine receptor. [126]
confirms the presence in neurons.
DUSP1 DUSP1 Model specifies that DUSP1 feedback loop occurs in the dendritic
shaft, the soma and the nucleus [18]
I-1 PPP1R1A Unpublished dataset
PPP2R3A PPP2R3A Preliminary studies suggest PPP2R3A is present in both cytoplasm
and nucleus of cells in the striatum [127]. PPP2R3A mediates
Ca2-dependent dephosphorylation at Thr-75 of DARPP-32 [127].
Enrichment analysis of modelled genes 796
After compiling the “genes in models” list, we related it to existing biological knowledge, 797
in the form of gene sets annotated with various biological categories, supplied through a 798
number of databases. Depending on each database’s focus, structured, controlled, and 799
descriptive terms are associated to each gene. As an example for this study, we chose to 800
use the following ontologies: Gene Ontology (GO) [128], REACTOME Pathway 801
Database (REACTOME) [129] and Disease Ontology (DO) [130]. Amongst these GO is 802
the largest and most commonly used ontology, classifying genes within domains 803
including Molecular Function, Biological Process and Cellular Compartment. We also 804
used REACTOME, a free and manually curated database in which genes are tagged 805
with terms representing biochemical reactions and pathways they are involved in. A 806
pathway is composed of one or more reactions or reaction-like events, such as binding, 807
complex formation, transport or polymerisation. 808
To relate “genes in models” to their associated diseases, we used the DO to provide 809
disease classifications. Multiple sources contain gene disease information. We used 810
annotations retrieved from the GeneRif [131], OMIM [132,133] and Ensemble 811
Variation [134] databases. Based on annotations in the different ontologies we aimed to 812
identify functionalities shared by the “genes in models”. The topONTO package 813
implemented in R [135] was used to undertake enrichment analysis (see Methods). 814
The results are summarised using word clouds to show significantly enriched terms, 815
based on GO annotations, describing Molecular Functions (Fig 7A) and Biological 816
Processs (Fig 7B) for our “genes in models”. It can be seen that a high number of 817
modelled genes are involved in molecular functions such as “G-protein 818
beta/gamma-subunit complex binding”, “G-protein beta/gamma-subunit complex 819
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binding”, “GTPase activity”, “calmodulin binding”, “3’,5’-cyclic-AMP 820
phosphodiesterase activity”, “high voltage-gated calcium channel activity”, “signal 821
transducer activity” and “calcium-transporting ATPase activity” amongst others. The 822
most common biological processes are “cellular response to glucagon stimulus”, “platelet 823
activation”, “calcium ion transmembrane transport”, and “activation of protein kinase 824
A activity”. 825
A B
Fig 7. GO enrichment analysis results for “genes in models”. A: Molecular
Function ontology terms enriched for “genes in models”. B: Biological Process ontology
terms enriched for “genes in models”. The synaptic proteome was used as a background
dataset. The list of significant terms was obtained with the Fisher’s exact test and the
elim algorithm, followed by Benjamini and Yekutieli multiple testing correction. The
terms shown in clouds scored less than 0.01 p-value after the correction. Font size is
proportional to the term significance.
The identified molecular functions show that genes included in annotated models 826
cover key synaptic processes mainly concentrating around energy production as well as 827
synaptic signalling and information transmission. Identified biological processes are 828
slightly more diverse. Fairly generic processes were identified, showing that the set of 829
modelled genes covers these functions in the synapse. More unique processes appear 830
indicating the synapse specific biological processes described by genes in models. 831
Fig 8 shows results of the REACTOME enrichment analysis that identified “G 832
alpha (s) signalling events”, “G alpha (z) signalling events” and “DARPP-32 events” as 833
the top enriched pathways. The first two terms are parallel to each other on the 834
pathway hierarchy and have a common parent term of “GPCR downstream signalling”. 835
A comparison of the remaining members of this pathway with the enrichment results 836
shows that they are all significantly enriched in terms of our “genes in models”. The 837
identification of signalling pathways highlights a focus of the analysed models indicating 838
the central role of G-protein signalling. 839
When considering common diseases amongst “genes in models”, Fig 9A shows a 840
significant enrichment of “schizophrenia” associated genes in the set of “genes in 841
models”, followed by “bipolar disorder”, “Huntington’s disease” and “Alzheimer’s 842
Disease”. The order of results is slightly rearranged when considering the whole cell as a 843
background dataset (Fig 9B). For instance, “Alzheimer’s Disease” becomes more 844
prominent, showing the second highest significance for enrichment in our dataset of 845
interest. On the other hand, “bipolar disorders” drops down the list to the fifth position 846
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Fig 8. REACTOME enrichment analysis results for “genes in models”. The
synaptic proteome was used as background dataset. The list of significant terms was
obtained with the Fisher’s exact test and the elim algorithm, followed by Benjamini
and Yekutieli multiple testing correction. The terms shown in clouds scored less than
0.01 p-value after the correction.
A B
Fig 9. DO enrichment analysis results of “genes in models”. Two background
datasets were used: synaptic proteome (A) and all human protein coding genes (B).
The list of significant terms was obtained with the Fisher’s exact test and the elim
algorithm, followed by Benjamini and Yekutieli multiple testing correction. The terms
shown in clouds scored less than 0.01 p-value after the correction.
and “autistic disorder” appears in the results. This shows how different diseases not 847
only affect specific tissues but can affect a larger number of body regions inducing their 848
effect. 849
Modelled genes and their overlap with disease genes 850
Based on the preceding enrichment analyses we wanted to test for specific associations 851
of modelled genes with disease. Since synapses play a crucial role in signal transduction 852
and are affected in many neurological diseases, these were addressed in more detail. We 853
PLOS 27/53
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/254094doi: bioRxiv preprint first posted online Jan. 28, 2018; 
picked seven representative examples of neurological disorders, 6 of which were based on 854
a list published by the Genes 2 Cognition online initiative: Attention Deficit 855
Hyperactivity Disorder (ADHD), Alzheimer’s Disease (AD), Autism, Bipolar Disorder 856
(BD), Depression and Schizophrenia. The seventh example was Parkinson’s Disease 857
(PD), motivated by our research interests. The list is a representative rather than 858
exhaustive sample of diseases affecting synapses, including diseases of mental health, 859
developmental disorders, as well as diseases of anatomical entity, such as 860
neurodegenerative diseases. Table 6 gives the DO identifiers and short descriptions of 861
each disease. 862
Table 6. Diseases of Interest and short descriptions.
Disease DOID Description
Alzheimer’s Disease (AD) DOID:10652 Tauopathy, characterized by memory lapses, emotional instability
and progressive loss of mental ability. It results in progressive
memory loss, impaired thinking, changes in personality and mood,
up to profound decline in cognitive and physical functioning.
Attention Deficit Hyperac-
tivity Disorder (ADHD)
DOID:1094 Specific developmental disorder, characterized by co-existence of
attentional problems and hyperactivity.
Autistic Disorder DOID:12849 An autism spectrum disorder, characterized by symptoms across
three symptom domains (communication, social, restricted repeti-
tive interests and behaviors) and delayed language development.




DOID:1470 An endogenous depression that is characterized by an all-
encompassing low mood accompanied by low self-esteem, and by
loss of interest or pleasure in normally enjoyable activities.
Parkinson’s Disease (PD) DOID:14330 Synucleinopathy, based on the degeneration of the central nervous
system that often impairs motor skills, speech, and other functions.
Schizophrenia DOID:5419 Psychotic disorder, characterized by a disintegration of thought
processes and of emotional responsiveness.
Onto Suite Miner [136] was used to obtain all genes linked to the DO IDs from the 863
databases supplying gene–disease association information (GeneRIF, OMIM and 864
EnsemblVariation). The various databases have different approaches to disease-gene 865
annotations. EnsemblVariation relies on genetic mutations (mostly Single Nucleotide 866
Polymorphisms, SNPs), whereas OMIM and GeneRIF contain curated text annotations 867
describing disease–gene associations. These can be queried with text-mining tools and 868
data can be extracted. The different sources were considered individually and jointly. 869
All presented results refer to the full set of disease associated genes irrespective of the 870
original data source. The number of genes linked to each of the diseases can be seen in 871
row: “Disease Genes” in Table 7. 872
Since not all disease genes are expressed in the synapse, we used the synaptic 873
proteome (Section “Comparison with proteomic data”) to filter the disease associated 874
genes for genes that are expressed in the synapse (see row: “Disease genes in the 875
synapse”, Table 7). Since almost all modelled genes are expressed in the synapse we 876
only present numbers describing the overlap between disease proteins found in the 877
synapse and modelled genes (see row “Disease Genes in Synapse and in Modelled 878
Genes”, Table 7) 879
There seem to be large differences in the number range of genes associated with 880
diseases. However, the proportions of genes associated with a disease and expressed in 881
the synapse range between 33% (Bipolar Disorder and Major Depressive Disorder) and 882
45% (Schizophrenia). When looking at the overlap of modelled genes and 883
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Table 7. Overlap of modelled and disease genes.









Disease Genes 1511 665 575 1140 616 620 1844
Disease Genes in the Synapse 645 (43%) 233 (35%) 255 (44%) 379 (33%) 202 (33%) 262 (42%) 828 (45%)
Disease Genes in Synapse and
in modelled Genes








Overlap of modelled and disease genes and their presence in the synapse and our modelled gene set. Disease information is
based on GeneRif, OMIM and EnsemblVariation database data. “AD” stands for Alzheimer’s Disease, “ADHD” for Attention
Deficit Hyperactivity Disorder and “PD” for Parkinson’s Disease. Numbers in brackets refer to the percentages. Percentages
in the “Disease Genes in the Synapse” column are relative to the total of “Disease Genes” and “Disease Genes in Synapse and
in Modelled Genes” is relative to the number of “Disease Genes in Synapse”.
disease-associated genes (in the synapse) numbers vary. Schizophrenia seems to have 884
the highest net overlap (92 genes), but also shows the highest number of total 885
associated genes (1844). In total, between 6.1% (Parkinson’s Disease) and 11.8% 886
(Autistic Disorder) of disease genes associated with any of the selected diseases 887
expressed in the synapse appeared in at least one model. 888
Table 8. Modelled genes associated with three or more of the selected diseases.










CACNA1C, DRD2, GRIN2A, GRIN2B 1 1 1 1 1 1 1
GRM5 1 1 1 1 0 1 1
CACNB2, DRD1 1 1 1 1 1 1 0
HOMER1 0 1 1 0 1 1 1
CACNA1S, GRM7 1 0 1 1 1 1 0
NOS1 1 1 0 1 0 1 1
GNB3, GRM2 0 1 0 1 1 1 0
GRIA2 0 1 1 0 1 1 0
GNAL 1 0 0 1 1 1 0
PLA2G6 0 0 0 1 0 1 1
ATP2A3, CACNA2D1, GRM3 0 0 0 1 1 1 0
GRIK2, GRM8, GRIP1, PPP1R1B 0 0 1 1 0 1 0
DLG4, NRGN 0 1 0 0 0 1 1
GRIA4 0 1 0 0 1 1 0
FYN, GRIA1, GRIN1, GRM1, GNB2L1 0 1 0 1 0 1 0
SHANK3 1 0 1 0 0 1 0
We were also interested in synaptic genes common to a number of diseases. Table 8 889
shows the 32 synaptic genes linked to three or more of the diseases included in the 890
analysis. Seven genes are associated to six or all seven tested diseases. The top coverage 891
disease associated genes, found in models annotated, include the protein family 892
voltage-dependent calcium channel family CACNA1C and CACNB2 and dopamine D1 893
and D2 receptors (DRD1, DRD2 ), the inotropic glutamate NMDA receptors, type 894
subunit 2A and 2B (GRIN2A, GRIN2B) as well as the glutamate metabotropic receptor 895
5 (GRM5). Of the set of modelled genes, 130 (around 50% of the total) are not 896
associated with any of the seven diseases. 897
PLOS 29/53
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/254094doi: bioRxiv preprint first posted online Jan. 28, 2018; 
In summary, the fraction of genes modelled is relatively small and might indicate 898
that it is challenging to use existing models to make disease predictions. On the other 899
hand the modelled genes can be starting points to extend models to obtain better 900
disease insights, as will be considered later (Approaches to including non-modelled 901
disease genes in models). 902
Family trees of entities 903
Our identification of entities in models makes it possible to query in which models a 904
particular entity is contained. The mapping of entities to genes allows querying models 905
by genes that are, or may be, modelled. It is also desirable to query models by families 906
of molecules. For example Gutierrez-Arenas et al. [18] and Nair et al. [17] include 907
PDE4A, whereas Kim et al. [30] and Oliveira et al. [28] include PDE4B in their models, 908
and Kim et al. [21] and Qi et al. [19] specify PDE4. It would be desirable to be able to 909
search for models containing any of the PDE4 subfamily of genes. 910
To enable query by class or family, we determined 29 hierarchical family trees of 911
“proteins”, “protein families” and “protein multimers” implied by the sets of genes 912
corresponding to each (Fig 10). Each “protein family” or “protein multimer” entity is 913
the parent to one or more “proteins” or “protein families”. Each child corresponds to a 914
subset of the proteins in the parent. Tree structures were generated for all “protein 915
multimers” and for “protein families” where a member of that family has been modelled 916
explicitly in at least one of our analysed models. This meant that, for example, PP1 is 917
not represented, since none of its children PPP1CA, PPP1CB and PPP1CC appear in 918
any model explicitly. Individual proteins appear only if they are part of a family or 919
multimer, and they appear in a model – thus, for example, GRIA4 and GRIN3 do not 920
appear. Proteins that do not belong to a family, e.g. PSD95 (DLG4 ), are not shown. 921
Any entity that is part of a family can be mapped to the root node of its tree. 922
Entities that do not belong to a family are implicitly their own root. This mapping of 923
“entities to entity families” (Fig 3) can be applied to the model-entity catalogue (Fig 4) 924
to give the simplified summary mapping of models to 104 family roots shown in Fig 11. 925
This facilitates comparison of entities across models trying to address the differences in 926
model detail between models. 927
Frequency of modelling 928
To give an indication of which are the frequently modelled entities and families of 929
entities, we determined the number of models in which each of the root entities in 930
Fig 12 appears (Table 9). About 50% of root entities appear only in one model. In 931
total, 26 (about 25%) of the entity roots were included in five models or more. The 932
three most frequently modelled entities and families are CaM, CaMKII and Ca, which 933
are included in 18, 22 and 23 out of 30 analysed models respectively. This is due to a 934
number of models focusing specifically on the Ca–CaM–CaMKII pathway or including it 935
as a model part, reflecting its central role in synaptic biology. These top coverage 936
families are followed by families such as PP3 and PP1, PKA and PPP1R, which are also 937
included in the models that include the phosphorylation-dephosphorylation circuit 938
(Section “Models of hippocampal synaptic signalling pathways”). Receptor related 939
families such as AMPAR appear with lower frequency, reflecting the fact that, while 940
crucial for synaptic physiology, not all models include them as a readout mechanism for 941
LTP and LTD. Even though our coverage of models is not complete, it seems likely that 942
cataloguing further models will not change the order much. 943
PLOS 30/53
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a









































































Fig 10. Family trees of “protein families” and “protein multimers”. “Proteins” are shown in italics; “protein
families” and “protein multimers” in roman. “Proteins” that do not belong to any family are not shown. Only proteins that
are specified in models are shown.
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Fig 11. Summary mapping of entities in models. The occurrence of an root
entity in a model is indicated by open circles. Lower-level entities are folded into their
root entity.
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Table 9. Numbers of entities or entity families found in models.
Entity family Models Frequency % Frequency
2AG, actin, ACTN, Adn, AKAP, AKAR3, CaMKIV, CaMKK,
cGMP, CHRM4, cortactin, CRH, CRHR, CSK, DAGL, DGK, DNM,
GKAP, GRIK2, Homer, IRSP53, KALRN, LYN, NO, NOS, PAK1,
PEBP1, PICK1, PSD93, PSD95, PTPN11, PTPRA, RAC1, RAC2,
RACK1, RAP1GAP, RHOC, RHOG, SAP102, Shank, SHC, SOS,
Spectrin, SRC, STEP, SYNGAP1
1 46 47.4
APC, CK1, FYN, GRB2, IP3R, PI3K, PIP2, PVALB, RASA1,
RASGRF, SAP97, SERCA
2 12 12.4
AA, DAG, GRIP1, Mg, Ng, RAS, VGCC 3 7 7.2
CDK5, DUSP, Glu, GTP, IP3, PLA2 4 6 6.2
DA, DRD, mGluR, NCX, PLC, PMCA 5 6 6.2
CB, NMDAR 6 2 2.1
ATP, MAP2K, MAPK, Raf 7 4 4.1
cAMP, Gabg, PKC, PP2 9 4 4.1
AC 10 1 1.0
AMPAR, PDE 12 2 2.1
PPP1R 14 1 1.0
PKA 15 1 1.0
PP1 16 1 1.0
PP3 17 1 1.0
CaM 18 1 1.0
CaMKII 22 1 1.0
Ca 23 1 1.0
“Models” is the number of models containing the entity or at least one member of the family. “Frequency” is the number of
appearances of the family or entity in the given number of models, and “% Frequnecy” is the frequency expressed as a
percentage.
Comparing models based on their entities 944
Having annotated the models with entities enabled us to compare models with each 945
other by applying a hierarchical clustering approach to the model-entity root mapping 946
(Fig 11). Ward’s 2D method, as implemented in R’s hclust function was used to give 947
the dendrogram shown in Fig 12. We also applied the clustering to the full model-entity 948
matrix (Fig 4), with similar results, though slightly less meaningful groupings. 949
In Fig 12 similar models cluster together. Three models (Byrne et al. [58], Pepke et 950
al. [20] and Stefan et al. [59]) are clustered together as they all contain the identical set 951
of entities: Ca, CaM and CaMKII. The closely related model of Zeng and Holmes [27] 952
includes CB as well, and the closely related models of Miller et al. [49] and Khan et 953
al. [32] are also centred on CaMKII. The related models of Smolen et al., 2006 [100] and 954
Smolen et al., 2012 [16] feature the MAPK pathway, in addition to CaMKII. 955
The group of models containing Li et al. [33], Graupner and Brunel [22], Mattioni 956
and Le Novère [34] and Zhabotinsky et al. [83] are all variations on the CaMKII 957
phosphorylation-dephosphorylation circuit, all adding PP1 and PP3 (calcineurin) to the 958
Ca–CaM-CaMKII pathway. All the models so far are hippocampal; Kim et al. [31] is 959
the closest related striatal model to those mentioned. The model of Sorokina et al. [23] 960
is dissimilar to other models, reflecting the large number of entities, particularly 961
scaffolding proteins, which are contained in this model but not in others. 962
The next cluster contains a sub-cluster of mostly striatal models [15, 17–19,21,30], 963
with the exception of Castellani et al. [82], which is one of the few hippocampal models 964
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Gutierrez−Arenas et al. (2014)
Nakano et al. (2010)
Nair et al. (2015)
Qi et al. (2010)
Oliveira et al. (2010)
Kim et al. (2010)
Kötter (1994)
Oliveira et al. (2012)
Castellani et al. (2005)
Kim et al. (2011)
Sorokina et al. (2011)
Zhabotinsky et al. (2006)
Mattioni and Le Novère (2013)
Graupner and Brunel (2007)
Li et al. (2012)
Smolen et al. (2006)
Smolen et al. (2012)
Castellani et al. (2001)
Hernjak et al. (2005)
Zeng and Holmes (2010)
Stefan et al. (2008)
Byrne et al. (2009)
Pepke et al. (2010)
Khan et al. (2011)
Miller et al. (2005)
Antunes and De Schutter (2012)
Antunes et al. (2016)
Bhalla and Iyengar (1999)
Kim et al. (2013)
Kuroda et al. (2001)
Fig 12. Clustering of model-entity family root matrix. Clustering as
implemented in R’s hclust function with the Ward.2D method.
to contain the AC–cAMP–PKA pathway as well as hydrolisation of cAMP to AMP by 965
PDE. The model of Bhalla and Iyengar contains these pathways and many more, 966
accounting for its loose connection with this cluster. In summary, we have shown that 967
models the entity composition can be used to the similarities between models. 968
Approaches to including non-modelled disease genes in models 969
Knowing which disease associated genes are included in models helps models with high 970
potential to explain disease impact on the synapse to be identified (“Modelled genes 971
and their overlap with disease genes”). It also allows us to identify disease associated 972
proteins which do not appear in the models we analysed. Of all disease associated genes, 973
1,248 are found in the synaptic proteome but not in any of the analysed models. 974
Table 10 shows the 32 genes that are associated with 5, 6 or all 7 diseases, and which do 975
not appear in any of the investigated models. Of these, COMT and SLC6A3 are 976
associated with all 7 diseases of interest. Since these genes are associated with all or 977
many studied diseases, they could be of interest when it comes to gaining a better 978
understanding of generic disease dysfunctions. 979
Supporting the idea that genes implicated in many diseases could be potentially 980
targets for modelling, we identified two genes, COMT and MAOA, that have been 981
included in metabolic models [137,138]. Functionally, the catechol O-methyltransferase 982
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(COMT ) degrades catechols, such as dopamine, by catalysing their methylation. This 983
methylation results in one of the major degradative pathways of the catecholamine 984
transmitters [139]. Dopamine is included in a number of analysed models [140, 141], and 985
it could be possible to explore what happens in these models if there is an excess of 986
dopamine due to COMT malfunction. 987
Table 10. Disease associated genes not appearing in any of the annotated models.










COMT, SLC6A3 1 1 1 1 1 1 1
GIGYF2 1 0 1 1 1 1 1
GSK3B, ABCB1 1 1 0 1 1 1 1
ANK3, ENO1, KIF5C, MAOA, PRNP,
SLC17A6, CSMD1
1 1 1 1 1 0 1
ACE, GAD1 0 1 1 1 1 1 0
DDC, FMR1 1 0 1 1 0 1 1
APAF1, DFNA5, ELAVL2, GRIK1, HINT1,
ITIH1, ITIH3, ITIH4, STT3A, LIG4, ND-
UFAB1, NDUFB7, NPY, NTRK3, GATB,
SMARCA2, MAD1L1, PRPF3, SH3PXD2A,
TRANK1, PPIF, NT5C2, KIF21B, RPRD2,
SYNE1, NGEF, TENM4, GNL3, MPP6,
MRPS21, RAB39A, CNNM2, OXR1, ANKS1B,
VARS2, AS3MT, PALB2, DCTN5, PPP1R21,
MTPN, SLC39A12, CHSY3
1 0 1 1 1 0 1
CNR1 1 1 0 0 1 1 1
YWHAZ 1 1 1 0 0 1 1
SNAP25 1 1 1 0 1 0 1
CNTNAP2 1 1 1 1 0 0 1
The table only lists genes that are associated to four or more diseases.
Genes associated will all studied diseases could represent generic disease mechanisms, 988
in which case exploring the role of COMT in dopaminergic models would indicate the 989
possible influence of the gene in many diseases. An alternative approach is to consider 990
disease specific genes not appearing in models and associated to only one of the selected 991
diseases. Integrating such proteins into pre-existing models could thus help to gain 992
disease-specific insights. 824 of the disease associated genes are specific to one disease 993
only. To identify genes that can be integrated into existing models, the list of 994
non-modelled disease associated genes was compared with genes in pathways enriched 995
amongst the modelled genes. 996
For example, all disease genes unique to Schizophrenia were compared with the list 997
of genes in pathways significantly enriched amongst the modelled genes, giving a list of 998
8 genes, each of which is found in one or more pathways (Table 11). One of these genes 999
is LAMTOR2. The LAMTOR2:LAMTOR3 complex binds MAPK components [142], 1000
together with other members of the MAPK2 and MAPK activation pathway, such as 1001
RAF1, MAPK1, MAPK3 and MAP2K2. In this role it contributes to the activation of 1002
the MAPK pathway which has a central role in striatal and cerebellar synapses. 1003
Including the influence of LAMTOR2 on the activity of MAPK in a pre-existing model 1004
could hence help to better understand its role and links to and effects on schizophrenia. 1005
Integrating LAMTOR2 activity in the model could be done mechanistically, or 1006
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Table 11. Schizophrenia specific genes not found in models and appearing in pathways that are enriched in
annotated models.
Gene Name Gene Name (long) REACTOME pathway Pathway ID





MAP2K and MAPK activation, FCERI
mediated MAPK activation, VEGFR2 me-






PSMB1 proteasome subunit beta
1
FCERI mediated MAPK activation,





PSMB4 proteasome subunit beta
4
FCERI mediated MAPK activation,





PSMC1 proteasome 26S subunit
and ATPase 1
FCERI mediated MAPK activation,





PSMC4 proteasome 26S subunit
and ATPase 4
FCERI mediated MAPK activation,





PSMD2 proteasome 26S subunit
and non-ATPase 2 and
FCERI mediated MAPK activation,





TUBB3 tubulin beta 3 class III Chaperonin-mediated protein folding R-HSA-390466
functionally, for example by influencing the MAPK concentration. 1007
Discussion 1008
We have developed a catalogue of genes whose corresponding proteins correspond to 1009
entities in computational models of synaptic plasticity. To achieve this we developed a 1010
new set of standard identifiers for entities in computational models, and mapped those 1011
entities corresponding to proteins and protein families onto genes. Although time and 1012
lack of machine-readable model descriptions constrained the number of models we could 1013
analyse, by selecting models from three brain regions (hippocampus, striatum and 1014
cerebellum) we are confident that we have covered the bulk of proteins in models. 1015
We were able to identify 294 genes that could be mapped to entities in 1016
computational models. This corresponds to 4.2% of the 6,706 known genes in the 1017
synaptic proteome. Enrichment analysis showed that, compared to the set of proteins 1018
found in the synapse, the genes in models tended to have more signalling functions, 1019
which reflects the focus on signalling pathways in such models. This suggests 1020
considerable scope for including new molecules in models. However, models of synapses 1021
at the molecular level are already complex and are beset by problems of determining 1022
parameters. One strategy to prioritise molecules to add to models is to add those most 1023
relevant for disease. Our comparison of the list of genes in models with databases of 1024
gene-disease association shows that many disease-associated genes are not currently 1025
included in synaptic models, and suggests targets for future modelling. 1026
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Targeting disease-relevant proteins for modelling 1027
The genes in models are more associated with neurological diseases, such as 1028
Schizophrenia, Alzheimer’s, Huntington’s disease and bipolar disorder, than randomly 1029
selected genes in the synaptic proteome or the whole genome. Nevertheless, depending 1030
on the disease, the number of disease-associated genes included in models range between 1031
6% and 12% of the disease-associated genes in the synapse. This suggests that there is 1032
considerable potential to include disease-related genes in models. Including these 1033
molecules could make these models more useful in helping elucidate disease mechanisms 1034
and helping to identify new drug targets. 1035
We identified two un-modelled genes associated with 7 neurological diseases, COMT 1036
and MAOA and we found they have close functional links with existing models. By 1037
incorporating pathway enrichment results, we identified LAMTOR, a gene uniquely 1038
associated with Schizophrenia. LAMTOR is linked to the MAP kinase pathway, which 1039
features in a number of existing models. This demonstrates the utility of our approach 1040
for identifying which proteins to incorporate in existing models so that they can make 1041
disease-associated predictions. Further investigation using this approach could indicate 1042
other target proteins to add to existing synaptic pathway models to make them more 1043
informative about the influence of diseases on the synapse. 1044
A new ontology for computational neuroscience models 1045
The challenge we faced mapping model entities to genes highlighted a gap between 1046
bioinformatics, where each gene is well-defined and has a commonly used identifier, and 1047
computational neuroscience, where the elements of models are defined at varying levels 1048
of precision: for example they may be proteins, protein families or multimers of proteins. 1049
Even within the same model, one element may be specified precisely, for example a 1050
particular isoform (PKMζ), and another element may be generic, for example 1051
“plasticity related proteins” [16]. From a bioinformatics perspective this may seem 1052
offensive, but from the viewpoint of computational neuroscience it is entirely valid: a 1053
computational model can be seen as a means to reasoning about a hypothesis; the 1054
formulation of the model is the hypothesis and the simulations embody the reasoning 1055
that generates the predictions arising from the hypothesis [143]. The modelling process 1056
sometimes even requires hypothetical elements, which have no existing identifier. For 1057
example, one seminal computational neuroscience model [144] contained hypothetical 1058
elements (“gating particles”) that predicted essential features of ion channels function. 1059
The problem of mapping model constituents onto biological entities was noted by the 1060
originators of the MIRIAM standard [118]. This standard suggests solving the problem 1061
of mapping entities at different levels of abstraction by using a “HasVersion” qualifier to 1062
map reactants in models to multiple entities, e.g. to map IP3R to Inositol 1063
1,4,5-triphosphate receoptors type 1, 2 and 3. Most of the models we investigated had 1064
not been annotated to MIRIAM standards, and we found it more efficient to define our 1065
own ontology containing proteins and protein families. We found that existing 1066
ontologies such as UniProt, HGNC gene families [145] and Neurolex [146] were not 1067
extensive enough to map proteins specified at different levels of precision (e.g. PDE4A, 1068
PDE4) to common families (e.g. PDE), though HGNC gene families covered about half 1069
of the protein families we identified. 1070
In the absence of a suitable ontology, we used HGNC gene families and curated other 1071
family relationships manually to give a full list of entities (Supporting Information 1072
Tables S1) and mappings of proteins to families and multimers in which they occur 1073
(Supporting Information Tables S3, S4). These tables form the kernel of an ontology, 1074
and we have demonstrated that it can be used to determine the potential genes 1075
underlying the proteins in computational models, and to cross-link these genes with 1076
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expression data. Furthermore, we have demonstrated that the ontology can be used to 1077
compare models, for example using hierarchical clustering, and to summarise of how 1078
often various protein families have been modelled. By annotating models with 1079
identifiers of brain region or neuron type, the set of possible proteins belonging to a 1080
model could be narrowed down according to the genes that are expressed in a given 1081
region. The same procedure could be used to link the genetic content of synaptic 1082
models with other types of data, for example spatial expression data from the Allen 1083
Brain atlas. This would make it possible to check that a particular model was valid in 1084
the brain region it is supposed to represent, or, conversely, could be used to find brain 1085
regions for which a particular model might be valid. 1086
The number of models analysed in this paper was limited by the time it took us to 1087
annotate models we had not constructed. While some repositories, such as the curated 1088
branch of BioModels, enforce curation of models to MIRIAM standards [118], it would 1089
be desirable for all models to be annotated consistently at the time of publication or 1090
deposition in a repository. Annotation would be a fairly quick process for authors 1091
familiar with the models, and the quality of the information would be higher than if 1092
annotated by third parties. Three of the 30 models we investigated were annotated to 1093
MIRIAM standards. We did not use the MIRIAM annotations of these models, partly so 1094
that our annotation of models was consistent and partly because the MIRIAM standard 1095
suggests mapping to external identifiers that are often at a finer level of granularity 1096
than we needed to compare models to proteomic data. Were more models curated to 1097
MIRIAM standards, it would be worthwhile developing a mapping to our identifiers. 1098
As discussed above, some models are of necessity not precise about which protein is 1099
specified. To address this, one option would be for the computational neuroscience and 1100
bioinformatics communities to adopt an ontology along the lines of the ones we have 1101
generated here. If the ontology were stored in the Interlex dynamic lexicon of 1102
biomedical terms, a development of Neurolex [146], it would be straightforward for 1103
authors to suggest new terms or relationships. The model metadata could be stored by 1104
adding fields to existing repository schema, or our data could be converted to a 1105
standalone, API-enabled database. 1106
Nomenclature 1107
The nomenclature we have used for entities has been decided by the authors. We have 1108
been guided by gene names, and some of our choices might be controversial, for example 1109
naming PP2B (calcineurin) PP3. Our rationale for using identifiers related to gene 1110
names is so there is more consistency between the names of members in a family. For 1111
example, in Fig 10, PP3 is the parent of the catalytic and regulatory subunits PPP3C 1112
and PPP3R; having PP2B as a parent would not be equally consistent. It would be 1113
desirable for the computational neuroscience and bioinformatics communities to agree a 1114
common nomenclature. 1115
New directions in modelling 1116
We have demonstrated the potential of our method of identifying entities in models and 1117
mapping them to genes to suggest new, disease-relevant directions for modelling. We 1118
believe there is considerable potential for the work to be adopted to suit the needs of 1119
the community. Our files are available (S1 File) and suggestions for additions or 1120
amendments are welcome. [We will also be making our files available via github.] 1121
More speculatively, despite the challenge of expanding the number and relevant 1122
proteins in models of synaptic plasticity, we believe that the time has come to 1123
incrementally increase the number of proteins involved in models, especially those 1124
involved in disease mechanisms. 1125
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Methods 1126
Identifying entities in models 1127
The question of what entities mean is outlined in “Analysis of proteins in synaptic 1128
models”, subection “Identifying entities in models”. The constituent entities of each 1129
model were identified by one of the authors (EMW, KFH or DCS) reading the paper, or 1130
extracting elements from a machine-readable representation of the model, for example 1131
CellML or Kappa descriptions in the cases of Bhalla and Iyengar [80] and Sorokina et 1132
al. [23] respectively. The name used to identify the entity in the model was then 1133
mapped to the standardised list of entities that we built up as we looked through the 1134
models. In some cases model entities were not specified enough to allow us to map them 1135
unambiguously onto a model entity – for example “Plasticity Related Protein” [16]. We 1136
did not consider a complex as an entity – for example a Ca-CaM-CaMKII complex 1137
would give rise to Ca (ion), CaM (“protein”) and CaMKII (“protein multimer”). In 1138
naming our standard entities, we have tried to use names commonly used in models, but 1139
for entities that have not appeared in many models we have tended to use the newer 1140
standard names that appear in the NCBI or UniProt databases. 1141
Mapping entities to a unique gene identifier 1142
To obtain a common identifier for all entities we searched for an ontology that could be 1143
used to identify our entities, especially “protein families” and “protein multimers”. We 1144
considered a number of potential ontologies: 1145
The Computational Neuroscience Ontology 1146
(http://bioportal.bioontology.org/ontologies/CNO) This ontology covers 1147
the description of the modelling technique (e.g. Integrate-and-fire neurons) rather 1148
than the components of the model. 1149
HGNC Gene families (http://www.genenames.org/) The Human Gene 1150
Organisation Gene Nomenclature Committee (HGNC) approves unique symbols 1151
and names for human genes, and also places genes in families, based on 1152
characteristics such as function, homology, domains and phenotype [145]. Placing 1153
genes into families is a manual process, often involving specialists who are expert 1154
in that family of genes. Often, but not always, genes in the same family have a 1155
common root symbol. The process of defining families is ongoing. 1156
InterPro protein families (http://www.ebi.ac.uk/interpro) The InterPro 1157
Consortium is a federation amalgamating protein signature databases (Gene3D, 1158
Conserved Domain Database, HAMAP, PANTHER, Pfam, PIRSF, PRINTS, 1159
ProDom, PROSITE, SMART, SUPERFAMILY, Structure-Function Linkage 1160
Database and TIGRFAMs) [147]. Protein signatures are predictive models build 1161
on fragments of amino acid sequences that share local features (e.g. conservation 1162
at different positions) known to be associated with a function or structure [148]. 1163
There are multiple computational approaches that are detecting such patterns and 1164
define types of signatures [149]. The similarity in signature matches between 1165
proteins is used to define a hierarchy of families. 1166
Manual NCBI search (www.ncbi.nlm.nih.gov/gene/) The National Center for 1167
Biotechnology Information (NCBI) provides access to biomedical and genomic 1168
information. We used their searchable database of genes, which can be queried 1169
with a number of different identifiers. 1170
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We intended to map out entities using information supplied by one of these 1171
ontologies, but no one source proved sufficient. In InterPro, there are a number of 1172
families that correspond exactly to proteins, for example Phospholipase A2 (IPR001211) 1173
and Phosphoinositide phospholipase C (IPR001192). However, some proteins, including 1174
SOS1 and SOS2, belong to very broad families. 1175
In the HGNC database we identified a relatively large number of our entities that 1176
correspond to existing HGNC gene families. For example the HGNC Homer family 1177
(short for “Homer scaffolding proteins”) comprises the genes HOMER1, HOMER2 and 1178
HOMER3 and the genes PPP3CA, PPP3CB, PPP3CC, PPP3R1 and PPP3R2 belong 1179
to the HGNC PP3 family (short for “Calcineurin”). Other entities do not correspond to 1180
a single gene family, but can be extracted from the database by selecting multiple 1181
families. For example SHANK, by which we mean the family of proteins encoded by 1182
SHANK1, SHANK2 and SHANK3 may be selected from the gene families list by 1183
selecting all genes that are in the “Ankyrin repeat domain containing” (ANKRD) and 1184
“PDZ domain containing” (PDZ) gene families. Some of our entities cannot be recovered 1185
by searching for families. For example SOS (by which we mean the proteins encoded by 1186
SOS1 and SOS2 ) are in both the “Rho guanine nucleotide exchange factors” and 1187
“Pleckstrin homology domain containing” families, but so are 35 other proteins. 1188
We also curated our own mappings by manually querying the NCBI portal by 1189
searching for human genes matching a full protein name and a common gene prefix, 1190
suffix or infix, if available. For example, Entrez IDs for a “protein family” of 1191
Voltage-dependent calcium channel were obtained with the following query: 1192
‘Voltage-dependent calcium channel[All Fields] AND CACN*[All Fields] AND ”Homo 1193
sapiens”[Organism]’. The top 20 results were considered and only entries with the 1194
closest description and gene summary to the search term were extracted. 1195
Although we were not able to map all our entities by relying on only one ontology, 1196
we found that HGNC families covered more of our entities than Interpro, so we used 1197
this as a basis for developing an ontology to describe the molecular components of 1198
computational neuroscience models. We tried to map all entities of type “protein family” 1199
and “protein multimer” to HGNC families. Manual NCBI mappings were used to check 1200
and verify that HGNC families represented the modelled group of genes. 1201
In situations where we were unable to find a corresponding HGNC family we (1) 1202
suggested some protein groups to be added to the list of HGNC families and await 1203
approval of the request; (2) we had no choice but to fall back on our manual NCBI 1204
mapping. The combination of the above lead us to our final mappings. S3 Table and S4 1205
Table show identified HGNC families as well as the genes belonging to them. The 1206
superscript given with the HGNC family name indicates its origin, the official HGNC 1207
mapping vs. custom mapping. The columns “IN.SYNAPSE” and “OUT.SYNAPSE” 1208
are explained in Section “Comparison with proteomic data”. 1209
Enrichment Analysis 1210
A commonly used method to find statistically significant commonalities between large 1211
gene lists is enrichment analysis, also known as over-representation analysis. Based on 1212
information contained in ontological databases, enrichment analysis can show if a set of 1213
“genes of interest” contains a significantly high number of genes with the same 1214
annotation. This approach allows us to gain a better understanding of underlying 1215
common themes in our “genes in models” list. 1216
The underlying principle of such an enrichment analysis is to estimate, for each 1217
specific category annotated in the database of interest, if the number of genes in our 1218
genes of interest set associated with a certain category is larger than expected by chance. 1219
To test this relationship statistically, the hypergeometric distribution or one-tailed 1220
Fisher’s exact test is commonly applied. Both are known to be equivalent [150]. 1221
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The four key numbers required to carry out the statistical calculations are: 1222
1. The number of elements in the full dataset, also considered as the background 1223
dataset, N . In our case these are all proteins part of the synaptic proteome. 1224
2. The number of elements n in the subset of the full dataset which is tested for 1225
enrichment. This is the number of genes in the “genes in models” list. 1226
3. The number of elements associated to a certain trait in the full dataset, T . It 1227
corresponds to the set of genes annotated to any term in one of the databases, e.g. 1228
“Schizophrenia”, which describes a disease in the DO database. 1229
4. The subset of n shared by the elements found in T , denoted as t. This refers to 1230
the number of genes within a category that are also present in our “genes in 1231
models” list. 1232
The probability of encountering the exact number of hits t of interest given N , n and T 1233
is calculated with the hypergeometric probability h(t; N, n, T ): 1234












To describe the probability of finding greater than or equal to the number of items of 1235
interest t, we use the cumulative hypergeometric probability: 1236
p(t; N, n, T ) =
T�
x=t














If this probability is less than a criterion (e.g. p < 0.01), the dataset is regarded as 1237
enriched [150] for the tested category. 1238
For the analysis, ontology terms for all genes in the background dataset N were 1239
obtained. Initially two background sets were considered, containing (1) all genes in the 1240
genome and (2) all proteins found in the synapse. Since results were quite similar and 1241
the focus of this study is on the synaptic region rather than the whole organism, we 1242
only present results obtained with the second dataset as the background set of genes. 1243
We analysed all terms that had at least one gene associated to our “genes in models”. 1244
For each such term, the p-value was calculated, indicating potential enrichment, and 1245
then corrected for multiple comparison, using the Benjamini and Yekutieli [151] method. 1246
Terms with adjusted p-values smaller than 0.01 are presented in the final results. 1247
topONTO and topGO 1248
Ontologies that supply functional annotation information are organised in a hierarchical 1249
structure, with the most generic terms at the top, and the most specific ones at the 1250
bottom. The higher the term is located in the hierarchy, the more genes are associated 1251
to it as it aggregates all genes from its child terms. Hence, a single gene can be found 1252
on different levels of annotation specificity. Depending on the purpose of the analysis it 1253
is important to be able to choose the level of retrieved terms. 1254
To retrieve the most specific and refined terms among significantly enriched ones, we 1255
used an algorithm proposed by Alexa et al. [152] and implemented for the GO database 1256
by the R topGO package. Since GO is represented as a Directed Acyclic Graph (DAG), 1257
the authors incorporated the underlying GO graph topology in the term scoring 1258
approach, removing strong correlations commonly occurring between high level terms. 1259
This allows the enrichment of a very generic term to be ignored, and less frequent but 1260
more specific and potentially more interesting low level ones to be identified. 1261
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Assuming that a child term is potentially more interesting than its more generic 1262
ancestors, significance of a term is calculated depending on its child terms. Out of 1263
multiple versions implementing this idea, we used the elim algorithm paired with 1264
Fisher’s exact test. The decision was based on the clear number of comparisons 1265
conducted by the algorithm. This number was further used to correct for the false 1266
discovery rate. 1267
In the elim approach [152], enrichment analysis starts at the bottom of the ontology 1268
graph. If a child term is significantly enriched amongst the genes of interest, this 1269
influences the number of genes annotated to its ancestor terms. All genes associated to 1270
the enriched child term are removed from the ancestor terms leaving most specific ones 1271
with the minimal indicated significance. 1272
We discovered that the algorithm leads to more refined results than a set-based 1273
enrichment analysis that ignores the ontology structure. Therefore, we were interested 1274
in applying a same approach to other gene annotation sets. This can be achieved with 1275
the topOnto R package [135]. It extends the advantage of the Alexa et al. method to 1276
any hierarchically structured dataset. Since both REACTOME and DO satisfy this 1277
requirement, we were able to apply the same approach to all chosen annotation sets. 1278
Supporting information 1279
S1 File. Data and code. A zip file containing the data tables, and mapping and 1280
analysis code that will reproduce the results in this paper. 1281
S1 Table. Full list of entities. List of entities containing the ID, name, type and 1282
for proteins, mapping to gene. 1283
S2 Table. Synaptic Proteome Studies. List of synaptic proteome publications 1284
and respective datasets used in this study. 1285
S3 Table. Protein family members. List of entities in distinct protein families - 1286
“in” and “out” of the synapse. 1287
S4 Table. Protein multimer members. List of entities in distinct protein 1288
multimers - “in” and “out” of the synapse. 1289
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[323] R. Mosca, A. Céol, A. Stein, R. Olivella, and P. Aloy. 3did: a catalog of domain-based
interactions of known three-dimensional structure. Nucleic acids research, 42(Database
issue):D374–9, 2014.
[324] A. J. Bordner and A. A. Gorin. Comprehensive inventory of protein complexes in the
Protein Data Bank from consistent classification of interfaces. BMC Bioinformatics, 9:234,
2008.
[325] S. Khor. Inferring domain-domain interactions from protein-protein interactions with
formal concept analysis. PloS one, 9(2):e88943, 2014.
[326] S. Yellaboina, A. Tasneem, D. V. Zaykin, B. Raghavachari, and R. Jothi. DOMINE: a
comprehensive collection of known and predicted domain-domain interactions. Nucleic
acids research, 39(Database issue):D730–5, 2011.
[327] P. Björkholm and E. L. L. Sonnhammer. Comparative analysis and unification of do-
main–domain interaction networks. Bioinformatics, 25(22):3020–3025, 2009.
[328] Q. Luo, P. Pagel, B. Vilne, and D. Frishman. DIMA 3.0: Domain Interaction Map. Nucleic
404 Bibliography
acids research, 39(Database issue):D724–9, 2011.
[329] K. Oh and G.-S. Yi. Prediction of scaffold proteins based on protein interaction and
domain architectures. BMC Bioinformatics, 17(6):220, 2016.
[330] L.-L. Zheng, C. Li, J. Ping, Y. Zhou, Y. Li, and P. Hao. The domain landscape of virus-host
interactomes. BioMed research international, 2014:867235, 2014.
[331] B. Kholodenko, M. B. Yaffe, and W. Kolch. Computational approaches for analyzing
information flow in biological networks. Science signaling, 5(220):re1, 2012.
[332] S. Lemeer and A. J. R. Heck. The phosphoproteomics data explosion. Current opinion in
chemical biology, 13(4):414–20, 2009.
[333] A. Bensimon, A. J. R. Heck, and R. Aebersold. Mass spectrometry-based proteomics and
network biology. Annual review of biochemistry, 81:379–405, 2012.
[334] C. Choudhary and M. Mann. Decoding signalling networks by mass spectrometry-based
proteomics. Nature reviews. Molecular cell biology, 11(6):427–39, 2010.
[335] B. Trost and A. Kusalik. Computational prediction of eukaryotic phosphorylation sites.
Bioinformatics (Oxford, England), 27(21):2927–35, 2011.
[336] H. Horn, E. M. Schoof, J. Kim, X. Robin, M. L. Miller, F. Diella, A. Palma, G. Cesareni,
L. J. Jensen, and R. Linding. KinomeXplorer: an integrated platform for kinome biology
studies. Nature Methods, 11(6):603–604, 2014.
[337] R. H. Newman, J. Hu, H.-S. Rho, Z. Xie, C. Woodard, J. Neiswinger, C. Cooper, M. Shirley,
H. M. Clark, S. Hu, W. Hwang, J. S. Jeong, G. Wu, J. Lin, X. Gao, Q. Ni, R. Goel, S. Xia,
H. Ji, K. N. Dalby, M. J. Birnbaum, P. A. Cole, S. Knapp, A. G. Ryazanov, D. J. Zack,
S. Blackshaw, T. Pawson, A.-C. Gingras, S. Desiderio, A. Pandey, B. E. Turk, J. Zhang,
H. Zhu, and J. Qian. Construction of human activity-based phosphorylation networks.
Molecular systems biology, 9:655, 2013.
[338] J. Hu, H.-S. Rho, R. H. Newman, J. Zhang, H. Zhu, and J. Qian. PhosphoNetworks: a
database for human phosphorylation networks. Bioinformatics (Oxford, England), 30(1):
141–2, 2014.
[339] P. V. Hornbeck, J. M. Kornhauser, S. Tkachev, B. Zhang, E. Skrzypek, B. Murray,
V. Latham, and M. Sullivan. PhosphoSitePlus: a comprehensive resource for investi-
gating the structure and function of experimentally determined post-translational mod-
ifications in man and mouse. Nucleic Acids Research, 40(D1):D261–D270, 2012.
[340] F. Gnad, J. Gunawardena, and M. Mann. PHOSIDA 2011: the posttranslational modifi-
cation database. Nucleic Acids Research, 39(Database):D253–D260, 2011.
[341] F. Diella, S. Cameron, C. Gemünd, R. Linding, A. Via, B. Kuster, T. Sicheritz-Pontén,
N. Blom, and T. J. Gibson. Phospho.ELM: A database of experimentally verified phos-
phorylation sites in eukaryotic proteins. BMC Bioinformatics, 5(1):79, 2004.
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